<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:0115c1e9-86f7-4f3a-bbf8-8fa576938990,g:045cb729-4483-407e-827c-5a674ce6607e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/Cover" xlink:type="simple" xlink:href="cmlf-20210804.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_754b2800-9f7d-42d5-b529-036ac372bcc7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_0959a009-e24a-4d6d-9c28-3540deb4ff3b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_754b2800-9f7d-42d5-b529-036ac372bcc7" xlink:to="loc_dei_EntityRegistrantName_0959a009-e24a-4d6d-9c28-3540deb4ff3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_fee3cc8d-9193-462a-800b-4d8a2949030d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_754b2800-9f7d-42d5-b529-036ac372bcc7" xlink:to="loc_dei_EntityCentralIndexKey_fee3cc8d-9193-462a-800b-4d8a2949030d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_0738bbb9-3fcc-4b2d-8601-9c99ccb321b5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_754b2800-9f7d-42d5-b529-036ac372bcc7" xlink:to="loc_dei_AmendmentFlag_0738bbb9-3fcc-4b2d-8601-9c99ccb321b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_57e32cb9-0457-4a9f-b6ff-647d1ed89797" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_754b2800-9f7d-42d5-b529-036ac372bcc7" xlink:to="loc_dei_DocumentType_57e32cb9-0457-4a9f-b6ff-647d1ed89797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_d69601d3-3f5f-4ff5-a995-958050cbf973" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_754b2800-9f7d-42d5-b529-036ac372bcc7" xlink:to="loc_dei_EntityFilerCategory_d69601d3-3f5f-4ff5-a995-958050cbf973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_a5e88e08-bae3-4cb5-9867-734cbb960294" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_754b2800-9f7d-42d5-b529-036ac372bcc7" xlink:to="loc_dei_EntitySmallBusiness_a5e88e08-bae3-4cb5-9867-734cbb960294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_6e674553-5f88-4613-b58c-46163ff8b1b6" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_754b2800-9f7d-42d5-b529-036ac372bcc7" xlink:to="loc_dei_EntityEmergingGrowthCompany_6e674553-5f88-4613-b58c-46163ff8b1b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_5c11a81c-4a82-4178-b1a8-3bc9d93c0665" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_754b2800-9f7d-42d5-b529-036ac372bcc7" xlink:to="loc_dei_EntityExTransitionPeriod_5c11a81c-4a82-4178-b1a8-3bc9d93c0665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/BalanceSheets" xlink:type="simple" xlink:href="cmlf-20210804.xsd#BalanceSheets"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/BalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_cff17d45-4d3b-4312-825d-cb6a5091257b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ea828311-db85-4643-880e-b4ff15e425aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_cff17d45-4d3b-4312-825d-cb6a5091257b" xlink:to="loc_us-gaap_StatementTable_ea828311-db85-4643-880e-b4ff15e425aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_b9aff966-d7e3-48c7-951c-eabca513c12d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ea828311-db85-4643-880e-b4ff15e425aa" xlink:to="loc_us-gaap_StatementClassOfStockAxis_b9aff966-d7e3-48c7-951c-eabca513c12d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_e2eacf2a-dbc6-446a-91e7-ab9cbac5f395" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b9aff966-d7e3-48c7-951c-eabca513c12d" xlink:to="loc_us-gaap_ClassOfStockDomain_e2eacf2a-dbc6-446a-91e7-ab9cbac5f395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_SeriesA1RedeemableConvertiblePreferredStockMember_c82316d4-b9ed-411f-ad73-0f38c618dba1" xlink:href="cmlf-20210804.xsd#cmlf_SeriesA1RedeemableConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e2eacf2a-dbc6-446a-91e7-ab9cbac5f395" xlink:to="loc_cmlf_SeriesA1RedeemableConvertiblePreferredStockMember_c82316d4-b9ed-411f-ad73-0f38c618dba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_SeriesA2RedeemableConvertiblePreferredStockMember_2680a26f-6d75-4c8f-a7c0-3e6169b8164a" xlink:href="cmlf-20210804.xsd#cmlf_SeriesA2RedeemableConvertiblePreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e2eacf2a-dbc6-446a-91e7-ab9cbac5f395" xlink:to="loc_cmlf_SeriesA2RedeemableConvertiblePreferredStockMember_2680a26f-6d75-4c8f-a7c0-3e6169b8164a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_SeriesBRedeemableConvertiblePreferredStockMember_04a09d15-0f2c-49e3-976c-e0f5b718c95a" xlink:href="cmlf-20210804.xsd#cmlf_SeriesBRedeemableConvertiblePreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e2eacf2a-dbc6-446a-91e7-ab9cbac5f395" xlink:to="loc_cmlf_SeriesBRedeemableConvertiblePreferredStockMember_04a09d15-0f2c-49e3-976c-e0f5b718c95a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_SeriesCRedeemableConvertiblePreferredStockMember_7c539331-f13f-4418-ad08-911b8a4ef0f9" xlink:href="cmlf-20210804.xsd#cmlf_SeriesCRedeemableConvertiblePreferredStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e2eacf2a-dbc6-446a-91e7-ab9cbac5f395" xlink:to="loc_cmlf_SeriesCRedeemableConvertiblePreferredStockMember_7c539331-f13f-4418-ad08-911b8a4ef0f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_41bd2837-155f-4b47-8fbf-89cdce2d4d6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e2eacf2a-dbc6-446a-91e7-ab9cbac5f395" xlink:to="loc_us-gaap_CommonClassAMember_41bd2837-155f-4b47-8fbf-89cdce2d4d6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_349247e2-aa79-457e-8a77-347c9af54bc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e2eacf2a-dbc6-446a-91e7-ab9cbac5f395" xlink:to="loc_us-gaap_CommonClassBMember_349247e2-aa79-457e-8a77-347c9af54bc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_15716cf4-ad70-4d7a-b7da-f37ef428276e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ea828311-db85-4643-880e-b4ff15e425aa" xlink:to="loc_dei_LegalEntityAxis_15716cf4-ad70-4d7a-b7da-f37ef428276e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_403f9700-ba1b-48ba-8d64-30258896a8f5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_15716cf4-ad70-4d7a-b7da-f37ef428276e" xlink:to="loc_dei_EntityDomain_403f9700-ba1b-48ba-8d64-30258896a8f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLifeSciencesIncMember_519e0547-80d0-4e52-a9a5-6affe91a7d3c" xlink:href="cmlf-20210804.xsd#cmlf_CMLifeSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_403f9700-ba1b-48ba-8d64-30258896a8f5" xlink:to="loc_cmlf_CMLifeSciencesIncMember_519e0547-80d0-4e52-a9a5-6affe91a7d3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_0fa79bac-9e0d-4b04-9904-91342701f8b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ea828311-db85-4643-880e-b4ff15e425aa" xlink:to="loc_us-gaap_StatementLineItems_0fa79bac-9e0d-4b04-9904-91342701f8b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_40745cd0-7857-4957-8bf8-7ec1cc796b28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0fa79bac-9e0d-4b04-9904-91342701f8b7" xlink:to="loc_us-gaap_AssetsAbstract_40745cd0-7857-4957-8bf8-7ec1cc796b28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_0bef6e51-d9f0-401f-87b3-4640ef980001" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_40745cd0-7857-4957-8bf8-7ec1cc796b28" xlink:to="loc_us-gaap_AssetsCurrentAbstract_0bef6e51-d9f0-401f-87b3-4640ef980001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e950b692-b9c6-4a25-a8a0-ff6a0d59b502" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0bef6e51-d9f0-401f-87b3-4640ef980001" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e950b692-b9c6-4a25-a8a0-ff6a0d59b502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_d8cce54e-e2d4-47ac-8f07-0d262081f054" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0bef6e51-d9f0-401f-87b3-4640ef980001" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_d8cce54e-e2d4-47ac-8f07-0d262081f054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromRelatedPartiesCurrent_04a44c8f-6c86-4174-8d6f-12248eb494c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0bef6e51-d9f0-401f-87b3-4640ef980001" xlink:to="loc_us-gaap_DueFromRelatedPartiesCurrent_04a44c8f-6c86-4174-8d6f-12248eb494c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_29444549-8b3f-42d5-80a6-0368cf0079df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0bef6e51-d9f0-401f-87b3-4640ef980001" xlink:to="loc_us-gaap_InventoryNet_29444549-8b3f-42d5-80a6-0368cf0079df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_057278fc-2e64-4d68-aad7-e09a2a000352" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0bef6e51-d9f0-401f-87b3-4640ef980001" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_057278fc-2e64-4d68-aad7-e09a2a000352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_1ae1fb40-bfef-4b22-b52d-a9379340b9f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0bef6e51-d9f0-401f-87b3-4640ef980001" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_1ae1fb40-bfef-4b22-b52d-a9379340b9f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_c2ebaf55-7757-49f1-bdbe-796503df8b21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0bef6e51-d9f0-401f-87b3-4640ef980001" xlink:to="loc_us-gaap_AssetsCurrent_c2ebaf55-7757-49f1-bdbe-796503df8b21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_0bc09531-3738-49df-9375-f6ff3d83aabf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_40745cd0-7857-4957-8bf8-7ec1cc796b28" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_0bc09531-3738-49df-9375-f6ff3d83aabf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_1d903deb-f328-4bb1-8ed3-69a993734adf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_40745cd0-7857-4957-8bf8-7ec1cc796b28" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_1d903deb-f328-4bb1-8ed3-69a993734adf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_739a2ca7-1655-46e3-9226-ccabed70a822" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_40745cd0-7857-4957-8bf8-7ec1cc796b28" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_739a2ca7-1655-46e3-9226-ccabed70a822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldInTrustNoncurrent_95374914-6995-4980-904b-18ab4428a3db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsHeldInTrustNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_40745cd0-7857-4957-8bf8-7ec1cc796b28" xlink:to="loc_us-gaap_AssetsHeldInTrustNoncurrent_95374914-6995-4980-904b-18ab4428a3db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_90334e42-4dbe-48c4-ae6d-82dd57a824c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_40745cd0-7857-4957-8bf8-7ec1cc796b28" xlink:to="loc_us-gaap_Assets_90334e42-4dbe-48c4-ae6d-82dd57a824c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_82c0c91a-ff94-42e5-b790-3cb36eaec956" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0fa79bac-9e0d-4b04-9904-91342701f8b7" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_82c0c91a-ff94-42e5-b790-3cb36eaec956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_d3164ab0-3268-4a1e-806f-6d4cf22e53db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_82c0c91a-ff94-42e5-b790-3cb36eaec956" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_d3164ab0-3268-4a1e-806f-6d4cf22e53db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_619b73c9-e94b-4831-b0c9-4db789243e28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d3164ab0-3268-4a1e-806f-6d4cf22e53db" xlink:to="loc_us-gaap_AccountsPayableCurrent_619b73c9-e94b-4831-b0c9-4db789243e28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_6d9f1bfa-cfee-4d51-b66e-4ab3ee1d742c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d3164ab0-3268-4a1e-806f-6d4cf22e53db" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_6d9f1bfa-cfee-4d51-b66e-4ab3ee1d742c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_7b1a6f2e-60d5-483e-a32e-7021c33e40dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d3164ab0-3268-4a1e-806f-6d4cf22e53db" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_7b1a6f2e-60d5-483e-a32e-7021c33e40dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrent_f1771d46-c56f-4000-b6d9-f999e1d788cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d3164ab0-3268-4a1e-806f-6d4cf22e53db" xlink:to="loc_us-gaap_DueToRelatedPartiesCurrent_f1771d46-c56f-4000-b6d9-f999e1d788cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsCurrent_2f9c7e05-4bc8-4971-be57-e8e1e1d61bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d3164ab0-3268-4a1e-806f-6d4cf22e53db" xlink:to="loc_us-gaap_CapitalLeaseObligationsCurrent_2f9c7e05-4bc8-4971-be57-e8e1e1d61bbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_2244d54b-bbc1-4bae-b189-37f4ece27e6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d3164ab0-3268-4a1e-806f-6d4cf22e53db" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_2244d54b-bbc1-4bae-b189-37f4ece27e6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_233c79ce-ea92-45c0-bed9-2532657c5ea9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d3164ab0-3268-4a1e-806f-6d4cf22e53db" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_233c79ce-ea92-45c0-bed9-2532657c5ea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_6d0441b1-e98a-4f49-a509-bad6133587ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d3164ab0-3268-4a1e-806f-6d4cf22e53db" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_6d0441b1-e98a-4f49-a509-bad6133587ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_AllOtherLiabilitiesCurrent_db54ca9f-24c7-43f4-a7cc-3c9b098572d8" xlink:href="cmlf-20210804.xsd#cmlf_AllOtherLiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d3164ab0-3268-4a1e-806f-6d4cf22e53db" xlink:to="loc_cmlf_AllOtherLiabilitiesCurrent_db54ca9f-24c7-43f4-a7cc-3c9b098572d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_14b5ae8e-20bf-4881-a6a5-b85fb02b53bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d3164ab0-3268-4a1e-806f-6d4cf22e53db" xlink:to="loc_us-gaap_LiabilitiesCurrent_14b5ae8e-20bf-4881-a6a5-b85fb02b53bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_62b59acc-a9e7-44af-9042-91dc303e5171" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_82c0c91a-ff94-42e5-b790-3cb36eaec956" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_62b59acc-a9e7-44af-9042-91dc303e5171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_53ebb77d-f2a5-4f15-9c9e-d77f98e3f9be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_82c0c91a-ff94-42e5-b790-3cb36eaec956" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_53ebb77d-f2a5-4f15-9c9e-d77f98e3f9be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsNoncurrent_b7bd8b70-6576-4190-a6d4-3e6c1ea30e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLeaseObligationsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_82c0c91a-ff94-42e5-b790-3cb36eaec956" xlink:to="loc_us-gaap_CapitalLeaseObligationsNoncurrent_b7bd8b70-6576-4190-a6d4-3e6c1ea30e0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_312c3b55-16b3-4197-b226-1071c2e723a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_82c0c91a-ff94-42e5-b790-3cb36eaec956" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_312c3b55-16b3-4197-b226-1071c2e723a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_8c7613fe-d21b-4070-9a51-015925702595" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_82c0c91a-ff94-42e5-b790-3cb36eaec956" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_8c7613fe-d21b-4070-9a51-015925702595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_ecd6288f-60f0-4a50-9242-4afd11dbd76a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_82c0c91a-ff94-42e5-b790-3cb36eaec956" xlink:to="loc_us-gaap_DerivativeLiabilities_ecd6288f-60f0-4a50-9242-4afd11dbd76a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_67788551-a380-41ba-a57e-5cea0a980dff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_82c0c91a-ff94-42e5-b790-3cb36eaec956" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_67788551-a380-41ba-a57e-5cea0a980dff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent_1d432cab-1e61-4d7c-bc10-2ccd7c2852d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_82c0c91a-ff94-42e5-b790-3cb36eaec956" xlink:to="loc_us-gaap_DeferredRevenueNoncurrent_1d432cab-1e61-4d7c-bc10-2ccd7c2852d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_AllOtherLiabilitiesNoncurrent_979740b6-4694-4a2e-876c-62245c774310" xlink:href="cmlf-20210804.xsd#cmlf_AllOtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_82c0c91a-ff94-42e5-b790-3cb36eaec956" xlink:to="loc_cmlf_AllOtherLiabilitiesNoncurrent_979740b6-4694-4a2e-876c-62245c774310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_949d6967-f7b0-4c41-8457-c9ef3a3491a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_82c0c91a-ff94-42e5-b790-3cb36eaec956" xlink:to="loc_us-gaap_Liabilities_949d6967-f7b0-4c41-8457-c9ef3a3491a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_5a5b22d4-d6c0-43d6-afc3-568e3c39ac9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_82c0c91a-ff94-42e5-b790-3cb36eaec956" xlink:to="loc_us-gaap_CommitmentsAndContingencies_5a5b22d4-d6c0-43d6-afc3-568e3c39ac9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_82ef00e0-ce2c-4d4c-8cdb-1dee55fec99f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_82c0c91a-ff94-42e5-b790-3cb36eaec956" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_82ef00e0-ce2c-4d4c-8cdb-1dee55fec99f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_bea0e9b1-9140-4c8c-83c1-8e667c3fedff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_82c0c91a-ff94-42e5-b790-3cb36eaec956" xlink:to="loc_us-gaap_StockholdersEquityAbstract_bea0e9b1-9140-4c8c-83c1-8e667c3fedff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_39c947c7-cf3f-4a62-8b29-4dfe4c4dd352" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_bea0e9b1-9140-4c8c-83c1-8e667c3fedff" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_39c947c7-cf3f-4a62-8b29-4dfe4c4dd352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_b89cbb90-f580-4484-986a-2f8d5beea4f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_bea0e9b1-9140-4c8c-83c1-8e667c3fedff" xlink:to="loc_us-gaap_PreferredStockValue_b89cbb90-f580-4484-986a-2f8d5beea4f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_482a72d0-5be8-4ce1-aada-cffa5ccd56f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_bea0e9b1-9140-4c8c-83c1-8e667c3fedff" xlink:to="loc_us-gaap_CommonStockValue_482a72d0-5be8-4ce1-aada-cffa5ccd56f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CommonStockValue1_b45e105e-74b4-4fff-94c2-5f2b01549223" xlink:href="cmlf-20210804.xsd#cmlf_CommonStockValue1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_bea0e9b1-9140-4c8c-83c1-8e667c3fedff" xlink:to="loc_cmlf_CommonStockValue1_b45e105e-74b4-4fff-94c2-5f2b01549223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_2b72533f-1763-4193-a150-396be8fa4e0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_bea0e9b1-9140-4c8c-83c1-8e667c3fedff" xlink:to="loc_us-gaap_AdditionalPaidInCapital_2b72533f-1763-4193-a150-396be8fa4e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_84551eb8-d1b7-42f7-9479-c082ccbbc694" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_bea0e9b1-9140-4c8c-83c1-8e667c3fedff" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_84551eb8-d1b7-42f7-9479-c082ccbbc694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f3a64d79-7776-4ecd-82bb-46c158886b22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_bea0e9b1-9140-4c8c-83c1-8e667c3fedff" xlink:to="loc_us-gaap_StockholdersEquity_f3a64d79-7776-4ecd-82bb-46c158886b22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_5667ea80-2aec-4b6b-88f6-6ebe080e63f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_82c0c91a-ff94-42e5-b790-3cb36eaec956" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_5667ea80-2aec-4b6b-88f6-6ebe080e63f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CommonStockToPossibleRedemption_c4b46703-060a-4f63-9063-6b960635211e" xlink:href="cmlf-20210804.xsd#cmlf_CommonStockToPossibleRedemption"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0fa79bac-9e0d-4b04-9904-91342701f8b7" xlink:to="loc_cmlf_CommonStockToPossibleRedemption_c4b46703-060a-4f63-9063-6b960635211e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized_fac3f0f4-3c48-49a2-b7db-f9d437534e0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0fa79bac-9e0d-4b04-9904-91342701f8b7" xlink:to="loc_us-gaap_TemporaryEquitySharesAuthorized_fac3f0f4-3c48-49a2-b7db-f9d437534e0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/BalanceSheetsParentheticals" xlink:type="simple" xlink:href="cmlf-20210804.xsd#BalanceSheetsParentheticals"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/BalanceSheetsParentheticals" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_ab916dd2-5f1b-4228-ad81-0515d8a1def4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_0dde5a2c-9a7f-46dd-818f-8a423c3657b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ab916dd2-5f1b-4228-ad81-0515d8a1def4" xlink:to="loc_us-gaap_StatementTable_0dde5a2c-9a7f-46dd-818f-8a423c3657b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_ef5dedc0-7cb3-409a-9c27-57cbafb5ce07" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0dde5a2c-9a7f-46dd-818f-8a423c3657b9" xlink:to="loc_dei_LegalEntityAxis_ef5dedc0-7cb3-409a-9c27-57cbafb5ce07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_18ae4f99-b2ff-460b-8d3f-1a281bf1df62" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_ef5dedc0-7cb3-409a-9c27-57cbafb5ce07" xlink:to="loc_dei_EntityDomain_18ae4f99-b2ff-460b-8d3f-1a281bf1df62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLifeSciencesIncMember_18156028-229d-40df-a023-4bed07f16cfd" xlink:href="cmlf-20210804.xsd#cmlf_CMLifeSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_18ae4f99-b2ff-460b-8d3f-1a281bf1df62" xlink:to="loc_cmlf_CMLifeSciencesIncMember_18156028-229d-40df-a023-4bed07f16cfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_69403a8c-d665-4a4f-8ddb-1e9b9d64e7a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0dde5a2c-9a7f-46dd-818f-8a423c3657b9" xlink:to="loc_us-gaap_StatementClassOfStockAxis_69403a8c-d665-4a4f-8ddb-1e9b9d64e7a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a2345539-52bd-4537-abde-db329cd56ee3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_69403a8c-d665-4a4f-8ddb-1e9b9d64e7a3" xlink:to="loc_us-gaap_ClassOfStockDomain_a2345539-52bd-4537-abde-db329cd56ee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_SeriesA1RedeemableConvertiblePreferredStockMember_b81fa64e-e653-40f9-a413-adc004a31566" xlink:href="cmlf-20210804.xsd#cmlf_SeriesA1RedeemableConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_a2345539-52bd-4537-abde-db329cd56ee3" xlink:to="loc_cmlf_SeriesA1RedeemableConvertiblePreferredStockMember_b81fa64e-e653-40f9-a413-adc004a31566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_SeriesA2RedeemableConvertiblePreferredStockMember_f460d1a6-df4e-47b5-81b9-23dee96ff0f8" xlink:href="cmlf-20210804.xsd#cmlf_SeriesA2RedeemableConvertiblePreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_a2345539-52bd-4537-abde-db329cd56ee3" xlink:to="loc_cmlf_SeriesA2RedeemableConvertiblePreferredStockMember_f460d1a6-df4e-47b5-81b9-23dee96ff0f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_SeriesBRedeemableConvertiblePreferredStockMember_f4bbf49a-a06e-4333-86ce-b9c758c0e527" xlink:href="cmlf-20210804.xsd#cmlf_SeriesBRedeemableConvertiblePreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_a2345539-52bd-4537-abde-db329cd56ee3" xlink:to="loc_cmlf_SeriesBRedeemableConvertiblePreferredStockMember_f4bbf49a-a06e-4333-86ce-b9c758c0e527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_SeriesCRedeemableConvertiblePreferredStockMember_d26d21ad-5706-4935-9457-792b0201630a" xlink:href="cmlf-20210804.xsd#cmlf_SeriesCRedeemableConvertiblePreferredStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_a2345539-52bd-4537-abde-db329cd56ee3" xlink:to="loc_cmlf_SeriesCRedeemableConvertiblePreferredStockMember_d26d21ad-5706-4935-9457-792b0201630a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_ee482c6f-7f90-47a6-b1f1-f05e052768d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_a2345539-52bd-4537-abde-db329cd56ee3" xlink:to="loc_us-gaap_CommonClassAMember_ee482c6f-7f90-47a6-b1f1-f05e052768d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_e9937dbc-c5b3-4461-9953-6986f73f76a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_a2345539-52bd-4537-abde-db329cd56ee3" xlink:to="loc_us-gaap_CommonClassBMember_e9937dbc-c5b3-4461-9953-6986f73f76a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_29657c38-0281-4061-bf6c-18ee0e10b247" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0dde5a2c-9a7f-46dd-818f-8a423c3657b9" xlink:to="loc_us-gaap_StatementLineItems_29657c38-0281-4061-bf6c-18ee0e10b247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_8639d863-d836-4336-8724-fa795ef23e88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_29657c38-0281-4061-bf6c-18ee0e10b247" xlink:to="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_8639d863-d836-4336-8724-fa795ef23e88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized_85283703-a2ca-4866-b9af-83b418ed8f83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_29657c38-0281-4061-bf6c-18ee0e10b247" xlink:to="loc_us-gaap_TemporaryEquitySharesAuthorized_85283703-a2ca-4866-b9af-83b418ed8f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_3bc4a9d0-194e-4e08-ab1a-f1a3c5cc1a0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_29657c38-0281-4061-bf6c-18ee0e10b247" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_3bc4a9d0-194e-4e08-ab1a-f1a3c5cc1a0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_0c6dbd88-f815-4792-a5bb-0ac5d2a947a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_29657c38-0281-4061-bf6c-18ee0e10b247" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_0c6dbd88-f815-4792-a5bb-0ac5d2a947a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLiquidationPreference_2cda6ca7-805b-429b-84f8-9fddf3300eca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_29657c38-0281-4061-bf6c-18ee0e10b247" xlink:to="loc_us-gaap_TemporaryEquityLiquidationPreference_2cda6ca7-805b-429b-84f8-9fddf3300eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CommonStockToPossibleRedemption_d053915d-fc79-47d9-b063-78ca052beaae" xlink:href="cmlf-20210804.xsd#cmlf_CommonStockToPossibleRedemption"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_29657c38-0281-4061-bf6c-18ee0e10b247" xlink:to="loc_cmlf_CommonStockToPossibleRedemption_d053915d-fc79-47d9-b063-78ca052beaae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityRedemptionPricePerShare_6df3a40b-b3c3-4d3f-8390-1ccca519f79b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_29657c38-0281-4061-bf6c-18ee0e10b247" xlink:to="loc_us-gaap_TemporaryEquityRedemptionPricePerShare_6df3a40b-b3c3-4d3f-8390-1ccca519f79b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_94a467aa-7c7d-4ac5-bc5c-6680b65e60ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_29657c38-0281-4061-bf6c-18ee0e10b247" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_94a467aa-7c7d-4ac5-bc5c-6680b65e60ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_92599f0a-1377-41c9-9772-4cea9e3b35ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_29657c38-0281-4061-bf6c-18ee0e10b247" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_92599f0a-1377-41c9-9772-4cea9e3b35ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_906b0c09-4fc8-411e-b21e-68558549f21d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_29657c38-0281-4061-bf6c-18ee0e10b247" xlink:to="loc_us-gaap_PreferredStockSharesIssued_906b0c09-4fc8-411e-b21e-68558549f21d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_ffd8509d-5d42-4852-909a-9aa2a5ad82b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_29657c38-0281-4061-bf6c-18ee0e10b247" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_ffd8509d-5d42-4852-909a-9aa2a5ad82b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_6d59a38a-9578-4b62-9445-5df251a93191" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_29657c38-0281-4061-bf6c-18ee0e10b247" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_6d59a38a-9578-4b62-9445-5df251a93191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_f3c514ca-2721-4eef-87f3-4a49344d0501" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_29657c38-0281-4061-bf6c-18ee0e10b247" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_f3c514ca-2721-4eef-87f3-4a49344d0501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_19f634c6-d38c-4b18-8dd7-7efc5f1c2f77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_29657c38-0281-4061-bf6c-18ee0e10b247" xlink:to="loc_us-gaap_CommonStockSharesIssued_19f634c6-d38c-4b18-8dd7-7efc5f1c2f77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_ce0762a5-bab6-4f3d-9633-1dcb3ff5d2c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_29657c38-0281-4061-bf6c-18ee0e10b247" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_ce0762a5-bab6-4f3d-9633-1dcb3ff5d2c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/StatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="cmlf-20210804.xsd#StatementsofOperationsandComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/StatementsofOperationsandComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_ae5fad78-6701-4aa0-8d07-c3f1af039660" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a31716f2-8730-48ae-9c19-dd7bb457327f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ae5fad78-6701-4aa0-8d07-c3f1af039660" xlink:to="loc_us-gaap_StatementTable_a31716f2-8730-48ae-9c19-dd7bb457327f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_90917aa0-2442-4453-86ef-2a6cdf30ebab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a31716f2-8730-48ae-9c19-dd7bb457327f" xlink:to="loc_us-gaap_StatementClassOfStockAxis_90917aa0-2442-4453-86ef-2a6cdf30ebab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_3b4d15de-c436-4e77-81b1-71a66abefcc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_90917aa0-2442-4453-86ef-2a6cdf30ebab" xlink:to="loc_us-gaap_ClassOfStockDomain_3b4d15de-c436-4e77-81b1-71a66abefcc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_85499092-fec9-46fc-9169-525ac2d4274d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3b4d15de-c436-4e77-81b1-71a66abefcc2" xlink:to="loc_us-gaap_CommonClassAMember_85499092-fec9-46fc-9169-525ac2d4274d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_48bb99de-dfde-4282-bb8b-ff8afbeded8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3b4d15de-c436-4e77-81b1-71a66abefcc2" xlink:to="loc_us-gaap_CommonClassBMember_48bb99de-dfde-4282-bb8b-ff8afbeded8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ClassARedeemableCommonStockMember_4c29f1cc-6c4b-4125-a569-72601de6a7ec" xlink:href="cmlf-20210804.xsd#cmlf_ClassARedeemableCommonStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3b4d15de-c436-4e77-81b1-71a66abefcc2" xlink:to="loc_cmlf_ClassARedeemableCommonStockMember_4c29f1cc-6c4b-4125-a569-72601de6a7ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ClassBNonredeemableCommonStockMember_0ac826bb-6856-451d-b991-5f17370e908b" xlink:href="cmlf-20210804.xsd#cmlf_ClassBNonredeemableCommonStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3b4d15de-c436-4e77-81b1-71a66abefcc2" xlink:to="loc_cmlf_ClassBNonredeemableCommonStockMember_0ac826bb-6856-451d-b991-5f17370e908b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_483e134c-1315-4821-b27e-8fc23fe3c8ba" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a31716f2-8730-48ae-9c19-dd7bb457327f" xlink:to="loc_srt_ProductOrServiceAxis_483e134c-1315-4821-b27e-8fc23fe3c8ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6684adaf-6a16-4f41-8ec4-1082157ec5b9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_483e134c-1315-4821-b27e-8fc23fe3c8ba" xlink:to="loc_srt_ProductsAndServicesDomain_6684adaf-6a16-4f41-8ec4-1082157ec5b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_DiagnosticTestMember_6ee85711-e2a8-41d1-b632-e5c3619b7561" xlink:href="cmlf-20210804.xsd#cmlf_DiagnosticTestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_6684adaf-6a16-4f41-8ec4-1082157ec5b9" xlink:to="loc_cmlf_DiagnosticTestMember_6ee85711-e2a8-41d1-b632-e5c3619b7561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_9d12cb0b-83dc-42db-95ea-90b0fcb8f979" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_6684adaf-6a16-4f41-8ec4-1082157ec5b9" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_9d12cb0b-83dc-42db-95ea-90b0fcb8f979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_d886fc14-907d-4808-afce-8790b50a4e99" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a31716f2-8730-48ae-9c19-dd7bb457327f" xlink:to="loc_dei_LegalEntityAxis_d886fc14-907d-4808-afce-8790b50a4e99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_b7692136-6309-4565-a34e-2aaeda091c35" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_d886fc14-907d-4808-afce-8790b50a4e99" xlink:to="loc_dei_EntityDomain_b7692136-6309-4565-a34e-2aaeda091c35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLifeSciencesIncMember_a7f79ae9-cedb-49f6-84bf-85c88748840d" xlink:href="cmlf-20210804.xsd#cmlf_CMLifeSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_b7692136-6309-4565-a34e-2aaeda091c35" xlink:to="loc_cmlf_CMLifeSciencesIncMember_a7f79ae9-cedb-49f6-84bf-85c88748840d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_60b59e39-123d-4d07-93e6-47d935048455" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a31716f2-8730-48ae-9c19-dd7bb457327f" xlink:to="loc_us-gaap_StatementLineItems_60b59e39-123d-4d07-93e6-47d935048455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_56138cfa-af8a-40d0-9b71-c0380954b8f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_60b59e39-123d-4d07-93e6-47d935048455" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_56138cfa-af8a-40d0-9b71-c0380954b8f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_587484c8-0df3-4229-9e0c-0d75e9c102df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_60b59e39-123d-4d07-93e6-47d935048455" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_587484c8-0df3-4229-9e0c-0d75e9c102df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_7339b721-ae2a-4951-9a8c-c331cd070f87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_60b59e39-123d-4d07-93e6-47d935048455" xlink:to="loc_us-gaap_GrossProfit_7339b721-ae2a-4951-9a8c-c331cd070f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_b4625cc1-4814-41e2-ac35-1facaaa06d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_60b59e39-123d-4d07-93e6-47d935048455" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_b4625cc1-4814-41e2-ac35-1facaaa06d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_b1276b21-58f0-411d-a827-32bbdff6691b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_60b59e39-123d-4d07-93e6-47d935048455" xlink:to="loc_us-gaap_SellingAndMarketingExpense_b1276b21-58f0-411d-a827-32bbdff6691b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_e7bb9248-371a-4ad2-848c-a999608ddfec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_60b59e39-123d-4d07-93e6-47d935048455" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_e7bb9248-371a-4ad2-848c-a999608ddfec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CostsAndExpensesRelatedPartyOperatingExpensesRelatedParty_44eec340-8bab-47c3-8f5d-39274e5a23e5" xlink:href="cmlf-20210804.xsd#cmlf_CostsAndExpensesRelatedPartyOperatingExpensesRelatedParty"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_60b59e39-123d-4d07-93e6-47d935048455" xlink:to="loc_cmlf_CostsAndExpensesRelatedPartyOperatingExpensesRelatedParty_44eec340-8bab-47c3-8f5d-39274e5a23e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_cc7c31d5-758f-4d04-bfa0-1daa5c8c8305" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_60b59e39-123d-4d07-93e6-47d935048455" xlink:to="loc_us-gaap_OperatingIncomeLoss_cc7c31d5-758f-4d04-bfa0-1daa5c8c8305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAbstract_0179eefb-2d13-4a10-a983-3c4cba1f8213" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_60b59e39-123d-4d07-93e6-47d935048455" xlink:to="loc_us-gaap_OtherIncomeAbstract_0179eefb-2d13-4a10-a983-3c4cba1f8213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_935cc144-2d7e-4e97-895f-a3c3140ded3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAbstract_0179eefb-2d13-4a10-a983-3c4cba1f8213" xlink:to="loc_us-gaap_InvestmentIncomeInterest_935cc144-2d7e-4e97-895f-a3c3140ded3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_0d533966-4aec-473e-acaf-0e4b5dfdec5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAbstract_0179eefb-2d13-4a10-a983-3c4cba1f8213" xlink:to="loc_us-gaap_InterestExpense_0d533966-4aec-473e-acaf-0e4b5dfdec5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_97f3cca1-4fee-4c4c-ac10-a7a61c07bb20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAbstract_0179eefb-2d13-4a10-a983-3c4cba1f8213" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_97f3cca1-4fee-4c4c-ac10-a7a61c07bb20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_ae1693e9-c0dd-47df-a81c-1350e9af4c21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAbstract_0179eefb-2d13-4a10-a983-3c4cba1f8213" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_ae1693e9-c0dd-47df-a81c-1350e9af4c21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOther_a712d394-ad4a-4592-891b-29142a9d2e6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeOther"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAbstract_0179eefb-2d13-4a10-a983-3c4cba1f8213" xlink:to="loc_us-gaap_InterestIncomeOther_a712d394-ad4a-4592-891b-29142a9d2e6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_db69401f-301b-4e1e-9375-973197b91e2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAbstract_0179eefb-2d13-4a10-a983-3c4cba1f8213" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_db69401f-301b-4e1e-9375-973197b91e2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ChangeInFairValueOfWarrantLiability_df2171dc-c283-4379-bd62-f6081b1228db" xlink:href="cmlf-20210804.xsd#cmlf_ChangeInFairValueOfWarrantLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAbstract_0179eefb-2d13-4a10-a983-3c4cba1f8213" xlink:to="loc_cmlf_ChangeInFairValueOfWarrantLiability_df2171dc-c283-4379-bd62-f6081b1228db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_TransactionCost_665a692f-9a41-4019-8d47-3861b8d02af8" xlink:href="cmlf-20210804.xsd#cmlf_TransactionCost"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAbstract_0179eefb-2d13-4a10-a983-3c4cba1f8213" xlink:to="loc_cmlf_TransactionCost_665a692f-9a41-4019-8d47-3861b8d02af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_2b4e8db5-9e04-4d24-9c5e-85a90a229e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAbstract_0179eefb-2d13-4a10-a983-3c4cba1f8213" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_2b4e8db5-9e04-4d24-9c5e-85a90a229e3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_cd3e0aca-e6f2-403d-81dc-8f74acc30b2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_60b59e39-123d-4d07-93e6-47d935048455" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_cd3e0aca-e6f2-403d-81dc-8f74acc30b2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_8bd2d2bd-3f49-49ca-9a0c-96eb0511e575" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_60b59e39-123d-4d07-93e6-47d935048455" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_8bd2d2bd-3f49-49ca-9a0c-96eb0511e575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_8487a05e-be50-4e8c-8b07-58be8f9e7a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_60b59e39-123d-4d07-93e6-47d935048455" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_8487a05e-be50-4e8c-8b07-58be8f9e7a3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_64597013-fe72-4736-8879-9caa38d4c6e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_60b59e39-123d-4d07-93e6-47d935048455" xlink:to="loc_us-gaap_NetIncomeLoss_64597013-fe72-4736-8879-9caa38d4c6e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockDividends_0d36b0ff-f401-4e0c-a6c7-ef99ca235df6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemablePreferredStockDividends"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_60b59e39-123d-4d07-93e6-47d935048455" xlink:to="loc_us-gaap_RedeemablePreferredStockDividends_0d36b0ff-f401-4e0c-a6c7-ef99ca235df6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_d3978f49-58a8-4dd6-ac28-1675d4e9fd81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_60b59e39-123d-4d07-93e6-47d935048455" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_d3978f49-58a8-4dd6-ac28-1675d4e9fd81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_1735becf-1b14-4c8a-9a3d-24e3941bbfd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_60b59e39-123d-4d07-93e6-47d935048455" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_1735becf-1b14-4c8a-9a3d-24e3941bbfd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_61291175-35cc-4319-9920-6e3211d99a9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_60b59e39-123d-4d07-93e6-47d935048455" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_61291175-35cc-4319-9920-6e3211d99a9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_78f78a6c-a4be-46c6-a550-e28056cb909a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_60b59e39-123d-4d07-93e6-47d935048455" xlink:to="loc_us-gaap_EarningsPerShareBasic_78f78a6c-a4be-46c6-a550-e28056cb909a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_066d39be-57e0-43e2-9a6f-5c5a90a0a2f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_60b59e39-123d-4d07-93e6-47d935048455" xlink:to="loc_us-gaap_EarningsPerShareDiluted_066d39be-57e0-43e2-9a6f-5c5a90a0a2f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_WeightedAverageSharesOutstandingOfClassACommonStock_00254610-1ec1-4647-b466-e8615c42bab0" xlink:href="cmlf-20210804.xsd#cmlf_WeightedAverageSharesOutstandingOfClassACommonStock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_60b59e39-123d-4d07-93e6-47d935048455" xlink:to="loc_cmlf_WeightedAverageSharesOutstandingOfClassACommonStock_00254610-1ec1-4647-b466-e8615c42bab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_BasicAndDilutedNetIncomePerShareClassACommonStock_8beba92a-b881-4cb5-919b-d08581b476b8" xlink:href="cmlf-20210804.xsd#cmlf_BasicAndDilutedNetIncomePerShareClassACommonStock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_60b59e39-123d-4d07-93e6-47d935048455" xlink:to="loc_cmlf_BasicAndDilutedNetIncomePerShareClassACommonStock_8beba92a-b881-4cb5-919b-d08581b476b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_6c690fc0-e80b-4f7d-96c7-7b93076a54ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_60b59e39-123d-4d07-93e6-47d935048455" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_6c690fc0-e80b-4f7d-96c7-7b93076a54ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_ccfd4c66-d340-4dd1-905f-1610cdd0ced3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_60b59e39-123d-4d07-93e6-47d935048455" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_ccfd4c66-d340-4dd1-905f-1610cdd0ced3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_1e65562b-8dea-4dd9-acf5-afab32b36901" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_60b59e39-123d-4d07-93e6-47d935048455" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_1e65562b-8dea-4dd9-acf5-afab32b36901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/StatementsofOperationsandComprehensiveLossParenthetical" xlink:type="simple" xlink:href="cmlf-20210804.xsd#StatementsofOperationsandComprehensiveLossParenthetical"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/StatementsofOperationsandComprehensiveLossParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_9daff68c-3a34-44fa-ba45-9f39b4b21d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_296ecf0d-e636-407e-831d-c1d77208b8f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9daff68c-3a34-44fa-ba45-9f39b4b21d1c" xlink:to="loc_us-gaap_StatementTable_296ecf0d-e636-407e-831d-c1d77208b8f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_61d2255a-7dee-4b18-a6eb-99f0e916d5d9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_296ecf0d-e636-407e-831d-c1d77208b8f2" xlink:to="loc_srt_ProductOrServiceAxis_61d2255a-7dee-4b18-a6eb-99f0e916d5d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ac942b27-1a49-408c-85d2-1de81d38e1c8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_61d2255a-7dee-4b18-a6eb-99f0e916d5d9" xlink:to="loc_srt_ProductsAndServicesDomain_ac942b27-1a49-408c-85d2-1de81d38e1c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_DiagnosticTestMember_6d8be2fe-c707-468e-9cd7-0c2c429c653d" xlink:href="cmlf-20210804.xsd#cmlf_DiagnosticTestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ac942b27-1a49-408c-85d2-1de81d38e1c8" xlink:to="loc_cmlf_DiagnosticTestMember_6d8be2fe-c707-468e-9cd7-0c2c429c653d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_9383689c-25d7-45e0-b65c-5cd8d5412fec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ac942b27-1a49-408c-85d2-1de81d38e1c8" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_9383689c-25d7-45e0-b65c-5cd8d5412fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b46ac620-fa3d-475b-abe6-fa36a23672c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_296ecf0d-e636-407e-831d-c1d77208b8f2" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b46ac620-fa3d-475b-abe6-fa36a23672c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_a05d3bc0-2294-474d-a6f6-8df0af27eae7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b46ac620-fa3d-475b-abe6-fa36a23672c8" xlink:to="loc_us-gaap_RelatedPartyDomain_a05d3bc0-2294-474d-a6f6-8df0af27eae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_f55ed1b9-9ba4-4974-8fb8-a8c6e8a1e6f4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AffiliatedEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_a05d3bc0-2294-474d-a6f6-8df0af27eae7" xlink:to="loc_srt_AffiliatedEntityMember_f55ed1b9-9ba4-4974-8fb8-a8c6e8a1e6f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f669c93f-d467-45d1-82ab-13ea76a66947" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_296ecf0d-e636-407e-831d-c1d77208b8f2" xlink:to="loc_us-gaap_StatementLineItems_f669c93f-d467-45d1-82ab-13ea76a66947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_27c7f4da-c38c-4623-bac6-6623b1b5a771" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f669c93f-d467-45d1-82ab-13ea76a66947" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_27c7f4da-c38c-4623-bac6-6623b1b5a771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_05b2b482-3d9c-4c59-9d46-c81f733891f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f669c93f-d467-45d1-82ab-13ea76a66947" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_05b2b482-3d9c-4c59-9d46-c81f733891f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/StatementofRedeemableConvertiblePreferredStockandShareholdersDeficit" xlink:type="simple" xlink:href="cmlf-20210804.xsd#StatementofRedeemableConvertiblePreferredStockandShareholdersDeficit"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/StatementofRedeemableConvertiblePreferredStockandShareholdersDeficit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_514e2305-182b-4058-8581-a64ca4b6d2d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_54d85924-908d-4ada-842d-6a7a0269d8a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_514e2305-182b-4058-8581-a64ca4b6d2d5" xlink:to="loc_us-gaap_StatementTable_54d85924-908d-4ada-842d-6a7a0269d8a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_aff56812-eff4-465a-bdd2-3f8820c18624" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_54d85924-908d-4ada-842d-6a7a0269d8a5" xlink:to="loc_us-gaap_StatementClassOfStockAxis_aff56812-eff4-465a-bdd2-3f8820c18624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_9ee620b8-0a69-42da-816c-b3891089cb95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_aff56812-eff4-465a-bdd2-3f8820c18624" xlink:to="loc_us-gaap_ClassOfStockDomain_9ee620b8-0a69-42da-816c-b3891089cb95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_52bbe43d-04ea-4fb6-b0f3-f6a37fecdb62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_9ee620b8-0a69-42da-816c-b3891089cb95" xlink:to="loc_us-gaap_CommonClassAMember_52bbe43d-04ea-4fb6-b0f3-f6a37fecdb62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_fec0d6fa-98c7-44e8-9f20-97f7d19cccff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_9ee620b8-0a69-42da-816c-b3891089cb95" xlink:to="loc_us-gaap_CommonClassBMember_fec0d6fa-98c7-44e8-9f20-97f7d19cccff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_7342136a-af0b-4861-9c2f-b84b2cf6596b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_54d85924-908d-4ada-842d-6a7a0269d8a5" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_7342136a-af0b-4861-9c2f-b84b2cf6596b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8c02cceb-6b8c-4d97-803c-4f8c3f1477b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7342136a-af0b-4861-9c2f-b84b2cf6596b" xlink:to="loc_us-gaap_EquityComponentDomain_8c02cceb-6b8c-4d97-803c-4f8c3f1477b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_19c053a9-9701-42c7-b5f8-9755c76d9d27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8c02cceb-6b8c-4d97-803c-4f8c3f1477b5" xlink:to="loc_us-gaap_CommonStockMember_19c053a9-9701-42c7-b5f8-9755c76d9d27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_65e017c2-de0b-42b8-bbd1-e9bda565583f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8c02cceb-6b8c-4d97-803c-4f8c3f1477b5" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_65e017c2-de0b-42b8-bbd1-e9bda565583f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_210e8e96-6c0c-4a3b-9a65-efbc554bf269" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8c02cceb-6b8c-4d97-803c-4f8c3f1477b5" xlink:to="loc_us-gaap_RetainedEarningsMember_210e8e96-6c0c-4a3b-9a65-efbc554bf269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_f6828584-661a-4f1a-a8fc-4586585663dc" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_54d85924-908d-4ada-842d-6a7a0269d8a5" xlink:to="loc_dei_LegalEntityAxis_f6828584-661a-4f1a-a8fc-4586585663dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_90f3a523-f203-400d-9195-4daae166b568" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_f6828584-661a-4f1a-a8fc-4586585663dc" xlink:to="loc_dei_EntityDomain_90f3a523-f203-400d-9195-4daae166b568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLifeSciencesIncMember_5bdaa97c-b53c-4d4f-98c7-5bf4ba5e334f" xlink:href="cmlf-20210804.xsd#cmlf_CMLifeSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_90f3a523-f203-400d-9195-4daae166b568" xlink:to="loc_cmlf_CMLifeSciencesIncMember_5bdaa97c-b53c-4d4f-98c7-5bf4ba5e334f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_7fb19d72-9cfa-4224-a1d0-ca497a60493e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_54d85924-908d-4ada-842d-6a7a0269d8a5" xlink:to="loc_us-gaap_StatementLineItems_7fb19d72-9cfa-4224-a1d0-ca497a60493e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_07de0056-47d8-4d5b-8f4b-4c8d329744f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7fb19d72-9cfa-4224-a1d0-ca497a60493e" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_07de0056-47d8-4d5b-8f4b-4c8d329744f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_e77633e7-8039-40a4-ba96-409124283586" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_07de0056-47d8-4d5b-8f4b-4c8d329744f1" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_e77633e7-8039-40a4-ba96-409124283586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_3dc7be45-1974-46fc-8d02-27ae0d4e268d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_07de0056-47d8-4d5b-8f4b-4c8d329744f1" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_3dc7be45-1974-46fc-8d02-27ae0d4e268d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_TemporaryEquityStockDividendsShares_ade506ce-ba16-4d87-bdd5-0218f0fdfa8e" xlink:href="cmlf-20210804.xsd#cmlf_TemporaryEquityStockDividendsShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_07de0056-47d8-4d5b-8f4b-4c8d329744f1" xlink:to="loc_cmlf_TemporaryEquityStockDividendsShares_ade506ce-ba16-4d87-bdd5-0218f0fdfa8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_TemporaryEquityStockIssuedDuringPeriodValueStockDividend_acdbcf43-51a2-4899-bc77-b5c0bfdddadb" xlink:href="cmlf-20210804.xsd#cmlf_TemporaryEquityStockIssuedDuringPeriodValueStockDividend"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_07de0056-47d8-4d5b-8f4b-4c8d329744f1" xlink:to="loc_cmlf_TemporaryEquityStockIssuedDuringPeriodValueStockDividend_acdbcf43-51a2-4899-bc77-b5c0bfdddadb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_TemporaryEquityCapitalContribution_a3e38db7-dd97-457c-b773-8edeaba59564" xlink:href="cmlf-20210804.xsd#cmlf_TemporaryEquityCapitalContribution"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_07de0056-47d8-4d5b-8f4b-4c8d329744f1" xlink:to="loc_cmlf_TemporaryEquityCapitalContribution_a3e38db7-dd97-457c-b773-8edeaba59564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_9fbfe02c-bb0c-4072-bdf3-b3fd10f7fccc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_07de0056-47d8-4d5b-8f4b-4c8d329744f1" xlink:to="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_9fbfe02c-bb0c-4072-bdf3-b3fd10f7fccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_4d8c01c8-264a-429b-8bbc-becb9bf46641" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_07de0056-47d8-4d5b-8f4b-4c8d329744f1" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_4d8c01c8-264a-429b-8bbc-becb9bf46641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_93fe2439-1571-4b80-af61-2f30ce66bcdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_07de0056-47d8-4d5b-8f4b-4c8d329744f1" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_93fe2439-1571-4b80-af61-2f30ce66bcdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d98ee83e-c347-41c6-b585-09651cb8bb30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7fb19d72-9cfa-4224-a1d0-ca497a60493e" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d98ee83e-c347-41c6-b585-09651cb8bb30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_1a652953-47f4-4e83-bc80-92bc92d5300d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d98ee83e-c347-41c6-b585-09651cb8bb30" xlink:to="loc_us-gaap_SharesOutstanding_1a652953-47f4-4e83-bc80-92bc92d5300d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1ce2a3e2-4794-4cb8-893c-d8ef50c0a7ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d98ee83e-c347-41c6-b585-09651cb8bb30" xlink:to="loc_us-gaap_StockholdersEquity_1ce2a3e2-4794-4cb8-893c-d8ef50c0a7ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e8ea8148-5f77-43da-8e11-4be772fe253f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d98ee83e-c347-41c6-b585-09651cb8bb30" xlink:to="loc_us-gaap_NetIncomeLoss_e8ea8148-5f77-43da-8e11-4be772fe253f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseInCarryingAmountOfRedeemablePreferredStock_6badf710-8dc1-48a6-9422-3386c5d484de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseInCarryingAmountOfRedeemablePreferredStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d98ee83e-c347-41c6-b585-09651cb8bb30" xlink:to="loc_us-gaap_IncreaseInCarryingAmountOfRedeemablePreferredStock_6badf710-8dc1-48a6-9422-3386c5d484de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6c7d6192-fe3d-4de9-9d63-4b37fd967520" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d98ee83e-c347-41c6-b585-09651cb8bb30" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6c7d6192-fe3d-4de9-9d63-4b37fd967520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_6ee491fb-fa56-4f57-8e02-51c92335ef33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d98ee83e-c347-41c6-b585-09651cb8bb30" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_6ee491fb-fa56-4f57-8e02-51c92335ef33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_SalesOfNetOfUnderwritingDiscountsinShares_1a5dfc1a-b30d-4a87-a188-99d9395e1217" xlink:href="cmlf-20210804.xsd#cmlf_SalesOfNetOfUnderwritingDiscountsinShares"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d98ee83e-c347-41c6-b585-09651cb8bb30" xlink:to="loc_cmlf_SalesOfNetOfUnderwritingDiscountsinShares_1a5dfc1a-b30d-4a87-a188-99d9395e1217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_SaleNetOfUnderwritingDiscounts_7b62e8bc-b2ae-4caf-b1de-11f645fb884c" xlink:href="cmlf-20210804.xsd#cmlf_SaleNetOfUnderwritingDiscounts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d98ee83e-c347-41c6-b585-09651cb8bb30" xlink:to="loc_cmlf_SaleNetOfUnderwritingDiscounts_7b62e8bc-b2ae-4caf-b1de-11f645fb884c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRedeemedOrCalledDuringPeriodShares_288c3da6-7990-495e-9309-f8b9e9f8afd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d98ee83e-c347-41c6-b585-09651cb8bb30" xlink:to="loc_us-gaap_StockRedeemedOrCalledDuringPeriodShares_288c3da6-7990-495e-9309-f8b9e9f8afd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRedeemedOrCalledDuringPeriodValue_caa3248f-f6d0-47cc-ae4f-109f75b41f26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d98ee83e-c347-41c6-b585-09651cb8bb30" xlink:to="loc_us-gaap_StockRedeemedOrCalledDuringPeriodValue_caa3248f-f6d0-47cc-ae4f-109f75b41f26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_1b2f7255-49f1-4cf0-ad8b-71bef723c158" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d98ee83e-c347-41c6-b585-09651cb8bb30" xlink:to="loc_us-gaap_SharesOutstanding_1b2f7255-49f1-4cf0-ad8b-71bef723c158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a15d25b9-3420-4a73-b2ff-ec040100be7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d98ee83e-c347-41c6-b585-09651cb8bb30" xlink:to="loc_us-gaap_StockholdersEquity_a15d25b9-3420-4a73-b2ff-ec040100be7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e613b6ba-9576-4b20-be2d-1ea51c71896f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d98ee83e-c347-41c6-b585-09651cb8bb30" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e613b6ba-9576-4b20-be2d-1ea51c71896f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/StatementofRedeemableConvertiblePreferredStockandShareholdersDeficitParenthetical" xlink:type="simple" xlink:href="cmlf-20210804.xsd#StatementofRedeemableConvertiblePreferredStockandShareholdersDeficitParenthetical"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/StatementofRedeemableConvertiblePreferredStockandShareholdersDeficitParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_54719633-0151-46c5-9013-a99931499f07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_44918dd4-a259-4401-bf33-614de01c1f01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_54719633-0151-46c5-9013-a99931499f07" xlink:to="loc_us-gaap_StatementTable_44918dd4-a259-4401-bf33-614de01c1f01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_6c6a63c7-124e-4c7d-aa8e-dbdd356308cd" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_44918dd4-a259-4401-bf33-614de01c1f01" xlink:to="loc_dei_LegalEntityAxis_6c6a63c7-124e-4c7d-aa8e-dbdd356308cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_93ac13ac-ad16-49d3-b9dd-ebc7f336f0bf" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_6c6a63c7-124e-4c7d-aa8e-dbdd356308cd" xlink:to="loc_dei_EntityDomain_93ac13ac-ad16-49d3-b9dd-ebc7f336f0bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLifeSciencesIncMember_4de10696-4188-40bb-ad1e-f796dbf533c0" xlink:href="cmlf-20210804.xsd#cmlf_CMLifeSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_93ac13ac-ad16-49d3-b9dd-ebc7f336f0bf" xlink:to="loc_cmlf_CMLifeSciencesIncMember_4de10696-4188-40bb-ad1e-f796dbf533c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_389edbf3-8550-4972-b87e-765d109dadae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_44918dd4-a259-4401-bf33-614de01c1f01" xlink:to="loc_us-gaap_StatementLineItems_389edbf3-8550-4972-b87e-765d109dadae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_SaleOfUnderwritingDiscounts_38d6c7e7-b642-4bf9-a87a-e81433a6d1e6" xlink:href="cmlf-20210804.xsd#cmlf_SaleOfUnderwritingDiscounts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_389edbf3-8550-4972-b87e-765d109dadae" xlink:to="loc_cmlf_SaleOfUnderwritingDiscounts_38d6c7e7-b642-4bf9-a87a-e81433a6d1e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/StatementofCashFlowsStatement" xlink:type="simple" xlink:href="cmlf-20210804.xsd#StatementofCashFlowsStatement"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/StatementofCashFlowsStatement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_bc00d4d3-cd42-488d-820d-ff6012d41daf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_6e5dfb69-bf19-4312-9d10-e4593769d2f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_bc00d4d3-cd42-488d-820d-ff6012d41daf" xlink:to="loc_us-gaap_StatementTable_6e5dfb69-bf19-4312-9d10-e4593769d2f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_c0e8db8e-880f-46cb-bd08-2b6b538341df" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6e5dfb69-bf19-4312-9d10-e4593769d2f6" xlink:to="loc_dei_LegalEntityAxis_c0e8db8e-880f-46cb-bd08-2b6b538341df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_f917b831-1ecc-4380-b81a-0bd2e6b11828" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_c0e8db8e-880f-46cb-bd08-2b6b538341df" xlink:to="loc_dei_EntityDomain_f917b831-1ecc-4380-b81a-0bd2e6b11828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLifeSciencesIncMember_66e77adc-77ae-49f9-b5c0-b096e5762c02" xlink:href="cmlf-20210804.xsd#cmlf_CMLifeSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_f917b831-1ecc-4380-b81a-0bd2e6b11828" xlink:to="loc_cmlf_CMLifeSciencesIncMember_66e77adc-77ae-49f9-b5c0-b096e5762c02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_219ac2e8-0336-4188-8e0d-df7cb77f39bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6e5dfb69-bf19-4312-9d10-e4593769d2f6" xlink:to="loc_us-gaap_StatementClassOfStockAxis_219ac2e8-0336-4188-8e0d-df7cb77f39bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_79419084-8be3-4787-9605-c48baaf8923e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_219ac2e8-0336-4188-8e0d-df7cb77f39bb" xlink:to="loc_us-gaap_ClassOfStockDomain_79419084-8be3-4787-9605-c48baaf8923e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_SeriesBRedeemableConvertiblePreferredStockMember_b44cf00e-3ddb-46c2-b879-fdbabe6f8776" xlink:href="cmlf-20210804.xsd#cmlf_SeriesBRedeemableConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_79419084-8be3-4787-9605-c48baaf8923e" xlink:to="loc_cmlf_SeriesBRedeemableConvertiblePreferredStockMember_b44cf00e-3ddb-46c2-b879-fdbabe6f8776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_SeriesCRedeemableConvertiblePreferredStockMember_b3d6e4f8-ebf7-4cbd-ac5b-a26e64f5351b" xlink:href="cmlf-20210804.xsd#cmlf_SeriesCRedeemableConvertiblePreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_79419084-8be3-4787-9605-c48baaf8923e" xlink:to="loc_cmlf_SeriesCRedeemableConvertiblePreferredStockMember_b3d6e4f8-ebf7-4cbd-ac5b-a26e64f5351b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_20660398-4a55-4778-a7e9-f3628ca83c98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6e5dfb69-bf19-4312-9d10-e4593769d2f6" xlink:to="loc_us-gaap_StatementLineItems_20660398-4a55-4778-a7e9-f3628ca83c98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_626d62fc-c3fe-4e8b-9253-ceef6e1f6009" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_20660398-4a55-4778-a7e9-f3628ca83c98" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_626d62fc-c3fe-4e8b-9253-ceef6e1f6009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7d53a588-4d7c-4d49-b6d9-881f6e7dee38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_626d62fc-c3fe-4e8b-9253-ceef6e1f6009" xlink:to="loc_us-gaap_NetIncomeLoss_7d53a588-4d7c-4d49-b6d9-881f6e7dee38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a30ec718-f93a-49e6-b001-176a1e0e8587" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_626d62fc-c3fe-4e8b-9253-ceef6e1f6009" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a30ec718-f93a-49e6-b001-176a1e0e8587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_bf1e6b48-8254-407a-85e0-d502c718272d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a30ec718-f93a-49e6-b001-176a1e0e8587" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_bf1e6b48-8254-407a-85e0-d502c718272d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_da002c22-4f83-4491-ab02-e2cb2c22ac99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a30ec718-f93a-49e6-b001-176a1e0e8587" xlink:to="loc_us-gaap_ShareBasedCompensation_da002c22-4f83-4491-ab02-e2cb2c22ac99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_e460f084-c384-447f-9560-347348cb3de2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a30ec718-f93a-49e6-b001-176a1e0e8587" xlink:to="loc_us-gaap_InventoryWriteDown_e460f084-c384-447f-9560-347348cb3de2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_NoncashLeaseExpense_ef084985-fe30-4a46-9dd3-f03a07e3cd6b" xlink:href="cmlf-20210804.xsd#cmlf_NoncashLeaseExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a30ec718-f93a-49e6-b001-176a1e0e8587" xlink:to="loc_cmlf_NoncashLeaseExpense_ef084985-fe30-4a46-9dd3-f03a07e3cd6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_48e989a5-91c7-4fbf-8a76-20c33d245752" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a30ec718-f93a-49e6-b001-176a1e0e8587" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_48e989a5-91c7-4fbf-8a76-20c33d245752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_2fb2e0e4-f7e4-4643-85a9-d377a7701b30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a30ec718-f93a-49e6-b001-176a1e0e8587" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_2fb2e0e4-f7e4-4643-85a9-d377a7701b30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_297fdf36-ff85-4316-afe8-99d6b12e4d22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a30ec718-f93a-49e6-b001-176a1e0e8587" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_297fdf36-ff85-4316-afe8-99d6b12e4d22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_a324ffca-e78b-4319-8c9d-19ab955e929b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a30ec718-f93a-49e6-b001-176a1e0e8587" xlink:to="loc_us-gaap_InvestmentIncomeInterest_a324ffca-e78b-4319-8c9d-19ab955e929b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_TransactionCosts_4c0e2fde-8871-46ee-8729-d420c1badadd" xlink:href="cmlf-20210804.xsd#cmlf_TransactionCosts"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a30ec718-f93a-49e6-b001-176a1e0e8587" xlink:to="loc_cmlf_TransactionCosts_4c0e2fde-8871-46ee-8729-d420c1badadd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_b5743578-9b03-4bc1-86e2-94e14c1865b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_626d62fc-c3fe-4e8b-9253-ceef6e1f6009" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_b5743578-9b03-4bc1-86e2-94e14c1865b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_7b464a46-44e6-44b9-8727-d368bace5183" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_b5743578-9b03-4bc1-86e2-94e14c1865b0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_7b464a46-44e6-44b9-8727-d368bace5183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_be8e3e96-bd28-4fc2-af58-978ab82f6108" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_b5743578-9b03-4bc1-86e2-94e14c1865b0" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_be8e3e96-bd28-4fc2-af58-978ab82f6108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_982c8390-a860-4d0c-822e-682ea501748a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_b5743578-9b03-4bc1-86e2-94e14c1865b0" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_982c8390-a860-4d0c-822e-682ea501748a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_IncreaseDecreaseInDueToFromRelatedParties_ac7d8e28-b040-42bb-b1ba-e77dac05268f" xlink:href="cmlf-20210804.xsd#cmlf_IncreaseDecreaseInDueToFromRelatedParties"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_b5743578-9b03-4bc1-86e2-94e14c1865b0" xlink:to="loc_cmlf_IncreaseDecreaseInDueToFromRelatedParties_ac7d8e28-b040-42bb-b1ba-e77dac05268f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_67e9d0d7-913b-4108-b588-de3fd8fe8a6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_b5743578-9b03-4bc1-86e2-94e14c1865b0" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_67e9d0d7-913b-4108-b588-de3fd8fe8a6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_5e3d7b92-f9c7-4839-b7dc-260aca8155fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_b5743578-9b03-4bc1-86e2-94e14c1865b0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_5e3d7b92-f9c7-4839-b7dc-260aca8155fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_aff3cc99-ee7d-4fcf-ae57-7c86153385b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_b5743578-9b03-4bc1-86e2-94e14c1865b0" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_aff3cc99-ee7d-4fcf-ae57-7c86153385b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_6344cf5e-c639-42bb-af7b-1f1714dd140a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_b5743578-9b03-4bc1-86e2-94e14c1865b0" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_6344cf5e-c639-42bb-af7b-1f1714dd140a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_d3800736-5534-490a-bdba-84e0ea812afc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_b5743578-9b03-4bc1-86e2-94e14c1865b0" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_d3800736-5534-490a-bdba-84e0ea812afc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_546e65d5-e049-4eac-b03d-14f35834a003" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_b5743578-9b03-4bc1-86e2-94e14c1865b0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_546e65d5-e049-4eac-b03d-14f35834a003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_86d7d10b-63cc-4d73-ab47-8ff95dd2a4a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_626d62fc-c3fe-4e8b-9253-ceef6e1f6009" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_86d7d10b-63cc-4d73-ab47-8ff95dd2a4a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9fadbbc2-14ca-4eb0-9957-0aa589ff4645" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_20660398-4a55-4778-a7e9-f3628ca83c98" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9fadbbc2-14ca-4eb0-9957-0aa589ff4645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_a20cb642-e97e-4aa2-aba7-b9171c0ed569" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9fadbbc2-14ca-4eb0-9957-0aa589ff4645" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_a20cb642-e97e-4aa2-aba7-b9171c0ed569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfMachineryAndEquipment_014c6f2c-866b-4b19-a3e9-188015bd8886" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfMachineryAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9fadbbc2-14ca-4eb0-9957-0aa589ff4645" xlink:to="loc_us-gaap_ProceedsFromSaleOfMachineryAndEquipment_014c6f2c-866b-4b19-a3e9-188015bd8886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToDevelopSoftware_3c502217-4ef4-4417-b52c-f89530111fe9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToDevelopSoftware"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9fadbbc2-14ca-4eb0-9957-0aa589ff4645" xlink:to="loc_us-gaap_PaymentsToDevelopSoftware_3c502217-4ef4-4417-b52c-f89530111fe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_cb937349-81f2-4c45-bd0a-dbd570a07596" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9fadbbc2-14ca-4eb0-9957-0aa589ff4645" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_cb937349-81f2-4c45-bd0a-dbd570a07596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_72e2819b-7685-4afa-b1d7-d61feb567a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9fadbbc2-14ca-4eb0-9957-0aa589ff4645" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_72e2819b-7685-4afa-b1d7-d61feb567a3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e087840-7866-440f-a30f-6c2877541128" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_20660398-4a55-4778-a7e9-f3628ca83c98" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e087840-7866-440f-a30f-6c2877541128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock_2dbba2c8-abf9-4137-aa93-e0ba751ed0bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e087840-7866-440f-a30f-6c2877541128" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock_2dbba2c8-abf9-4137-aa93-e0ba751ed0bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributedCapital_77c3a446-ebde-4663-a860-e6e131743533" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromContributedCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e087840-7866-440f-a30f-6c2877541128" xlink:to="loc_us-gaap_ProceedsFromContributedCapital_77c3a446-ebde-4663-a860-e6e131743533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_84ae99d6-665b-48d9-be53-e64e10f1f3dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e087840-7866-440f-a30f-6c2877541128" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_84ae99d6-665b-48d9-be53-e64e10f1f3dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_7befd54b-4260-49f5-abee-90cc60d4cee2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e087840-7866-440f-a30f-6c2877541128" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_7befd54b-4260-49f5-abee-90cc60d4cee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_d47ab5d2-f7b8-450c-972d-f9625c17a2eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e087840-7866-440f-a30f-6c2877541128" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_d47ab5d2-f7b8-450c-972d-f9625c17a2eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_db2cd3eb-faba-42e3-bf3c-348a45298da4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermCapitalLeaseObligations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e087840-7866-440f-a30f-6c2877541128" xlink:to="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_db2cd3eb-faba-42e3-bf3c-348a45298da4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_PaymentOfTransactionCosts_be7ea357-c8bb-4b1e-a8fc-ee9ab8700750" xlink:href="cmlf-20210804.xsd#cmlf_PaymentOfTransactionCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e087840-7866-440f-a30f-6c2877541128" xlink:to="loc_cmlf_PaymentOfTransactionCosts_be7ea357-c8bb-4b1e-a8fc-ee9ab8700750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_4a339bc7-6b91-4a87-abce-245601d5423a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e087840-7866-440f-a30f-6c2877541128" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_4a339bc7-6b91-4a87-abce-245601d5423a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_ead36ddf-5cd3-4271-a37a-3fe2c861bbfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e087840-7866-440f-a30f-6c2877541128" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_ead36ddf-5cd3-4271-a37a-3fe2c861bbfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRelatedPartyDebt_c8ab57b2-9828-4497-bd2c-faaf62010a80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e087840-7866-440f-a30f-6c2877541128" xlink:to="loc_us-gaap_ProceedsFromRelatedPartyDebt_c8ab57b2-9828-4497-bd2c-faaf62010a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfRelatedPartyDebt_32ffb0d1-2124-499d-91ac-1307c5edc144" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e087840-7866-440f-a30f-6c2877541128" xlink:to="loc_us-gaap_RepaymentsOfRelatedPartyDebt_32ffb0d1-2124-499d-91ac-1307c5edc144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_DeferredOfferingCostsIncludedInAccruedOfferingCosts_c6f39791-55a2-4900-9fad-762847f23939" xlink:href="cmlf-20210804.xsd#cmlf_DeferredOfferingCostsIncludedInAccruedOfferingCosts"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e087840-7866-440f-a30f-6c2877541128" xlink:to="loc_cmlf_DeferredOfferingCostsIncludedInAccruedOfferingCosts_c6f39791-55a2-4900-9fad-762847f23939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_55bbfae1-36dd-4327-aace-aaf34db1881a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e087840-7866-440f-a30f-6c2877541128" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_55bbfae1-36dd-4327-aace-aaf34db1881a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5419f264-860f-4c4e-ac14-723ed8bcbd3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_20660398-4a55-4778-a7e9-f3628ca83c98" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5419f264-860f-4c4e-ac14-723ed8bcbd3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a1baef6c-7c65-4016-ad1d-b3cbb7ecd37e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_20660398-4a55-4778-a7e9-f3628ca83c98" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a1baef6c-7c65-4016-ad1d-b3cbb7ecd37e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c61ed34b-f465-4d53-90bc-087122fd7ee9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_20660398-4a55-4778-a7e9-f3628ca83c98" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c61ed34b-f465-4d53-90bc-087122fd7ee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_a346da8f-114f-42cf-9dbe-3a7e2cbe5d33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_20660398-4a55-4778-a7e9-f3628ca83c98" xlink:to="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_a346da8f-114f-42cf-9dbe-3a7e2cbe5d33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_4e47b609-320c-45de-a8a5-fb69b6ac7ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_a346da8f-114f-42cf-9dbe-3a7e2cbe5d33" xlink:to="loc_us-gaap_InterestPaidNet_4e47b609-320c-45de-a8a5-fb69b6ac7ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_a844d4e8-45be-436f-bca9-b0c4916a5649" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_a346da8f-114f-42cf-9dbe-3a7e2cbe5d33" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_a844d4e8-45be-436f-bca9-b0c4916a5649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_SoftwareDevelopmentCostsIncurredButNotYetPaid_238db58e-01bd-4565-8b7a-d13c78055693" xlink:href="cmlf-20210804.xsd#cmlf_SoftwareDevelopmentCostsIncurredButNotYetPaid"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_a346da8f-114f-42cf-9dbe-3a7e2cbe5d33" xlink:to="loc_cmlf_SoftwareDevelopmentCostsIncurredButNotYetPaid_238db58e-01bd-4565-8b7a-d13c78055693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_NoncashRedeemablePreferredStockDividends_0c2f0ade-de21-4d83-b564-e2d25fbdece7" xlink:href="cmlf-20210804.xsd#cmlf_NoncashRedeemablePreferredStockDividends"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_a346da8f-114f-42cf-9dbe-3a7e2cbe5d33" xlink:to="loc_cmlf_NoncashRedeemablePreferredStockDividends_0c2f0ade-de21-4d83-b564-e2d25fbdece7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentDecreaseForgiveness_48bb9649-d73b-49d0-b5fd-e8f03041d07a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentDecreaseForgiveness"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_a346da8f-114f-42cf-9dbe-3a7e2cbe5d33" xlink:to="loc_us-gaap_DebtInstrumentDecreaseForgiveness_48bb9649-d73b-49d0-b5fd-e8f03041d07a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_41315b8c-291e-4d7e-b327-3dc4dbb96de3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_a346da8f-114f-42cf-9dbe-3a7e2cbe5d33" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_41315b8c-291e-4d7e-b327-3dc4dbb96de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_TransactionCostsIncurredButNotYetPaid_54d941a2-315f-4a0b-b323-646d0932d09e" xlink:href="cmlf-20210804.xsd#cmlf_TransactionCostsIncurredButNotYetPaid"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_a346da8f-114f-42cf-9dbe-3a7e2cbe5d33" xlink:to="loc_cmlf_TransactionCostsIncurredButNotYetPaid_54d941a2-315f-4a0b-b323-646d0932d09e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_InitialClassificationOfCommonStockSubjectToPossibleRedemption_9b33f221-012f-47a2-b423-395500982502" xlink:href="cmlf-20210804.xsd#cmlf_InitialClassificationOfCommonStockSubjectToPossibleRedemption"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_a346da8f-114f-42cf-9dbe-3a7e2cbe5d33" xlink:to="loc_cmlf_InitialClassificationOfCommonStockSubjectToPossibleRedemption_9b33f221-012f-47a2-b423-395500982502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ChangeInValueOfCommonStockSubjectToPossibleRedemption_501fd91e-a67a-4778-869c-6a92657808df" xlink:href="cmlf-20210804.xsd#cmlf_ChangeInValueOfCommonStockSubjectToPossibleRedemption"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_a346da8f-114f-42cf-9dbe-3a7e2cbe5d33" xlink:to="loc_cmlf_ChangeInValueOfCommonStockSubjectToPossibleRedemption_501fd91e-a67a-4778-869c-6a92657808df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_InitialClassificationOfWarrantLiabilities_bfef88fa-4bc2-48c1-8162-7df762355e95" xlink:href="cmlf-20210804.xsd#cmlf_InitialClassificationOfWarrantLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_a346da8f-114f-42cf-9dbe-3a7e2cbe5d33" xlink:to="loc_cmlf_InitialClassificationOfWarrantLiabilities_bfef88fa-4bc2-48c1-8162-7df762355e95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_DeferredUnderwritingFeePayable_159c25ca-75da-42fd-819f-84098e907bf3" xlink:href="cmlf-20210804.xsd#cmlf_DeferredUnderwritingFeePayable"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_a346da8f-114f-42cf-9dbe-3a7e2cbe5d33" xlink:to="loc_cmlf_DeferredUnderwritingFeePayable_159c25ca-75da-42fd-819f-84098e907bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_OfferingCostsPaidDirectlyBySponsorInConsiderationForTheIssuanceOfClassBCommonStock_fc638844-7b00-4216-999a-d779ba67167d" xlink:href="cmlf-20210804.xsd#cmlf_OfferingCostsPaidDirectlyBySponsorInConsiderationForTheIssuanceOfClassBCommonStock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_a346da8f-114f-42cf-9dbe-3a7e2cbe5d33" xlink:to="loc_cmlf_OfferingCostsPaidDirectlyBySponsorInConsiderationForTheIssuanceOfClassBCommonStock_fc638844-7b00-4216-999a-d779ba67167d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_PaymentOfOfferingCostsThroughPromissoryNoteRelatedParty_807daf74-d0bd-4fd1-9f32-0c9f52633ec9" xlink:href="cmlf-20210804.xsd#cmlf_PaymentOfOfferingCostsThroughPromissoryNoteRelatedParty"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_a346da8f-114f-42cf-9dbe-3a7e2cbe5d33" xlink:to="loc_cmlf_PaymentOfOfferingCostsThroughPromissoryNoteRelatedParty_807daf74-d0bd-4fd1-9f32-0c9f52633ec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/OrganizationandDescriptionofBusiness" xlink:type="simple" xlink:href="cmlf-20210804.xsd#OrganizationandDescriptionofBusiness"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/OrganizationandDescriptionofBusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6c1bc7ca-5c68-412b-8cc6-b8f1686ec7bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_f7cb1696-0c0e-48b5-8b25-ab1e47e936b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6c1bc7ca-5c68-412b-8cc6-b8f1686ec7bf" xlink:to="loc_us-gaap_NatureOfOperations_f7cb1696-0c0e-48b5-8b25-ab1e47e936b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/OrganizationandDescriptionofBusinessDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#OrganizationandDescriptionofBusinessDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/OrganizationandDescriptionofBusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c687dd8e-9050-4435-958c-0f5585f05230" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_OrganizationAndDescriptionOfBusinessTable_6efb8bc7-0686-4190-800a-9c0e5af8cd1e" xlink:href="cmlf-20210804.xsd#cmlf_OrganizationAndDescriptionOfBusinessTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c687dd8e-9050-4435-958c-0f5585f05230" xlink:to="loc_cmlf_OrganizationAndDescriptionOfBusinessTable_6efb8bc7-0686-4190-800a-9c0e5af8cd1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7ea9f32e-360a-4adb-b741-333b8d91b5b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_OrganizationAndDescriptionOfBusinessTable_6efb8bc7-0686-4190-800a-9c0e5af8cd1e" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7ea9f32e-360a-4adb-b741-333b8d91b5b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_93c6715a-f704-478c-a81a-756d7325f96f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7ea9f32e-360a-4adb-b741-333b8d91b5b7" xlink:to="loc_us-gaap_RelatedPartyDomain_93c6715a-f704-478c-a81a-756d7325f96f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_35fab397-9c21-425c-90c0-7476b7ca18c0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AffiliatedEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_93c6715a-f704-478c-a81a-756d7325f96f" xlink:to="loc_srt_AffiliatedEntityMember_35fab397-9c21-425c-90c0-7476b7ca18c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_OrganizationAndDescriptionOfBusinessLineItems_7dc43b51-524d-4a69-91b3-4faf511c1988" xlink:href="cmlf-20210804.xsd#cmlf_OrganizationAndDescriptionOfBusinessLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_OrganizationAndDescriptionOfBusinessTable_6efb8bc7-0686-4190-800a-9c0e5af8cd1e" xlink:to="loc_cmlf_OrganizationAndDescriptionOfBusinessLineItems_7dc43b51-524d-4a69-91b3-4faf511c1988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_RelatedPartyTransactionFundingCommitmentToBeReceivedMaximum_c85b9d83-2fe2-4733-b0db-4b26822349cf" xlink:href="cmlf-20210804.xsd#cmlf_RelatedPartyTransactionFundingCommitmentToBeReceivedMaximum"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_OrganizationAndDescriptionOfBusinessLineItems_7dc43b51-524d-4a69-91b3-4faf511c1988" xlink:to="loc_cmlf_RelatedPartyTransactionFundingCommitmentToBeReceivedMaximum_c85b9d83-2fe2-4733-b0db-4b26822349cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="cmlf-20210804.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_bf2d2430-3a0f-4a3b-a392-ef8c16bd4816" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_2dad79ff-2e2a-4d63-8568-f0bf54023d72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf2d2430-3a0f-4a3b-a392-ef8c16bd4816" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_2dad79ff-2e2a-4d63-8568-f0bf54023d72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="cmlf-20210804.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_263a9dcb-b6b3-4332-8dcc-d5fa9e26b20c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_df534a23-4ee1-4731-8240-c71842bb8a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_263a9dcb-b6b3-4332-8dcc-d5fa9e26b20c" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_df534a23-4ee1-4731-8240-c71842bb8a0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_48c12ce7-f84f-40f6-87b2-aed5a33f8315" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_263a9dcb-b6b3-4332-8dcc-d5fa9e26b20c" xlink:to="loc_us-gaap_UseOfEstimates_48c12ce7-f84f-40f6-87b2-aed5a33f8315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_48e55897-1901-42e3-82aa-5926c8f59c7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_263a9dcb-b6b3-4332-8dcc-d5fa9e26b20c" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_48e55897-1901-42e3-82aa-5926c8f59c7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_a13fb808-22d1-4d94-ac08-93cc517a7755" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_263a9dcb-b6b3-4332-8dcc-d5fa9e26b20c" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_a13fb808-22d1-4d94-ac08-93cc517a7755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_79e7fb97-64b7-414f-b1ef-3f6e965811a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_263a9dcb-b6b3-4332-8dcc-d5fa9e26b20c" xlink:to="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_79e7fb97-64b7-414f-b1ef-3f6e965811a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_ffa90991-9472-46b3-9620-76e298838d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_263a9dcb-b6b3-4332-8dcc-d5fa9e26b20c" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_ffa90991-9472-46b3-9620-76e298838d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_4e5b4159-9b83-4155-9ca5-45030b00d086" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_263a9dcb-b6b3-4332-8dcc-d5fa9e26b20c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_4e5b4159-9b83-4155-9ca5-45030b00d086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalUseSoftwarePolicy_09049275-1eb4-4e5a-be63-0af4167ad3b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternalUseSoftwarePolicy"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_263a9dcb-b6b3-4332-8dcc-d5fa9e26b20c" xlink:to="loc_us-gaap_InternalUseSoftwarePolicy_09049275-1eb4-4e5a-be63-0af4167ad3b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_7b009589-e939-4595-a061-253841a521c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_263a9dcb-b6b3-4332-8dcc-d5fa9e26b20c" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_7b009589-e939-4595-a061-253841a521c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_8d4ef4d5-173e-47bd-aa3a-faa12d22378a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_263a9dcb-b6b3-4332-8dcc-d5fa9e26b20c" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_8d4ef4d5-173e-47bd-aa3a-faa12d22378a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_293f935a-c2c9-4a2d-9acf-77b02b7453c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_263a9dcb-b6b3-4332-8dcc-d5fa9e26b20c" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_293f935a-c2c9-4a2d-9acf-77b02b7453c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_413b6fdf-9331-4696-b458-e6b7e5e5036d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_263a9dcb-b6b3-4332-8dcc-d5fa9e26b20c" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_413b6fdf-9331-4696-b458-e6b7e5e5036d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_2b35a92c-8930-4d58-aed3-f3685a779c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_263a9dcb-b6b3-4332-8dcc-d5fa9e26b20c" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_2b35a92c-8930-4d58-aed3-f3685a779c5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_d04bc16b-c39a-44ea-95c5-970544513f12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_263a9dcb-b6b3-4332-8dcc-d5fa9e26b20c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_d04bc16b-c39a-44ea-95c5-970544513f12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock_2a9b5328-1811-4f10-a7e5-91d1f12fa76f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_263a9dcb-b6b3-4332-8dcc-d5fa9e26b20c" xlink:to="loc_us-gaap_CostOfSalesPolicyTextBlock_2a9b5328-1811-4f10-a7e5-91d1f12fa76f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_607c5b10-f0d7-49ec-ac25-d23a964604f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_263a9dcb-b6b3-4332-8dcc-d5fa9e26b20c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_607c5b10-f0d7-49ec-ac25-d23a964604f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_6c37bb4e-ec72-47ea-a29a-a7e64db91af9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_263a9dcb-b6b3-4332-8dcc-d5fa9e26b20c" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_6c37bb4e-ec72-47ea-a29a-a7e64db91af9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_OtherIncomeAndExpensePolicyTextBlock_0f2ea135-fe0c-44ea-a79f-d4d5e7b3042c" xlink:href="cmlf-20210804.xsd#cmlf_OtherIncomeAndExpensePolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_263a9dcb-b6b3-4332-8dcc-d5fa9e26b20c" xlink:to="loc_cmlf_OtherIncomeAndExpensePolicyTextBlock_0f2ea135-fe0c-44ea-a79f-d4d5e7b3042c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_3411f1f8-a797-427c-8cd4-2213103fb4a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_263a9dcb-b6b3-4332-8dcc-d5fa9e26b20c" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_3411f1f8-a797-427c-8cd4-2213103fb4a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_f26c2253-5300-499a-9ec3-acf6cf036ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_263a9dcb-b6b3-4332-8dcc-d5fa9e26b20c" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_f26c2253-5300-499a-9ec3-acf6cf036ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_4549686e-c6c3-452a-b5d7-833b30d37c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_263a9dcb-b6b3-4332-8dcc-d5fa9e26b20c" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_4549686e-c6c3-452a-b5d7-833b30d37c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="cmlf-20210804.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ee840b43-8b3f-45ad-aafb-1ebdf104df91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_41baf694-d2c0-4370-9c25-42ba49f566b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ee840b43-8b3f-45ad-aafb-1ebdf104df91" xlink:to="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_41baf694-d2c0-4370-9c25-42ba49f566b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_458d5dba-59ec-4f56-b1cf-eb012af3f6ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ee840b43-8b3f-45ad-aafb-1ebdf104df91" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_458d5dba-59ec-4f56-b1cf-eb012af3f6ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_29a1292d-860d-4065-b80d-8bf8b0a50cbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ee840b43-8b3f-45ad-aafb-1ebdf104df91" xlink:to="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_29a1292d-860d-4065-b80d-8bf8b0a50cbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a6c57d83-78c2-43aa-b7be-fb176d496b49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0ea640e4-a1fe-416a-93e5-8e7f82d0b5a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a6c57d83-78c2-43aa-b7be-fb176d496b49" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0ea640e4-a1fe-416a-93e5-8e7f82d0b5a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_59ba0fe6-7ba0-4362-9b61-ae89238cfa39" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0ea640e4-a1fe-416a-93e5-8e7f82d0b5a7" xlink:to="loc_srt_RangeAxis_59ba0fe6-7ba0-4362-9b61-ae89238cfa39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d2e68858-31a3-47b6-ae97-e0e9b22f1eab" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_59ba0fe6-7ba0-4362-9b61-ae89238cfa39" xlink:to="loc_srt_RangeMember_d2e68858-31a3-47b6-ae97-e0e9b22f1eab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4466e794-1641-4701-8a9e-632f57f2e3dc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d2e68858-31a3-47b6-ae97-e0e9b22f1eab" xlink:to="loc_srt_MinimumMember_4466e794-1641-4701-8a9e-632f57f2e3dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_55a44835-8e29-4cbc-b955-096c10cb7dd3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d2e68858-31a3-47b6-ae97-e0e9b22f1eab" xlink:to="loc_srt_MaximumMember_55a44835-8e29-4cbc-b955-096c10cb7dd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d725a9c8-63da-4c74-abc4-e1f2a948d15e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0ea640e4-a1fe-416a-93e5-8e7f82d0b5a7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d725a9c8-63da-4c74-abc4-e1f2a948d15e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ede02523-0154-4c51-8d80-19888f72194c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d725a9c8-63da-4c74-abc4-e1f2a948d15e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ede02523-0154-4c51-8d80-19888f72194c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember_57e1d121-882a-4c2b-af7f-e06ca4a07f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ede02523-0154-4c51-8d80-19888f72194c" xlink:to="loc_us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember_57e1d121-882a-4c2b-af7f-e06ca4a07f9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_5490be84-d037-48fa-87f7-1b0be289b14d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ede02523-0154-4c51-8d80-19888f72194c" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_5490be84-d037-48fa-87f7-1b0be289b14d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_GovernmentAssistanceAxis_07b986cb-ba13-4bc2-9727-c5ab13c2b701" xlink:href="cmlf-20210804.xsd#cmlf_GovernmentAssistanceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0ea640e4-a1fe-416a-93e5-8e7f82d0b5a7" xlink:to="loc_cmlf_GovernmentAssistanceAxis_07b986cb-ba13-4bc2-9727-c5ab13c2b701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_GovernmentAssistanceDomain_7bbb913c-a882-4176-9889-62df5e95e52a" xlink:href="cmlf-20210804.xsd#cmlf_GovernmentAssistanceDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_GovernmentAssistanceAxis_07b986cb-ba13-4bc2-9727-c5ab13c2b701" xlink:to="loc_cmlf_GovernmentAssistanceDomain_7bbb913c-a882-4176-9889-62df5e95e52a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_GovernmentAssistanceCARESActProviderReliefFundMember_65c09a1a-f3fa-46eb-91d6-2dc9f3c5ceef" xlink:href="cmlf-20210804.xsd#cmlf_GovernmentAssistanceCARESActProviderReliefFundMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_GovernmentAssistanceDomain_7bbb913c-a882-4176-9889-62df5e95e52a" xlink:to="loc_cmlf_GovernmentAssistanceCARESActProviderReliefFundMember_65c09a1a-f3fa-46eb-91d6-2dc9f3c5ceef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_GovernmentAssistanceCARESActEmployeeRetentionCreditMember_42ec8afb-5408-4064-9793-bc6d0dc84bfa" xlink:href="cmlf-20210804.xsd#cmlf_GovernmentAssistanceCARESActEmployeeRetentionCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_GovernmentAssistanceDomain_7bbb913c-a882-4176-9889-62df5e95e52a" xlink:to="loc_cmlf_GovernmentAssistanceCARESActEmployeeRetentionCreditMember_42ec8afb-5408-4064-9793-bc6d0dc84bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2dad63d7-4d1b-47dc-824f-8786434e9ded" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0ea640e4-a1fe-416a-93e5-8e7f82d0b5a7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2dad63d7-4d1b-47dc-824f-8786434e9ded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_03e035f6-0221-488b-b268-96622a5215ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2dad63d7-4d1b-47dc-824f-8786434e9ded" xlink:to="loc_us-gaap_NetIncomeLoss_03e035f6-0221-488b-b268-96622a5215ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_daebd06b-cc3a-4275-a496-aa06f6a50b87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2dad63d7-4d1b-47dc-824f-8786434e9ded" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_daebd06b-cc3a-4275-a496-aa06f6a50b87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_fc8841d9-5ece-4c9a-b20c-9eec7abf4fa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2dad63d7-4d1b-47dc-824f-8786434e9ded" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_fc8841d9-5ece-4c9a-b20c-9eec7abf4fa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ProceedsFromGovernmentAssistance_715f3fe9-f42d-4048-80d6-31ae96c7d048" xlink:href="cmlf-20210804.xsd#cmlf_ProceedsFromGovernmentAssistance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2dad63d7-4d1b-47dc-824f-8786434e9ded" xlink:to="loc_cmlf_ProceedsFromGovernmentAssistance_715f3fe9-f42d-4048-80d6-31ae96c7d048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_02b5cb6a-7480-4f1b-8dc1-2ab844b1c71c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2dad63d7-4d1b-47dc-824f-8786434e9ded" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_02b5cb6a-7480-4f1b-8dc1-2ab844b1c71c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_5b77fa53-5c91-4928-8b34-56a05a80552e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2dad63d7-4d1b-47dc-824f-8786434e9ded" xlink:to="loc_us-gaap_InventoryWriteDown_5b77fa53-5c91-4928-8b34-56a05a80552e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_48cacffa-f3df-4704-8ab2-b460439184f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2dad63d7-4d1b-47dc-824f-8786434e9ded" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_48cacffa-f3df-4704-8ab2-b460439184f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_4f1b00ab-9ae1-419e-96c6-35ad957991d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2dad63d7-4d1b-47dc-824f-8786434e9ded" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_4f1b00ab-9ae1-419e-96c6-35ad957991d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_RevenueRecognitionStandardPaymentTerm_5028a265-0534-4039-b922-f2f928e81042" xlink:href="cmlf-20210804.xsd#cmlf_RevenueRecognitionStandardPaymentTerm"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2dad63d7-4d1b-47dc-824f-8786434e9ded" xlink:to="loc_cmlf_RevenueRecognitionStandardPaymentTerm_5028a265-0534-4039-b922-f2f928e81042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_af56e87c-c8fa-4527-8e18-c891c2080627" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2dad63d7-4d1b-47dc-824f-8786434e9ded" xlink:to="loc_us-gaap_NumberOfReportableSegments_af56e87c-c8fa-4527-8e18-c891c2080627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_5c8b90b6-16aa-443c-8891-e107fcccd03f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2dad63d7-4d1b-47dc-824f-8786434e9ded" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_5c8b90b6-16aa-443c-8891-e107fcccd03f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/SummaryofSignificantAccountingPoliciesConcentrationRiskDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#SummaryofSignificantAccountingPoliciesConcentrationRiskDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/SummaryofSignificantAccountingPoliciesConcentrationRiskDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_37e15add-56f1-41f1-b240-ed75d54fe756" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_62158ba5-df5d-46bd-bd64-f3d1cceb3252" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_37e15add-56f1-41f1-b240-ed75d54fe756" xlink:to="loc_us-gaap_ConcentrationRiskTable_62158ba5-df5d-46bd-bd64-f3d1cceb3252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_32f09195-649e-4726-b6a3-a9ba8b643417" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_62158ba5-df5d-46bd-bd64-f3d1cceb3252" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_32f09195-649e-4726-b6a3-a9ba8b643417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_f0683d77-d158-49f5-9ec7-4521760b57bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_32f09195-649e-4726-b6a3-a9ba8b643417" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_f0683d77-d158-49f5-9ec7-4521760b57bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_0a386101-cd63-46d5-b07e-bbbc90c8e251" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_f0683d77-d158-49f5-9ec7-4521760b57bd" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_0a386101-cd63-46d5-b07e-bbbc90c8e251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember_205b91ee-d7c7-48ec-84fd-84e1ceac862e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_f0683d77-d158-49f5-9ec7-4521760b57bd" xlink:to="loc_us-gaap_SupplierConcentrationRiskMember_205b91ee-d7c7-48ec-84fd-84e1ceac862e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_040c2c57-e29e-4565-a79d-02d56dae1af4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_62158ba5-df5d-46bd-bd64-f3d1cceb3252" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_040c2c57-e29e-4565-a79d-02d56dae1af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2f73e5b7-fa43-490e-bc5e-24f4eb5f02ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_040c2c57-e29e-4565-a79d-02d56dae1af4" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2f73e5b7-fa43-490e-bc5e-24f4eb5f02ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_91d5d375-2a79-4d79-8bd7-bd1e206968be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2f73e5b7-fa43-490e-bc5e-24f4eb5f02ef" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_91d5d375-2a79-4d79-8bd7-bd1e206968be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_a986eff7-ff2a-4285-a594-6aeb37a1a82b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2f73e5b7-fa43-490e-bc5e-24f4eb5f02ef" xlink:to="loc_us-gaap_AccountsReceivableMember_a986eff7-ff2a-4285-a594-6aeb37a1a82b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsTotalMember_b0da3a6d-5006-471d-b522-c69d2647e65f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsTotalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2f73e5b7-fa43-490e-bc5e-24f4eb5f02ef" xlink:to="loc_us-gaap_CostOfGoodsTotalMember_b0da3a6d-5006-471d-b522-c69d2647e65f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_b5d06c62-ed56-4f81-be4d-bd5f5ee95606" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2f73e5b7-fa43-490e-bc5e-24f4eb5f02ef" xlink:to="loc_us-gaap_SalesRevenueNetMember_b5d06c62-ed56-4f81-be4d-bd5f5ee95606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_b84fbb1e-5925-426b-8748-33208bd01e5c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_62158ba5-df5d-46bd-bd64-f3d1cceb3252" xlink:to="loc_srt_MajorCustomersAxis_b84fbb1e-5925-426b-8748-33208bd01e5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_fb86d5a4-f5d3-4170-8dc0-f023af8d8838" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_b84fbb1e-5925-426b-8748-33208bd01e5c" xlink:to="loc_srt_NameOfMajorCustomerDomain_fb86d5a4-f5d3-4170-8dc0-f023af8d8838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_PayorAMember_841cfdfc-b6fc-4c46-8db6-93b6d3ad737a" xlink:href="cmlf-20210804.xsd#cmlf_PayorAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_fb86d5a4-f5d3-4170-8dc0-f023af8d8838" xlink:to="loc_cmlf_PayorAMember_841cfdfc-b6fc-4c46-8db6-93b6d3ad737a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_PayorBMember_86168666-25fb-413b-ad2c-e342b0fcb82c" xlink:href="cmlf-20210804.xsd#cmlf_PayorBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_fb86d5a4-f5d3-4170-8dc0-f023af8d8838" xlink:to="loc_cmlf_PayorBMember_86168666-25fb-413b-ad2c-e342b0fcb82c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_PayorCMember_06044d38-7caa-4ede-9098-a42643cbc169" xlink:href="cmlf-20210804.xsd#cmlf_PayorCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_fb86d5a4-f5d3-4170-8dc0-f023af8d8838" xlink:to="loc_cmlf_PayorCMember_06044d38-7caa-4ede-9098-a42643cbc169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_PayorDMember_a32bbb8d-3a0d-4bed-8746-bf95d96773bc" xlink:href="cmlf-20210804.xsd#cmlf_PayorDMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_fb86d5a4-f5d3-4170-8dc0-f023af8d8838" xlink:to="loc_cmlf_PayorDMember_a32bbb8d-3a0d-4bed-8746-bf95d96773bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_PayorEMember_a146cf63-dcd6-4449-a1b4-b0308fb59e97" xlink:href="cmlf-20210804.xsd#cmlf_PayorEMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_fb86d5a4-f5d3-4170-8dc0-f023af8d8838" xlink:to="loc_cmlf_PayorEMember_a146cf63-dcd6-4449-a1b4-b0308fb59e97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_c3953d84-bf46-4c32-921b-6968bd24436a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_62158ba5-df5d-46bd-bd64-f3d1cceb3252" xlink:to="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_c3953d84-bf46-4c32-921b-6968bd24436a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_0841d669-57aa-4ddc-96e5-7d21f52117b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_c3953d84-bf46-4c32-921b-6968bd24436a" xlink:to="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_0841d669-57aa-4ddc-96e5-7d21f52117b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_SupplierAMember_84cd331b-a4b3-4ca0-8ff8-56482da72dbc" xlink:href="cmlf-20210804.xsd#cmlf_SupplierAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_0841d669-57aa-4ddc-96e5-7d21f52117b8" xlink:to="loc_cmlf_SupplierAMember_84cd331b-a4b3-4ca0-8ff8-56482da72dbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_SupplierBMember_2be3f1c7-62d0-4662-9114-1d3f7affffed" xlink:href="cmlf-20210804.xsd#cmlf_SupplierBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_0841d669-57aa-4ddc-96e5-7d21f52117b8" xlink:to="loc_cmlf_SupplierBMember_2be3f1c7-62d0-4662-9114-1d3f7affffed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_df1cac5e-c20c-4f7f-80c0-a01e34d10617" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_62158ba5-df5d-46bd-bd64-f3d1cceb3252" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_df1cac5e-c20c-4f7f-80c0-a01e34d10617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_9611308c-ab23-4133-8342-53f9e32b3c25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_df1cac5e-c20c-4f7f-80c0-a01e34d10617" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_9611308c-ab23-4133-8342-53f9e32b3c25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_bfb07579-4f1a-4c3e-932f-d6845de65afa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5678e3ca-1730-4de5-ae6f-50c6593cbe07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bfb07579-4f1a-4c3e-932f-d6845de65afa" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5678e3ca-1730-4de5-ae6f-50c6593cbe07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_e5f853e8-3c9e-447e-abb7-d2ca6bef3026" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bfb07579-4f1a-4c3e-932f-d6845de65afa" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_e5f853e8-3c9e-447e-abb7-d2ca6bef3026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_87911349-d07a-442d-9dc7-3b4f91ae7d46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bfb07579-4f1a-4c3e-932f-d6845de65afa" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_87911349-d07a-442d-9dc7-3b4f91ae7d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/RevenueRecognition" xlink:type="simple" xlink:href="cmlf-20210804.xsd#RevenueRecognition"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/RevenueRecognition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_bf9dde3d-2223-43b9-82ca-8213d58a1dd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_978e2d80-63e0-488a-8006-042b11591f21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_bf9dde3d-2223-43b9-82ca-8213d58a1dd6" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_978e2d80-63e0-488a-8006-042b11591f21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/RevenueRecognitionTables" xlink:type="simple" xlink:href="cmlf-20210804.xsd#RevenueRecognitionTables"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/RevenueRecognitionTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_17a9c81b-2ed4-4f45-a057-326911c3655f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_1f7889a1-9087-4cf2-9a5a-d35ceea9347a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_17a9c81b-2ed4-4f45-a057-326911c3655f" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_1f7889a1-9087-4cf2-9a5a-d35ceea9347a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_69f725b5-fadd-422d-b6fc-f41a5b0a700f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_17a9c81b-2ed4-4f45-a057-326911c3655f" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_69f725b5-fadd-422d-b6fc-f41a5b0a700f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/RevenueRecognitionDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#RevenueRecognitionDisaggregationofRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/RevenueRecognitionDisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f8b3353d-cf0d-4612-9ec5-3ef48003035b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_06ebec86-c328-4e9a-8a02-3dd2b8d0a8a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f8b3353d-cf0d-4612-9ec5-3ef48003035b" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_06ebec86-c328-4e9a-8a02-3dd2b8d0a8a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e32759bc-4f37-45d9-b1f8-9b9b3de64ac3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_06ebec86-c328-4e9a-8a02-3dd2b8d0a8a6" xlink:to="loc_srt_ProductOrServiceAxis_e32759bc-4f37-45d9-b1f8-9b9b3de64ac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ad4d00f3-b404-4683-ac68-8ff11ac5e9a0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_e32759bc-4f37-45d9-b1f8-9b9b3de64ac3" xlink:to="loc_srt_ProductsAndServicesDomain_ad4d00f3-b404-4683-ac68-8ff11ac5e9a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_DiagnosticTestMember_a283c9a0-1393-4e59-a248-5de713fcc4e0" xlink:href="cmlf-20210804.xsd#cmlf_DiagnosticTestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ad4d00f3-b404-4683-ac68-8ff11ac5e9a0" xlink:to="loc_cmlf_DiagnosticTestMember_a283c9a0-1393-4e59-a248-5de713fcc4e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_DiagnosticTestThirdPartyInsuranceMember_b24c2842-4444-4a3a-a6ea-011a1af241fd" xlink:href="cmlf-20210804.xsd#cmlf_DiagnosticTestThirdPartyInsuranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_DiagnosticTestMember_a283c9a0-1393-4e59-a248-5de713fcc4e0" xlink:to="loc_cmlf_DiagnosticTestThirdPartyInsuranceMember_b24c2842-4444-4a3a-a6ea-011a1af241fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_DiagnosticTestInstitutionalCustomersMember_2ef9d662-e945-4e07-94f5-8f0f78c1e94c" xlink:href="cmlf-20210804.xsd#cmlf_DiagnosticTestInstitutionalCustomersMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_DiagnosticTestMember_a283c9a0-1393-4e59-a248-5de713fcc4e0" xlink:to="loc_cmlf_DiagnosticTestInstitutionalCustomersMember_2ef9d662-e945-4e07-94f5-8f0f78c1e94c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_DiagnosticTestSelfPayMember_d58016d7-0469-4c77-91b5-2d17fe01f009" xlink:href="cmlf-20210804.xsd#cmlf_DiagnosticTestSelfPayMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_DiagnosticTestMember_a283c9a0-1393-4e59-a248-5de713fcc4e0" xlink:to="loc_cmlf_DiagnosticTestSelfPayMember_d58016d7-0469-4c77-91b5-2d17fe01f009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_40f7a110-2229-4925-9213-13d81d77341d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ad4d00f3-b404-4683-ac68-8ff11ac5e9a0" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_40f7a110-2229-4925-9213-13d81d77341d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_74fbf769-0e08-4892-b845-1081d9349ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_06ebec86-c328-4e9a-8a02-3dd2b8d0a8a6" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_74fbf769-0e08-4892-b845-1081d9349ae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e3cfdd5f-5306-409a-b3bc-bbbe99780be3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_74fbf769-0e08-4892-b845-1081d9349ae4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e3cfdd5f-5306-409a-b3bc-bbbe99780be3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/RevenueRecognitionNarrrativeDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#RevenueRecognitionNarrrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/RevenueRecognitionNarrrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_fc7afb1a-8847-409f-9aa7-e67b53abf8e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_31058cd4-b117-4ab4-b5c6-3c8aa686a061" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_fc7afb1a-8847-409f-9aa7-e67b53abf8e3" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_31058cd4-b117-4ab4-b5c6-3c8aa686a061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_f27e5510-b4d2-4688-ace5-805ea9c3f7b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_31058cd4-b117-4ab4-b5c6-3c8aa686a061" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_f27e5510-b4d2-4688-ace5-805ea9c3f7b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_104cc963-392a-4261-9739-8fce134ce7d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_31058cd4-b117-4ab4-b5c6-3c8aa686a061" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_104cc963-392a-4261-9739-8fce134ce7d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_0ede6d76-2406-429d-a5fa-b4ede49dd71e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_104cc963-392a-4261-9739-8fce134ce7d6" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_0ede6d76-2406-429d-a5fa-b4ede49dd71e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_a1de8779-3d13-422f-bedf-4f01bfd1eb53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_104cc963-392a-4261-9739-8fce134ce7d6" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_a1de8779-3d13-422f-bedf-4f01bfd1eb53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_4c335d70-6d5a-4575-853f-f71a2c39563e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_104cc963-392a-4261-9739-8fce134ce7d6" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_4c335d70-6d5a-4575-853f-f71a2c39563e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_91fd494b-0176-486f-b025-d9b587e4cecd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_104cc963-392a-4261-9739-8fce134ce7d6" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_91fd494b-0176-486f-b025-d9b587e4cecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_de44f32d-0049-4a08-a6d6-9e7b1c656581" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_104cc963-392a-4261-9739-8fce134ce7d6" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_de44f32d-0049-4a08-a6d6-9e7b1c656581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNet_81cbaf65-797c-4eec-8b4e-e73c487a8eb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_104cc963-392a-4261-9739-8fce134ce7d6" xlink:to="loc_us-gaap_CapitalizedContractCostNet_81cbaf65-797c-4eec-8b4e-e73c487a8eb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNetCurrent_043dc026-ab2d-4960-89ea-daf5a1b47fea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostNetCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_104cc963-392a-4261-9739-8fce134ce7d6" xlink:to="loc_us-gaap_CapitalizedContractCostNetCurrent_043dc026-ab2d-4960-89ea-daf5a1b47fea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNetNoncurrent_aeba70e1-fbc1-4a02-b553-2c700634a293" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostNetNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_104cc963-392a-4261-9739-8fce134ce7d6" xlink:to="loc_us-gaap_CapitalizedContractCostNetNoncurrent_aeba70e1-fbc1-4a02-b553-2c700634a293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization_b53fc7ac-d936-4772-8977-14d583afb70c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_104cc963-392a-4261-9739-8fce134ce7d6" xlink:to="loc_us-gaap_CapitalizedContractCostAmortization_b53fc7ac-d936-4772-8977-14d583afb70c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/RevenueRecognitionNarrrativeDetails_1" xlink:type="simple" xlink:href="cmlf-20210804.xsd#RevenueRecognitionNarrrativeDetails_1"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/RevenueRecognitionNarrrativeDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/RevenueRecognitionContractAssetsandContractLiabilitiesDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#RevenueRecognitionContractAssetsandContractLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/RevenueRecognitionContractAssetsandContractLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f4e11173-b4b9-4cb8-bc03-74915fcd1bef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ChangeInContractWithCustomerAssetRollForward_4860e168-7106-4651-a610-bea52cf405bb" xlink:href="cmlf-20210804.xsd#cmlf_ChangeInContractWithCustomerAssetRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f4e11173-b4b9-4cb8-bc03-74915fcd1bef" xlink:to="loc_cmlf_ChangeInContractWithCustomerAssetRollForward_4860e168-7106-4651-a610-bea52cf405bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_f9be232c-b4ab-456a-9fdc-7ecc1fef33ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_ChangeInContractWithCustomerAssetRollForward_4860e168-7106-4651-a610-bea52cf405bb" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_f9be232c-b4ab-456a-9fdc-7ecc1fef33ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ContractWithCustomerAssetAdditions_50855412-012f-41e8-a15a-20b1d147a4b8" xlink:href="cmlf-20210804.xsd#cmlf_ContractWithCustomerAssetAdditions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_ChangeInContractWithCustomerAssetRollForward_4860e168-7106-4651-a610-bea52cf405bb" xlink:to="loc_cmlf_ContractWithCustomerAssetAdditions_50855412-012f-41e8-a15a-20b1d147a4b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable_14333c64-c7d1-4b4c-89b3-fae64ec38739" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetReclassifiedToReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_ChangeInContractWithCustomerAssetRollForward_4860e168-7106-4651-a610-bea52cf405bb" xlink:to="loc_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable_14333c64-c7d1-4b4c-89b3-fae64ec38739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ContractWithCustomerAssetRevenueRecognized_4bf4323a-3c42-40d5-a4ae-0ec5e6eb56c7" xlink:href="cmlf-20210804.xsd#cmlf_ContractWithCustomerAssetRevenueRecognized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_ChangeInContractWithCustomerAssetRollForward_4860e168-7106-4651-a610-bea52cf405bb" xlink:to="loc_cmlf_ContractWithCustomerAssetRevenueRecognized_4bf4323a-3c42-40d5-a4ae-0ec5e6eb56c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_d6eefcd9-3fd1-4f3f-b678-d0b474b562d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_ChangeInContractWithCustomerAssetRollForward_4860e168-7106-4651-a610-bea52cf405bb" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_d6eefcd9-3fd1-4f3f-b678-d0b474b562d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ChangeInContractWithCustomerLiabilityRollForward_990ede15-995e-444e-aa95-260a2c4218b5" xlink:href="cmlf-20210804.xsd#cmlf_ChangeInContractWithCustomerLiabilityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f4e11173-b4b9-4cb8-bc03-74915fcd1bef" xlink:to="loc_cmlf_ChangeInContractWithCustomerLiabilityRollForward_990ede15-995e-444e-aa95-260a2c4218b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_e9901567-3804-403d-87fc-b6e953dd0a18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_ChangeInContractWithCustomerLiabilityRollForward_990ede15-995e-444e-aa95-260a2c4218b5" xlink:to="loc_us-gaap_ContractWithCustomerLiability_e9901567-3804-403d-87fc-b6e953dd0a18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ContractWithCustomerLiabilityAdditions_5f5d8fad-8ec0-444e-b97a-05790a7d7867" xlink:href="cmlf-20210804.xsd#cmlf_ContractWithCustomerLiabilityAdditions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_ChangeInContractWithCustomerLiabilityRollForward_990ede15-995e-444e-aa95-260a2c4218b5" xlink:to="loc_cmlf_ContractWithCustomerLiabilityAdditions_5f5d8fad-8ec0-444e-b97a-05790a7d7867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_20680764-49ce-4979-a144-243eb3fe86d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_ChangeInContractWithCustomerLiabilityRollForward_990ede15-995e-444e-aa95-260a2c4218b5" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_20680764-49ce-4979-a144-243eb3fe86d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance_692a39a3-78a8-4cab-a174-3c462b9c89a9" xlink:href="cmlf-20210804.xsd#cmlf_ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_ChangeInContractWithCustomerLiabilityRollForward_990ede15-995e-444e-aa95-260a2c4218b5" xlink:to="loc_cmlf_ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance_692a39a3-78a8-4cab-a174-3c462b9c89a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_d613c68f-6298-4302-b208-d6347f3735f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_ChangeInContractWithCustomerLiabilityRollForward_990ede15-995e-444e-aa95-260a2c4218b5" xlink:to="loc_us-gaap_ContractWithCustomerLiability_d613c68f-6298-4302-b208-d6347f3735f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="cmlf-20210804.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0dfa6e1f-6612-40a9-bd4a-da757316f923" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_7cc123b1-0f04-4efb-8b20-566f6ae86867" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0dfa6e1f-6612-40a9-bd4a-da757316f923" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_7cc123b1-0f04-4efb-8b20-566f6ae86867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="cmlf-20210804.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_d4d381f3-fdb2-4695-b2cf-89bbc80ae3c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_f6d2a0cb-ab07-4524-83d4-a55c8fedb5b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_d4d381f3-fdb2-4695-b2cf-89bbc80ae3c5" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_f6d2a0cb-ab07-4524-83d4-a55c8fedb5b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#FairValueMeasurementsDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/FairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_56639bdc-0899-4e9e-8f45-d1d638891cf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9652f9b2-1b9c-442f-ac38-f95652a09f90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_56639bdc-0899-4e9e-8f45-d1d638891cf1" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9652f9b2-1b9c-442f-ac38-f95652a09f90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_cb1033c8-bb1a-46a4-9758-397e532d2cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9652f9b2-1b9c-442f-ac38-f95652a09f90" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_cb1033c8-bb1a-46a4-9758-397e532d2cdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_b812815d-8a94-406c-b39f-388d1cf87007" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_cb1033c8-bb1a-46a4-9758-397e532d2cdf" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_b812815d-8a94-406c-b39f-388d1cf87007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_83060dd6-a70b-44df-9b1b-630fc02b2e80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_b812815d-8a94-406c-b39f-388d1cf87007" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_83060dd6-a70b-44df-9b1b-630fc02b2e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_26de8f90-49b0-48df-873f-4d99e365712f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9652f9b2-1b9c-442f-ac38-f95652a09f90" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_26de8f90-49b0-48df-873f-4d99e365712f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_103430d2-0165-4107-8bdb-d6b404382475" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_26de8f90-49b0-48df-873f-4d99e365712f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_103430d2-0165-4107-8bdb-d6b404382475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_e5b4f769-d892-483d-bbcb-e06a26e100ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_103430d2-0165-4107-8bdb-d6b404382475" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_e5b4f769-d892-483d-bbcb-e06a26e100ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_5e287476-2855-4516-b75f-9015ca976ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_103430d2-0165-4107-8bdb-d6b404382475" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_5e287476-2855-4516-b75f-9015ca976ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_5fd9fb1b-1892-4212-b4e9-3f604ec54b2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_103430d2-0165-4107-8bdb-d6b404382475" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_5fd9fb1b-1892-4212-b4e9-3f604ec54b2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_057ac6f6-c054-43c3-8ea8-72a7fa4f9172" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9652f9b2-1b9c-442f-ac38-f95652a09f90" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_057ac6f6-c054-43c3-8ea8-72a7fa4f9172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_69b11fd7-727c-4fae-a144-ad8935c58b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_057ac6f6-c054-43c3-8ea8-72a7fa4f9172" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_69b11fd7-727c-4fae-a144-ad8935c58b0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_57ebbe3d-4525-45bc-9315-a3497e205797" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_69b11fd7-727c-4fae-a144-ad8935c58b0b" xlink:to="loc_us-gaap_MoneyMarketFundsMember_57ebbe3d-4525-45bc-9315-a3497e205797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_5b0698b7-4584-47a8-8b6a-adc739426215" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9652f9b2-1b9c-442f-ac38-f95652a09f90" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_5b0698b7-4584-47a8-8b6a-adc739426215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_fe42091b-3532-45b2-ac9f-0ad47564ba91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_5b0698b7-4584-47a8-8b6a-adc739426215" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_fe42091b-3532-45b2-ac9f-0ad47564ba91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_c86a1afa-57a5-4523-8cb7-055d549f130f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_5b0698b7-4584-47a8-8b6a-adc739426215" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_c86a1afa-57a5-4523-8cb7-055d549f130f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/PropertyandEquipment" xlink:type="simple" xlink:href="cmlf-20210804.xsd#PropertyandEquipment"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/PropertyandEquipment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_533d975c-b830-4592-bc43-c00ef053e486" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_1d153f23-3e3d-47db-af21-623e20938b0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_533d975c-b830-4592-bc43-c00ef053e486" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_1d153f23-3e3d-47db-af21-623e20938b0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/PropertyandEquipmentTables" xlink:type="simple" xlink:href="cmlf-20210804.xsd#PropertyandEquipmentTables"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/PropertyandEquipmentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_ecf599e0-0a03-45e3-b53d-7c722042acba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_4900fc42-ae01-4166-800f-b565450d0917" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_ecf599e0-0a03-45e3-b53d-7c722042acba" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_4900fc42-ae01-4166-800f-b565450d0917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/PropertyandEquipmentComponentsDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#PropertyandEquipmentComponentsDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/PropertyandEquipmentComponentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0e8ce15f-0f6d-42ed-8232-55129ac9251a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4128f589-e343-4f90-ac64-19388ddba379" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0e8ce15f-0f6d-42ed-8232-55129ac9251a" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4128f589-e343-4f90-ac64-19388ddba379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_06aaef10-2f80-4501-ba8c-29066179a731" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4128f589-e343-4f90-ac64-19388ddba379" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_06aaef10-2f80-4501-ba8c-29066179a731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f030742-253d-4caf-93c8-a2922f5401be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_06aaef10-2f80-4501-ba8c-29066179a731" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f030742-253d-4caf-93c8-a2922f5401be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_2b47a03a-6400-4a5f-bd70-93e04cd558eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f030742-253d-4caf-93c8-a2922f5401be" xlink:to="loc_us-gaap_EquipmentMember_2b47a03a-6400-4a5f-bd70-93e04cd558eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_EquipmentHeldUnderCapitalLeaseMember_af406b65-940d-4d5e-9344-cb4e56423b6d" xlink:href="cmlf-20210804.xsd#cmlf_EquipmentHeldUnderCapitalLeaseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f030742-253d-4caf-93c8-a2922f5401be" xlink:to="loc_cmlf_EquipmentHeldUnderCapitalLeaseMember_af406b65-940d-4d5e-9344-cb4e56423b6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_BuildingHeldUnderCapitalLeaseMember_b288c507-8485-43ed-b789-c3e903769e20" xlink:href="cmlf-20210804.xsd#cmlf_BuildingHeldUnderCapitalLeaseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f030742-253d-4caf-93c8-a2922f5401be" xlink:to="loc_cmlf_BuildingHeldUnderCapitalLeaseMember_b288c507-8485-43ed-b789-c3e903769e20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_58316525-db6f-4472-823c-ef37519ff0f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f030742-253d-4caf-93c8-a2922f5401be" xlink:to="loc_us-gaap_ConstructionInProgressMember_58316525-db6f-4472-823c-ef37519ff0f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_5342a039-f73c-4f34-bc81-6e76bff9ab01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f030742-253d-4caf-93c8-a2922f5401be" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_5342a039-f73c-4f34-bc81-6e76bff9ab01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_2ff0aa19-086c-4a02-8b97-2b823654bdcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f030742-253d-4caf-93c8-a2922f5401be" xlink:to="loc_us-gaap_ComputerEquipmentMember_2ff0aa19-086c-4a02-8b97-2b823654bdcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_FurnitureFixturesAndOtherEquipmentMember_f05e688a-3e3b-45da-8c8a-8a00a0d95cfe" xlink:href="cmlf-20210804.xsd#cmlf_FurnitureFixturesAndOtherEquipmentMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f030742-253d-4caf-93c8-a2922f5401be" xlink:to="loc_cmlf_FurnitureFixturesAndOtherEquipmentMember_f05e688a-3e3b-45da-8c8a-8a00a0d95cfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_fc2312a5-b464-4254-9f77-a836ca3e33a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f030742-253d-4caf-93c8-a2922f5401be" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_fc2312a5-b464-4254-9f77-a836ca3e33a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7f60f848-0594-40bb-9dbf-08dcfd78bcc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4128f589-e343-4f90-ac64-19388ddba379" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7f60f848-0594-40bb-9dbf-08dcfd78bcc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_dffbf5c7-97b6-41c8-b766-b4b2d44d2d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7f60f848-0594-40bb-9dbf-08dcfd78bcc7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_dffbf5c7-97b6-41c8-b766-b4b2d44d2d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_3541485f-7b80-4798-965c-c76a7c3c1e08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7f60f848-0594-40bb-9dbf-08dcfd78bcc7" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_3541485f-7b80-4798-965c-c76a7c3c1e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_c9b60ef6-3c3d-4d0e-a1c2-1596f23b5ed5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7f60f848-0594-40bb-9dbf-08dcfd78bcc7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_c9b60ef6-3c3d-4d0e-a1c2-1596f23b5ed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/PropertyandEquipmentNarrativeDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#PropertyandEquipmentNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/PropertyandEquipmentNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_18aa8db5-7559-45f0-a072-a3eb94b4d745" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_fbb0a8f7-38aa-49dc-927f-115c7922cbb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_18aa8db5-7559-45f0-a072-a3eb94b4d745" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_fbb0a8f7-38aa-49dc-927f-115c7922cbb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_208e1605-a792-4c88-9161-a6b330e434ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_18aa8db5-7559-45f0-a072-a3eb94b4d745" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_208e1605-a792-4c88-9161-a6b330e434ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_a8763dc6-5879-43c6-9062-79ed4099b05e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_18aa8db5-7559-45f0-a072-a3eb94b4d745" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_a8763dc6-5879-43c6-9062-79ed4099b05e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_1eccc416-47d0-4a1f-bc90-a8c832dd3ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_18aa8db5-7559-45f0-a072-a3eb94b4d745" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_1eccc416-47d0-4a1f-bc90-a8c832dd3ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/PropertyandEquipmentDepreciationandAmortizationDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#PropertyandEquipmentDepreciationandAmortizationDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/PropertyandEquipmentDepreciationandAmortizationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_8ef769d1-cea3-4007-85dc-0a1881140f2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_543b98fd-0c2e-48ab-a4e0-d0aad89db730" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_8ef769d1-cea3-4007-85dc-0a1881140f2d" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_543b98fd-0c2e-48ab-a4e0-d0aad89db730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_28b47e24-44f5-4670-8929-21dd0c3ad9e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_543b98fd-0c2e-48ab-a4e0-d0aad89db730" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_28b47e24-44f5-4670-8929-21dd0c3ad9e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_3195b51a-6f48-4464-83d3-8d0bef020279" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_28b47e24-44f5-4670-8929-21dd0c3ad9e8" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_3195b51a-6f48-4464-83d3-8d0bef020279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_06565d34-9132-46ec-8041-d630ccc9d2e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3195b51a-6f48-4464-83d3-8d0bef020279" xlink:to="loc_us-gaap_CostOfSalesMember_06565d34-9132-46ec-8041-d630ccc9d2e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_2fa5870e-54a2-4038-9356-5890e920272d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3195b51a-6f48-4464-83d3-8d0bef020279" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_2fa5870e-54a2-4038-9356-5890e920272d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_1f4306c9-9d86-4886-a2a2-6a44691701b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3195b51a-6f48-4464-83d3-8d0bef020279" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_1f4306c9-9d86-4886-a2a2-6a44691701b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_f970cadc-49e0-4315-9793-78de422c9571" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3195b51a-6f48-4464-83d3-8d0bef020279" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_f970cadc-49e0-4315-9793-78de422c9571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_faedaa46-0140-45f5-805e-b986407cf163" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_543b98fd-0c2e-48ab-a4e0-d0aad89db730" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_faedaa46-0140-45f5-805e-b986407cf163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_c900b4b5-abdc-40b2-9acb-5ec37b1c93e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_faedaa46-0140-45f5-805e-b986407cf163" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_c900b4b5-abdc-40b2-9acb-5ec37b1c93e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/RelatedPartyTransactions" xlink:type="simple" xlink:href="cmlf-20210804.xsd#RelatedPartyTransactions"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/RelatedPartyTransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_03950502-c4a1-4d66-92d7-27527cf6311e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_2eaceab5-dbf6-4a9f-be55-89eaf567eaca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_03950502-c4a1-4d66-92d7-27527cf6311e" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_2eaceab5-dbf6-4a9f-be55-89eaf567eaca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/RelatedPartyTransactionsTables" xlink:type="simple" xlink:href="cmlf-20210804.xsd#RelatedPartyTransactionsTables"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/RelatedPartyTransactionsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_4db732bf-2a73-484c-ac74-054c03ebb0c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_a00fd1d1-f662-4af3-a8f4-34a50cca9aca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_4db732bf-2a73-484c-ac74-054c03ebb0c7" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_a00fd1d1-f662-4af3-a8f4-34a50cca9aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/RelatedPartyTransactionsNarrativeDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#RelatedPartyTransactionsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/RelatedPartyTransactionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_8e40cd22-91a6-4e23-9d9f-0e00fcfd3536" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d36b01b7-b815-4388-9331-3b6b2a228481" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_8e40cd22-91a6-4e23-9d9f-0e00fcfd3536" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d36b01b7-b815-4388-9331-3b6b2a228481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a88905a0-fb51-4f3a-bbc8-1b5275125ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d36b01b7-b815-4388-9331-3b6b2a228481" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a88905a0-fb51-4f3a-bbc8-1b5275125ac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_d7de03b1-e388-42ec-8550-4bd153ca0dd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a88905a0-fb51-4f3a-bbc8-1b5275125ac2" xlink:to="loc_us-gaap_RelatedPartyDomain_d7de03b1-e388-42ec-8550-4bd153ca0dd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_2b67c2b5-8a91-4b19-916c-a2c76826bfc4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AffiliatedEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_d7de03b1-e388-42ec-8550-4bd153ca0dd5" xlink:to="loc_srt_AffiliatedEntityMember_2b67c2b5-8a91-4b19-916c-a2c76826bfc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_df9c15c7-e5b4-4426-bc3d-bc30945b4303" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d36b01b7-b815-4388-9331-3b6b2a228481" xlink:to="loc_srt_ProductOrServiceAxis_df9c15c7-e5b4-4426-bc3d-bc30945b4303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_fc8b5d15-8a95-4279-a675-21df8a1aa30c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_df9c15c7-e5b4-4426-bc3d-bc30945b4303" xlink:to="loc_srt_ProductsAndServicesDomain_fc8b5d15-8a95-4279-a675-21df8a1aa30c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_DiagnosticTestMember_35368fb3-0b32-4842-8781-308a8cbed17d" xlink:href="cmlf-20210804.xsd#cmlf_DiagnosticTestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_fc8b5d15-8a95-4279-a675-21df8a1aa30c" xlink:to="loc_cmlf_DiagnosticTestMember_35368fb3-0b32-4842-8781-308a8cbed17d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_dbf44a93-c783-4c2d-a7c1-ca0d4a08b060" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_fc8b5d15-8a95-4279-a675-21df8a1aa30c" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_dbf44a93-c783-4c2d-a7c1-ca0d4a08b060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_6673fbfd-bf24-431e-97d6-4a036d2e6aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d36b01b7-b815-4388-9331-3b6b2a228481" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_6673fbfd-bf24-431e-97d6-4a036d2e6aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_ea97838b-ab67-4199-bd3b-56c4e4a796fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_6673fbfd-bf24-431e-97d6-4a036d2e6aa2" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_ea97838b-ab67-4199-bd3b-56c4e4a796fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ContributionAgreementMember_b884c2ed-aabc-4152-8fd3-45fcdca2fea7" xlink:href="cmlf-20210804.xsd#cmlf_ContributionAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_ea97838b-ab67-4199-bd3b-56c4e4a796fb" xlink:to="loc_cmlf_ContributionAgreementMember_b884c2ed-aabc-4152-8fd3-45fcdca2fea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_RelatedPartyTSAAgreementMember_fb3027da-e266-4670-ba19-00a15afbe7ff" xlink:href="cmlf-20210804.xsd#cmlf_RelatedPartyTSAAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_ea97838b-ab67-4199-bd3b-56c4e4a796fb" xlink:to="loc_cmlf_RelatedPartyTSAAgreementMember_fb3027da-e266-4670-ba19-00a15afbe7ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_RelatedPartyServiceAgreementsMember_e54759b3-a875-48ba-b8a1-0e529d09d807" xlink:href="cmlf-20210804.xsd#cmlf_RelatedPartyServiceAgreementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_ea97838b-ab67-4199-bd3b-56c4e4a796fb" xlink:to="loc_cmlf_RelatedPartyServiceAgreementsMember_e54759b3-a875-48ba-b8a1-0e529d09d807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_1915d6dd-89a3-4df9-8051-02158febc3a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d36b01b7-b815-4388-9331-3b6b2a228481" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_1915d6dd-89a3-4df9-8051-02158febc3a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_RelatedPartyTransactionDividendRate_36d2b13d-84cc-4b48-8364-d2d7ba61e767" xlink:href="cmlf-20210804.xsd#cmlf_RelatedPartyTransactionDividendRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1915d6dd-89a3-4df9-8051-02158febc3a9" xlink:to="loc_cmlf_RelatedPartyTransactionDividendRate_36d2b13d-84cc-4b48-8364-d2d7ba61e767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_RelatedPartyTransactionFundingCommitmentToBeReceivedMaximum_f6d39af0-cbb4-4837-8eee-1cb3da8f3752" xlink:href="cmlf-20210804.xsd#cmlf_RelatedPartyTransactionFundingCommitmentToBeReceivedMaximum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1915d6dd-89a3-4df9-8051-02158febc3a9" xlink:to="loc_cmlf_RelatedPartyTransactionFundingCommitmentToBeReceivedMaximum_f6d39af0-cbb4-4837-8eee-1cb3da8f3752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CumulativeFunding_e77df3f9-bc83-4ce4-8f3b-5d446ff8f929" xlink:href="cmlf-20210804.xsd#cmlf_CumulativeFunding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1915d6dd-89a3-4df9-8051-02158febc3a9" xlink:to="loc_cmlf_CumulativeFunding_e77df3f9-bc83-4ce4-8f3b-5d446ff8f929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_d87a9d6b-d25e-4a2c-8158-2ddc20ffa776" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1915d6dd-89a3-4df9-8051-02158febc3a9" xlink:to="loc_us-gaap_RevenueFromRelatedParties_d87a9d6b-d25e-4a2c-8158-2ddc20ffa776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromRelatedPartiesCurrent_453c5793-be95-4e1f-8067-390dc42137e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1915d6dd-89a3-4df9-8051-02158febc3a9" xlink:to="loc_us-gaap_DueFromRelatedPartiesCurrent_453c5793-be95-4e1f-8067-390dc42137e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_1dba9410-eedd-4e1a-81d6-130a7410d52c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1915d6dd-89a3-4df9-8051-02158febc3a9" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_1dba9410-eedd-4e1a-81d6-130a7410d52c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrent_2d906e43-534d-4575-add4-74d090d75681" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1915d6dd-89a3-4df9-8051-02158febc3a9" xlink:to="loc_us-gaap_DueToRelatedPartiesCurrent_2d906e43-534d-4575-add4-74d090d75681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/RelatedPartyTransactionsRelatedPartyExpensesDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#RelatedPartyTransactionsRelatedPartyExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/RelatedPartyTransactionsRelatedPartyExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_393eab8b-8b2f-49b4-9696-fb8846f3274b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c7d29bf0-e9c6-4b7e-ae28-9682024c7210" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_393eab8b-8b2f-49b4-9696-fb8846f3274b" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c7d29bf0-e9c6-4b7e-ae28-9682024c7210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e1e05cef-5e68-4527-9695-d69d327830ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c7d29bf0-e9c6-4b7e-ae28-9682024c7210" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e1e05cef-5e68-4527-9695-d69d327830ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_35a3253f-be24-474b-89f2-1a68df825e00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e1e05cef-5e68-4527-9695-d69d327830ed" xlink:to="loc_us-gaap_RelatedPartyDomain_35a3253f-be24-474b-89f2-1a68df825e00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_ddb44db9-b777-48de-bbc1-d0cc4c126bf8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AffiliatedEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_35a3253f-be24-474b-89f2-1a68df825e00" xlink:to="loc_srt_AffiliatedEntityMember_ddb44db9-b777-48de-bbc1-d0cc4c126bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_4f781789-aaa7-4f9f-a6e5-f3b2012b146d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c7d29bf0-e9c6-4b7e-ae28-9682024c7210" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_4f781789-aaa7-4f9f-a6e5-f3b2012b146d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_3553dc6b-bdc8-4481-83f9-9ba90ebe76d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_4f781789-aaa7-4f9f-a6e5-f3b2012b146d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_3553dc6b-bdc8-4481-83f9-9ba90ebe76d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_f1d9f312-a2f9-416a-93bd-9025537d3839" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3553dc6b-bdc8-4481-83f9-9ba90ebe76d0" xlink:to="loc_us-gaap_CostOfSalesMember_f1d9f312-a2f9-416a-93bd-9025537d3839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_RelatedPartyExpensesMember_a68ecf43-01c1-4901-adb0-1b2b5aa51c43" xlink:href="cmlf-20210804.xsd#cmlf_RelatedPartyExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3553dc6b-bdc8-4481-83f9-9ba90ebe76d0" xlink:to="loc_cmlf_RelatedPartyExpensesMember_a68ecf43-01c1-4901-adb0-1b2b5aa51c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_03c0d4b0-de73-4e1a-8911-75bae5d1c0c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c7d29bf0-e9c6-4b7e-ae28-9682024c7210" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_03c0d4b0-de73-4e1a-8911-75bae5d1c0c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_a88f58f4-fa1a-48e1-83b7-ec4a5b3ea1e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_03c0d4b0-de73-4e1a-8911-75bae5d1c0c4" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_a88f58f4-fa1a-48e1-83b7-ec4a5b3ea1e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/LongTermDebt" xlink:type="simple" xlink:href="cmlf-20210804.xsd#LongTermDebt"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/LongTermDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_aa68678d-5f34-4e3d-8968-26a40b50f76f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_3ca87987-bba6-4864-9c59-aca89474400c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_aa68678d-5f34-4e3d-8968-26a40b50f76f" xlink:to="loc_us-gaap_LongTermDebtTextBlock_3ca87987-bba6-4864-9c59-aca89474400c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/LongTermDebtTables" xlink:type="simple" xlink:href="cmlf-20210804.xsd#LongTermDebtTables"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/LongTermDebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_9ef0d4cb-eed3-4425-8af8-9f4f9008baf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_8a02d334-2dd3-4772-8849-70bbf904d272" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9ef0d4cb-eed3-4425-8af8-9f4f9008baf5" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_8a02d334-2dd3-4772-8849-70bbf904d272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_4961b5dd-0b23-4a4c-83ae-ebbe36a1f869" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9ef0d4cb-eed3-4425-8af8-9f4f9008baf5" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_4961b5dd-0b23-4a4c-83ae-ebbe36a1f869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/LongTermDebt2016FundingCommitmentDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#LongTermDebt2016FundingCommitmentDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/LongTermDebt2016FundingCommitmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_115dfb12-fddf-4088-b322-3b3cd6ddc46d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_57e5b774-a651-49d4-8233-e180f556cee1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_115dfb12-fddf-4088-b322-3b3cd6ddc46d" xlink:to="loc_us-gaap_DebtInstrumentTable_57e5b774-a651-49d4-8233-e180f556cee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_fe0027f4-ee50-4d7f-8f01-142773c429a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_57e5b774-a651-49d4-8233-e180f556cee1" xlink:to="loc_us-gaap_DebtInstrumentAxis_fe0027f4-ee50-4d7f-8f01-142773c429a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9e4011f2-0dfb-4245-9e2b-1805579776e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_fe0027f4-ee50-4d7f-8f01-142773c429a1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9e4011f2-0dfb-4245-9e2b-1805579776e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_DECDLoanAgreementMember_fe080b29-e1a5-428c-bf2a-7d4519cac9fc" xlink:href="cmlf-20210804.xsd#cmlf_DECDLoanAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9e4011f2-0dfb-4245-9e2b-1805579776e5" xlink:to="loc_cmlf_DECDLoanAgreementMember_fe080b29-e1a5-428c-bf2a-7d4519cac9fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_PrincipalForgivenessPhaseAxis_06a866eb-2654-49c7-a856-981486b1040b" xlink:href="cmlf-20210804.xsd#cmlf_PrincipalForgivenessPhaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_57e5b774-a651-49d4-8233-e180f556cee1" xlink:to="loc_cmlf_PrincipalForgivenessPhaseAxis_06a866eb-2654-49c7-a856-981486b1040b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_PrincipalForgivenessPhaseDomain_4009c076-0bca-4a0c-b0b9-f0ededa4716c" xlink:href="cmlf-20210804.xsd#cmlf_PrincipalForgivenessPhaseDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_PrincipalForgivenessPhaseAxis_06a866eb-2654-49c7-a856-981486b1040b" xlink:to="loc_cmlf_PrincipalForgivenessPhaseDomain_4009c076-0bca-4a0c-b0b9-f0ededa4716c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_PrincipalForgivenessPhase1Member_95c6e818-962e-4f50-a21a-eb410b3bf958" xlink:href="cmlf-20210804.xsd#cmlf_PrincipalForgivenessPhase1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_PrincipalForgivenessPhaseDomain_4009c076-0bca-4a0c-b0b9-f0ededa4716c" xlink:to="loc_cmlf_PrincipalForgivenessPhase1Member_95c6e818-962e-4f50-a21a-eb410b3bf958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_PrincipalForgivenessPhase2Member_997e89e4-e7dc-4fc8-ae2e-9ba44dbf5268" xlink:href="cmlf-20210804.xsd#cmlf_PrincipalForgivenessPhase2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_PrincipalForgivenessPhaseDomain_4009c076-0bca-4a0c-b0b9-f0ededa4716c" xlink:to="loc_cmlf_PrincipalForgivenessPhase2Member_997e89e4-e7dc-4fc8-ae2e-9ba44dbf5268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_PrincipalForgivenessPhase3Member_e1ba612b-a267-444e-831c-eb2f6e906b7a" xlink:href="cmlf-20210804.xsd#cmlf_PrincipalForgivenessPhase3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_PrincipalForgivenessPhaseDomain_4009c076-0bca-4a0c-b0b9-f0ededa4716c" xlink:to="loc_cmlf_PrincipalForgivenessPhase3Member_e1ba612b-a267-444e-831c-eb2f6e906b7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_PrincipalForgivenessPhase4Member_1702219a-2531-4b83-8db0-4dbde3e17d32" xlink:href="cmlf-20210804.xsd#cmlf_PrincipalForgivenessPhase4Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_PrincipalForgivenessPhaseDomain_4009c076-0bca-4a0c-b0b9-f0ededa4716c" xlink:to="loc_cmlf_PrincipalForgivenessPhase4Member_1702219a-2531-4b83-8db0-4dbde3e17d32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_80019849-7e33-4a00-9958-70cd847545ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_57e5b774-a651-49d4-8233-e180f556cee1" xlink:to="loc_us-gaap_DebtInstrumentLineItems_80019849-7e33-4a00-9958-70cd847545ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_92e000a5-1af1-4284-a9f8-3df83c80a138" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80019849-7e33-4a00-9958-70cd847545ac" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_92e000a5-1af1-4284-a9f8-3df83c80a138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_DebtInstrumentFundingCommitment_d35283e6-ddec-4332-be33-441cfbee67da" xlink:href="cmlf-20210804.xsd#cmlf_DebtInstrumentFundingCommitment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80019849-7e33-4a00-9958-70cd847545ac" xlink:to="loc_cmlf_DebtInstrumentFundingCommitment_d35283e6-ddec-4332-be33-441cfbee67da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_a411ac02-937c-4e09-b53d-a4a15cb3e3be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80019849-7e33-4a00-9958-70cd847545ac" xlink:to="loc_us-gaap_DebtInstrumentTerm_a411ac02-937c-4e09-b53d-a4a15cb3e3be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6f607d7f-c7ab-4475-96fb-c099e1d11eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80019849-7e33-4a00-9958-70cd847545ac" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6f607d7f-c7ab-4475-96fb-c099e1d11eb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_DebtInstrumentConditionalPrincipalForgivenessMaximum_ac91ea59-8946-42ee-9fe9-b1d24aa47f77" xlink:href="cmlf-20210804.xsd#cmlf_DebtInstrumentConditionalPrincipalForgivenessMaximum"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80019849-7e33-4a00-9958-70cd847545ac" xlink:to="loc_cmlf_DebtInstrumentConditionalPrincipalForgivenessMaximum_ac91ea59-8946-42ee-9fe9-b1d24aa47f77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_DebtInstrumentPrincipalForgivenessNumberOfPositionsCreatedAndMaintainedOver24MonthPeriod_b9cfb10e-fa03-46a6-93b6-69be223f61f6" xlink:href="cmlf-20210804.xsd#cmlf_DebtInstrumentPrincipalForgivenessNumberOfPositionsCreatedAndMaintainedOver24MonthPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80019849-7e33-4a00-9958-70cd847545ac" xlink:to="loc_cmlf_DebtInstrumentPrincipalForgivenessNumberOfPositionsCreatedAndMaintainedOver24MonthPeriod_b9cfb10e-fa03-46a6-93b6-69be223f61f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_DebtInstrumentPrincipalForgivenessAverageCompensationForPositionsCreatedOver24MonthPeriod_9f183e4f-2975-4282-8d01-5e2dba30e66b" xlink:href="cmlf-20210804.xsd#cmlf_DebtInstrumentPrincipalForgivenessAverageCompensationForPositionsCreatedOver24MonthPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80019849-7e33-4a00-9958-70cd847545ac" xlink:to="loc_cmlf_DebtInstrumentPrincipalForgivenessAverageCompensationForPositionsCreatedOver24MonthPeriod_9f183e4f-2975-4282-8d01-5e2dba30e66b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_DebtInstrumentPrincipalForgivenessNumberOfPositionsCreatedOver24MonthPeriod_74ccb4cd-f502-4c0c-8168-21db2c9be596" xlink:href="cmlf-20210804.xsd#cmlf_DebtInstrumentPrincipalForgivenessNumberOfPositionsCreatedOver24MonthPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80019849-7e33-4a00-9958-70cd847545ac" xlink:to="loc_cmlf_DebtInstrumentPrincipalForgivenessNumberOfPositionsCreatedOver24MonthPeriod_74ccb4cd-f502-4c0c-8168-21db2c9be596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_DebtInstrumentPrincipalForgivenessNumberOfPositionsMaintainedOver24MonthPeriod_82eb6956-a79d-4f2f-bcc5-05a715a1c1d3" xlink:href="cmlf-20210804.xsd#cmlf_DebtInstrumentPrincipalForgivenessNumberOfPositionsMaintainedOver24MonthPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80019849-7e33-4a00-9958-70cd847545ac" xlink:to="loc_cmlf_DebtInstrumentPrincipalForgivenessNumberOfPositionsMaintainedOver24MonthPeriod_82eb6956-a79d-4f2f-bcc5-05a715a1c1d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_LoanForgivenessIncome_b82c7f31-0217-4ea3-82b5-e896248f3a72" xlink:href="cmlf-20210804.xsd#cmlf_LoanForgivenessIncome"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80019849-7e33-4a00-9958-70cd847545ac" xlink:to="loc_cmlf_LoanForgivenessIncome_b82c7f31-0217-4ea3-82b5-e896248f3a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_a40a3838-a4a8-4753-b7bf-e5e9be46b4b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80019849-7e33-4a00-9958-70cd847545ac" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_a40a3838-a4a8-4753-b7bf-e5e9be46b4b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_aea85fa0-ca1d-4e55-8d96-5f8366b3dbf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80019849-7e33-4a00-9958-70cd847545ac" xlink:to="loc_us-gaap_LongTermDebt_aea85fa0-ca1d-4e55-8d96-5f8366b3dbf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/LongTermDebtPhasedFundingandPotentialLoanForgivenessMilestonesDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#LongTermDebtPhasedFundingandPotentialLoanForgivenessMilestonesDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/LongTermDebtPhasedFundingandPotentialLoanForgivenessMilestonesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2aebdddb-ee0c-4d35-a292-4d095ac15353" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a6380f40-7ade-4400-8ca6-4fd01626117f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2aebdddb-ee0c-4d35-a292-4d095ac15353" xlink:to="loc_us-gaap_DebtInstrumentTable_a6380f40-7ade-4400-8ca6-4fd01626117f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_daf50950-e668-45e7-8607-c5fbd5ffd5ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a6380f40-7ade-4400-8ca6-4fd01626117f" xlink:to="loc_us-gaap_DebtInstrumentAxis_daf50950-e668-45e7-8607-c5fbd5ffd5ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c67b9a98-7f72-45db-82ab-ef894ed2a5c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_daf50950-e668-45e7-8607-c5fbd5ffd5ee" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c67b9a98-7f72-45db-82ab-ef894ed2a5c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_DECDLoanAgreementMember_59b829b9-5632-463c-ab7f-8c8a5387edee" xlink:href="cmlf-20210804.xsd#cmlf_DECDLoanAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c67b9a98-7f72-45db-82ab-ef894ed2a5c7" xlink:to="loc_cmlf_DECDLoanAgreementMember_59b829b9-5632-463c-ab7f-8c8a5387edee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_PrincipalForgivenessPhaseAxis_438e6e31-2f16-4e42-af28-f87c2be7596f" xlink:href="cmlf-20210804.xsd#cmlf_PrincipalForgivenessPhaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a6380f40-7ade-4400-8ca6-4fd01626117f" xlink:to="loc_cmlf_PrincipalForgivenessPhaseAxis_438e6e31-2f16-4e42-af28-f87c2be7596f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_PrincipalForgivenessPhaseDomain_55bca782-04b6-43d6-9565-a885075f72fe" xlink:href="cmlf-20210804.xsd#cmlf_PrincipalForgivenessPhaseDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_PrincipalForgivenessPhaseAxis_438e6e31-2f16-4e42-af28-f87c2be7596f" xlink:to="loc_cmlf_PrincipalForgivenessPhaseDomain_55bca782-04b6-43d6-9565-a885075f72fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_PrincipalForgivenessPhase1Member_b293350e-6f49-4aa7-b245-59a9473b1036" xlink:href="cmlf-20210804.xsd#cmlf_PrincipalForgivenessPhase1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_PrincipalForgivenessPhaseDomain_55bca782-04b6-43d6-9565-a885075f72fe" xlink:to="loc_cmlf_PrincipalForgivenessPhase1Member_b293350e-6f49-4aa7-b245-59a9473b1036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_PrincipalForgivenessPhase2Member_7da54a4e-f393-4f52-b8c6-9da37066d44a" xlink:href="cmlf-20210804.xsd#cmlf_PrincipalForgivenessPhase2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_PrincipalForgivenessPhaseDomain_55bca782-04b6-43d6-9565-a885075f72fe" xlink:to="loc_cmlf_PrincipalForgivenessPhase2Member_7da54a4e-f393-4f52-b8c6-9da37066d44a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_PrincipalForgivenessPhase3Member_cb2d1ada-73bf-4cb0-8a89-e628431f6de3" xlink:href="cmlf-20210804.xsd#cmlf_PrincipalForgivenessPhase3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_PrincipalForgivenessPhaseDomain_55bca782-04b6-43d6-9565-a885075f72fe" xlink:to="loc_cmlf_PrincipalForgivenessPhase3Member_cb2d1ada-73bf-4cb0-8a89-e628431f6de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_PrincipalForgivenessPhase4Member_9fdcb371-ce20-4c4e-b38c-209dc463097a" xlink:href="cmlf-20210804.xsd#cmlf_PrincipalForgivenessPhase4Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_PrincipalForgivenessPhaseDomain_55bca782-04b6-43d6-9565-a885075f72fe" xlink:to="loc_cmlf_PrincipalForgivenessPhase4Member_9fdcb371-ce20-4c4e-b38c-209dc463097a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_bb1187de-e0d2-48cc-baee-2f3e8645f889" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a6380f40-7ade-4400-8ca6-4fd01626117f" xlink:to="loc_us-gaap_DebtInstrumentLineItems_bb1187de-e0d2-48cc-baee-2f3e8645f889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_DebtInstrumentFundingCommitment_5f4841b4-252d-418e-938d-c6a868e2ac2d" xlink:href="cmlf-20210804.xsd#cmlf_DebtInstrumentFundingCommitment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bb1187de-e0d2-48cc-baee-2f3e8645f889" xlink:to="loc_cmlf_DebtInstrumentFundingCommitment_5f4841b4-252d-418e-938d-c6a868e2ac2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_DebtInstrumentConditionalPrincipalForgivenessMaximum_a4c94a2f-d8b1-48a4-884a-60a5cbcd7597" xlink:href="cmlf-20210804.xsd#cmlf_DebtInstrumentConditionalPrincipalForgivenessMaximum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bb1187de-e0d2-48cc-baee-2f3e8645f889" xlink:to="loc_cmlf_DebtInstrumentConditionalPrincipalForgivenessMaximum_a4c94a2f-d8b1-48a4-884a-60a5cbcd7597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/LongTermDebt2020MasterLoanAgreementDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#LongTermDebt2020MasterLoanAgreementDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/LongTermDebt2020MasterLoanAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_c1747614-3194-486c-9e8d-a4cc8ce26938" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_0b33386f-ec0c-4b15-b666-c5ea18eee960" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c1747614-3194-486c-9e8d-a4cc8ce26938" xlink:to="loc_us-gaap_DebtInstrumentTable_0b33386f-ec0c-4b15-b666-c5ea18eee960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b3d1e271-0535-41d7-9683-58d960ed5090" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_0b33386f-ec0c-4b15-b666-c5ea18eee960" xlink:to="loc_us-gaap_DebtInstrumentAxis_b3d1e271-0535-41d7-9683-58d960ed5090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f44c19ab-ef65-4dc9-bc5a-ea03ed8bc8f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_b3d1e271-0535-41d7-9683-58d960ed5090" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f44c19ab-ef65-4dc9-bc5a-ea03ed8bc8f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_EquipmentNotesMember_12fa4daf-28a2-4676-8a50-fc349cd91ad6" xlink:href="cmlf-20210804.xsd#cmlf_EquipmentNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f44c19ab-ef65-4dc9-bc5a-ea03ed8bc8f4" xlink:to="loc_cmlf_EquipmentNotesMember_12fa4daf-28a2-4676-8a50-fc349cd91ad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_e9eb00d3-fe7f-41ab-aaac-d1264f20d6ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_0b33386f-ec0c-4b15-b666-c5ea18eee960" xlink:to="loc_us-gaap_DebtInstrumentLineItems_e9eb00d3-fe7f-41ab-aaac-d1264f20d6ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_fc024849-aad7-4e64-a1f1-56f0aed24b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e9eb00d3-fe7f-41ab-aaac-d1264f20d6ca" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_fc024849-aad7-4e64-a1f1-56f0aed24b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_DebtInstrumentDepositAccountPercentageOfPrincipalOutstanding_f44e4836-0fcd-4d51-9a34-ab5e7db8f179" xlink:href="cmlf-20210804.xsd#cmlf_DebtInstrumentDepositAccountPercentageOfPrincipalOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e9eb00d3-fe7f-41ab-aaac-d1264f20d6ca" xlink:to="loc_cmlf_DebtInstrumentDepositAccountPercentageOfPrincipalOutstanding_f44e4836-0fcd-4d51-9a34-ab5e7db8f179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_DebtInstrumentNumberOfConsecutiveMonthlyPaymentsRequired_c378ede9-b7ec-4fa5-999e-5aee6fc84a0d" xlink:href="cmlf-20210804.xsd#cmlf_DebtInstrumentNumberOfConsecutiveMonthlyPaymentsRequired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e9eb00d3-fe7f-41ab-aaac-d1264f20d6ca" xlink:to="loc_cmlf_DebtInstrumentNumberOfConsecutiveMonthlyPaymentsRequired_c378ede9-b7ec-4fa5-999e-5aee6fc84a0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_DebtInstrumentPeriodicPaymentPrincipalAndInterest_e1b3bc36-a835-4597-8505-c177179c34eb" xlink:href="cmlf-20210804.xsd#cmlf_DebtInstrumentPeriodicPaymentPrincipalAndInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e9eb00d3-fe7f-41ab-aaac-d1264f20d6ca" xlink:to="loc_cmlf_DebtInstrumentPeriodicPaymentPrincipalAndInterest_e1b3bc36-a835-4597-8505-c177179c34eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_978565a1-da80-4e54-a275-4d93827849a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e9eb00d3-fe7f-41ab-aaac-d1264f20d6ca" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_978565a1-da80-4e54-a275-4d93827849a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_d958866a-5cd5-4df9-8dd2-2896c74132da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e9eb00d3-fe7f-41ab-aaac-d1264f20d6ca" xlink:to="loc_us-gaap_LongTermDebt_d958866a-5cd5-4df9-8dd2-2896c74132da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/LongTermDebt2020MasterLeaseAgreementDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#LongTermDebt2020MasterLeaseAgreementDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/LongTermDebt2020MasterLeaseAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_422de9f1-3672-4189-9d0a-a39beeb142cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleLeasebackTransactionTable_5c85c3cf-a261-4678-99e1-189be2fe4366" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleLeasebackTransactionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_422de9f1-3672-4189-9d0a-a39beeb142cd" xlink:to="loc_us-gaap_SaleLeasebackTransactionTable_5c85c3cf-a261-4678-99e1-189be2fe4366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9b5876bb-db5e-4d56-a76a-805d61481fc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleLeasebackTransactionTable_5c85c3cf-a261-4678-99e1-189be2fe4366" xlink:to="loc_us-gaap_DebtInstrumentAxis_9b5876bb-db5e-4d56-a76a-805d61481fc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ce4c3c7e-7c0e-4e2c-9d30-be506ba07b19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_9b5876bb-db5e-4d56-a76a-805d61481fc0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ce4c3c7e-7c0e-4e2c-9d30-be506ba07b19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_MasterLeaseAgreementMember_33c04e6f-1cd5-47ae-9c17-d9280b73802e" xlink:href="cmlf-20210804.xsd#cmlf_MasterLeaseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ce4c3c7e-7c0e-4e2c-9d30-be506ba07b19" xlink:to="loc_cmlf_MasterLeaseAgreementMember_33c04e6f-1cd5-47ae-9c17-d9280b73802e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_27bba4d4-0f36-4f0a-815a-a20616b0ce09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleLeasebackTransactionTable_5c85c3cf-a261-4678-99e1-189be2fe4366" xlink:to="loc_us-gaap_DebtInstrumentLineItems_27bba4d4-0f36-4f0a-815a-a20616b0ce09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_beb755f5-263a-4a99-a6c4-68efc7a5a739" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_27bba4d4-0f36-4f0a-815a-a20616b0ce09" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_beb755f5-263a-4a99-a6c4-68efc7a5a739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CapitalLeaseBargainPurchaseOptionPurchaseAmount_f1be6369-decb-45af-8484-ee68e0e724eb" xlink:href="cmlf-20210804.xsd#cmlf_CapitalLeaseBargainPurchaseOptionPurchaseAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_27bba4d4-0f36-4f0a-815a-a20616b0ce09" xlink:to="loc_cmlf_CapitalLeaseBargainPurchaseOptionPurchaseAmount_f1be6369-decb-45af-8484-ee68e0e724eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_a95e6f19-c074-4ba5-a08d-1906f41e7038" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_27bba4d4-0f36-4f0a-815a-a20616b0ce09" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_a95e6f19-c074-4ba5-a08d-1906f41e7038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_DebtInstrumentNumberOfConsecutiveMonthlyPaymentsRequired_908430d1-9b28-4eed-a780-98389f0557cf" xlink:href="cmlf-20210804.xsd#cmlf_DebtInstrumentNumberOfConsecutiveMonthlyPaymentsRequired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_27bba4d4-0f36-4f0a-815a-a20616b0ce09" xlink:to="loc_cmlf_DebtInstrumentNumberOfConsecutiveMonthlyPaymentsRequired_908430d1-9b28-4eed-a780-98389f0557cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_DebtInstrumentPeriodicPaymentPrincipalAndInterest_a03d479a-2a59-4ebb-b1b5-1afc943d53ab" xlink:href="cmlf-20210804.xsd#cmlf_DebtInstrumentPeriodicPaymentPrincipalAndInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_27bba4d4-0f36-4f0a-815a-a20616b0ce09" xlink:to="loc_cmlf_DebtInstrumentPeriodicPaymentPrincipalAndInterest_a03d479a-2a59-4ebb-b1b5-1afc943d53ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6fcd5ca6-9fde-42e9-a882-b824617c7eae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_27bba4d4-0f36-4f0a-815a-a20616b0ce09" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6fcd5ca6-9fde-42e9-a882-b824617c7eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_LetterOfCreditDepositRequiredPercentage_4978a915-ad71-451c-880d-b42ac15e9868" xlink:href="cmlf-20210804.xsd#cmlf_LetterOfCreditDepositRequiredPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_27bba4d4-0f36-4f0a-815a-a20616b0ce09" xlink:to="loc_cmlf_LetterOfCreditDepositRequiredPercentage_4978a915-ad71-451c-880d-b42ac15e9868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_LetterOfCreditAllowedPercentageReductionWhenCertainTermsAreMet_338b54c8-a619-4690-a6bb-fbd459cf4fbe" xlink:href="cmlf-20210804.xsd#cmlf_LetterOfCreditAllowedPercentageReductionWhenCertainTermsAreMet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_27bba4d4-0f36-4f0a-815a-a20616b0ce09" xlink:to="loc_cmlf_LetterOfCreditAllowedPercentageReductionWhenCertainTermsAreMet_338b54c8-a619-4690-a6bb-fbd459cf4fbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_51baaa10-5fb0-463b-9345-eaacae1d298c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_27bba4d4-0f36-4f0a-815a-a20616b0ce09" xlink:to="loc_us-gaap_LongTermDebt_51baaa10-5fb0-463b-9345-eaacae1d298c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/LongTermDebtMaturitiesDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#LongTermDebtMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/LongTermDebtMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_3f0e060d-c33a-4342-b60e-77b5d53430a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_741fd9c4-223c-4f1a-837d-579874a8da52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_3f0e060d-c33a-4342-b60e-77b5d53430a8" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_741fd9c4-223c-4f1a-837d-579874a8da52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_d08dbb1d-74f7-4bc0-ac67-30b008e4ab58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_3f0e060d-c33a-4342-b60e-77b5d53430a8" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_d08dbb1d-74f7-4bc0-ac67-30b008e4ab58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_dd74c6d0-a106-4525-8988-8baf469ffc4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_3f0e060d-c33a-4342-b60e-77b5d53430a8" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_dd74c6d0-a106-4525-8988-8baf469ffc4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_26007108-82a7-4bf4-a9bb-bda30c91f0a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_3f0e060d-c33a-4342-b60e-77b5d53430a8" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_26007108-82a7-4bf4-a9bb-bda30c91f0a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_1fd7a2b1-21aa-408f-8449-4b7d87f42b61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_3f0e060d-c33a-4342-b60e-77b5d53430a8" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_1fd7a2b1-21aa-408f-8449-4b7d87f42b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_c932a2c7-a21a-47cf-8998-bb852604e486" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_3f0e060d-c33a-4342-b60e-77b5d53430a8" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_c932a2c7-a21a-47cf-8998-bb852604e486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_29e1bcb8-aac9-46e0-ba1c-b14e90edfd84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_3f0e060d-c33a-4342-b60e-77b5d53430a8" xlink:to="loc_us-gaap_LongTermDebt_29e1bcb8-aac9-46e0-ba1c-b14e90edfd84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_b96b0a18-69a7-42c5-b57b-7aee33016b00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_3f0e060d-c33a-4342-b60e-77b5d53430a8" xlink:to="loc_us-gaap_LongTermDebtCurrent_b96b0a18-69a7-42c5-b57b-7aee33016b00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_de30b51b-f194-4c37-90fb-e55116b254f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_3f0e060d-c33a-4342-b60e-77b5d53430a8" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_de30b51b-f194-4c37-90fb-e55116b254f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/LongTermDebtMaturitiesDetails_1" xlink:type="simple" xlink:href="cmlf-20210804.xsd#LongTermDebtMaturitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/LongTermDebtMaturitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="cmlf-20210804.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_44e3f82c-1801-4d2c-92cc-8e4453c65c11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_4fd0ca0f-d85e-43ef-92f3-74cf9e1ad265" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_44e3f82c-1801-4d2c-92cc-8e4453c65c11" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_4fd0ca0f-d85e-43ef-92f3-74cf9e1ad265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/CommitmentsandContingenciesTables" xlink:type="simple" xlink:href="cmlf-20210804.xsd#CommitmentsandContingenciesTables"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/CommitmentsandContingenciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_29f38f01-9684-4c57-8628-d77fe4a9868b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_1c58aed7-9c61-404a-8fae-f640aef8a04a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_29f38f01-9684-4c57-8628-d77fe4a9868b" xlink:to="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_1c58aed7-9c61-404a-8fae-f640aef8a04a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock_b185da99-c7ef-43e6-909e-1b47c4e71bd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_29f38f01-9684-4c57-8628-d77fe4a9868b" xlink:to="loc_us-gaap_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock_b185da99-c7ef-43e6-909e-1b47c4e71bd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e4c1da31-2c55-4d2a-9219-9e7ad2c2cc8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_5c9fb545-e5f6-4edf-a874-f32e311e7b0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e4c1da31-2c55-4d2a-9219-9e7ad2c2cc8f" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_5c9fb545-e5f6-4edf-a874-f32e311e7b0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_e0dd2c29-d819-4162-88a1-0748755507f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_5c9fb545-e5f6-4edf-a874-f32e311e7b0e" xlink:to="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_e0dd2c29-d819-4162-88a1-0748755507f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_ea67c8dd-1a2c-4b3a-bbf8-d7637123eded" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_e0dd2c29-d819-4162-88a1-0748755507f8" xlink:to="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_ea67c8dd-1a2c-4b3a-bbf8-d7637123eded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ISMMSLeaseMember_40298c48-f98f-444d-9ccc-08d2e6b3f28d" xlink:href="cmlf-20210804.xsd#cmlf_ISMMSLeaseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_ea67c8dd-1a2c-4b3a-bbf8-d7637123eded" xlink:to="loc_cmlf_ISMMSLeaseMember_40298c48-f98f-444d-9ccc-08d2e6b3f28d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ConnecticutOfficeSpaceLeaseMember_44313274-25fd-4c5d-b4d9-83b06377b272" xlink:href="cmlf-20210804.xsd#cmlf_ConnecticutOfficeSpaceLeaseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_ea67c8dd-1a2c-4b3a-bbf8-d7637123eded" xlink:to="loc_cmlf_ConnecticutOfficeSpaceLeaseMember_44313274-25fd-4c5d-b4d9-83b06377b272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ConnecticutLabSpaceLeaseMember_ac8c3336-808d-4222-8ed9-f9db0bb3e9af" xlink:href="cmlf-20210804.xsd#cmlf_ConnecticutLabSpaceLeaseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_ea67c8dd-1a2c-4b3a-bbf8-d7637123eded" xlink:to="loc_cmlf_ConnecticutLabSpaceLeaseMember_ac8c3336-808d-4222-8ed9-f9db0bb3e9af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f3ab3a72-0d49-4f97-9fb7-9112f8966f2e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_5c9fb545-e5f6-4edf-a874-f32e311e7b0e" xlink:to="loc_srt_RangeAxis_f3ab3a72-0d49-4f97-9fb7-9112f8966f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a6f5f9b5-e445-4acd-8f7a-38f22f20d428" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_f3ab3a72-0d49-4f97-9fb7-9112f8966f2e" xlink:to="loc_srt_RangeMember_a6f5f9b5-e445-4acd-8f7a-38f22f20d428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5008b57d-af59-4185-8010-551f15dacb45" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a6f5f9b5-e445-4acd-8f7a-38f22f20d428" xlink:to="loc_srt_MinimumMember_5008b57d-af59-4185-8010-551f15dacb45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9e5e150a-2542-4d42-8fd1-b94933795e52" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a6f5f9b5-e445-4acd-8f7a-38f22f20d428" xlink:to="loc_srt_MaximumMember_9e5e150a-2542-4d42-8fd1-b94933795e52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermAxis_1253ada5-9d47-4440-8a02-82a9923d89cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseContractualTermAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_5c9fb545-e5f6-4edf-a874-f32e311e7b0e" xlink:to="loc_us-gaap_LeaseContractualTermAxis_1253ada5-9d47-4440-8a02-82a9923d89cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_d252f2a6-c9ef-4673-8313-78d26577dea2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermAxis_1253ada5-9d47-4440-8a02-82a9923d89cf" xlink:to="loc_us-gaap_LeaseContractualTermDomain_d252f2a6-c9ef-4673-8313-78d26577dea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_OneRenewalPeriodMember_02dfcc66-df8f-41ea-bc7a-dbd2139938ac" xlink:href="cmlf-20210804.xsd#cmlf_OneRenewalPeriodMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermDomain_d252f2a6-c9ef-4673-8313-78d26577dea2" xlink:to="loc_cmlf_OneRenewalPeriodMember_02dfcc66-df8f-41ea-bc7a-dbd2139938ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_TwoRenewalPeriodsMember_2d8b445a-688a-49cc-a870-550fa3eb2fb4" xlink:href="cmlf-20210804.xsd#cmlf_TwoRenewalPeriodsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermDomain_d252f2a6-c9ef-4673-8313-78d26577dea2" xlink:to="loc_cmlf_TwoRenewalPeriodsMember_2d8b445a-688a-49cc-a870-550fa3eb2fb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_21e6a591-20f4-4683-b629-1868cb5a032a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_5c9fb545-e5f6-4edf-a874-f32e311e7b0e" xlink:to="loc_us-gaap_OperatingLeasedAssetsLineItems_21e6a591-20f4-4683-b629-1868cb5a032a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_941cee16-212c-44f5-aa83-3c18279f9caf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_21e6a591-20f4-4683-b629-1868cb5a032a" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_941cee16-212c-44f5-aa83-3c18279f9caf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_2a04e22f-a1c0-4afe-a3ab-1f92579bd374" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_21e6a591-20f4-4683-b629-1868cb5a032a" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_2a04e22f-a1c0-4afe-a3ab-1f92579bd374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_3d249f83-3901-4b23-bb4a-00a53a7748d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCash"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_21e6a591-20f4-4683-b629-1868cb5a032a" xlink:to="loc_us-gaap_RestrictedCash_3d249f83-3901-4b23-bb4a-00a53a7748d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseAndRentalExpense_39b77a4b-9f82-440d-afd8-7f0d866bbc49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseAndRentalExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_21e6a591-20f4-4683-b629-1868cb5a032a" xlink:to="loc_us-gaap_LeaseAndRentalExpense_39b77a4b-9f82-440d-afd8-7f0d866bbc49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_MonthToMonthOperatingLeaseRentExpense_5178d992-ed1b-476c-96a5-502440a25d01" xlink:href="cmlf-20210804.xsd#cmlf_MonthToMonthOperatingLeaseRentExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_21e6a591-20f4-4683-b629-1868cb5a032a" xlink:to="loc_cmlf_MonthToMonthOperatingLeaseRentExpense_5178d992-ed1b-476c-96a5-502440a25d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CapitalLeaseObligationTerm_2ab1489d-908d-4880-9632-f6cce5eafe13" xlink:href="cmlf-20210804.xsd#cmlf_CapitalLeaseObligationTerm"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_21e6a591-20f4-4683-b629-1868cb5a032a" xlink:to="loc_cmlf_CapitalLeaseObligationTerm_2ab1489d-908d-4880-9632-f6cce5eafe13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CapitalLeasesOfLesseeInterestRate_a440ca26-d5a5-439a-a3e7-80fdc2bf5cf1" xlink:href="cmlf-20210804.xsd#cmlf_CapitalLeasesOfLesseeInterestRate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_21e6a591-20f4-4683-b629-1868cb5a032a" xlink:to="loc_cmlf_CapitalLeasesOfLesseeInterestRate_a440ca26-d5a5-439a-a3e7-80fdc2bf5cf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CapitalLeaseRenewalTerm_f048ace1-ecfa-45ec-8e6a-5c6f3e1f8020" xlink:href="cmlf-20210804.xsd#cmlf_CapitalLeaseRenewalTerm"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_21e6a591-20f4-4683-b629-1868cb5a032a" xlink:to="loc_cmlf_CapitalLeaseRenewalTerm_f048ace1-ecfa-45ec-8e6a-5c6f3e1f8020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CapitalLeaseCancellationFee_0b165336-2d2e-4d09-8ab2-273e54bad84e" xlink:href="cmlf-20210804.xsd#cmlf_CapitalLeaseCancellationFee"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_21e6a591-20f4-4683-b629-1868cb5a032a" xlink:to="loc_cmlf_CapitalLeaseCancellationFee_0b165336-2d2e-4d09-8ab2-273e54bad84e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CapitalLeaseInterestRateStatedPercentage_3850494d-bd98-43fc-bcb3-cb4949c9a8ff" xlink:href="cmlf-20210804.xsd#cmlf_CapitalLeaseInterestRateStatedPercentage"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_21e6a591-20f4-4683-b629-1868cb5a032a" xlink:to="loc_cmlf_CapitalLeaseInterestRateStatedPercentage_3850494d-bd98-43fc-bcb3-cb4949c9a8ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasedAssetsGross_3cbe33c9-5d0b-461d-85b2-ec51815b0c39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLeasedAssetsGross"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_21e6a591-20f4-4683-b629-1868cb5a032a" xlink:to="loc_us-gaap_CapitalLeasedAssetsGross_3cbe33c9-5d0b-461d-85b2-ec51815b0c39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation_74e0acb2-9a58-47e6-8e97-eb356eef0434" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_21e6a591-20f4-4683-b629-1868cb5a032a" xlink:to="loc_us-gaap_CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation_74e0acb2-9a58-47e6-8e97-eb356eef0434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasesIncomeStatementInterestExpense_b6da2eaa-b347-44c8-ad11-3b9f1a6658f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLeasesIncomeStatementInterestExpense"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_21e6a591-20f4-4683-b629-1868cb5a032a" xlink:to="loc_us-gaap_CapitalLeasesIncomeStatementInterestExpense_b6da2eaa-b347-44c8-ad11-3b9f1a6658f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/CommitmentsandContingenciesOperatingLeasePaymentsDueDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#CommitmentsandContingenciesOperatingLeasePaymentsDueDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/CommitmentsandContingenciesOperatingLeasePaymentsDueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1cb6698b-1bb2-42f0-9939-1a2cae468755" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_eb6d1c4e-ff11-4e74-9aad-eef683d66647" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1cb6698b-1bb2-42f0-9939-1a2cae468755" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_eb6d1c4e-ff11-4e74-9aad-eef683d66647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_e26a9eeb-19af-4b0b-a1e0-1b8978726f26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1cb6698b-1bb2-42f0-9939-1a2cae468755" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_e26a9eeb-19af-4b0b-a1e0-1b8978726f26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_07c4067b-ea93-44d3-8feb-480dbd7aa136" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1cb6698b-1bb2-42f0-9939-1a2cae468755" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_07c4067b-ea93-44d3-8feb-480dbd7aa136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_2628053f-0ffc-4fd6-8f9a-491135d2facc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1cb6698b-1bb2-42f0-9939-1a2cae468755" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_2628053f-0ffc-4fd6-8f9a-491135d2facc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_0a9635db-6bc8-4b06-a09e-f052c1b1555b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1cb6698b-1bb2-42f0-9939-1a2cae468755" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_0a9635db-6bc8-4b06-a09e-f052c1b1555b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_f0a68431-7adc-4a76-8b30-5a9a5b23cfcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1cb6698b-1bb2-42f0-9939-1a2cae468755" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_f0a68431-7adc-4a76-8b30-5a9a5b23cfcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_OperatingLeasesFutureMinimumPaymentsDueAfterYearFour_0837534d-b3f8-4f08-a54a-bcd9bca3d813" xlink:href="cmlf-20210804.xsd#cmlf_OperatingLeasesFutureMinimumPaymentsDueAfterYearFour"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1cb6698b-1bb2-42f0-9939-1a2cae468755" xlink:to="loc_cmlf_OperatingLeasesFutureMinimumPaymentsDueAfterYearFour_0837534d-b3f8-4f08-a54a-bcd9bca3d813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_6fec037a-e3d4-4577-a7c6-5088310df2d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1cb6698b-1bb2-42f0-9939-1a2cae468755" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_6fec037a-e3d4-4577-a7c6-5088310df2d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_1a2ca5e8-0a6c-4ece-9fd6-6d9b23da6706" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1cb6698b-1bb2-42f0-9939-1a2cae468755" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_1a2ca5e8-0a6c-4ece-9fd6-6d9b23da6706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/CommitmentsandContingenciesCapitalLeasePaymentsDueDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#CommitmentsandContingenciesCapitalLeasePaymentsDueDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/CommitmentsandContingenciesCapitalLeasePaymentsDueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bc5e02e5-bc5b-4dd4-b40f-0983f8b507e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear_14e21262-0e32-4e65-9013-2dc475df87ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bc5e02e5-bc5b-4dd4-b40f-0983f8b507e1" xlink:to="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear_14e21262-0e32-4e65-9013-2dc475df87ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent_6649a33c-d2e8-478f-97b8-525b019babec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bc5e02e5-bc5b-4dd4-b40f-0983f8b507e1" xlink:to="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent_6649a33c-d2e8-478f-97b8-525b019babec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears_e630d354-67d1-4aae-9357-525f7653ed36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bc5e02e5-bc5b-4dd4-b40f-0983f8b507e1" xlink:to="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears_e630d354-67d1-4aae-9357-525f7653ed36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears_5ec7fd9b-8365-4b2b-8cae-1d1e67c0ac94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bc5e02e5-bc5b-4dd4-b40f-0983f8b507e1" xlink:to="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears_5ec7fd9b-8365-4b2b-8cae-1d1e67c0ac94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears_c69ceaad-c44f-4e7b-8742-6533be1b864e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bc5e02e5-bc5b-4dd4-b40f-0983f8b507e1" xlink:to="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears_c69ceaad-c44f-4e7b-8742-6533be1b864e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears_c5d04c16-b1e5-4ef7-b442-45b5f9993913" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bc5e02e5-bc5b-4dd4-b40f-0983f8b507e1" xlink:to="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears_c5d04c16-b1e5-4ef7-b442-45b5f9993913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CapitalLeasesFutureMinimumPaymentsDueAfterYearFour_d2b6fd22-1965-4daf-bca1-4c2c5f702ec6" xlink:href="cmlf-20210804.xsd#cmlf_CapitalLeasesFutureMinimumPaymentsDueAfterYearFour"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bc5e02e5-bc5b-4dd4-b40f-0983f8b507e1" xlink:to="loc_cmlf_CapitalLeasesFutureMinimumPaymentsDueAfterYearFour_d2b6fd22-1965-4daf-bca1-4c2c5f702ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafter_3ceaf03f-81bc-49e2-a521-013a2ed11f54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafter"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bc5e02e5-bc5b-4dd4-b40f-0983f8b507e1" xlink:to="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafter_3ceaf03f-81bc-49e2-a521-013a2ed11f54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDue_ebe0821f-37ea-4682-b0f9-53b163e3ce6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bc5e02e5-bc5b-4dd4-b40f-0983f8b507e1" xlink:to="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDue_ebe0821f-37ea-4682-b0f9-53b163e3ce6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments_72566c98-f3cf-419a-a66c-cbe63fcb9145" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bc5e02e5-bc5b-4dd4-b40f-0983f8b507e1" xlink:to="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments_72566c98-f3cf-419a-a66c-cbe63fcb9145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments_4eb4d8c1-f522-4f45-b196-af8c76ff6e48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bc5e02e5-bc5b-4dd4-b40f-0983f8b507e1" xlink:to="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments_4eb4d8c1-f522-4f45-b196-af8c76ff6e48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsCurrent_7b7c6d97-8c08-4975-b186-e20a060dffa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bc5e02e5-bc5b-4dd4-b40f-0983f8b507e1" xlink:to="loc_us-gaap_CapitalLeaseObligationsCurrent_7b7c6d97-8c08-4975-b186-e20a060dffa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsNoncurrent_3de847c7-4dcb-4a4f-9611-cc371c5551df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLeaseObligationsNoncurrent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bc5e02e5-bc5b-4dd4-b40f-0983f8b507e1" xlink:to="loc_us-gaap_CapitalLeaseObligationsNoncurrent_3de847c7-4dcb-4a4f-9611-cc371c5551df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/CommitmentsandContingenciesCapitalLeasePaymentsDueDetails_1" xlink:type="simple" xlink:href="cmlf-20210804.xsd#CommitmentsandContingenciesCapitalLeasePaymentsDueDetails_1"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/CommitmentsandContingenciesCapitalLeasePaymentsDueDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="cmlf-20210804.xsd#StockBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8f8aa443-32cd-4322-a4ad-242a7586165b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_7a148f9d-20ff-4e31-a516-87a02cf753a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8f8aa443-32cd-4322-a4ad-242a7586165b" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_7a148f9d-20ff-4e31-a516-87a02cf753a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="cmlf-20210804.xsd#StockBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/StockBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_35289ba7-6097-42ee-bfe3-f39ffb243c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_4aa5accd-d881-46c4-9063-7c52af1cc962" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_35289ba7-6097-42ee-bfe3-f39ffb243c5b" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_4aa5accd-d881-46c4-9063-7c52af1cc962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_0412fcb3-c556-4edc-8f48-68b7b5f0d530" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_35289ba7-6097-42ee-bfe3-f39ffb243c5b" xlink:to="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_0412fcb3-c556-4edc-8f48-68b7b5f0d530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_934460a4-076c-4790-93a5-7a5da08a8101" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_35289ba7-6097-42ee-bfe3-f39ffb243c5b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_934460a4-076c-4790-93a5-7a5da08a8101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_21eaa0ce-2b25-40f0-97da-406fd2af2051" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_35289ba7-6097-42ee-bfe3-f39ffb243c5b" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_21eaa0ce-2b25-40f0-97da-406fd2af2051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/StockBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#StockBasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/StockBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_aa083be2-b1dd-4d5d-b507-eb5e777edb31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dd23c4ae-b0f8-495c-8f07-f0961cfff7c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_aa083be2-b1dd-4d5d-b507-eb5e777edb31" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dd23c4ae-b0f8-495c-8f07-f0961cfff7c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_7d25dfa4-c3af-450d-bff7-6a00b85b9136" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dd23c4ae-b0f8-495c-8f07-f0961cfff7c5" xlink:to="loc_us-gaap_AwardTypeAxis_7d25dfa4-c3af-450d-bff7-6a00b85b9136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c5369f4a-e778-4e5f-b813-2b9c8d7d94b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_7d25dfa4-c3af-450d-bff7-6a00b85b9136" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c5369f4a-e778-4e5f-b813-2b9c8d7d94b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_eaae3c10-a124-4964-881a-553c7206f48a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c5369f4a-e778-4e5f-b813-2b9c8d7d94b1" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_eaae3c10-a124-4964-881a-553c7206f48a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_bdac94a4-4741-4ccb-809c-58944108c094" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c5369f4a-e778-4e5f-b813-2b9c8d7d94b1" xlink:to="loc_us-gaap_EmployeeStockOptionMember_bdac94a4-4741-4ccb-809c-58944108c094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_a04ec6cd-cc41-4807-86e9-07b1d2d2fe1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dd23c4ae-b0f8-495c-8f07-f0961cfff7c5" xlink:to="loc_us-gaap_GranteeStatusAxis_a04ec6cd-cc41-4807-86e9-07b1d2d2fe1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_cd2b0aed-5d01-4a2c-8011-5a496b64ee1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusAxis_a04ec6cd-cc41-4807-86e9-07b1d2d2fe1a" xlink:to="loc_us-gaap_GranteeStatusDomain_cd2b0aed-5d01-4a2c-8011-5a496b64ee1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_62fc5975-5b7a-4457-ad0f-8977e2b079c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusDomain_cd2b0aed-5d01-4a2c-8011-5a496b64ee1b" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_62fc5975-5b7a-4457-ad0f-8977e2b079c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_f40adeb9-17ce-4fb8-8ac4-97ecc357170b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusDomain_cd2b0aed-5d01-4a2c-8011-5a496b64ee1b" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_f40adeb9-17ce-4fb8-8ac4-97ecc357170b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_f7a1a3b4-db8e-4e45-baa3-f8253405ed5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dd23c4ae-b0f8-495c-8f07-f0961cfff7c5" xlink:to="loc_us-gaap_PlanNameAxis_f7a1a3b4-db8e-4e45-baa3-f8253405ed5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_2c2b1ab2-3698-463f-865f-e5c8ffd94ab4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_f7a1a3b4-db8e-4e45-baa3-f8253405ed5b" xlink:to="loc_us-gaap_PlanNameDomain_2c2b1ab2-3698-463f-865f-e5c8ffd94ab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_A2017StockIncentivePlanMember_402aac86-62b7-4776-b130-2b93c62cf72e" xlink:href="cmlf-20210804.xsd#cmlf_A2017StockIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_2c2b1ab2-3698-463f-865f-e5c8ffd94ab4" xlink:to="loc_cmlf_A2017StockIncentivePlanMember_402aac86-62b7-4776-b130-2b93c62cf72e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_a41c7557-c7e3-4765-bbf6-74a10674b8ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dd23c4ae-b0f8-495c-8f07-f0961cfff7c5" xlink:to="loc_us-gaap_StatementClassOfStockAxis_a41c7557-c7e3-4765-bbf6-74a10674b8ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_4bd63b07-fa09-4a48-b82c-bf04dbacfc59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a41c7557-c7e3-4765-bbf6-74a10674b8ce" xlink:to="loc_us-gaap_ClassOfStockDomain_4bd63b07-fa09-4a48-b82c-bf04dbacfc59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_66d4b9ec-3de4-4952-b070-1700ac59b839" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_4bd63b07-fa09-4a48-b82c-bf04dbacfc59" xlink:to="loc_us-gaap_CommonClassAMember_66d4b9ec-3de4-4952-b070-1700ac59b839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_e3085e45-162c-4eeb-a932-259b3081974e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_4bd63b07-fa09-4a48-b82c-bf04dbacfc59" xlink:to="loc_us-gaap_CommonClassBMember_e3085e45-162c-4eeb-a932-259b3081974e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_748b54d5-85c3-465e-b483-ebca8d114566" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dd23c4ae-b0f8-495c-8f07-f0961cfff7c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_748b54d5-85c3-465e-b483-ebca8d114566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_913e8b14-5a11-4b78-b224-bac44d1e5e68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_748b54d5-85c3-465e-b483-ebca8d114566" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_913e8b14-5a11-4b78-b224-bac44d1e5e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CommonStockMinimumVotingRightsPercentage_bbf9b951-2b48-4a72-8faa-cd93807c0626" xlink:href="cmlf-20210804.xsd#cmlf_CommonStockMinimumVotingRightsPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_748b54d5-85c3-465e-b483-ebca8d114566" xlink:to="loc_cmlf_CommonStockMinimumVotingRightsPercentage_bbf9b951-2b48-4a72-8faa-cd93807c0626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_18da1777-2828-4737-8641-961fbb1e9246" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_748b54d5-85c3-465e-b483-ebca8d114566" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_18da1777-2828-4737-8641-961fbb1e9246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_8e0a79ad-1541-4234-aa9a-fd98dd46ba79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_748b54d5-85c3-465e-b483-ebca8d114566" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_8e0a79ad-1541-4234-aa9a-fd98dd46ba79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ShareBasedPaymentArrangementNumberOfIndividualsGranted_6a6e10ac-fcb8-4044-96ea-10286330c710" xlink:href="cmlf-20210804.xsd#cmlf_ShareBasedPaymentArrangementNumberOfIndividualsGranted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_748b54d5-85c3-465e-b483-ebca8d114566" xlink:to="loc_cmlf_ShareBasedPaymentArrangementNumberOfIndividualsGranted_6a6e10ac-fcb8-4044-96ea-10286330c710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b18f6393-bc5f-4907-8bea-d0c9ed26f96d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_748b54d5-85c3-465e-b483-ebca8d114566" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b18f6393-bc5f-4907-8bea-d0c9ed26f96d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_e4f72f25-f6f4-44dd-8d0b-20bb8fc2f9df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_748b54d5-85c3-465e-b483-ebca8d114566" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_e4f72f25-f6f4-44dd-8d0b-20bb8fc2f9df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_35e8a9d1-35e9-40ee-b5d6-e37d17ed65bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_748b54d5-85c3-465e-b483-ebca8d114566" xlink:to="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_35e8a9d1-35e9-40ee-b5d6-e37d17ed65bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_954f1695-1097-4e33-b03e-b7db1ea8b31e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_748b54d5-85c3-465e-b483-ebca8d114566" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_954f1695-1097-4e33-b03e-b7db1ea8b31e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_b3f60245-f274-4786-90da-c57bed25633c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_748b54d5-85c3-465e-b483-ebca8d114566" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_b3f60245-f274-4786-90da-c57bed25633c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_ded0e627-ed59-4a1e-998c-5fdc205425d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_748b54d5-85c3-465e-b483-ebca8d114566" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_ded0e627-ed59-4a1e-998c-5fdc205425d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_223ba038-cfe9-44e8-89b0-e491ad6ccea1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_748b54d5-85c3-465e-b483-ebca8d114566" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_223ba038-cfe9-44e8-89b0-e491ad6ccea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_040f4a4b-4573-481e-8185-8e9788b319f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_748b54d5-85c3-465e-b483-ebca8d114566" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_040f4a4b-4573-481e-8185-8e9788b319f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_8c287c40-3fe1-488c-8b68-93d74b09cef1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_748b54d5-85c3-465e-b483-ebca8d114566" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_8c287c40-3fe1-488c-8b68-93d74b09cef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3bf99a5f-8c41-4c4c-b64b-455a9ad4bd5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_748b54d5-85c3-465e-b483-ebca8d114566" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3bf99a5f-8c41-4c4c-b64b-455a9ad4bd5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#StockBasedCompensationSummaryofStockBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5404be1a-65fb-4b04-bbac-935b0cf5a67e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_233fd390-d0be-4268-b526-f6dcf0903ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5404be1a-65fb-4b04-bbac-935b0cf5a67e" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_233fd390-d0be-4268-b526-f6dcf0903ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_3737b6fb-a931-4b32-bfe2-5aa60165bf02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_233fd390-d0be-4268-b526-f6dcf0903ca6" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_3737b6fb-a931-4b32-bfe2-5aa60165bf02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_68890f51-6b21-4878-ae9f-651b8bb2865c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3737b6fb-a931-4b32-bfe2-5aa60165bf02" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_68890f51-6b21-4878-ae9f-651b8bb2865c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_35980ace-bda8-4e5c-9c29-225d35345405" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_68890f51-6b21-4878-ae9f-651b8bb2865c" xlink:to="loc_us-gaap_CostOfSalesMember_35980ace-bda8-4e5c-9c29-225d35345405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_31169b8d-d9d7-46ea-8b43-6b95bc983a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_68890f51-6b21-4878-ae9f-651b8bb2865c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_31169b8d-d9d7-46ea-8b43-6b95bc983a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_73aea838-f682-4949-99c4-3eb7168300db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_68890f51-6b21-4878-ae9f-651b8bb2865c" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_73aea838-f682-4949-99c4-3eb7168300db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_a22784b0-1925-4976-a687-8c68538493f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_68890f51-6b21-4878-ae9f-651b8bb2865c" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_a22784b0-1925-4976-a687-8c68538493f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_8489254e-60e7-42c6-97c3-896438c31890" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_233fd390-d0be-4268-b526-f6dcf0903ca6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_8489254e-60e7-42c6-97c3-896438c31890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_8c2d8c40-70fa-4f1a-bfb2-eaadd56c6454" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_8489254e-60e7-42c6-97c3-896438c31890" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_8c2d8c40-70fa-4f1a-bfb2-eaadd56c6454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#StockBasedCompensationSummaryofStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_45b82602-b056-489e-968c-8730cc55dac3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f52015f9-efe0-4423-a5e0-f9e0900c1bb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_45b82602-b056-489e-968c-8730cc55dac3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f52015f9-efe0-4423-a5e0-f9e0900c1bb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_03db58ae-ad5c-44c2-9546-4d5d4e062315" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f52015f9-efe0-4423-a5e0-f9e0900c1bb4" xlink:to="loc_us-gaap_StatementClassOfStockAxis_03db58ae-ad5c-44c2-9546-4d5d4e062315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_5dcc359b-5ef2-46db-81ec-b73f7f71ca8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_03db58ae-ad5c-44c2-9546-4d5d4e062315" xlink:to="loc_us-gaap_ClassOfStockDomain_5dcc359b-5ef2-46db-81ec-b73f7f71ca8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_6ce765d2-8ee4-484c-ad54-a1871b4483e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_5dcc359b-5ef2-46db-81ec-b73f7f71ca8f" xlink:to="loc_us-gaap_CommonClassAMember_6ce765d2-8ee4-484c-ad54-a1871b4483e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_64a45f8f-9d90-4ea6-b5f8-c0ccca8e82e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_5dcc359b-5ef2-46db-81ec-b73f7f71ca8f" xlink:to="loc_us-gaap_CommonClassBMember_64a45f8f-9d90-4ea6-b5f8-c0ccca8e82e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_17361dbf-27e9-4c16-9644-a14e60540419" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f52015f9-efe0-4423-a5e0-f9e0900c1bb4" xlink:to="loc_us-gaap_PlanNameAxis_17361dbf-27e9-4c16-9644-a14e60540419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_fab2c2c9-c533-4092-9b48-d6b4f27b2ca0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_17361dbf-27e9-4c16-9644-a14e60540419" xlink:to="loc_us-gaap_PlanNameDomain_fab2c2c9-c533-4092-9b48-d6b4f27b2ca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_A2017StockIncentivePlanMember_8e61282c-df04-4aee-9069-0d8aa4adf3e2" xlink:href="cmlf-20210804.xsd#cmlf_A2017StockIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_fab2c2c9-c533-4092-9b48-d6b4f27b2ca0" xlink:to="loc_cmlf_A2017StockIncentivePlanMember_8e61282c-df04-4aee-9069-0d8aa4adf3e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_51d6dd3b-1116-48db-ac99-2bef75485b0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f52015f9-efe0-4423-a5e0-f9e0900c1bb4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_51d6dd3b-1116-48db-ac99-2bef75485b0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNumberOfSharesAvailableForGrantOutstanding_c9b4c6a9-f69e-445a-a5a3-53533e4d0477" xlink:href="cmlf-20210804.xsd#cmlf_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNumberOfSharesAvailableForGrantOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_51d6dd3b-1116-48db-ac99-2bef75485b0e" xlink:to="loc_cmlf_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNumberOfSharesAvailableForGrantOutstanding_c9b4c6a9-f69e-445a-a5a3-53533e4d0477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod_5576156c-d890-4ef6-bdc1-77b28366ed43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_51d6dd3b-1116-48db-ac99-2bef75485b0e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod_5576156c-d890-4ef6-bdc1-77b28366ed43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_256cab15-934b-485a-9f67-52b3bfe58a2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_51d6dd3b-1116-48db-ac99-2bef75485b0e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_256cab15-934b-485a-9f67-52b3bfe58a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_eef42dff-6b78-449d-9863-04b0dfa02692" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_256cab15-934b-485a-9f67-52b3bfe58a2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_eef42dff-6b78-449d-9863-04b0dfa02692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_02bcd772-aa33-41f2-9e69-77b36be3d51e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_256cab15-934b-485a-9f67-52b3bfe58a2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_02bcd772-aa33-41f2-9e69-77b36be3d51e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_02fadb06-f73e-4ba8-a787-c436e0a3d285" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_256cab15-934b-485a-9f67-52b3bfe58a2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_02fadb06-f73e-4ba8-a787-c436e0a3d285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_64b10936-3045-4b17-8319-7ccce0add29f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_256cab15-934b-485a-9f67-52b3bfe58a2e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_64b10936-3045-4b17-8319-7ccce0add29f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_11d5f3cf-3004-477f-8bd4-7277c4d60930" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_256cab15-934b-485a-9f67-52b3bfe58a2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_11d5f3cf-3004-477f-8bd4-7277c4d60930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_52389fcd-6ba7-4789-a544-563b7513bbd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_51d6dd3b-1116-48db-ac99-2bef75485b0e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_52389fcd-6ba7-4789-a544-563b7513bbd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_021718dc-3683-47a6-b601-da235492f7f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_51d6dd3b-1116-48db-ac99-2bef75485b0e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_021718dc-3683-47a6-b601-da235492f7f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_dde60ed9-431e-49fe-9b61-f698719a5ecb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_021718dc-3683-47a6-b601-da235492f7f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_dde60ed9-431e-49fe-9b61-f698719a5ecb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_fa402ac5-6504-4327-b265-bc0e9653efe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_021718dc-3683-47a6-b601-da235492f7f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_fa402ac5-6504-4327-b265-bc0e9653efe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_dbd0c734-9e5e-4f0d-a939-112eb48704e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_021718dc-3683-47a6-b601-da235492f7f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_dbd0c734-9e5e-4f0d-a939-112eb48704e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_b3de7ffe-f043-4f28-9560-6d5b719f507e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_021718dc-3683-47a6-b601-da235492f7f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_b3de7ffe-f043-4f28-9560-6d5b719f507e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_ee51e6ec-4de1-4033-a129-e5d29bbfb41d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_51d6dd3b-1116-48db-ac99-2bef75485b0e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_ee51e6ec-4de1-4033-a129-e5d29bbfb41d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_f95cb24c-3d02-4d91-84dd-425d5381f48c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_51d6dd3b-1116-48db-ac99-2bef75485b0e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_f95cb24c-3d02-4d91-84dd-425d5381f48c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_aa5b2738-be15-4318-b1c8-d01ab325833b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_51d6dd3b-1116-48db-ac99-2bef75485b0e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_aa5b2738-be15-4318-b1c8-d01ab325833b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0b30dc83-2187-43bd-a1c3-08499672bf36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_51d6dd3b-1116-48db-ac99-2bef75485b0e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0b30dc83-2187-43bd-a1c3-08499672bf36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_b7b8bdc4-0917-4817-b4b4-05aee298a866" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_51d6dd3b-1116-48db-ac99-2bef75485b0e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_b7b8bdc4-0917-4817-b4b4-05aee298a866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/StockBasedCompensationSummaryofExercisePriceRangeDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#StockBasedCompensationSummaryofExercisePriceRangeDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/StockBasedCompensationSummaryofExercisePriceRangeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d6843f28-2968-400b-a9c4-a2be41324df0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_35555323-3421-41af-a4b6-ea5c8b9ae0c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d6843f28-2968-400b-a9c4-a2be41324df0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_35555323-3421-41af-a4b6-ea5c8b9ae0c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_b4535b93-25ad-417a-8d4f-608ffffeb9f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_35555323-3421-41af-a4b6-ea5c8b9ae0c8" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_b4535b93-25ad-417a-8d4f-608ffffeb9f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2702fb45-3678-4459-90bb-36a86342acdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_b4535b93-25ad-417a-8d4f-608ffffeb9f0" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2702fb45-3678-4459-90bb-36a86342acdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ExercisePriceOneMember_21307b5d-62fc-4ece-b30d-73a93be7b02a" xlink:href="cmlf-20210804.xsd#cmlf_ExercisePriceOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2702fb45-3678-4459-90bb-36a86342acdd" xlink:to="loc_cmlf_ExercisePriceOneMember_21307b5d-62fc-4ece-b30d-73a93be7b02a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ExercisePriceTwoMember_1afa58ae-8535-4605-abff-f4b5290c2bc8" xlink:href="cmlf-20210804.xsd#cmlf_ExercisePriceTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2702fb45-3678-4459-90bb-36a86342acdd" xlink:to="loc_cmlf_ExercisePriceTwoMember_1afa58ae-8535-4605-abff-f4b5290c2bc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ExercisePriceThreeMember_1332d8e3-a131-42ec-86e0-b243bbd3edcb" xlink:href="cmlf-20210804.xsd#cmlf_ExercisePriceThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2702fb45-3678-4459-90bb-36a86342acdd" xlink:to="loc_cmlf_ExercisePriceThreeMember_1332d8e3-a131-42ec-86e0-b243bbd3edcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ExercisePriceFourMember_f4bfa636-f1d7-4c7c-8c12-73caf65c7fa3" xlink:href="cmlf-20210804.xsd#cmlf_ExercisePriceFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2702fb45-3678-4459-90bb-36a86342acdd" xlink:to="loc_cmlf_ExercisePriceFourMember_f4bfa636-f1d7-4c7c-8c12-73caf65c7fa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_8d661918-5c89-4ef5-a1ad-6a57ef110150" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_35555323-3421-41af-a4b6-ea5c8b9ae0c8" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_8d661918-5c89-4ef5-a1ad-6a57ef110150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_e3dcd869-ca48-4803-8156-a683c4017cee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_8d661918-5c89-4ef5-a1ad-6a57ef110150" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_e3dcd869-ca48-4803-8156-a683c4017cee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_a1025d53-9244-491f-8b1d-4e9ddfd93d2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_8d661918-5c89-4ef5-a1ad-6a57ef110150" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_a1025d53-9244-491f-8b1d-4e9ddfd93d2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_d7c11cdb-6a8e-4650-8257-5f8449bf6885" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_8d661918-5c89-4ef5-a1ad-6a57ef110150" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_d7c11cdb-6a8e-4650-8257-5f8449bf6885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/StockBasedCompensationSummaryofEstimatedFairValueofStockOptionAwardsDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#StockBasedCompensationSummaryofEstimatedFairValueofStockOptionAwardsDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/StockBasedCompensationSummaryofEstimatedFairValueofStockOptionAwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_976a0849-1531-4406-a9fa-e598763217d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9fac8f8d-b358-4da8-b4bb-1126aa2614dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_976a0849-1531-4406-a9fa-e598763217d6" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9fac8f8d-b358-4da8-b4bb-1126aa2614dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_12b5c6e9-104c-4f42-8346-ecfc29162ba3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9fac8f8d-b358-4da8-b4bb-1126aa2614dc" xlink:to="loc_srt_RangeAxis_12b5c6e9-104c-4f42-8346-ecfc29162ba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a66bbbd9-137e-42bf-80fa-b9b159ff1e7c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_12b5c6e9-104c-4f42-8346-ecfc29162ba3" xlink:to="loc_srt_RangeMember_a66bbbd9-137e-42bf-80fa-b9b159ff1e7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8ec71ec8-8008-44fa-b3c9-c478ff206c88" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a66bbbd9-137e-42bf-80fa-b9b159ff1e7c" xlink:to="loc_srt_MinimumMember_8ec71ec8-8008-44fa-b3c9-c478ff206c88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_30617582-477c-48c3-a07e-97d05951c05e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a66bbbd9-137e-42bf-80fa-b9b159ff1e7c" xlink:to="loc_srt_MaximumMember_30617582-477c-48c3-a07e-97d05951c05e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_0c350be5-9dd7-4829-baaf-7ac96671d4d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9fac8f8d-b358-4da8-b4bb-1126aa2614dc" xlink:to="loc_us-gaap_StatementClassOfStockAxis_0c350be5-9dd7-4829-baaf-7ac96671d4d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_24f9c2e0-6301-4f16-b3ef-e68a798843b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_0c350be5-9dd7-4829-baaf-7ac96671d4d4" xlink:to="loc_us-gaap_ClassOfStockDomain_24f9c2e0-6301-4f16-b3ef-e68a798843b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_8eb0ada8-24fb-4bd6-b01a-b46297322a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_24f9c2e0-6301-4f16-b3ef-e68a798843b0" xlink:to="loc_us-gaap_CommonClassAMember_8eb0ada8-24fb-4bd6-b01a-b46297322a4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_a70078aa-05c2-42e8-a6a2-8eed6348b643" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_24f9c2e0-6301-4f16-b3ef-e68a798843b0" xlink:to="loc_us-gaap_CommonClassBMember_a70078aa-05c2-42e8-a6a2-8eed6348b643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_30e18e26-2330-4195-acb6-d0a774df86b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9fac8f8d-b358-4da8-b4bb-1126aa2614dc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_30e18e26-2330-4195-acb6-d0a774df86b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_ce9082a6-bcd1-4b27-b56f-5572e840870d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_30e18e26-2330-4195-acb6-d0a774df86b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_ce9082a6-bcd1-4b27-b56f-5572e840870d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_6397007d-302e-4b4b-b643-2c1c049fc6e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_30e18e26-2330-4195-acb6-d0a774df86b2" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_6397007d-302e-4b4b-b643-2c1c049fc6e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_5c314031-0df8-4555-8150-8a6b229cd6b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_30e18e26-2330-4195-acb6-d0a774df86b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_5c314031-0df8-4555-8150-8a6b229cd6b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_133a1386-2d9c-46d2-b8d8-c1c89f2fe0f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_30e18e26-2330-4195-acb6-d0a774df86b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_133a1386-2d9c-46d2-b8d8-c1c89f2fe0f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_4cd9136a-8d8b-49fc-8841-4be8bd3ee915" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_30e18e26-2330-4195-acb6-d0a774df86b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_4cd9136a-8d8b-49fc-8841-4be8bd3ee915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_66be5e8e-6ac8-43f8-83c9-94e671e29bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_30e18e26-2330-4195-acb6-d0a774df86b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_66be5e8e-6ac8-43f8-83c9-94e671e29bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_79b72544-eaeb-4fdf-8046-4a0f326cd10f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_30e18e26-2330-4195-acb6-d0a774df86b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_79b72544-eaeb-4fdf-8046-4a0f326cd10f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/RedeemableConvertiblePreferredStock" xlink:type="simple" xlink:href="cmlf-20210804.xsd#RedeemableConvertiblePreferredStock"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/RedeemableConvertiblePreferredStock" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_31037332-74fc-45d8-9e3c-71e38c997d9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_TemporaryEquityTextBlock_ab1fcc06-1316-4051-bbb1-93ca336749e7" xlink:href="cmlf-20210804.xsd#cmlf_TemporaryEquityTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_31037332-74fc-45d8-9e3c-71e38c997d9c" xlink:to="loc_cmlf_TemporaryEquityTextBlock_ab1fcc06-1316-4051-bbb1-93ca336749e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/RedeemableConvertiblePreferredStockTables" xlink:type="simple" xlink:href="cmlf-20210804.xsd#RedeemableConvertiblePreferredStockTables"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/RedeemableConvertiblePreferredStockTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_87c0a290-8cdf-460a-8312-401b66566de8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityTableTextBlock_0b3a4dd9-27e9-40c4-83cc-dbd1483ebd1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_87c0a290-8cdf-460a-8312-401b66566de8" xlink:to="loc_us-gaap_TemporaryEquityTableTextBlock_0b3a4dd9-27e9-40c4-83cc-dbd1483ebd1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/RedeemableConvertiblePreferredStockDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#RedeemableConvertiblePreferredStockDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/RedeemableConvertiblePreferredStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_d59f9d9c-8837-4dc3-a596-0ce630a6dd37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_4f202360-a2ea-4e74-8a63-76d14a1aad6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_d59f9d9c-8837-4dc3-a596-0ce630a6dd37" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_4f202360-a2ea-4e74-8a63-76d14a1aad6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_4a67fba6-0a45-4c89-be4e-099b221983e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_4f202360-a2ea-4e74-8a63-76d14a1aad6c" xlink:to="loc_us-gaap_StatementClassOfStockAxis_4a67fba6-0a45-4c89-be4e-099b221983e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_c51af024-cd2e-4f53-91b6-6411b37b9966" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_4a67fba6-0a45-4c89-be4e-099b221983e4" xlink:to="loc_us-gaap_ClassOfStockDomain_c51af024-cd2e-4f53-91b6-6411b37b9966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_SeriesARedeemableConvertiblePreferredStockMember_a884eacf-1864-4e94-a9b1-0c927f26e936" xlink:href="cmlf-20210804.xsd#cmlf_SeriesARedeemableConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_c51af024-cd2e-4f53-91b6-6411b37b9966" xlink:to="loc_cmlf_SeriesARedeemableConvertiblePreferredStockMember_a884eacf-1864-4e94-a9b1-0c927f26e936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_SeriesA1RedeemableConvertiblePreferredStockMember_c76a8a69-6225-4857-aa76-469e178bc774" xlink:href="cmlf-20210804.xsd#cmlf_SeriesA1RedeemableConvertiblePreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_c51af024-cd2e-4f53-91b6-6411b37b9966" xlink:to="loc_cmlf_SeriesA1RedeemableConvertiblePreferredStockMember_c76a8a69-6225-4857-aa76-469e178bc774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_SeriesA2RedeemableConvertiblePreferredStockMember_969665cf-55e3-4c83-8536-3457ac79503d" xlink:href="cmlf-20210804.xsd#cmlf_SeriesA2RedeemableConvertiblePreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_c51af024-cd2e-4f53-91b6-6411b37b9966" xlink:to="loc_cmlf_SeriesA2RedeemableConvertiblePreferredStockMember_969665cf-55e3-4c83-8536-3457ac79503d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_SeriesBRedeemableConvertiblePreferredStockMember_b7c68f4e-3a00-43fc-b902-95e9714fee11" xlink:href="cmlf-20210804.xsd#cmlf_SeriesBRedeemableConvertiblePreferredStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_c51af024-cd2e-4f53-91b6-6411b37b9966" xlink:to="loc_cmlf_SeriesBRedeemableConvertiblePreferredStockMember_b7c68f4e-3a00-43fc-b902-95e9714fee11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_SeriesCRedeemableConvertiblePreferredStockMember_53933fa2-367e-4292-9815-df6e8fb77c63" xlink:href="cmlf-20210804.xsd#cmlf_SeriesCRedeemableConvertiblePreferredStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_c51af024-cd2e-4f53-91b6-6411b37b9966" xlink:to="loc_cmlf_SeriesCRedeemableConvertiblePreferredStockMember_53933fa2-367e-4292-9815-df6e8fb77c63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_TemporaryEquityLiquidationPeriodAxis_bac0d7a2-5a9c-42a5-9f68-96bc590f8304" xlink:href="cmlf-20210804.xsd#cmlf_TemporaryEquityLiquidationPeriodAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_4f202360-a2ea-4e74-8a63-76d14a1aad6c" xlink:to="loc_cmlf_TemporaryEquityLiquidationPeriodAxis_bac0d7a2-5a9c-42a5-9f68-96bc590f8304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_TemporaryEquityLiquidationPeriodDomain_8edc777f-8818-4461-b4a9-a9f7f43bd249" xlink:href="cmlf-20210804.xsd#cmlf_TemporaryEquityLiquidationPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_TemporaryEquityLiquidationPeriodAxis_bac0d7a2-5a9c-42a5-9f68-96bc590f8304" xlink:to="loc_cmlf_TemporaryEquityLiquidationPeriodDomain_8edc777f-8818-4461-b4a9-a9f7f43bd249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_LiquidationPeriodOneMember_672d4a75-47f1-4265-b9ad-d0fa1556a182" xlink:href="cmlf-20210804.xsd#cmlf_LiquidationPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_TemporaryEquityLiquidationPeriodDomain_8edc777f-8818-4461-b4a9-a9f7f43bd249" xlink:to="loc_cmlf_LiquidationPeriodOneMember_672d4a75-47f1-4265-b9ad-d0fa1556a182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_LiquidationPeriodTwoMember_d4536ccf-7d51-4526-9166-aa6b6fc23766" xlink:href="cmlf-20210804.xsd#cmlf_LiquidationPeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_TemporaryEquityLiquidationPeriodDomain_8edc777f-8818-4461-b4a9-a9f7f43bd249" xlink:to="loc_cmlf_LiquidationPeriodTwoMember_d4536ccf-7d51-4526-9166-aa6b6fc23766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_LiquidationPeriodThreeMember_c9e9be78-ff5f-481c-8eeb-cdde233ee1b3" xlink:href="cmlf-20210804.xsd#cmlf_LiquidationPeriodThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_TemporaryEquityLiquidationPeriodDomain_8edc777f-8818-4461-b4a9-a9f7f43bd249" xlink:to="loc_cmlf_LiquidationPeriodThreeMember_c9e9be78-ff5f-481c-8eeb-cdde233ee1b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems_af4b039d-d56b-4f04-a15b-950c4f674a92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_4f202360-a2ea-4e74-8a63-76d14a1aad6c" xlink:to="loc_us-gaap_TemporaryEquityLineItems_af4b039d-d56b-4f04-a15b-950c4f674a92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_3b504d98-7b2a-4d06-bca1-becdda2045c2" xlink:href="cmlf-20210804.xsd#cmlf_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_af4b039d-d56b-4f04-a15b-950c4f674a92" xlink:to="loc_cmlf_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_3b504d98-7b2a-4d06-bca1-becdda2045c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_TemporaryEquitySharesIssuedPricePerShare_bed6ebf8-7f72-4cc6-b6ff-82cae397e5d4" xlink:href="cmlf-20210804.xsd#cmlf_TemporaryEquitySharesIssuedPricePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_af4b039d-d56b-4f04-a15b-950c4f674a92" xlink:to="loc_cmlf_TemporaryEquitySharesIssuedPricePerShare_bed6ebf8-7f72-4cc6-b6ff-82cae397e5d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_TemporaryEquitySharesIssuedExcessOfFairValueOverNetBookValueOfAssetsAndLiabilitiesAcquired_8474420a-7fc8-4b45-92a1-2b7c575ef3ba" xlink:href="cmlf-20210804.xsd#cmlf_TemporaryEquitySharesIssuedExcessOfFairValueOverNetBookValueOfAssetsAndLiabilitiesAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_af4b039d-d56b-4f04-a15b-950c4f674a92" xlink:to="loc_cmlf_TemporaryEquitySharesIssuedExcessOfFairValueOverNetBookValueOfAssetsAndLiabilitiesAcquired_8474420a-7fc8-4b45-92a1-2b7c575ef3ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_TemporaryEquityDividendRatePercentage_95daebe3-d7fe-423c-8d9f-97238a6c9f71" xlink:href="cmlf-20210804.xsd#cmlf_TemporaryEquityDividendRatePercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_af4b039d-d56b-4f04-a15b-950c4f674a92" xlink:to="loc_cmlf_TemporaryEquityDividendRatePercentage_95daebe3-d7fe-423c-8d9f-97238a6c9f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized_02e99455-95a5-4d4a-9381-2605af428d92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_af4b039d-d56b-4f04-a15b-950c4f674a92" xlink:to="loc_us-gaap_TemporaryEquitySharesAuthorized_02e99455-95a5-4d4a-9381-2605af428d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_NumberOfSeriesOfTemporaryEquity_998b727e-dfdc-41e2-ad9f-5b9403478a32" xlink:href="cmlf-20210804.xsd#cmlf_NumberOfSeriesOfTemporaryEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_af4b039d-d56b-4f04-a15b-950c4f674a92" xlink:to="loc_cmlf_NumberOfSeriesOfTemporaryEquity_998b727e-dfdc-41e2-ad9f-5b9403478a32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_d3def538-260f-4242-b55b-ce43584f51a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_af4b039d-d56b-4f04-a15b-950c4f674a92" xlink:to="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_d3def538-260f-4242-b55b-ce43584f51a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock_47836bc1-c6f9-406d-b20c-acf32d1ecadd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_af4b039d-d56b-4f04-a15b-950c4f674a92" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock_47836bc1-c6f9-406d-b20c-acf32d1ecadd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_af1cb7d6-1dab-4030-84ef-46c5fcffe726" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_af4b039d-d56b-4f04-a15b-950c4f674a92" xlink:to="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_af1cb7d6-1dab-4030-84ef-46c5fcffe726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_TemporaryEquityConversionRatio_64e8bbe7-4abb-46bd-bc62-f210b3c76596" xlink:href="cmlf-20210804.xsd#cmlf_TemporaryEquityConversionRatio"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_af4b039d-d56b-4f04-a15b-950c4f674a92" xlink:to="loc_cmlf_TemporaryEquityConversionRatio_64e8bbe7-4abb-46bd-bc62-f210b3c76596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLiquidationPreferencePerShare_93cb9954-0c87-4e0f-a8a1-aa17a1518eed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreferencePerShare"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_af4b039d-d56b-4f04-a15b-950c4f674a92" xlink:to="loc_us-gaap_TemporaryEquityLiquidationPreferencePerShare_93cb9954-0c87-4e0f-a8a1-aa17a1518eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/RedeemableConvertiblePreferredStockScheduleofRedeemablePreferredSharesDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#RedeemableConvertiblePreferredStockScheduleofRedeemablePreferredSharesDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/RedeemableConvertiblePreferredStockScheduleofRedeemablePreferredSharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_bed33031-96cb-4876-baa3-15535ec89f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_f612f2df-ba66-40e6-8a0d-a758afb142b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_bed33031-96cb-4876-baa3-15535ec89f6c" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_f612f2df-ba66-40e6-8a0d-a758afb142b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_f02b81cc-12ad-4f11-b75a-45d1347575f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_f612f2df-ba66-40e6-8a0d-a758afb142b8" xlink:to="loc_us-gaap_StatementClassOfStockAxis_f02b81cc-12ad-4f11-b75a-45d1347575f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_52f479b8-3ce4-4996-987e-1918162d2389" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_f02b81cc-12ad-4f11-b75a-45d1347575f0" xlink:to="loc_us-gaap_ClassOfStockDomain_52f479b8-3ce4-4996-987e-1918162d2389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_SeriesA1RedeemableConvertiblePreferredStockMember_4468712b-79f1-4fa5-bec0-f03d7b18bf29" xlink:href="cmlf-20210804.xsd#cmlf_SeriesA1RedeemableConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_52f479b8-3ce4-4996-987e-1918162d2389" xlink:to="loc_cmlf_SeriesA1RedeemableConvertiblePreferredStockMember_4468712b-79f1-4fa5-bec0-f03d7b18bf29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_SeriesA2RedeemableConvertiblePreferredStockMember_9651820b-afcb-49ee-b5c5-7e4774ecb36f" xlink:href="cmlf-20210804.xsd#cmlf_SeriesA2RedeemableConvertiblePreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_52f479b8-3ce4-4996-987e-1918162d2389" xlink:to="loc_cmlf_SeriesA2RedeemableConvertiblePreferredStockMember_9651820b-afcb-49ee-b5c5-7e4774ecb36f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_SeriesBRedeemableConvertiblePreferredStockMember_1b0cf880-4589-4727-9ae5-eb5f4a81fbed" xlink:href="cmlf-20210804.xsd#cmlf_SeriesBRedeemableConvertiblePreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_52f479b8-3ce4-4996-987e-1918162d2389" xlink:to="loc_cmlf_SeriesBRedeemableConvertiblePreferredStockMember_1b0cf880-4589-4727-9ae5-eb5f4a81fbed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_SeriesCRedeemableConvertiblePreferredStockMember_3db9dd62-7001-4fd8-9a73-5f7095e4a989" xlink:href="cmlf-20210804.xsd#cmlf_SeriesCRedeemableConvertiblePreferredStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_52f479b8-3ce4-4996-987e-1918162d2389" xlink:to="loc_cmlf_SeriesCRedeemableConvertiblePreferredStockMember_3db9dd62-7001-4fd8-9a73-5f7095e4a989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems_332e7a8d-4b13-4028-8358-d0b9af03b1e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_f612f2df-ba66-40e6-8a0d-a758afb142b8" xlink:to="loc_us-gaap_TemporaryEquityLineItems_332e7a8d-4b13-4028-8358-d0b9af03b1e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized_ff00a220-27db-432a-b336-89b3c13dd95b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_332e7a8d-4b13-4028-8358-d0b9af03b1e8" xlink:to="loc_us-gaap_TemporaryEquitySharesAuthorized_ff00a220-27db-432a-b336-89b3c13dd95b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_a712f6b3-6870-4ad8-806c-45a5bf7b5a23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_332e7a8d-4b13-4028-8358-d0b9af03b1e8" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_a712f6b3-6870-4ad8-806c-45a5bf7b5a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_7d504d28-425c-4682-8c46-0ccd886f3eaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_332e7a8d-4b13-4028-8358-d0b9af03b1e8" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_7d504d28-425c-4682-8c46-0ccd886f3eaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_d5fe07d7-5ab8-4ea1-aae6-db84933bc52c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_332e7a8d-4b13-4028-8358-d0b9af03b1e8" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_d5fe07d7-5ab8-4ea1-aae6-db84933bc52c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLiquidationPreference_32c90925-7aa2-438c-b411-752fe31c196a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_332e7a8d-4b13-4028-8358-d0b9af03b1e8" xlink:to="loc_us-gaap_TemporaryEquityLiquidationPreference_32c90925-7aa2-438c-b411-752fe31c196a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/CommonStock" xlink:type="simple" xlink:href="cmlf-20210804.xsd#CommonStock"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/CommonStock" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_18cc05e5-34e7-4629-9c25-a6bc1e05ff51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_0976f03d-3d91-4851-9e41-62707705016d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_18cc05e5-34e7-4629-9c25-a6bc1e05ff51" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_0976f03d-3d91-4851-9e41-62707705016d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/CommonStockDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#CommonStockDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/CommonStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_1ff2874a-da1d-4a37-8efe-54d66c951542" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_73bf0b98-d78c-4677-88a1-e9570be52fd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1ff2874a-da1d-4a37-8efe-54d66c951542" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_73bf0b98-d78c-4677-88a1-e9570be52fd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_038862da-ce69-4d6a-a37e-3fe27409bba5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_73bf0b98-d78c-4677-88a1-e9570be52fd2" xlink:to="loc_us-gaap_StatementClassOfStockAxis_038862da-ce69-4d6a-a37e-3fe27409bba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_eade3338-8de7-4867-804d-158301bad242" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_038862da-ce69-4d6a-a37e-3fe27409bba5" xlink:to="loc_us-gaap_ClassOfStockDomain_eade3338-8de7-4867-804d-158301bad242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_76bd284f-ae8d-4ee6-9b2a-403372ea0ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_eade3338-8de7-4867-804d-158301bad242" xlink:to="loc_us-gaap_CommonClassAMember_76bd284f-ae8d-4ee6-9b2a-403372ea0ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_6e88cd7c-385d-4e68-86ff-affc5ea540fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_eade3338-8de7-4867-804d-158301bad242" xlink:to="loc_us-gaap_CommonClassBMember_6e88cd7c-385d-4e68-86ff-affc5ea540fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_5320ff9f-c22f-42bc-8415-96dc8e5b2579" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_73bf0b98-d78c-4677-88a1-e9570be52fd2" xlink:to="loc_us-gaap_ClassOfStockLineItems_5320ff9f-c22f-42bc-8415-96dc8e5b2579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_NumberOfClassesOfCommonStock_8fe66c51-3b44-4d2b-bb67-f4b5ecf88a1c" xlink:href="cmlf-20210804.xsd#cmlf_NumberOfClassesOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_5320ff9f-c22f-42bc-8415-96dc8e5b2579" xlink:to="loc_cmlf_NumberOfClassesOfCommonStock_8fe66c51-3b44-4d2b-bb67-f4b5ecf88a1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesConverted1_a229476a-5028-447d-a76e-ebd580a2c029" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_5320ff9f-c22f-42bc-8415-96dc8e5b2579" xlink:to="loc_us-gaap_ConversionOfStockSharesConverted1_a229476a-5028-447d-a76e-ebd580a2c029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ConversionOfStockConversionRatio_fcdc0ca9-9ea8-45f6-ac36-82767502896f" xlink:href="cmlf-20210804.xsd#cmlf_ConversionOfStockConversionRatio"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_5320ff9f-c22f-42bc-8415-96dc8e5b2579" xlink:to="loc_cmlf_ConversionOfStockConversionRatio_fcdc0ca9-9ea8-45f6-ac36-82767502896f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_885c5677-a6b9-4773-a06e-8e00ee00bf63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_5320ff9f-c22f-42bc-8415-96dc8e5b2579" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_885c5677-a6b9-4773-a06e-8e00ee00bf63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_8ff4d787-f88c-4a93-988c-1b295c20a6c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_5320ff9f-c22f-42bc-8415-96dc8e5b2579" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_8ff4d787-f88c-4a93-988c-1b295c20a6c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_NumberOfVotesAllowedForEachShare_15985e9b-450d-4c3a-8e02-d72dc73f72c2" xlink:href="cmlf-20210804.xsd#cmlf_NumberOfVotesAllowedForEachShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_5320ff9f-c22f-42bc-8415-96dc8e5b2579" xlink:to="loc_cmlf_NumberOfVotesAllowedForEachShare_15985e9b-450d-4c3a-8e02-d72dc73f72c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_5bccbacd-3ee7-4b12-ad25-eb395bd7a6e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_5320ff9f-c22f-42bc-8415-96dc8e5b2579" xlink:to="loc_us-gaap_CommonStockSharesIssued_5bccbacd-3ee7-4b12-ad25-eb395bd7a6e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_e917fad6-6832-4732-b86e-c96ccfbc940c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_5320ff9f-c22f-42bc-8415-96dc8e5b2579" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_e917fad6-6832-4732-b86e-c96ccfbc940c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/IncomeTaxes" xlink:type="simple" xlink:href="cmlf-20210804.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_183ebb40-0362-4513-bc2d-fbcfc2303fdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_71be1613-19af-4ec0-9147-4b9ee7a3de9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_183ebb40-0362-4513-bc2d-fbcfc2303fdd" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_71be1613-19af-4ec0-9147-4b9ee7a3de9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="cmlf-20210804.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_831f05cb-edb0-4e3a-a996-eb13dd24b2c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_b35036a5-c274-471f-8df9-4fd45834416d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_831f05cb-edb0-4e3a-a996-eb13dd24b2c2" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_b35036a5-c274-471f-8df9-4fd45834416d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_9c97c0fc-bf6e-45a1-8d54-f8a03494d5d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_831f05cb-edb0-4e3a-a996-eb13dd24b2c2" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_9c97c0fc-bf6e-45a1-8d54-f8a03494d5d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_e426a4f5-f671-4212-a8d1-6380f01fba71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_831f05cb-edb0-4e3a-a996-eb13dd24b2c2" xlink:to="loc_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_e426a4f5-f671-4212-a8d1-6380f01fba71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfTaxCreditCarryforwardsTextBlock_6148ec41-ecf3-4c97-8347-090a0e5e8fec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfTaxCreditCarryforwardsTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_831f05cb-edb0-4e3a-a996-eb13dd24b2c2" xlink:to="loc_us-gaap_SummaryOfTaxCreditCarryforwardsTextBlock_6148ec41-ecf3-4c97-8347-090a0e5e8fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_4d85e754-32fb-43c4-9655-71ee26ee8dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_831f05cb-edb0-4e3a-a996-eb13dd24b2c2" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_4d85e754-32fb-43c4-9655-71ee26ee8dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_e1d268f3-5b76-45bd-b72c-4c10df214a04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ee0df55b-8e36-4b7f-9cda-13c3a40c56b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e1d268f3-5b76-45bd-b72c-4c10df214a04" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ee0df55b-8e36-4b7f-9cda-13c3a40c56b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_b5933600-1d77-485f-a8a6-e59395b758ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e1d268f3-5b76-45bd-b72c-4c10df214a04" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_b5933600-1d77-485f-a8a6-e59395b758ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_TaxCreditCarryforwardExchangedForCashPaymentNetBenefit_7e805730-a72f-4b2f-88b2-159c6c5e1228" xlink:href="cmlf-20210804.xsd#cmlf_TaxCreditCarryforwardExchangedForCashPaymentNetBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e1d268f3-5b76-45bd-b72c-4c10df214a04" xlink:to="loc_cmlf_TaxCreditCarryforwardExchangedForCashPaymentNetBenefit_7e805730-a72f-4b2f-88b2-159c6c5e1228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#IncomeTaxesReconciliationofEffectiveTaxRateDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_a9864f9e-bab6-4c03-b296-f509204a49e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_8d5dc3c4-d668-40c8-9ff7-ab81e481ee8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a9864f9e-bab6-4c03-b296-f509204a49e8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_8d5dc3c4-d668-40c8-9ff7-ab81e481ee8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_239a7ecf-0963-464f-afdf-1b3e720a1dea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a9864f9e-bab6-4c03-b296-f509204a49e8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_239a7ecf-0963-464f-afdf-1b3e720a1dea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_1fb4b83f-0a98-4f50-8d52-d74d7425d363" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a9864f9e-bab6-4c03-b296-f509204a49e8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_1fb4b83f-0a98-4f50-8d52-d74d7425d363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_3b47152c-e2d3-4a93-bda0-70382bc9aa41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a9864f9e-bab6-4c03-b296-f509204a49e8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_3b47152c-e2d3-4a93-bda0-70382bc9aa41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_9ed9a11d-0717-44a6-8dda-dca573883f04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a9864f9e-bab6-4c03-b296-f509204a49e8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_9ed9a11d-0717-44a6-8dda-dca573883f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_0dd1b404-05f9-4b4a-ae13-0ba40e269095" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a9864f9e-bab6-4c03-b296-f509204a49e8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_0dd1b404-05f9-4b4a-ae13-0ba40e269095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_24697eaa-a3ac-4195-8e53-f5b929f450e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a9864f9e-bab6-4c03-b296-f509204a49e8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_24697eaa-a3ac-4195-8e53-f5b929f450e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/IncomeTaxesNetDeferredTaxAssetsDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#IncomeTaxesNetDeferredTaxAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/IncomeTaxesNetDeferredTaxAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_bb422fbb-37e3-4b14-90fe-900e4538bea8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_cdf3d625-1c1f-4d26-a7a8-1e6314620aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_bb422fbb-37e3-4b14-90fe-900e4538bea8" xlink:to="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_cdf3d625-1c1f-4d26-a7a8-1e6314620aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_5f8ba4d5-753e-4459-9695-5d67314f4c23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_cdf3d625-1c1f-4d26-a7a8-1e6314620aa9" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_5f8ba4d5-753e-4459-9695-5d67314f4c23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_36bf2075-297f-4f54-987b-ef6080e27e06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_cdf3d625-1c1f-4d26-a7a8-1e6314620aa9" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_36bf2075-297f-4f54-987b-ef6080e27e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_19c2f426-6115-4a74-a74a-bed648bf61e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_cdf3d625-1c1f-4d26-a7a8-1e6314620aa9" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_19c2f426-6115-4a74-a74a-bed648bf61e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_1912df3c-1c94-46aa-bfd3-9ce4bcbb34a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_cdf3d625-1c1f-4d26-a7a8-1e6314620aa9" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_1912df3c-1c94-46aa-bfd3-9ce4bcbb34a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_8aadb398-7d56-41ac-bd30-3e040128d36e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_cdf3d625-1c1f-4d26-a7a8-1e6314620aa9" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_8aadb398-7d56-41ac-bd30-3e040128d36e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome_a1439d91-a37b-4b49-b67d-3ff06ac06b47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_cdf3d625-1c1f-4d26-a7a8-1e6314620aa9" xlink:to="loc_us-gaap_DeferredTaxAssetsDeferredIncome_a1439d91-a37b-4b49-b67d-3ff06ac06b47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_DeferredTaxAssetsTaxDeferredExpenseEmployerTaxes_9d56042c-8e7c-4d68-9468-30a7e35c13b0" xlink:href="cmlf-20210804.xsd#cmlf_DeferredTaxAssetsTaxDeferredExpenseEmployerTaxes"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_cdf3d625-1c1f-4d26-a7a8-1e6314620aa9" xlink:to="loc_cmlf_DeferredTaxAssetsTaxDeferredExpenseEmployerTaxes_9d56042c-8e7c-4d68-9468-30a7e35c13b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetInterestCarryforward_d2792496-357a-42ed-8f06-05809fdc81e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetInterestCarryforward"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_cdf3d625-1c1f-4d26-a7a8-1e6314620aa9" xlink:to="loc_us-gaap_DeferredTaxAssetInterestCarryforward_d2792496-357a-42ed-8f06-05809fdc81e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_5f9c6c44-5342-409d-bbbf-0a01da3b16c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_cdf3d625-1c1f-4d26-a7a8-1e6314620aa9" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_5f9c6c44-5342-409d-bbbf-0a01da3b16c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_157ee004-0977-4bec-afb9-b572f1078916" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_cdf3d625-1c1f-4d26-a7a8-1e6314620aa9" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_157ee004-0977-4bec-afb9-b572f1078916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_3f6ce34d-7b86-4aea-8dee-9bf08327e693" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_cdf3d625-1c1f-4d26-a7a8-1e6314620aa9" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_3f6ce34d-7b86-4aea-8dee-9bf08327e693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_27a0280a-7762-430a-9606-92ad97f48f18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_cdf3d625-1c1f-4d26-a7a8-1e6314620aa9" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_27a0280a-7762-430a-9606-92ad97f48f18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_bb955628-26a4-4fb1-84ad-833742c46bb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_bb422fbb-37e3-4b14-90fe-900e4538bea8" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_bb955628-26a4-4fb1-84ad-833742c46bb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_1815d7c3-aee7-40f9-b913-042dc79cf579" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_bb955628-26a4-4fb1-84ad-833742c46bb6" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_1815d7c3-aee7-40f9-b913-042dc79cf579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_7fc51426-b0b8-428e-a9ea-b0ae48f5849d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_bb955628-26a4-4fb1-84ad-833742c46bb6" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_7fc51426-b0b8-428e-a9ea-b0ae48f5849d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_67e4e972-27ae-4fe4-a237-9fdcff3c7dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_bb955628-26a4-4fb1-84ad-833742c46bb6" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_67e4e972-27ae-4fe4-a237-9fdcff3c7dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_0e2c037b-cb6d-43f3-9a1b-6a833e52a99c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_bb422fbb-37e3-4b14-90fe-900e4538bea8" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_0e2c037b-cb6d-43f3-9a1b-6a833e52a99c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/IncomeTaxesNetOperatingLossandTaxCreditCarryforwardsDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#IncomeTaxesNetOperatingLossandTaxCreditCarryforwardsDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/IncomeTaxesNetOperatingLossandTaxCreditCarryforwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_43227d25-60cb-45bb-8cb2-b1a30e59f066" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_eb55ce75-1ac6-45bc-b868-26fb80dbe4ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_43227d25-60cb-45bb-8cb2-b1a30e59f066" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_eb55ce75-1ac6-45bc-b868-26fb80dbe4ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_6190a375-df62-4de1-9b9a-1d1d60ef7b95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_eb55ce75-1ac6-45bc-b868-26fb80dbe4ed" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_6190a375-df62-4de1-9b9a-1d1d60ef7b95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_b720f28e-2af4-48f2-b33e-6972df1449df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_6190a375-df62-4de1-9b9a-1d1d60ef7b95" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_b720f28e-2af4-48f2-b33e-6972df1449df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_49773f14-bfc7-4aba-aeda-ceb63f1a19d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_b720f28e-2af4-48f2-b33e-6972df1449df" xlink:to="loc_us-gaap_DomesticCountryMember_49773f14-bfc7-4aba-aeda-ceb63f1a19d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_659c8e3c-77c2-4e7d-bc3f-550066d2a914" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_b720f28e-2af4-48f2-b33e-6972df1449df" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_659c8e3c-77c2-4e7d-bc3f-550066d2a914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_04207e8a-79fd-48d6-96fc-27c9c23c92ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_eb55ce75-1ac6-45bc-b868-26fb80dbe4ed" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_04207e8a-79fd-48d6-96fc-27c9c23c92ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_OperatingLossCarryforwardsSubjectToExpiration_34f7e895-0760-445b-b269-28349a1c96bb" xlink:href="cmlf-20210804.xsd#cmlf_OperatingLossCarryforwardsSubjectToExpiration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_04207e8a-79fd-48d6-96fc-27c9c23c92ff" xlink:to="loc_cmlf_OperatingLossCarryforwardsSubjectToExpiration_34f7e895-0760-445b-b269-28349a1c96bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_OperatingLossCarryforwardsNotSubjectToExpiration_cfea1b77-45c5-487b-ae42-2cf404d887d1" xlink:href="cmlf-20210804.xsd#cmlf_OperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_04207e8a-79fd-48d6-96fc-27c9c23c92ff" xlink:to="loc_cmlf_OperatingLossCarryforwardsNotSubjectToExpiration_cfea1b77-45c5-487b-ae42-2cf404d887d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardTable_b161b818-d073-4849-bc4a-63f2e1f7add5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_43227d25-60cb-45bb-8cb2-b1a30e59f066" xlink:to="loc_us-gaap_TaxCreditCarryforwardTable_b161b818-d073-4849-bc4a-63f2e1f7add5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_27f1e331-1403-4809-b27c-d245a52cf880" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_b161b818-d073-4849-bc4a-63f2e1f7add5" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_27f1e331-1403-4809-b27c-d245a52cf880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_1fd35e04-6ca6-4b29-9a7c-97f2c197afff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_27f1e331-1403-4809-b27c-d245a52cf880" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_1fd35e04-6ca6-4b29-9a7c-97f2c197afff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember_7f5f79cc-a182-4755-ac8e-4de2d808b0bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_1fd35e04-6ca6-4b29-9a7c-97f2c197afff" xlink:to="loc_us-gaap_ResearchMember_7f5f79cc-a182-4755-ac8e-4de2d808b0bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ResearchAndExperimentalTaxCreditCarryforwardMember_c51c29e9-dcf5-4b3d-92ed-5b4f464c0036" xlink:href="cmlf-20210804.xsd#cmlf_ResearchAndExperimentalTaxCreditCarryforwardMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_1fd35e04-6ca6-4b29-9a7c-97f2c197afff" xlink:to="loc_cmlf_ResearchAndExperimentalTaxCreditCarryforwardMember_c51c29e9-dcf5-4b3d-92ed-5b4f464c0036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_9fd38c9d-7c91-4902-ab08-f467f4618e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_b161b818-d073-4849-bc4a-63f2e1f7add5" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_9fd38c9d-7c91-4902-ab08-f467f4618e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_e2f847b2-c59c-43ca-9350-d971d8160106" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_1abbe56e-62e2-4a46-a4d0-7f765ba852d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_1ca158f5-f0c9-4bb6-93de-024230cbe9ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardLineItems_fbcc991a-2ea7-4f79-bb09-8cd10b5b0526" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_b161b818-d073-4849-bc4a-63f2e1f7add5" xlink:to="loc_us-gaap_TaxCreditCarryforwardLineItems_fbcc991a-2ea7-4f79-bb09-8cd10b5b0526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_7335c273-928a-4724-bb7e-ef8dbd338de7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_fbcc991a-2ea7-4f79-bb09-8cd10b5b0526" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_7335c273-928a-4724-bb7e-ef8dbd338de7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#IncomeTaxesUnrecognizedTaxBenefitsDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_45bf7afd-0994-482c-866a-a2be1b8dd856" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_6bea718e-ac37-40e1-aad1-3fa452cfc422" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_45bf7afd-0994-482c-866a-a2be1b8dd856" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_6bea718e-ac37-40e1-aad1-3fa452cfc422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_31047d96-5240-4406-8a55-9e5edd6d9b0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_6bea718e-ac37-40e1-aad1-3fa452cfc422" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_31047d96-5240-4406-8a55-9e5edd6d9b0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_5940064d-6d82-4ea3-9260-3fc7043eb36e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_6bea718e-ac37-40e1-aad1-3fa452cfc422" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_5940064d-6d82-4ea3-9260-3fc7043eb36e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_555e5f92-6c89-4974-b41a-b1fd8cc9d1d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_6bea718e-ac37-40e1-aad1-3fa452cfc422" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_555e5f92-6c89-4974-b41a-b1fd8cc9d1d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/NetLossperShare" xlink:type="simple" xlink:href="cmlf-20210804.xsd#NetLossperShare"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/NetLossperShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_61095a2e-289f-4e1e-a425-b2ca2197cc80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_d28680b6-8a03-455c-82e4-55a86677fbf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_61095a2e-289f-4e1e-a425-b2ca2197cc80" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_d28680b6-8a03-455c-82e4-55a86677fbf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/NetLossperShareTables" xlink:type="simple" xlink:href="cmlf-20210804.xsd#NetLossperShareTables"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/NetLossperShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_7c3b366e-de71-47b7-8ae4-fe2c0ed02fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_a542f750-1a8d-4b03-9b6d-56b1ebb48f38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7c3b366e-de71-47b7-8ae4-fe2c0ed02fc9" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_a542f750-1a8d-4b03-9b6d-56b1ebb48f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_d4d5ca13-fadf-4972-aea2-bf4655ab876f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7c3b366e-de71-47b7-8ae4-fe2c0ed02fc9" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_d4d5ca13-fadf-4972-aea2-bf4655ab876f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/NetLossperShareBasicDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#NetLossperShareBasicDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/NetLossperShareBasicDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_01879658-6da7-4a71-b46d-336f7f0647e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_7db344f8-39ed-49e5-a1dc-332609db3bce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_01879658-6da7-4a71-b46d-336f7f0647e9" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_7db344f8-39ed-49e5-a1dc-332609db3bce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_2e610cba-65e8-452a-a38c-ab3173d09f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_7db344f8-39ed-49e5-a1dc-332609db3bce" xlink:to="loc_us-gaap_StatementClassOfStockAxis_2e610cba-65e8-452a-a38c-ab3173d09f3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_ae5074c1-5b57-435b-89cd-92615a20678c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2e610cba-65e8-452a-a38c-ab3173d09f3e" xlink:to="loc_us-gaap_ClassOfStockDomain_ae5074c1-5b57-435b-89cd-92615a20678c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_2ab1a046-a4ed-40ca-9631-cb9058139756" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_ae5074c1-5b57-435b-89cd-92615a20678c" xlink:to="loc_us-gaap_CommonClassAMember_2ab1a046-a4ed-40ca-9631-cb9058139756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_5cf517b9-45f7-4d2c-9f30-ba0045de5190" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_ae5074c1-5b57-435b-89cd-92615a20678c" xlink:to="loc_us-gaap_CommonClassBMember_5cf517b9-45f7-4d2c-9f30-ba0045de5190" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_11940483-3984-401a-878a-20b3a7bc070c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_7db344f8-39ed-49e5-a1dc-332609db3bce" xlink:to="loc_us-gaap_EarningsPerShareBasicLineItems_11940483-3984-401a-878a-20b3a7bc070c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_a08546b6-3446-432d-a4d1-4941a1a21bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_11940483-3984-401a-878a-20b3a7bc070c" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_a08546b6-3446-432d-a4d1-4941a1a21bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_88d272da-766d-40d9-9e0a-fb75f6bc0036" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_a08546b6-3446-432d-a4d1-4941a1a21bc7" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_88d272da-766d-40d9-9e0a-fb75f6bc0036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_WeightedAverageNumberOfSharesOutstandingBasicForAllocationOfNetLoss_585b6cca-3fed-4e96-824c-5aa9af52c39e" xlink:href="cmlf-20210804.xsd#cmlf_WeightedAverageNumberOfSharesOutstandingBasicForAllocationOfNetLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_a08546b6-3446-432d-a4d1-4941a1a21bc7" xlink:to="loc_cmlf_WeightedAverageNumberOfSharesOutstandingBasicForAllocationOfNetLoss_585b6cca-3fed-4e96-824c-5aa9af52c39e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_c9c26c00-15c5-4e8d-acde-5e7c4ab12c95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_11940483-3984-401a-878a-20b3a7bc070c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_c9c26c00-15c5-4e8d-acde-5e7c4ab12c95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_02f9925a-b299-41b3-ad80-2274fd313d95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_c9c26c00-15c5-4e8d-acde-5e7c4ab12c95" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_02f9925a-b299-41b3-ad80-2274fd313d95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_a7beddbf-9ba4-4ebc-9c9e-21da13e2f4b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_11940483-3984-401a-878a-20b3a7bc070c" xlink:to="loc_us-gaap_EarningsPerShareBasic_a7beddbf-9ba4-4ebc-9c9e-21da13e2f4b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/NetLossperShareDilutedDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#NetLossperShareDilutedDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/NetLossperShareDilutedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_6c6ca9c0-8dc0-4070-84a8-7d1a03dcff46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_7aa7a080-bd0e-44f4-a90c-7fd42b888018" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6c6ca9c0-8dc0-4070-84a8-7d1a03dcff46" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_7aa7a080-bd0e-44f4-a90c-7fd42b888018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_46bc644e-3371-4994-b342-d03dc9f51732" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_7aa7a080-bd0e-44f4-a90c-7fd42b888018" xlink:to="loc_us-gaap_StatementClassOfStockAxis_46bc644e-3371-4994-b342-d03dc9f51732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_32f4b252-2933-4699-a7b8-f911d77c36ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_46bc644e-3371-4994-b342-d03dc9f51732" xlink:to="loc_us-gaap_ClassOfStockDomain_32f4b252-2933-4699-a7b8-f911d77c36ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_84858532-f208-4981-b0a2-1eee9a3cfbdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_32f4b252-2933-4699-a7b8-f911d77c36ce" xlink:to="loc_us-gaap_CommonClassAMember_84858532-f208-4981-b0a2-1eee9a3cfbdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_96be89c3-a9a3-4ced-90fc-095e61740847" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_32f4b252-2933-4699-a7b8-f911d77c36ce" xlink:to="loc_us-gaap_CommonClassBMember_96be89c3-a9a3-4ced-90fc-095e61740847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedLineItems_9b4598cc-cc18-41fc-a189-2578274f58d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_7aa7a080-bd0e-44f4-a90c-7fd42b888018" xlink:to="loc_us-gaap_EarningsPerShareDilutedLineItems_9b4598cc-cc18-41fc-a189-2578274f58d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_1483523a-7c73-4e04-b289-fb659201ab74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_9b4598cc-cc18-41fc-a189-2578274f58d1" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_1483523a-7c73-4e04-b289-fb659201ab74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecurities_5ba6a97f-e80c-40ee-9225-9e2c8698945f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DilutiveSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_9b4598cc-cc18-41fc-a189-2578274f58d1" xlink:to="loc_us-gaap_DilutiveSecurities_5ba6a97f-e80c-40ee-9225-9e2c8698945f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_2074655e-91be-45e9-80d5-77802f6e3dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_9b4598cc-cc18-41fc-a189-2578274f58d1" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_2074655e-91be-45e9-80d5-77802f6e3dd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_39462a1e-9cb2-4d01-80ca-131db661d968" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_9b4598cc-cc18-41fc-a189-2578274f58d1" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_39462a1e-9cb2-4d01-80ca-131db661d968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_4e6e1403-869a-4b65-ba24-f6821a94b983" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_9b4598cc-cc18-41fc-a189-2578274f58d1" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_4e6e1403-869a-4b65-ba24-f6821a94b983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0f7223cf-5122-4ef6-9a13-ad58151fba0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_9b4598cc-cc18-41fc-a189-2578274f58d1" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0f7223cf-5122-4ef6-9a13-ad58151fba0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_f9ceb1ac-b16e-4127-bf86-a0b310ecdc0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_9b4598cc-cc18-41fc-a189-2578274f58d1" xlink:to="loc_us-gaap_EarningsPerShareBasic_f9ceb1ac-b16e-4127-bf86-a0b310ecdc0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_EarningsPerShareDilutiveNetLossPosition_71717922-6e19-4154-bc48-76d8643fcb67" xlink:href="cmlf-20210804.xsd#cmlf_EarningsPerShareDilutiveNetLossPosition"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_9b4598cc-cc18-41fc-a189-2578274f58d1" xlink:to="loc_cmlf_EarningsPerShareDilutiveNetLossPosition_71717922-6e19-4154-bc48-76d8643fcb67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/NetLossperSharePotentiallyDilutiveSecuritiesDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#NetLossperSharePotentiallyDilutiveSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/NetLossperSharePotentiallyDilutiveSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_af0cd295-25cb-4a42-8e3d-ec0aac0e6ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_3536578d-afb2-4266-a1fd-317d296cf650" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_af0cd295-25cb-4a42-8e3d-ec0aac0e6ec3" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_3536578d-afb2-4266-a1fd-317d296cf650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_fd13a02f-ae6e-4a27-a11f-ece2b3a8c503" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_3536578d-afb2-4266-a1fd-317d296cf650" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_fd13a02f-ae6e-4a27-a11f-ece2b3a8c503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_60399d04-03e5-44da-adb6-98cae673c49d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_fd13a02f-ae6e-4a27-a11f-ece2b3a8c503" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_60399d04-03e5-44da-adb6-98cae673c49d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_a4b2b74a-332c-47a2-82a1-a0c4d1d2b241" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_60399d04-03e5-44da-adb6-98cae673c49d" xlink:to="loc_us-gaap_EmployeeStockOptionMember_a4b2b74a-332c-47a2-82a1-a0c4d1d2b241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableConvertiblePreferredStockMember_f8333598-2e24-46f0-b1aa-207cbe6b0270" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_60399d04-03e5-44da-adb6-98cae673c49d" xlink:to="loc_us-gaap_RedeemableConvertiblePreferredStockMember_f8333598-2e24-46f0-b1aa-207cbe6b0270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_984a01fe-31d1-4411-bc1f-95f6ce9b72f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_3536578d-afb2-4266-a1fd-317d296cf650" xlink:to="loc_us-gaap_StatementClassOfStockAxis_984a01fe-31d1-4411-bc1f-95f6ce9b72f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_82e94626-0583-4a69-9cd7-a3d14e8f817f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_984a01fe-31d1-4411-bc1f-95f6ce9b72f1" xlink:to="loc_us-gaap_ClassOfStockDomain_82e94626-0583-4a69-9cd7-a3d14e8f817f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_ff3dc0e4-9563-47bd-863f-d5cea01199f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_82e94626-0583-4a69-9cd7-a3d14e8f817f" xlink:to="loc_us-gaap_CommonClassAMember_ff3dc0e4-9563-47bd-863f-d5cea01199f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_f2fec7cd-801e-4834-a919-853b3c8c4e19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_82e94626-0583-4a69-9cd7-a3d14e8f817f" xlink:to="loc_us-gaap_CommonClassBMember_f2fec7cd-801e-4834-a919-853b3c8c4e19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_53c72813-4229-4671-b3c3-ff96e0745a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_3536578d-afb2-4266-a1fd-317d296cf650" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_53c72813-4229-4671-b3c3-ff96e0745a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d9cdcb86-f479-4d5a-874b-f2bf8a15085b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_53c72813-4229-4671-b3c3-ff96e0745a1f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d9cdcb86-f479-4d5a-874b-f2bf8a15085b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/SupplementalFinancialInformation" xlink:type="simple" xlink:href="cmlf-20210804.xsd#SupplementalFinancialInformation"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/SupplementalFinancialInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_2c61dc88-9967-45ba-b057-447cbc0cdc00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_fcf40d05-e47b-43e7-9000-a608f3ea8ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_2c61dc88-9967-45ba-b057-447cbc0cdc00" xlink:to="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_fcf40d05-e47b-43e7-9000-a608f3ea8ec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/SupplementalFinancialInformationTables" xlink:type="simple" xlink:href="cmlf-20210804.xsd#SupplementalFinancialInformationTables"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/SupplementalFinancialInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_fedf67cb-56d4-4d1b-b07b-16d14d47cabe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_aa317dc5-9dc7-4394-8cc1-453d5bc91cbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_fedf67cb-56d4-4d1b-b07b-16d14d47cabe" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_aa317dc5-9dc7-4394-8cc1-453d5bc91cbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/SupplementalFinancialInformationDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#SupplementalFinancialInformationDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/SupplementalFinancialInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_c8616495-2a99-4b32-aa7c-ff3d7992467a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrentAbstract_439e5905-eeba-4861-8917-1d50c20a2370" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_c8616495-2a99-4b32-aa7c-ff3d7992467a" xlink:to="loc_us-gaap_OtherLiabilitiesCurrentAbstract_439e5905-eeba-4861-8917-1d50c20a2370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_AccruedBonusCurrent_bbe32674-371e-4794-a492-e560f5a83a72" xlink:href="cmlf-20210804.xsd#cmlf_AccruedBonusCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_439e5905-eeba-4861-8917-1d50c20a2370" xlink:to="loc_cmlf_AccruedBonusCurrent_bbe32674-371e-4794-a492-e560f5a83a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent_e2ea60da-aa6f-482c-85f8-951aafbddf00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_439e5905-eeba-4861-8917-1d50c20a2370" xlink:to="loc_us-gaap_AccruedSalariesCurrent_e2ea60da-aa6f-482c-85f8-951aafbddf00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent_cc74379f-8c8c-48f1-8943-ebb41543c1a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_439e5905-eeba-4861-8917-1d50c20a2370" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrent_cc74379f-8c8c-48f1-8943-ebb41543c1a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrent_dcb4838e-8313-44bb-8a21-8330bf4e2a48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_439e5905-eeba-4861-8917-1d50c20a2370" xlink:to="loc_us-gaap_AccruedSalesCommissionCurrent_dcb4838e-8313-44bb-8a21-8330bf4e2a48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_b566837c-f66b-47e0-88b6-5cc23d6fc1d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_439e5905-eeba-4861-8917-1d50c20a2370" xlink:to="loc_us-gaap_LongTermDebtCurrent_b566837c-f66b-47e0-88b6-5cc23d6fc1d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent_195f0fa9-f4b3-45bb-96fe-6df8d3d691d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_439e5905-eeba-4861-8917-1d50c20a2370" xlink:to="loc_us-gaap_OtherSundryLiabilitiesCurrent_195f0fa9-f4b3-45bb-96fe-6df8d3d691d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_a82ec7e0-6be1-4bf8-b198-afdbe8ebb7c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_439e5905-eeba-4861-8917-1d50c20a2370" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_a82ec7e0-6be1-4bf8-b198-afdbe8ebb7c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/SubsequentEvents" xlink:type="simple" xlink:href="cmlf-20210804.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_53aa3eee-9884-45cf-91a3-bf40f400e734" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_31a9997d-21d4-4905-8ef7-bb1a366656d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_53aa3eee-9884-45cf-91a3-bf40f400e734" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_31a9997d-21d4-4905-8ef7-bb1a366656d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/DescriptionofOrganizationandBusinessOperations" xlink:type="simple" xlink:href="cmlf-20210804.xsd#DescriptionofOrganizationandBusinessOperations"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/DescriptionofOrganizationandBusinessOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_803eed9d-a7e2-44a7-a459-3865b517994b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_DescriptionofOrganizationandBusinessOperationsDetailsTable_7d9584ea-f5a7-4d41-8d6a-14607e4ae707" xlink:href="cmlf-20210804.xsd#cmlf_DescriptionofOrganizationandBusinessOperationsDetailsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_803eed9d-a7e2-44a7-a459-3865b517994b" xlink:to="loc_cmlf_DescriptionofOrganizationandBusinessOperationsDetailsTable_7d9584ea-f5a7-4d41-8d6a-14607e4ae707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_9cd5ae01-b4f6-4226-bbc5-840752993755" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_DescriptionofOrganizationandBusinessOperationsDetailsTable_7d9584ea-f5a7-4d41-8d6a-14607e4ae707" xlink:to="loc_dei_LegalEntityAxis_9cd5ae01-b4f6-4226-bbc5-840752993755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_ea38ea30-6dac-4f48-abce-026d293de102" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_9cd5ae01-b4f6-4226-bbc5-840752993755" xlink:to="loc_dei_EntityDomain_ea38ea30-6dac-4f48-abce-026d293de102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLifeSciencesIncMember_14bb0305-c4a2-4020-ac53-67e99e1118e6" xlink:href="cmlf-20210804.xsd#cmlf_CMLifeSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_ea38ea30-6dac-4f48-abce-026d293de102" xlink:to="loc_cmlf_CMLifeSciencesIncMember_14bb0305-c4a2-4020-ac53-67e99e1118e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_DescriptionofOrganizationandBusinessOperationsDetailsLineItems_cabf4803-37a7-4919-bc66-80d3831600c0" xlink:href="cmlf-20210804.xsd#cmlf_DescriptionofOrganizationandBusinessOperationsDetailsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_DescriptionofOrganizationandBusinessOperationsDetailsTable_7d9584ea-f5a7-4d41-8d6a-14607e4ae707" xlink:to="loc_cmlf_DescriptionofOrganizationandBusinessOperationsDetailsLineItems_cabf4803-37a7-4919-bc66-80d3831600c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_0f3c363d-50ef-4171-8209-3e6690993ee3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_DescriptionofOrganizationandBusinessOperationsDetailsLineItems_cabf4803-37a7-4919-bc66-80d3831600c0" xlink:to="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_0f3c363d-50ef-4171-8209-3e6690993ee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/DescriptionofOrganizationandBusinessOperationsDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#DescriptionofOrganizationandBusinessOperationsDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/DescriptionofOrganizationandBusinessOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0883b817-f421-4488-905e-0e7f23f0b74b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_DescriptionofOrganizationandBusinessOperationsDetailsTable_7a911699-dcef-4873-8af1-82bf786e7ddf" xlink:href="cmlf-20210804.xsd#cmlf_DescriptionofOrganizationandBusinessOperationsDetailsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0883b817-f421-4488-905e-0e7f23f0b74b" xlink:to="loc_cmlf_DescriptionofOrganizationandBusinessOperationsDetailsTable_7a911699-dcef-4873-8af1-82bf786e7ddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_cf8d8a0e-13c6-4780-b635-88019dd56ad1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_DescriptionofOrganizationandBusinessOperationsDetailsTable_7a911699-dcef-4873-8af1-82bf786e7ddf" xlink:to="loc_srt_TitleOfIndividualAxis_cf8d8a0e-13c6-4780-b635-88019dd56ad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_a72b8df2-d3fa-4ff9-9ae4-8ac1907362aa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_cf8d8a0e-13c6-4780-b635-88019dd56ad1" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_a72b8df2-d3fa-4ff9-9ae4-8ac1907362aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLSHoldingsLLCMember_1eb2c90a-656d-4f05-bb77-1d1317943483" xlink:href="cmlf-20210804.xsd#cmlf_CMLSHoldingsLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_a72b8df2-d3fa-4ff9-9ae4-8ac1907362aa" xlink:to="loc_cmlf_CMLSHoldingsLLCMember_1eb2c90a-656d-4f05-bb77-1d1317943483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_d6bdc59d-0162-4221-a574-03afba56705d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_DescriptionofOrganizationandBusinessOperationsDetailsTable_7a911699-dcef-4873-8af1-82bf786e7ddf" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_d6bdc59d-0162-4221-a574-03afba56705d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1046ce5c-95a9-465f-9a79-17bf6fa66943" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_d6bdc59d-0162-4221-a574-03afba56705d" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1046ce5c-95a9-465f-9a79-17bf6fa66943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_94f24152-377b-437f-8821-a9d5e10f595a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1046ce5c-95a9-465f-9a79-17bf6fa66943" xlink:to="loc_us-gaap_IPOMember_94f24152-377b-437f-8821-a9d5e10f595a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_9f3b8786-7551-46b4-b96a-9619e672bf85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1046ce5c-95a9-465f-9a79-17bf6fa66943" xlink:to="loc_us-gaap_OverAllotmentOptionMember_9f3b8786-7551-46b4-b96a-9619e672bf85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_4f17c8a1-0e26-4083-acd5-d82f09a66e8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrivatePlacementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1046ce5c-95a9-465f-9a79-17bf6fa66943" xlink:to="loc_us-gaap_PrivatePlacementMember_4f17c8a1-0e26-4083-acd5-d82f09a66e8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a0bc1b12-a688-44a9-97bc-70cab3840f55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_DescriptionofOrganizationandBusinessOperationsDetailsTable_7a911699-dcef-4873-8af1-82bf786e7ddf" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a0bc1b12-a688-44a9-97bc-70cab3840f55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1eea0793-d8be-46a0-a24d-0fad68c5ccf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a0bc1b12-a688-44a9-97bc-70cab3840f55" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1eea0793-d8be-46a0-a24d-0fad68c5ccf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_SponsorMember_85f46e3c-e845-43b4-ba38-215ea1171c7e" xlink:href="cmlf-20210804.xsd#cmlf_SponsorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1eea0793-d8be-46a0-a24d-0fad68c5ccf1" xlink:to="loc_cmlf_SponsorMember_85f46e3c-e845-43b4-ba38-215ea1171c7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_2271705e-f87c-43dd-9deb-2fd7d4d733a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_DescriptionofOrganizationandBusinessOperationsDetailsTable_7a911699-dcef-4873-8af1-82bf786e7ddf" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_2271705e-f87c-43dd-9deb-2fd7d4d733a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_65f7c500-266d-436e-9843-1fcb4f9e31d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_2271705e-f87c-43dd-9deb-2fd7d4d733a2" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_65f7c500-266d-436e-9843-1fcb4f9e31d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ExchangeActMember_4529b5a5-830f-44bf-b472-7cd43dcb5999" xlink:href="cmlf-20210804.xsd#cmlf_ExchangeActMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_65f7c500-266d-436e-9843-1fcb4f9e31d2" xlink:to="loc_cmlf_ExchangeActMember_4529b5a5-830f-44bf-b472-7cd43dcb5999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_8169f156-4753-4a31-9341-17bfd9af2f82" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_DescriptionofOrganizationandBusinessOperationsDetailsTable_7a911699-dcef-4873-8af1-82bf786e7ddf" xlink:to="loc_dei_LegalEntityAxis_8169f156-4753-4a31-9341-17bfd9af2f82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_c1c8db66-6311-47c9-bca7-eba2017f142c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_8169f156-4753-4a31-9341-17bfd9af2f82" xlink:to="loc_dei_EntityDomain_c1c8db66-6311-47c9-bca7-eba2017f142c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLifeSciencesIncMember_8f6725e2-d2ac-4753-9a55-45ce865c8c7f" xlink:href="cmlf-20210804.xsd#cmlf_CMLifeSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_c1c8db66-6311-47c9-bca7-eba2017f142c" xlink:to="loc_cmlf_CMLifeSciencesIncMember_8f6725e2-d2ac-4753-9a55-45ce865c8c7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_DescriptionofOrganizationandBusinessOperationsDetailsLineItems_8e4258fa-ed36-454d-a380-46275aa9b499" xlink:href="cmlf-20210804.xsd#cmlf_DescriptionofOrganizationandBusinessOperationsDetailsLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_DescriptionofOrganizationandBusinessOperationsDetailsTable_7a911699-dcef-4873-8af1-82bf786e7ddf" xlink:to="loc_cmlf_DescriptionofOrganizationandBusinessOperationsDetailsLineItems_8e4258fa-ed36-454d-a380-46275aa9b499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_e8e1e73d-d5b1-41fd-a678-ce4ed82d7c42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_DescriptionofOrganizationandBusinessOperationsDetailsLineItems_8e4258fa-ed36-454d-a380-46275aa9b499" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_e8e1e73d-d5b1-41fd-a678-ce4ed82d7c42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_6467526f-d65c-4e83-a568-814441ce1039" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_DescriptionofOrganizationandBusinessOperationsDetailsLineItems_8e4258fa-ed36-454d-a380-46275aa9b499" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_6467526f-d65c-4e83-a568-814441ce1039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_cc5946c6-6964-43bb-a293-bf88105d61d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_DescriptionofOrganizationandBusinessOperationsDetailsLineItems_8e4258fa-ed36-454d-a380-46275aa9b499" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_cc5946c6-6964-43bb-a293-bf88105d61d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_c6873a55-b2e0-4b43-838e-3bd5467e4398" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_DescriptionofOrganizationandBusinessOperationsDetailsLineItems_8e4258fa-ed36-454d-a380-46275aa9b499" xlink:to="loc_us-gaap_SharesIssued_c6873a55-b2e0-4b43-838e-3bd5467e4398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_ed243b57-99e7-4f4a-8c90-a4ca69ef6ded" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_DescriptionofOrganizationandBusinessOperationsDetailsLineItems_8e4258fa-ed36-454d-a380-46275aa9b499" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_ed243b57-99e7-4f4a-8c90-a4ca69ef6ded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_GeneratingGrossProceeds_1ebca9fe-e539-4247-b5b0-febfaad65781" xlink:href="cmlf-20210804.xsd#cmlf_GeneratingGrossProceeds"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_DescriptionofOrganizationandBusinessOperationsDetailsLineItems_8e4258fa-ed36-454d-a380-46275aa9b499" xlink:to="loc_cmlf_GeneratingGrossProceeds_1ebca9fe-e539-4247-b5b0-febfaad65781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_0a87ff00-460f-4202-9a8b-d7806787b566" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_DescriptionofOrganizationandBusinessOperationsDetailsLineItems_8e4258fa-ed36-454d-a380-46275aa9b499" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_0a87ff00-460f-4202-9a8b-d7806787b566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_fbded045-4698-402c-a9c9-3597175e7c61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_DescriptionofOrganizationandBusinessOperationsDetailsLineItems_8e4258fa-ed36-454d-a380-46275aa9b499" xlink:to="loc_us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_fbded045-4698-402c-a9c9-3597175e7c61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_DistributionOrServicingAndDeferredUnderwritingFees_4e81683e-5eb1-4842-8ab0-a26ef357e47c" xlink:href="cmlf-20210804.xsd#cmlf_DistributionOrServicingAndDeferredUnderwritingFees"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_DescriptionofOrganizationandBusinessOperationsDetailsLineItems_8e4258fa-ed36-454d-a380-46275aa9b499" xlink:to="loc_cmlf_DistributionOrServicingAndDeferredUnderwritingFees_4e81683e-5eb1-4842-8ab0-a26ef357e47c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherUnderwritingExpense_7144ce72-6061-4d43-9746-b81973fabecc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherUnderwritingExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_DescriptionofOrganizationandBusinessOperationsDetailsLineItems_8e4258fa-ed36-454d-a380-46275aa9b499" xlink:to="loc_us-gaap_OtherUnderwritingExpense_7144ce72-6061-4d43-9746-b81973fabecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_TransactionCosts_83266c52-8e43-45d4-a74f-a8ad843ce47a" xlink:href="cmlf-20210804.xsd#cmlf_TransactionCosts"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_DescriptionofOrganizationandBusinessOperationsDetailsLineItems_8e4258fa-ed36-454d-a380-46275aa9b499" xlink:to="loc_cmlf_TransactionCosts_83266c52-8e43-45d4-a74f-a8ad843ce47a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_IncludedInShareholdersEquity_72f6357e-5c50-4cba-a6d6-838bd6dc9bb1" xlink:href="cmlf-20210804.xsd#cmlf_IncludedInShareholdersEquity"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_DescriptionofOrganizationandBusinessOperationsDetailsLineItems_8e4258fa-ed36-454d-a380-46275aa9b499" xlink:to="loc_cmlf_IncludedInShareholdersEquity_72f6357e-5c50-4cba-a6d6-838bd6dc9bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_UnitsHeldInTheTrustAccount_4d664001-ea66-4eaf-94ec-c787d2fbb4cd" xlink:href="cmlf-20210804.xsd#cmlf_UnitsHeldInTheTrustAccount"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_DescriptionofOrganizationandBusinessOperationsDetailsLineItems_8e4258fa-ed36-454d-a380-46275aa9b499" xlink:to="loc_cmlf_UnitsHeldInTheTrustAccount_4d664001-ea66-4eaf-94ec-c787d2fbb4cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_7fe7c05e-de60-411b-9f18-10734d2497c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_DescriptionofOrganizationandBusinessOperationsDetailsLineItems_8e4258fa-ed36-454d-a380-46275aa9b499" xlink:to="loc_us-gaap_SharePrice_7fe7c05e-de60-411b-9f18-10734d2497c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_AggregateFairMarketValue_0df0e9dc-9e17-47d6-b174-f0a566dff079" xlink:href="cmlf-20210804.xsd#cmlf_AggregateFairMarketValue"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_DescriptionofOrganizationandBusinessOperationsDetailsLineItems_8e4258fa-ed36-454d-a380-46275aa9b499" xlink:to="loc_cmlf_AggregateFairMarketValue_0df0e9dc-9e17-47d6-b174-f0a566dff079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_BusinessCombinationThresholdVotingInterestToBeAcquired_f0bd7a9f-ca93-43e9-acd5-4e87e6f00bc9" xlink:href="cmlf-20210804.xsd#cmlf_BusinessCombinationThresholdVotingInterestToBeAcquired"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_DescriptionofOrganizationandBusinessOperationsDetailsLineItems_8e4258fa-ed36-454d-a380-46275aa9b499" xlink:to="loc_cmlf_BusinessCombinationThresholdVotingInterestToBeAcquired_f0bd7a9f-ca93-43e9-acd5-4e87e6f00bc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_FiniteLivedTangibleAssetsNet_c518c346-2c03-4c60-8b2c-4f75ec63ef27" xlink:href="cmlf-20210804.xsd#cmlf_FiniteLivedTangibleAssetsNet"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_DescriptionofOrganizationandBusinessOperationsDetailsLineItems_8e4258fa-ed36-454d-a380-46275aa9b499" xlink:to="loc_cmlf_FiniteLivedTangibleAssetsNet_c518c346-2c03-4c60-8b2c-4f75ec63ef27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_RedemptionsOfPublicShares_b9f8e17e-eb53-41d7-b39d-a2438d62fea6" xlink:href="cmlf-20210804.xsd#cmlf_RedemptionsOfPublicShares"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_DescriptionofOrganizationandBusinessOperationsDetailsLineItems_8e4258fa-ed36-454d-a380-46275aa9b499" xlink:to="loc_cmlf_RedemptionsOfPublicShares_b9f8e17e-eb53-41d7-b39d-a2438d62fea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense_d36a80d8-3fbc-4115-8017-99aa628970ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_DescriptionofOrganizationandBusinessOperationsDetailsLineItems_8e4258fa-ed36-454d-a380-46275aa9b499" xlink:to="loc_us-gaap_InterestAndDebtExpense_d36a80d8-3fbc-4115-8017-99aa628970ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_InitialPublicOfferingPricePerUnit_f7104b18-ffa1-4542-8ae0-eb83ef500524" xlink:href="cmlf-20210804.xsd#cmlf_InitialPublicOfferingPricePerUnit"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_DescriptionofOrganizationandBusinessOperationsDetailsLineItems_8e4258fa-ed36-454d-a380-46275aa9b499" xlink:to="loc_cmlf_InitialPublicOfferingPricePerUnit_f7104b18-ffa1-4542-8ae0-eb83ef500524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_LiquidationOfTheTrustAccountPerShare_206b2011-a062-4ec6-84da-7eb449815ad0" xlink:href="cmlf-20210804.xsd#cmlf_LiquidationOfTheTrustAccountPerShare"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_DescriptionofOrganizationandBusinessOperationsDetailsLineItems_8e4258fa-ed36-454d-a380-46275aa9b499" xlink:to="loc_cmlf_LiquidationOfTheTrustAccountPerShare_206b2011-a062-4ec6-84da-7eb449815ad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_TransactionCostsAmount_4e890114-78a7-48f7-8e42-43b44df1e2a9" xlink:href="cmlf-20210804.xsd#cmlf_TransactionCostsAmount"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_DescriptionofOrganizationandBusinessOperationsDetailsLineItems_8e4258fa-ed36-454d-a380-46275aa9b499" xlink:to="loc_cmlf_TransactionCostsAmount_4e890114-78a7-48f7-8e42-43b44df1e2a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_PercentageOfOutstandingVotingSecurities_c906d029-b6e5-40a4-bc78-b32b858e1c29" xlink:href="cmlf-20210804.xsd#cmlf_PercentageOfOutstandingVotingSecurities"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_DescriptionofOrganizationandBusinessOperationsDetailsLineItems_8e4258fa-ed36-454d-a380-46275aa9b499" xlink:to="loc_cmlf_PercentageOfOutstandingVotingSecurities_c906d029-b6e5-40a4-bc78-b32b858e1c29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_PercentageOfPublicShares_2e03890f-3080-4fb3-b266-7a6c09bfb577" xlink:href="cmlf-20210804.xsd#cmlf_PercentageOfPublicShares"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_DescriptionofOrganizationandBusinessOperationsDetailsLineItems_8e4258fa-ed36-454d-a380-46275aa9b499" xlink:to="loc_cmlf_PercentageOfPublicShares_2e03890f-3080-4fb3-b266-7a6c09bfb577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/RestatementofPreviouslyIssuedFinancialStatements" xlink:type="simple" xlink:href="cmlf-20210804.xsd#RestatementofPreviouslyIssuedFinancialStatements"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/RestatementofPreviouslyIssuedFinancialStatements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_RestatementOfFinancialStatementAbstract_637482ad-91c4-4214-a167-51815456964f" xlink:href="cmlf-20210804.xsd#cmlf_RestatementOfFinancialStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_RestatementOfPreviouslyIssuedFinancialStatementsTable_9b74d0f6-880c-4339-b742-3bd3c087f216" xlink:href="cmlf-20210804.xsd#cmlf_RestatementOfPreviouslyIssuedFinancialStatementsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_RestatementOfFinancialStatementAbstract_637482ad-91c4-4214-a167-51815456964f" xlink:to="loc_cmlf_RestatementOfPreviouslyIssuedFinancialStatementsTable_9b74d0f6-880c-4339-b742-3bd3c087f216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_ba942026-2974-43b2-bc75-42f752b0d25f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_RestatementOfPreviouslyIssuedFinancialStatementsTable_9b74d0f6-880c-4339-b742-3bd3c087f216" xlink:to="loc_dei_LegalEntityAxis_ba942026-2974-43b2-bc75-42f752b0d25f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_49d4f525-2454-4605-a7d9-206891f65f45" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_ba942026-2974-43b2-bc75-42f752b0d25f" xlink:to="loc_dei_EntityDomain_49d4f525-2454-4605-a7d9-206891f65f45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLifeSciencesIncMember_380013a6-deb6-434b-9884-be4911b33fe2" xlink:href="cmlf-20210804.xsd#cmlf_CMLifeSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_49d4f525-2454-4605-a7d9-206891f65f45" xlink:to="loc_cmlf_CMLifeSciencesIncMember_380013a6-deb6-434b-9884-be4911b33fe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_RestatementOfPreviouslyIssuedFinancialStatementsLineItems_fa80a7b9-b85f-410c-ac2c-10c703648abb" xlink:href="cmlf-20210804.xsd#cmlf_RestatementOfPreviouslyIssuedFinancialStatementsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_RestatementOfPreviouslyIssuedFinancialStatementsTable_9b74d0f6-880c-4339-b742-3bd3c087f216" xlink:to="loc_cmlf_RestatementOfPreviouslyIssuedFinancialStatementsLineItems_fa80a7b9-b85f-410c-ac2c-10c703648abb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_RestatementOfFinancialStatementTextBlock_2a8cc501-54d9-42d0-a577-074b488eae62" xlink:href="cmlf-20210804.xsd#cmlf_RestatementOfFinancialStatementTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_RestatementOfPreviouslyIssuedFinancialStatementsLineItems_fa80a7b9-b85f-410c-ac2c-10c703648abb" xlink:to="loc_cmlf_RestatementOfFinancialStatementTextBlock_2a8cc501-54d9-42d0-a577-074b488eae62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/RestatementofPreviouslyIssuedFinancialStatementsTables" xlink:type="simple" xlink:href="cmlf-20210804.xsd#RestatementofPreviouslyIssuedFinancialStatementsTables"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/RestatementofPreviouslyIssuedFinancialStatementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_RestatementOfFinancialStatementAbstract_4725be91-af1c-41e3-b62c-0f89407e4117" xlink:href="cmlf-20210804.xsd#cmlf_RestatementOfFinancialStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_RestatementOfPreviouslyIssuedFinancialStatementsTable_b0409ac5-6fc5-4b58-8226-078bf9e3108d" xlink:href="cmlf-20210804.xsd#cmlf_RestatementOfPreviouslyIssuedFinancialStatementsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_RestatementOfFinancialStatementAbstract_4725be91-af1c-41e3-b62c-0f89407e4117" xlink:to="loc_cmlf_RestatementOfPreviouslyIssuedFinancialStatementsTable_b0409ac5-6fc5-4b58-8226-078bf9e3108d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_566f55f4-b44d-4426-a286-b50c305ca98f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_RestatementOfPreviouslyIssuedFinancialStatementsTable_b0409ac5-6fc5-4b58-8226-078bf9e3108d" xlink:to="loc_dei_LegalEntityAxis_566f55f4-b44d-4426-a286-b50c305ca98f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_adb73210-9fce-42ee-b365-679f9962597a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_566f55f4-b44d-4426-a286-b50c305ca98f" xlink:to="loc_dei_EntityDomain_adb73210-9fce-42ee-b365-679f9962597a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLifeSciencesIncMember_a791c76b-d310-4cf8-81e2-25d8c820a507" xlink:href="cmlf-20210804.xsd#cmlf_CMLifeSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_adb73210-9fce-42ee-b365-679f9962597a" xlink:to="loc_cmlf_CMLifeSciencesIncMember_a791c76b-d310-4cf8-81e2-25d8c820a507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_RestatementOfPreviouslyIssuedFinancialStatementsLineItems_bf04ed8f-7a9f-4d28-b4b5-ea522cb1ac07" xlink:href="cmlf-20210804.xsd#cmlf_RestatementOfPreviouslyIssuedFinancialStatementsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_RestatementOfPreviouslyIssuedFinancialStatementsTable_b0409ac5-6fc5-4b58-8226-078bf9e3108d" xlink:to="loc_cmlf_RestatementOfPreviouslyIssuedFinancialStatementsLineItems_bf04ed8f-7a9f-4d28-b4b5-ea522cb1ac07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock_e536c52c-425d-4cc5-b5d5-9febbc68ca0c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfCondensedCashFlowStatementTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_RestatementOfPreviouslyIssuedFinancialStatementsLineItems_bf04ed8f-7a9f-4d28-b4b5-ea522cb1ac07" xlink:to="loc_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock_e536c52c-425d-4cc5-b5d5-9febbc68ca0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/RestatementofPreviouslyIssuedFinancialStatementsDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#RestatementofPreviouslyIssuedFinancialStatementsDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/RestatementofPreviouslyIssuedFinancialStatementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_RestatementOfFinancialStatementAbstract_330779ab-4094-4ce6-8381-ca9f7416b658" xlink:href="cmlf-20210804.xsd#cmlf_RestatementOfFinancialStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_RestatementOfPreviouslyIssuedFinancialStatementsTable_c35d7d01-4f17-4122-b7c0-edd6ca9d4ba6" xlink:href="cmlf-20210804.xsd#cmlf_RestatementOfPreviouslyIssuedFinancialStatementsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_RestatementOfFinancialStatementAbstract_330779ab-4094-4ce6-8381-ca9f7416b658" xlink:to="loc_cmlf_RestatementOfPreviouslyIssuedFinancialStatementsTable_c35d7d01-4f17-4122-b7c0-edd6ca9d4ba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_65464e63-6892-4bad-8dfc-993557b703ed" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_RestatementOfPreviouslyIssuedFinancialStatementsTable_c35d7d01-4f17-4122-b7c0-edd6ca9d4ba6" xlink:to="loc_dei_LegalEntityAxis_65464e63-6892-4bad-8dfc-993557b703ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_42d5baad-f8bd-4ff0-8805-234363dcfca2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_65464e63-6892-4bad-8dfc-993557b703ed" xlink:to="loc_dei_EntityDomain_42d5baad-f8bd-4ff0-8805-234363dcfca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLifeSciencesIncMember_d0387a42-058b-4683-800e-1b731720051e" xlink:href="cmlf-20210804.xsd#cmlf_CMLifeSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_42d5baad-f8bd-4ff0-8805-234363dcfca2" xlink:to="loc_cmlf_CMLifeSciencesIncMember_d0387a42-058b-4683-800e-1b731720051e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_RestatementOfPreviouslyIssuedFinancialStatementsLineItems_481f939b-3edb-432b-a496-a0741a6f74d9" xlink:href="cmlf-20210804.xsd#cmlf_RestatementOfPreviouslyIssuedFinancialStatementsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_RestatementOfPreviouslyIssuedFinancialStatementsTable_c35d7d01-4f17-4122-b7c0-edd6ca9d4ba6" xlink:to="loc_cmlf_RestatementOfPreviouslyIssuedFinancialStatementsLineItems_481f939b-3edb-432b-a496-a0741a6f74d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_OutstandingSharesPercentage_44ec5b28-7e89-49fd-a05a-eeface7952a7" xlink:href="cmlf-20210804.xsd#cmlf_OutstandingSharesPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_RestatementOfPreviouslyIssuedFinancialStatementsLineItems_481f939b-3edb-432b-a496-a0741a6f74d9" xlink:to="loc_cmlf_OutstandingSharesPercentage_44ec5b28-7e89-49fd-a05a-eeface7952a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/RestatementofPreviouslyIssuedFinancialStatementsDetailsScheduleofpreviouslyreportedoperatingexpensescashflowsorcash" xlink:type="simple" xlink:href="cmlf-20210804.xsd#RestatementofPreviouslyIssuedFinancialStatementsDetailsScheduleofpreviouslyreportedoperatingexpensescashflowsorcash"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/RestatementofPreviouslyIssuedFinancialStatementsDetailsScheduleofpreviouslyreportedoperatingexpensescashflowsorcash" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ScheduleOfPreviouslyReportedOperatingExpensesCashFlowsOrCashAbstract_7b9505a6-240b-4710-9c9a-cf200a7ffa52" xlink:href="cmlf-20210804.xsd#cmlf_ScheduleOfPreviouslyReportedOperatingExpensesCashFlowsOrCashAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedCashFlowStatementTable_5775eba6-0064-4ccc-8741-37bcefd33262" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CondensedCashFlowStatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_ScheduleOfPreviouslyReportedOperatingExpensesCashFlowsOrCashAbstract_7b9505a6-240b-4710-9c9a-cf200a7ffa52" xlink:to="loc_srt_CondensedCashFlowStatementTable_5775eba6-0064-4ccc-8741-37bcefd33262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_14d9ec40-a098-4a29-8d8c-67d523e5de31" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementTable_5775eba6-0064-4ccc-8741-37bcefd33262" xlink:to="loc_srt_RestatementAxis_14d9ec40-a098-4a29-8d8c-67d523e5de31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_a13fd119-bd15-4c45-b6fd-2e3d128f0bcf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_14d9ec40-a098-4a29-8d8c-67d523e5de31" xlink:to="loc_srt_RestatementDomain_a13fd119-bd15-4c45-b6fd-2e3d128f0bcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_f6a08e85-d18c-4f33-9240-30714e31be80" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_a13fd119-bd15-4c45-b6fd-2e3d128f0bcf" xlink:to="loc_srt_RestatementAdjustmentMember_f6a08e85-d18c-4f33-9240-30714e31be80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_e1a82b98-74ec-470e-a583-9e18d048a320" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_a13fd119-bd15-4c45-b6fd-2e3d128f0bcf" xlink:to="loc_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_e1a82b98-74ec-470e-a583-9e18d048a320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_08f9fd9a-6910-4079-b1fd-766019b461d1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_a13fd119-bd15-4c45-b6fd-2e3d128f0bcf" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_08f9fd9a-6910-4079-b1fd-766019b461d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_cd82ba26-83a5-4217-9ba8-27b47467db29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementTable_5775eba6-0064-4ccc-8741-37bcefd33262" xlink:to="loc_us-gaap_StatementClassOfStockAxis_cd82ba26-83a5-4217-9ba8-27b47467db29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_29cda92e-07dd-4c05-82b6-e74592cf7e85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_cd82ba26-83a5-4217-9ba8-27b47467db29" xlink:to="loc_us-gaap_ClassOfStockDomain_29cda92e-07dd-4c05-82b6-e74592cf7e85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_4365f67c-054d-4240-ba43-a7e605376e6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_29cda92e-07dd-4c05-82b6-e74592cf7e85" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_4365f67c-054d-4240-ba43-a7e605376e6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonredeemablePreferredStockMember_f25deb1e-014d-4642-a835-1a3a51762dad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonredeemablePreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_29cda92e-07dd-4c05-82b6-e74592cf7e85" xlink:to="loc_us-gaap_NonredeemablePreferredStockMember_f25deb1e-014d-4642-a835-1a3a51762dad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_6087f3c9-d198-4f28-bffc-2a9d1dca5f0a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementTable_5775eba6-0064-4ccc-8741-37bcefd33262" xlink:to="loc_dei_LegalEntityAxis_6087f3c9-d198-4f28-bffc-2a9d1dca5f0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_99c93577-5355-47b4-b929-d3f0b4411eb9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_6087f3c9-d198-4f28-bffc-2a9d1dca5f0a" xlink:to="loc_dei_EntityDomain_99c93577-5355-47b4-b929-d3f0b4411eb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLifeSciencesIncMember_45ef3059-fcc7-4f39-ad87-c17b5ea1d4c7" xlink:href="cmlf-20210804.xsd#cmlf_CMLifeSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_99c93577-5355-47b4-b929-d3f0b4411eb9" xlink:to="loc_cmlf_CMLifeSciencesIncMember_45ef3059-fcc7-4f39-ad87-c17b5ea1d4c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_01be5d39-8d5e-4376-9df7-3ea7467bb661" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CondensedCashFlowStatementsCaptionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementTable_5775eba6-0064-4ccc-8741-37bcefd33262" xlink:to="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_01be5d39-8d5e-4376-9df7-3ea7467bb661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_WarrantLiability_ba12a092-ce59-4ea4-ba29-cbabbb582eaf" xlink:href="cmlf-20210804.xsd#cmlf_WarrantLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_01be5d39-8d5e-4376-9df7-3ea7467bb661" xlink:to="loc_cmlf_WarrantLiability_ba12a092-ce59-4ea4-ba29-cbabbb582eaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_f04b8b04-ff4a-4cce-a802-2119afb6fa42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_WarrantLiability_ba12a092-ce59-4ea4-ba29-cbabbb582eaf" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_f04b8b04-ff4a-4cce-a802-2119afb6fa42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ClassACommonStockOfForum_4ec92142-4296-45fc-a0d0-fb44c7033939" xlink:href="cmlf-20210804.xsd#cmlf_ClassACommonStockOfForum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_WarrantLiability_ba12a092-ce59-4ea4-ba29-cbabbb582eaf" xlink:to="loc_cmlf_ClassACommonStockOfForum_4ec92142-4296-45fc-a0d0-fb44c7033939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_73474055-a5f5-4f93-8911-80a3f8e2234b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_WarrantLiability_ba12a092-ce59-4ea4-ba29-cbabbb582eaf" xlink:to="loc_us-gaap_AdditionalPaidInCapital_73474055-a5f5-4f93-8911-80a3f8e2234b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_12079fed-7181-4118-b6e3-bc49274dfbb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_WarrantLiability_ba12a092-ce59-4ea4-ba29-cbabbb582eaf" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_12079fed-7181-4118-b6e3-bc49274dfbb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_TotalStockholdersEquity_be4dd09e-d534-47d4-84e1-d660294e5237" xlink:href="cmlf-20210804.xsd#cmlf_TotalStockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_WarrantLiability_ba12a092-ce59-4ea4-ba29-cbabbb582eaf" xlink:to="loc_cmlf_TotalStockholdersEquity_be4dd09e-d534-47d4-84e1-d660294e5237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_BalanceSheetAsOfDecember312020AuditedAbstract_da61ace8-0d8f-4625-b6c2-4e075b13ce7a" xlink:href="cmlf-20210804.xsd#cmlf_BalanceSheetAsOfDecember312020AuditedAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_01be5d39-8d5e-4376-9df7-3ea7467bb661" xlink:to="loc_cmlf_BalanceSheetAsOfDecember312020AuditedAbstract_da61ace8-0d8f-4625-b6c2-4e075b13ce7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_WarrantsLiabilities_308b00b0-eb87-4872-bdf1-c0a64144ea3b" xlink:href="cmlf-20210804.xsd#cmlf_WarrantsLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_BalanceSheetAsOfDecember312020AuditedAbstract_da61ace8-0d8f-4625-b6c2-4e075b13ce7a" xlink:to="loc_cmlf_WarrantsLiabilities_308b00b0-eb87-4872-bdf1-c0a64144ea3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_PeriodFromJuly102020InceptionToSeptember302020UnauditedAbstract_4098de14-a31b-4f9d-a214-c9a1dbfa964c" xlink:href="cmlf-20210804.xsd#cmlf_PeriodFromJuly102020InceptionToSeptember302020UnauditedAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_01be5d39-8d5e-4376-9df7-3ea7467bb661" xlink:to="loc_cmlf_PeriodFromJuly102020InceptionToSeptember302020UnauditedAbstract_4098de14-a31b-4f9d-a214-c9a1dbfa964c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_9e684c24-36e0-4e58-bcc1-b4c0b0f519b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_PeriodFromJuly102020InceptionToSeptember302020UnauditedAbstract_4098de14-a31b-4f9d-a214-c9a1dbfa964c" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_9e684c24-36e0-4e58-bcc1-b4c0b0f519b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_TransactionCosts_f1ccf738-4f09-4ce1-a77c-e4e8e2d80800" xlink:href="cmlf-20210804.xsd#cmlf_TransactionCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_PeriodFromJuly102020InceptionToSeptember302020UnauditedAbstract_4098de14-a31b-4f9d-a214-c9a1dbfa964c" xlink:to="loc_cmlf_TransactionCosts_f1ccf738-4f09-4ce1-a77c-e4e8e2d80800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_8612266f-3a76-4a1d-9749-9a10a09c9d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_PeriodFromJuly102020InceptionToSeptember302020UnauditedAbstract_4098de14-a31b-4f9d-a214-c9a1dbfa964c" xlink:to="loc_us-gaap_NetIncomeLoss_8612266f-3a76-4a1d-9749-9a10a09c9d8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_88617eae-9936-478d-988f-8af05056ad33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_PeriodFromJuly102020InceptionToSeptember302020UnauditedAbstract_4098de14-a31b-4f9d-a214-c9a1dbfa964c" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_88617eae-9936-478d-988f-8af05056ad33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_110ef798-1b6e-4e29-ad4c-e754a4b4e2a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_PeriodFromJuly102020InceptionToSeptember302020UnauditedAbstract_4098de14-a31b-4f9d-a214-c9a1dbfa964c" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_110ef798-1b6e-4e29-ad4c-e754a4b4e2a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CashFlowStatementForThePeriodFromJuly102020InceptionToSeptember302020UnauditedAbstract_3dacf76f-efa6-49de-b3c7-dbc86402c1b1" xlink:href="cmlf-20210804.xsd#cmlf_CashFlowStatementForThePeriodFromJuly102020InceptionToSeptember302020UnauditedAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_01be5d39-8d5e-4376-9df7-3ea7467bb661" xlink:to="loc_cmlf_CashFlowStatementForThePeriodFromJuly102020InceptionToSeptember302020UnauditedAbstract_3dacf76f-efa6-49de-b3c7-dbc86402c1b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_949a0e11-04af-46a9-b552-3deeb5fbfa7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_CashFlowStatementForThePeriodFromJuly102020InceptionToSeptember302020UnauditedAbstract_3dacf76f-efa6-49de-b3c7-dbc86402c1b1" xlink:to="loc_us-gaap_NetIncomeLoss_949a0e11-04af-46a9-b552-3deeb5fbfa7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_AllocationOfInitialPublicOfferingCostsToWarrantLiability_2239fb76-d72f-4234-9b1f-b1cc3f3be99d" xlink:href="cmlf-20210804.xsd#cmlf_AllocationOfInitialPublicOfferingCostsToWarrantLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_CashFlowStatementForThePeriodFromJuly102020InceptionToSeptember302020UnauditedAbstract_3dacf76f-efa6-49de-b3c7-dbc86402c1b1" xlink:to="loc_cmlf_AllocationOfInitialPublicOfferingCostsToWarrantLiability_2239fb76-d72f-4234-9b1f-b1cc3f3be99d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ChangeInFairValueOfWarrantLiabilities_0b42ea1c-8022-4cb5-a9ea-1fea94388f82" xlink:href="cmlf-20210804.xsd#cmlf_ChangeInFairValueOfWarrantLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_CashFlowStatementForThePeriodFromJuly102020InceptionToSeptember302020UnauditedAbstract_3dacf76f-efa6-49de-b3c7-dbc86402c1b1" xlink:to="loc_cmlf_ChangeInFairValueOfWarrantLiabilities_0b42ea1c-8022-4cb5-a9ea-1fea94388f82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_InitialClassificationOfWarrantLiability_22ab49d6-e2cd-4c6a-a875-01f547770864" xlink:href="cmlf-20210804.xsd#cmlf_InitialClassificationOfWarrantLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_CashFlowStatementForThePeriodFromJuly102020InceptionToSeptember302020UnauditedAbstract_3dacf76f-efa6-49de-b3c7-dbc86402c1b1" xlink:to="loc_cmlf_InitialClassificationOfWarrantLiability_22ab49d6-e2cd-4c6a-a875-01f547770864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_InitialClassificationOfCommonStockSubjectToPossibleRedemptioninDollarsPerShare_3c43f196-1eaa-4586-afa0-e4730d8cf2f1" xlink:href="cmlf-20210804.xsd#cmlf_InitialClassificationOfCommonStockSubjectToPossibleRedemptioninDollarsPerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_CashFlowStatementForThePeriodFromJuly102020InceptionToSeptember302020UnauditedAbstract_3dacf76f-efa6-49de-b3c7-dbc86402c1b1" xlink:to="loc_cmlf_InitialClassificationOfCommonStockSubjectToPossibleRedemptioninDollarsPerShare_3c43f196-1eaa-4586-afa0-e4730d8cf2f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ChangeInValueOfCommonStockSubjectToPossiblesRedemption_82bab16e-d0f0-4bcd-b743-ea494121ad3f" xlink:href="cmlf-20210804.xsd#cmlf_ChangeInValueOfCommonStockSubjectToPossiblesRedemption"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_CashFlowStatementForThePeriodFromJuly102020InceptionToSeptember302020UnauditedAbstract_3dacf76f-efa6-49de-b3c7-dbc86402c1b1" xlink:to="loc_cmlf_ChangeInValueOfCommonStockSubjectToPossiblesRedemption_82bab16e-d0f0-4bcd-b743-ea494121ad3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/SummaryofSignificantAccountingPolicies_1" xlink:type="simple" xlink:href="cmlf-20210804.xsd#SummaryofSignificantAccountingPolicies_1"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/SummaryofSignificantAccountingPolicies_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a3e9d46f-3f09-4610-9ffd-0e9f405afbee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_SignificantAccountingPoliciesTable_2ec7dba3-a1b6-4851-82e9-41a9b144a6e1" xlink:href="cmlf-20210804.xsd#cmlf_SignificantAccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a3e9d46f-3f09-4610-9ffd-0e9f405afbee" xlink:to="loc_cmlf_SignificantAccountingPoliciesTable_2ec7dba3-a1b6-4851-82e9-41a9b144a6e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_3386155d-f9a6-4eab-9a97-e5f2569de684" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SignificantAccountingPoliciesTable_2ec7dba3-a1b6-4851-82e9-41a9b144a6e1" xlink:to="loc_dei_LegalEntityAxis_3386155d-f9a6-4eab-9a97-e5f2569de684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_2a6d6c05-70e4-4ff8-a59f-4a32b23e9dc3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_3386155d-f9a6-4eab-9a97-e5f2569de684" xlink:to="loc_dei_EntityDomain_2a6d6c05-70e4-4ff8-a59f-4a32b23e9dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLifeSciencesIncMember_18be96f3-9d51-4f0e-a413-d3f865ee7c5a" xlink:href="cmlf-20210804.xsd#cmlf_CMLifeSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_2a6d6c05-70e4-4ff8-a59f-4a32b23e9dc3" xlink:to="loc_cmlf_CMLifeSciencesIncMember_18be96f3-9d51-4f0e-a413-d3f865ee7c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_SignificantAccountingPoliciesLineItems_ad3cb96a-31f3-4473-9427-8964db03600d" xlink:href="cmlf-20210804.xsd#cmlf_SignificantAccountingPoliciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SignificantAccountingPoliciesTable_2ec7dba3-a1b6-4851-82e9-41a9b144a6e1" xlink:to="loc_cmlf_SignificantAccountingPoliciesLineItems_ad3cb96a-31f3-4473-9427-8964db03600d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_703e84a9-d3fc-40f0-b033-881e2ed6af33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SignificantAccountingPoliciesLineItems_ad3cb96a-31f3-4473-9427-8964db03600d" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_703e84a9-d3fc-40f0-b033-881e2ed6af33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/AccountingPoliciesbyPolicyPolicies" xlink:type="simple" xlink:href="cmlf-20210804.xsd#AccountingPoliciesbyPolicyPolicies"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/AccountingPoliciesbyPolicyPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_34f233e8-6496-45f7-b5ea-33f6e38e8d09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_SignificantAccountingPoliciesTable_70e1251f-0c4b-4c20-af43-fd7ab8e8abd2" xlink:href="cmlf-20210804.xsd#cmlf_SignificantAccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_34f233e8-6496-45f7-b5ea-33f6e38e8d09" xlink:to="loc_cmlf_SignificantAccountingPoliciesTable_70e1251f-0c4b-4c20-af43-fd7ab8e8abd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_8ab32925-d020-486f-a665-da132c0cb864" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SignificantAccountingPoliciesTable_70e1251f-0c4b-4c20-af43-fd7ab8e8abd2" xlink:to="loc_dei_LegalEntityAxis_8ab32925-d020-486f-a665-da132c0cb864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_69f1ca3a-7d83-4767-a148-6d87cf2402aa" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_8ab32925-d020-486f-a665-da132c0cb864" xlink:to="loc_dei_EntityDomain_69f1ca3a-7d83-4767-a148-6d87cf2402aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLifeSciencesIncMember_4f1ddbf1-0384-4baf-8b08-f409764dc2fc" xlink:href="cmlf-20210804.xsd#cmlf_CMLifeSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_69f1ca3a-7d83-4767-a148-6d87cf2402aa" xlink:to="loc_cmlf_CMLifeSciencesIncMember_4f1ddbf1-0384-4baf-8b08-f409764dc2fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_SignificantAccountingPoliciesLineItems_3a764ab8-fabd-4829-b88b-0ed1e125c5b5" xlink:href="cmlf-20210804.xsd#cmlf_SignificantAccountingPoliciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SignificantAccountingPoliciesTable_70e1251f-0c4b-4c20-af43-fd7ab8e8abd2" xlink:to="loc_cmlf_SignificantAccountingPoliciesLineItems_3a764ab8-fabd-4829-b88b-0ed1e125c5b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_83962cce-d463-4544-865d-64e643e96022" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SignificantAccountingPoliciesLineItems_3a764ab8-fabd-4829-b88b-0ed1e125c5b5" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_83962cce-d463-4544-865d-64e643e96022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_EmergingGrowthCompanyPolicyTextBlock_f5b34a54-8d06-4a06-a0cc-5c842e1f7fae" xlink:href="cmlf-20210804.xsd#cmlf_EmergingGrowthCompanyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SignificantAccountingPoliciesLineItems_3a764ab8-fabd-4829-b88b-0ed1e125c5b5" xlink:to="loc_cmlf_EmergingGrowthCompanyPolicyTextBlock_f5b34a54-8d06-4a06-a0cc-5c842e1f7fae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_1c1a86bd-ba15-493b-b1c7-df4eec938c5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SignificantAccountingPoliciesLineItems_3a764ab8-fabd-4829-b88b-0ed1e125c5b5" xlink:to="loc_us-gaap_UseOfEstimates_1c1a86bd-ba15-493b-b1c7-df4eec938c5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_5b85e541-d6b1-47bf-9d58-056a4117f1ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SignificantAccountingPoliciesLineItems_3a764ab8-fabd-4829-b88b-0ed1e125c5b5" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_5b85e541-d6b1-47bf-9d58-056a4117f1ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_1c1a6c75-04e4-40c3-a4b3-86faefccb552" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SignificantAccountingPoliciesLineItems_3a764ab8-fabd-4829-b88b-0ed1e125c5b5" xlink:to="loc_us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_1c1a6c75-04e4-40c3-a4b3-86faefccb552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy_125025bb-a75a-419e-b120-83711bf4ac0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SignificantAccountingPoliciesLineItems_3a764ab8-fabd-4829-b88b-0ed1e125c5b5" xlink:to="loc_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy_125025bb-a75a-419e-b120-83711bf4ac0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_WarrantLiabilityPolicyTextBlock_0f34760a-0519-4e47-9080-56e5e848cfb0" xlink:href="cmlf-20210804.xsd#cmlf_WarrantLiabilityPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SignificantAccountingPoliciesLineItems_3a764ab8-fabd-4829-b88b-0ed1e125c5b5" xlink:to="loc_cmlf_WarrantLiabilityPolicyTextBlock_0f34760a-0519-4e47-9080-56e5e848cfb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_b036e10d-9116-4c1c-b3cf-abdadd2c34c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SignificantAccountingPoliciesLineItems_3a764ab8-fabd-4829-b88b-0ed1e125c5b5" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_b036e10d-9116-4c1c-b3cf-abdadd2c34c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_b5cb9717-2d89-40a2-a2ed-ebcb7ad2e5d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SignificantAccountingPoliciesLineItems_3a764ab8-fabd-4829-b88b-0ed1e125c5b5" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_b5cb9717-2d89-40a2-a2ed-ebcb7ad2e5d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_e9678279-87b2-41a2-9442-c26fd8f55b21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SignificantAccountingPoliciesLineItems_3a764ab8-fabd-4829-b88b-0ed1e125c5b5" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_e9678279-87b2-41a2-9442-c26fd8f55b21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_5c94a591-4299-4bad-a3d6-9b2b34f66de2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SignificantAccountingPoliciesLineItems_3a764ab8-fabd-4829-b88b-0ed1e125c5b5" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_5c94a591-4299-4bad-a3d6-9b2b34f66de2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_d1b74505-6c3f-49d9-9180-27aa534d54a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SignificantAccountingPoliciesLineItems_3a764ab8-fabd-4829-b88b-0ed1e125c5b5" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_d1b74505-6c3f-49d9-9180-27aa534d54a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionLeasesCapital_c7db57dd-1772-4d78-86ee-dbe417a15811" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionLeasesCapital"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SignificantAccountingPoliciesLineItems_3a764ab8-fabd-4829-b88b-0ed1e125c5b5" xlink:to="loc_us-gaap_RevenueRecognitionLeasesCapital_c7db57dd-1772-4d78-86ee-dbe417a15811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_4e065d7b-1112-4d17-aef3-735e18e72696" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SignificantAccountingPoliciesLineItems_3a764ab8-fabd-4829-b88b-0ed1e125c5b5" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_4e065d7b-1112-4d17-aef3-735e18e72696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_a10ff5b3-5f9a-4d3e-88ad-d1aed2fa8b46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SignificantAccountingPoliciesLineItems_3a764ab8-fabd-4829-b88b-0ed1e125c5b5" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_a10ff5b3-5f9a-4d3e-88ad-d1aed2fa8b46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/SummaryofSignificantAccountingPoliciesTables_1" xlink:type="simple" xlink:href="cmlf-20210804.xsd#SummaryofSignificantAccountingPoliciesTables_1"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/SummaryofSignificantAccountingPoliciesTables_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_2bf6446c-e065-4017-84f3-29b0a524f28b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_SignificantAccountingPoliciesTable_066f6255-7cb8-4553-90fd-a090a8800ae2" xlink:href="cmlf-20210804.xsd#cmlf_SignificantAccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2bf6446c-e065-4017-84f3-29b0a524f28b" xlink:to="loc_cmlf_SignificantAccountingPoliciesTable_066f6255-7cb8-4553-90fd-a090a8800ae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_86c7a50d-8a1e-4cb1-b2ae-c8f638a7def1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SignificantAccountingPoliciesTable_066f6255-7cb8-4553-90fd-a090a8800ae2" xlink:to="loc_dei_LegalEntityAxis_86c7a50d-8a1e-4cb1-b2ae-c8f638a7def1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_cd410aab-baf1-4e3e-bc17-1dfdb20ce591" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_86c7a50d-8a1e-4cb1-b2ae-c8f638a7def1" xlink:to="loc_dei_EntityDomain_cd410aab-baf1-4e3e-bc17-1dfdb20ce591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLifeSciencesIncMember_e84446e6-f884-4796-8e1b-b8dc9b7e5688" xlink:href="cmlf-20210804.xsd#cmlf_CMLifeSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_cd410aab-baf1-4e3e-bc17-1dfdb20ce591" xlink:to="loc_cmlf_CMLifeSciencesIncMember_e84446e6-f884-4796-8e1b-b8dc9b7e5688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_SignificantAccountingPoliciesLineItems_9f66b121-0f91-417e-bb67-275e06b75b84" xlink:href="cmlf-20210804.xsd#cmlf_SignificantAccountingPoliciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SignificantAccountingPoliciesTable_066f6255-7cb8-4553-90fd-a090a8800ae2" xlink:to="loc_cmlf_SignificantAccountingPoliciesLineItems_9f66b121-0f91-417e-bb67-275e06b75b84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_69e6ba69-7c93-4e20-bc91-8f1bd53edd10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SignificantAccountingPoliciesLineItems_9f66b121-0f91-417e-bb67-275e06b75b84" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_69e6ba69-7c93-4e20-bc91-8f1bd53edd10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#SummaryofSignificantAccountingPoliciesDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a7d30300-b122-4886-ac10-3baa5ac35fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_SummaryofSignificantAccountingPoliciesDetailsTable_82f7f3c6-e665-4372-b8b6-eb0bddbea5bb" xlink:href="cmlf-20210804.xsd#cmlf_SummaryofSignificantAccountingPoliciesDetailsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a7d30300-b122-4886-ac10-3baa5ac35fd1" xlink:to="loc_cmlf_SummaryofSignificantAccountingPoliciesDetailsTable_82f7f3c6-e665-4372-b8b6-eb0bddbea5bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_2ca9af9d-b750-4e33-842c-6926f6069cb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SummaryofSignificantAccountingPoliciesDetailsTable_82f7f3c6-e665-4372-b8b6-eb0bddbea5bb" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_2ca9af9d-b750-4e33-842c-6926f6069cb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_005066a7-3ff0-4351-9818-c2af2c39e8ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_2ca9af9d-b750-4e33-842c-6926f6069cb3" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_005066a7-3ff0-4351-9818-c2af2c39e8ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_WarrantLiabilityMember_5326d3f4-586c-4f54-b445-cda7da73da0e" xlink:href="cmlf-20210804.xsd#cmlf_WarrantLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_005066a7-3ff0-4351-9818-c2af2c39e8ff" xlink:to="loc_cmlf_WarrantLiabilityMember_5326d3f4-586c-4f54-b445-cda7da73da0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_e6b94952-45d5-4f01-b9e0-ee72b26455b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_005066a7-3ff0-4351-9818-c2af2c39e8ff" xlink:to="loc_us-gaap_IPOMember_e6b94952-45d5-4f01-b9e0-ee72b26455b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_d8f77692-7693-4855-a636-2e877682ee7e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SummaryofSignificantAccountingPoliciesDetailsTable_82f7f3c6-e665-4372-b8b6-eb0bddbea5bb" xlink:to="loc_dei_LegalEntityAxis_d8f77692-7693-4855-a636-2e877682ee7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_2a8fbef1-6c8c-443c-97da-57c5ffb877ef" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_d8f77692-7693-4855-a636-2e877682ee7e" xlink:to="loc_dei_EntityDomain_2a8fbef1-6c8c-443c-97da-57c5ffb877ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLifeSciencesIncMember_17987983-b606-484b-a7c1-756d102c27d7" xlink:href="cmlf-20210804.xsd#cmlf_CMLifeSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_2a8fbef1-6c8c-443c-97da-57c5ffb877ef" xlink:to="loc_cmlf_CMLifeSciencesIncMember_17987983-b606-484b-a7c1-756d102c27d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_39443914-c0ee-477f-9cb4-e630246e2026" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SummaryofSignificantAccountingPoliciesDetailsTable_82f7f3c6-e665-4372-b8b6-eb0bddbea5bb" xlink:to="loc_us-gaap_StatementClassOfStockAxis_39443914-c0ee-477f-9cb4-e630246e2026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_c76dee2c-2a06-4491-9861-dfb9f3fda477" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_39443914-c0ee-477f-9cb4-e630246e2026" xlink:to="loc_us-gaap_ClassOfStockDomain_c76dee2c-2a06-4491-9861-dfb9f3fda477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_15ba7c86-2502-4da4-bf27-1ae7f5fd09f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_c76dee2c-2a06-4491-9861-dfb9f3fda477" xlink:to="loc_us-gaap_CommonClassAMember_15ba7c86-2502-4da4-bf27-1ae7f5fd09f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_SummaryofSignificantAccountingPoliciesDetailsLineItems_7707ba41-b297-4bfe-b7e5-986ffe83c429" xlink:href="cmlf-20210804.xsd#cmlf_SummaryofSignificantAccountingPoliciesDetailsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SummaryofSignificantAccountingPoliciesDetailsTable_82f7f3c6-e665-4372-b8b6-eb0bddbea5bb" xlink:to="loc_cmlf_SummaryofSignificantAccountingPoliciesDetailsLineItems_7707ba41-b297-4bfe-b7e5-986ffe83c429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOwnershipInterestsOfferingCosts_b0f36195-2b93-4020-93e0-293b51edb2cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOwnershipInterestsOfferingCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SummaryofSignificantAccountingPoliciesDetailsLineItems_7707ba41-b297-4bfe-b7e5-986ffe83c429" xlink:to="loc_us-gaap_OtherOwnershipInterestsOfferingCosts_b0f36195-2b93-4020-93e0-293b51edb2cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_OfferingCosts_af539c69-f858-4976-8fe0-1359d4e37e6e" xlink:href="cmlf-20210804.xsd#cmlf_OfferingCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SummaryofSignificantAccountingPoliciesDetailsLineItems_7707ba41-b297-4bfe-b7e5-986ffe83c429" xlink:to="loc_cmlf_OfferingCosts_af539c69-f858-4976-8fe0-1359d4e37e6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_14d0cdf0-94ad-4d28-9180-e32104ff58af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SummaryofSignificantAccountingPoliciesDetailsLineItems_7707ba41-b297-4bfe-b7e5-986ffe83c429" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_14d0cdf0-94ad-4d28-9180-e32104ff58af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_ddb2336c-ad5f-4ecc-a0f4-f9e059a74b05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SummaryofSignificantAccountingPoliciesDetailsLineItems_7707ba41-b297-4bfe-b7e5-986ffe83c429" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_ddb2336c-ad5f-4ecc-a0f4-f9e059a74b05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e57ae0a0-dc80-4544-bc3e-e7fab66f715e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SummaryofSignificantAccountingPoliciesDetailsLineItems_7707ba41-b297-4bfe-b7e5-986ffe83c429" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e57ae0a0-dc80-4544-bc3e-e7fab66f715e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_PrivatePlacementToPurchaseOrdinaryShares_96de084b-00cc-4f09-b2b8-f85173628fd8" xlink:href="cmlf-20210804.xsd#cmlf_PrivatePlacementToPurchaseOrdinaryShares"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SummaryofSignificantAccountingPoliciesDetailsLineItems_7707ba41-b297-4bfe-b7e5-986ffe83c429" xlink:to="loc_cmlf_PrivatePlacementToPurchaseOrdinaryShares_96de084b-00cc-4f09-b2b8-f85173628fd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalDepositInsuranceCorporationPremiumExpense_52787a47-b96d-48e2-a058-e930d3ab88ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalDepositInsuranceCorporationPremiumExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SummaryofSignificantAccountingPoliciesDetailsLineItems_7707ba41-b297-4bfe-b7e5-986ffe83c429" xlink:to="loc_us-gaap_FederalDepositInsuranceCorporationPremiumExpense_52787a47-b96d-48e2-a058-e930d3ab88ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_OperatingBankAccount_3ea5202d-5fdd-4afc-b7fb-c39867d900d7" xlink:href="cmlf-20210804.xsd#cmlf_OperatingBankAccount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SummaryofSignificantAccountingPoliciesDetailsLineItems_7707ba41-b297-4bfe-b7e5-986ffe83c429" xlink:to="loc_cmlf_OperatingBankAccount_3ea5202d-5fdd-4afc-b7fb-c39867d900d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_WorkingCapitalDeficit_1dfaa39c-9d80-456b-bc4d-8b9acd7875a8" xlink:href="cmlf-20210804.xsd#cmlf_WorkingCapitalDeficit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SummaryofSignificantAccountingPoliciesDetailsLineItems_7707ba41-b297-4bfe-b7e5-986ffe83c429" xlink:to="loc_cmlf_WorkingCapitalDeficit_1dfaa39c-9d80-456b-bc4d-8b9acd7875a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_d426c481-45b8-4171-9b51-0d41cb372b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SummaryofSignificantAccountingPoliciesDetailsLineItems_7707ba41-b297-4bfe-b7e5-986ffe83c429" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_d426c481-45b8-4171-9b51-0d41cb372b7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CertainLoansAmount_6951eca5-4f98-4c24-8f22-ae19f93435e9" xlink:href="cmlf-20210804.xsd#cmlf_CertainLoansAmount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SummaryofSignificantAccountingPoliciesDetailsLineItems_7707ba41-b297-4bfe-b7e5-986ffe83c429" xlink:to="loc_cmlf_CertainLoansAmount_6951eca5-4f98-4c24-8f22-ae19f93435e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_WorkingCapitalLoans_c7d72a56-9344-4919-b8cd-6e4dfcbf7e40" xlink:href="cmlf-20210804.xsd#cmlf_WorkingCapitalLoans"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SummaryofSignificantAccountingPoliciesDetailsLineItems_7707ba41-b297-4bfe-b7e5-986ffe83c429" xlink:to="loc_cmlf_WorkingCapitalLoans_c7d72a56-9344-4919-b8cd-6e4dfcbf7e40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/SummaryofSignificantAccountingPoliciesDetailsScheduleofcalculationofbasicanddilutednetincomelosspercommonshare" xlink:type="simple" xlink:href="cmlf-20210804.xsd#SummaryofSignificantAccountingPoliciesDetailsScheduleofcalculationofbasicanddilutednetincomelosspercommonshare"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/SummaryofSignificantAccountingPoliciesDetailsScheduleofcalculationofbasicanddilutednetincomelosspercommonshare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_dc83c815-69b2-4dec-a6af-8c029bca25ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_SummaryofSignificantAccountingPoliciesDetailsTable_c3981769-9bee-44f8-8f81-af23ce59108e" xlink:href="cmlf-20210804.xsd#cmlf_SummaryofSignificantAccountingPoliciesDetailsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dc83c815-69b2-4dec-a6af-8c029bca25ae" xlink:to="loc_cmlf_SummaryofSignificantAccountingPoliciesDetailsTable_c3981769-9bee-44f8-8f81-af23ce59108e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_ea24233e-fc78-44b1-a13a-44f8dc11a06b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SummaryofSignificantAccountingPoliciesDetailsTable_c3981769-9bee-44f8-8f81-af23ce59108e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_ea24233e-fc78-44b1-a13a-44f8dc11a06b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_81daaca4-519a-4c33-94ca-0fbc3012da0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_ea24233e-fc78-44b1-a13a-44f8dc11a06b" xlink:to="loc_us-gaap_ClassOfStockDomain_81daaca4-519a-4c33-94ca-0fbc3012da0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ClassARedeemableCommonStockMember_7cc65f3c-c16b-481f-89f4-757f3fc15113" xlink:href="cmlf-20210804.xsd#cmlf_ClassARedeemableCommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_81daaca4-519a-4c33-94ca-0fbc3012da0a" xlink:to="loc_cmlf_ClassARedeemableCommonStockMember_7cc65f3c-c16b-481f-89f4-757f3fc15113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ClassBNonredeemableCommonStockMember_c5151db5-fb43-4d7f-83cf-e285a5a50447" xlink:href="cmlf-20210804.xsd#cmlf_ClassBNonredeemableCommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_81daaca4-519a-4c33-94ca-0fbc3012da0a" xlink:to="loc_cmlf_ClassBNonredeemableCommonStockMember_c5151db5-fb43-4d7f-83cf-e285a5a50447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_da31f883-55c6-467d-8818-174b515980f5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SummaryofSignificantAccountingPoliciesDetailsTable_c3981769-9bee-44f8-8f81-af23ce59108e" xlink:to="loc_dei_LegalEntityAxis_da31f883-55c6-467d-8818-174b515980f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_7217fee2-c794-4956-9079-951a5d2bed39" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_da31f883-55c6-467d-8818-174b515980f5" xlink:to="loc_dei_EntityDomain_7217fee2-c794-4956-9079-951a5d2bed39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLifeSciencesIncMember_8057da78-440e-4b12-9d0a-be7c43cfe336" xlink:href="cmlf-20210804.xsd#cmlf_CMLifeSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_7217fee2-c794-4956-9079-951a5d2bed39" xlink:to="loc_cmlf_CMLifeSciencesIncMember_8057da78-440e-4b12-9d0a-be7c43cfe336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_SummaryofSignificantAccountingPoliciesDetailsLineItems_837ad595-9162-4409-8809-cfdac6d9252b" xlink:href="cmlf-20210804.xsd#cmlf_SummaryofSignificantAccountingPoliciesDetailsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SummaryofSignificantAccountingPoliciesDetailsTable_c3981769-9bee-44f8-8f81-af23ce59108e" xlink:to="loc_cmlf_SummaryofSignificantAccountingPoliciesDetailsLineItems_837ad595-9162-4409-8809-cfdac6d9252b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_RedeemableClassACommonStockAbstract_d2636474-8cfd-43ac-9577-23c3c739ec0f" xlink:href="cmlf-20210804.xsd#cmlf_RedeemableClassACommonStockAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SummaryofSignificantAccountingPoliciesDetailsLineItems_837ad595-9162-4409-8809-cfdac6d9252b" xlink:to="loc_cmlf_RedeemableClassACommonStockAbstract_d2636474-8cfd-43ac-9577-23c3c739ec0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_NumeratorEarningsAllocableToRedeemableClassACommonStockAbstract_4d76f4fc-66a1-44c6-8202-6094cfdb0714" xlink:href="cmlf-20210804.xsd#cmlf_NumeratorEarningsAllocableToRedeemableClassACommonStockAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_RedeemableClassACommonStockAbstract_d2636474-8cfd-43ac-9577-23c3c739ec0f" xlink:to="loc_cmlf_NumeratorEarningsAllocableToRedeemableClassACommonStockAbstract_4d76f4fc-66a1-44c6-8202-6094cfdb0714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOther_a75e5796-385c-46a2-a222-5a3b3b3ebf20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeOther"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_NumeratorEarningsAllocableToRedeemableClassACommonStockAbstract_4d76f4fc-66a1-44c6-8202-6094cfdb0714" xlink:to="loc_us-gaap_InterestIncomeOther_a75e5796-385c-46a2-a222-5a3b3b3ebf20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_IncomeAndFranchiseTax_670dbe10-0cd2-43dd-b61a-7e997735fceb" xlink:href="cmlf-20210804.xsd#cmlf_IncomeAndFranchiseTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_NumeratorEarningsAllocableToRedeemableClassACommonStockAbstract_4d76f4fc-66a1-44c6-8202-6094cfdb0714" xlink:to="loc_cmlf_IncomeAndFranchiseTax_670dbe10-0cd2-43dd-b61a-7e997735fceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_NetEarnings_8472a8b5-c822-47c1-b720-3decd8692474" xlink:href="cmlf-20210804.xsd#cmlf_NetEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_NumeratorEarningsAllocableToRedeemableClassACommonStockAbstract_4d76f4fc-66a1-44c6-8202-6094cfdb0714" xlink:to="loc_cmlf_NetEarnings_8472a8b5-c822-47c1-b720-3decd8692474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_DenominatorWeightedAverageRedeemableClassACommonStockAbstract_f604a1ae-ad87-4ab0-9883-e2bf71076a76" xlink:href="cmlf-20210804.xsd#cmlf_DenominatorWeightedAverageRedeemableClassACommonStockAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_RedeemableClassACommonStockAbstract_d2636474-8cfd-43ac-9577-23c3c739ec0f" xlink:to="loc_cmlf_DenominatorWeightedAverageRedeemableClassACommonStockAbstract_f604a1ae-ad87-4ab0-9883-e2bf71076a76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_RedeemableClassACommonStockBasicAndDiluted_30a2e86b-fdbe-4f91-8a0f-07e8a64cdf07" xlink:href="cmlf-20210804.xsd#cmlf_RedeemableClassACommonStockBasicAndDiluted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_DenominatorWeightedAverageRedeemableClassACommonStockAbstract_f604a1ae-ad87-4ab0-9883-e2bf71076a76" xlink:to="loc_cmlf_RedeemableClassACommonStockBasicAndDiluted_30a2e86b-fdbe-4f91-8a0f-07e8a64cdf07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_EarningsBasicAndDilutedRedeemableClassACommonStockInDollarsPerShare_af651e9c-8be8-44dd-aa50-b8d05ec2802d" xlink:href="cmlf-20210804.xsd#cmlf_EarningsBasicAndDilutedRedeemableClassACommonStockInDollarsPerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_DenominatorWeightedAverageRedeemableClassACommonStockAbstract_f604a1ae-ad87-4ab0-9883-e2bf71076a76" xlink:to="loc_cmlf_EarningsBasicAndDilutedRedeemableClassACommonStockInDollarsPerShare_af651e9c-8be8-44dd-aa50-b8d05ec2802d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_NonRedeemableClassAAndBCommonStockAbstract_cb12720c-4708-4bed-8fbc-c7b943184fe8" xlink:href="cmlf-20210804.xsd#cmlf_NonRedeemableClassAAndBCommonStockAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_RedeemableClassACommonStockAbstract_d2636474-8cfd-43ac-9577-23c3c739ec0f" xlink:to="loc_cmlf_NonRedeemableClassAAndBCommonStockAbstract_cb12720c-4708-4bed-8fbc-c7b943184fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_NumeratorNetIncomeLossMinusRedeemableNetEarningsAbstract_48450f68-1543-4a37-874f-5d9f3201bcff" xlink:href="cmlf-20210804.xsd#cmlf_NumeratorNetIncomeLossMinusRedeemableNetEarningsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_NonRedeemableClassAAndBCommonStockAbstract_cb12720c-4708-4bed-8fbc-c7b943184fe8" xlink:to="loc_cmlf_NumeratorNetIncomeLossMinusRedeemableNetEarningsAbstract_48450f68-1543-4a37-874f-5d9f3201bcff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_781ffc8f-3470-441b-b645-6ba1ccf8fa94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_NumeratorNetIncomeLossMinusRedeemableNetEarningsAbstract_48450f68-1543-4a37-874f-5d9f3201bcff" xlink:to="loc_us-gaap_ProfitLoss_781ffc8f-3470-441b-b645-6ba1ccf8fa94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_RedeemableNetEarnings_495ff189-4323-4938-8642-a9407d3ff942" xlink:href="cmlf-20210804.xsd#cmlf_RedeemableNetEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_NumeratorNetIncomeLossMinusRedeemableNetEarningsAbstract_48450f68-1543-4a37-874f-5d9f3201bcff" xlink:to="loc_cmlf_RedeemableNetEarnings_495ff189-4323-4938-8642-a9407d3ff942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_1c85d30f-94de-4206-9893-79a5fa08af17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_NumeratorNetIncomeLossMinusRedeemableNetEarningsAbstract_48450f68-1543-4a37-874f-5d9f3201bcff" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_1c85d30f-94de-4206-9893-79a5fa08af17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ClassBNonredeemableCommonStockBasicInShares_01d36baf-9479-4fa9-b85f-999a65f67994" xlink:href="cmlf-20210804.xsd#cmlf_ClassBNonredeemableCommonStockBasicInShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_NumeratorNetIncomeLossMinusRedeemableNetEarningsAbstract_48450f68-1543-4a37-874f-5d9f3201bcff" xlink:to="loc_cmlf_ClassBNonredeemableCommonStockBasicInShares_01d36baf-9479-4fa9-b85f-999a65f67994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_EarningsBasicClassBNonredeemableCommonStockinShares_756a6207-a72a-4ae4-8ba4-8e6e57ac133a" xlink:href="cmlf-20210804.xsd#cmlf_EarningsBasicClassBNonredeemableCommonStockinShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_NumeratorNetIncomeLossMinusRedeemableNetEarningsAbstract_48450f68-1543-4a37-874f-5d9f3201bcff" xlink:to="loc_cmlf_EarningsBasicClassBNonredeemableCommonStockinShares_756a6207-a72a-4ae4-8ba4-8e6e57ac133a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_NonRedeemableClassAAndBCommonStockBasicAndDilutedInShares_de12e44d-ec19-4899-b295-1684b0c12180" xlink:href="cmlf-20210804.xsd#cmlf_NonRedeemableClassAAndBCommonStockBasicAndDilutedInShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SummaryofSignificantAccountingPoliciesDetailsLineItems_837ad595-9162-4409-8809-cfdac6d9252b" xlink:to="loc_cmlf_NonRedeemableClassAAndBCommonStockBasicAndDilutedInShares_de12e44d-ec19-4899-b295-1684b0c12180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_LossBasicAndDilutedNonRedeemableClassAAndBCommonStock_c5830016-34e8-4cb5-a0bb-9376c8521b9c" xlink:href="cmlf-20210804.xsd#cmlf_LossBasicAndDilutedNonRedeemableClassAAndBCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SummaryofSignificantAccountingPoliciesDetailsLineItems_837ad595-9162-4409-8809-cfdac6d9252b" xlink:to="loc_cmlf_LossBasicAndDilutedNonRedeemableClassAAndBCommonStock_c5830016-34e8-4cb5-a0bb-9376c8521b9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/InitialPublicOffering" xlink:type="simple" xlink:href="cmlf-20210804.xsd#InitialPublicOffering"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/InitialPublicOffering" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ProposedPublicOfferingDisclosureAbstract_0a798356-b7d1-4820-9d6d-89973f7e9689" xlink:href="cmlf-20210804.xsd#cmlf_ProposedPublicOfferingDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_InitialPublicOfferingDetailsTable_e4ccb5a3-a353-43e2-bd0a-fd5021c08da8" xlink:href="cmlf-20210804.xsd#cmlf_InitialPublicOfferingDetailsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_ProposedPublicOfferingDisclosureAbstract_0a798356-b7d1-4820-9d6d-89973f7e9689" xlink:to="loc_cmlf_InitialPublicOfferingDetailsTable_e4ccb5a3-a353-43e2-bd0a-fd5021c08da8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_6ceee123-8705-41b9-88d0-9e7b46b7f76e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_InitialPublicOfferingDetailsTable_e4ccb5a3-a353-43e2-bd0a-fd5021c08da8" xlink:to="loc_dei_LegalEntityAxis_6ceee123-8705-41b9-88d0-9e7b46b7f76e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_d5973ede-3d2e-455e-8d74-ddf996f13261" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_6ceee123-8705-41b9-88d0-9e7b46b7f76e" xlink:to="loc_dei_EntityDomain_d5973ede-3d2e-455e-8d74-ddf996f13261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLifeSciencesIncMember_a103c3be-a81b-4cf7-8069-46d459c59a6e" xlink:href="cmlf-20210804.xsd#cmlf_CMLifeSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_d5973ede-3d2e-455e-8d74-ddf996f13261" xlink:to="loc_cmlf_CMLifeSciencesIncMember_a103c3be-a81b-4cf7-8069-46d459c59a6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_InitialPublicOfferingDetailsLineItems_1f896c1b-2511-4f4e-b6a1-abaea323853b" xlink:href="cmlf-20210804.xsd#cmlf_InitialPublicOfferingDetailsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_InitialPublicOfferingDetailsTable_e4ccb5a3-a353-43e2-bd0a-fd5021c08da8" xlink:to="loc_cmlf_InitialPublicOfferingDetailsLineItems_1f896c1b-2511-4f4e-b6a1-abaea323853b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_InitialPublicOfferingTextBlock_d4d19d7f-fc94-4346-8a6a-a0542507e5c7" xlink:href="cmlf-20210804.xsd#cmlf_InitialPublicOfferingTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_InitialPublicOfferingDetailsLineItems_1f896c1b-2511-4f4e-b6a1-abaea323853b" xlink:to="loc_cmlf_InitialPublicOfferingTextBlock_d4d19d7f-fc94-4346-8a6a-a0542507e5c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/InitialPublicOfferingDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#InitialPublicOfferingDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/InitialPublicOfferingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ProposedPublicOfferingDisclosureAbstract_ee1678f5-1c94-4960-89aa-9d812f182ba0" xlink:href="cmlf-20210804.xsd#cmlf_ProposedPublicOfferingDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_InitialPublicOfferingDetailsTable_bdc3bedf-9eb3-49b8-bcdb-8022dac48f25" xlink:href="cmlf-20210804.xsd#cmlf_InitialPublicOfferingDetailsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_ProposedPublicOfferingDisclosureAbstract_ee1678f5-1c94-4960-89aa-9d812f182ba0" xlink:to="loc_cmlf_InitialPublicOfferingDetailsTable_bdc3bedf-9eb3-49b8-bcdb-8022dac48f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_fcdc099a-5617-4a86-a835-aebfe6c17258" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_InitialPublicOfferingDetailsTable_bdc3bedf-9eb3-49b8-bcdb-8022dac48f25" xlink:to="loc_us-gaap_StatementClassOfStockAxis_fcdc099a-5617-4a86-a835-aebfe6c17258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d7a33e81-5283-4582-8ec3-afeeaa726af4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_fcdc099a-5617-4a86-a835-aebfe6c17258" xlink:to="loc_us-gaap_ClassOfStockDomain_d7a33e81-5283-4582-8ec3-afeeaa726af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_7b813ab4-ec42-420a-883c-ce4a32c749e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d7a33e81-5283-4582-8ec3-afeeaa726af4" xlink:to="loc_us-gaap_CommonClassAMember_7b813ab4-ec42-420a-883c-ce4a32c749e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_c9552663-ebeb-4c44-bce0-ea26ac97fb8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_InitialPublicOfferingDetailsTable_bdc3bedf-9eb3-49b8-bcdb-8022dac48f25" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_c9552663-ebeb-4c44-bce0-ea26ac97fb8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_f25b7c92-8e1d-4f61-87c3-8e2997f596cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_c9552663-ebeb-4c44-bce0-ea26ac97fb8f" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_f25b7c92-8e1d-4f61-87c3-8e2997f596cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_6918f57f-8ecd-4302-a4c0-ea4a77f6901e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_f25b7c92-8e1d-4f61-87c3-8e2997f596cb" xlink:to="loc_us-gaap_OverAllotmentOptionMember_6918f57f-8ecd-4302-a4c0-ea4a77f6901e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_c321901a-07d4-4396-984c-c49edc011cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_f25b7c92-8e1d-4f61-87c3-8e2997f596cb" xlink:to="loc_us-gaap_IPOMember_c321901a-07d4-4396-984c-c49edc011cdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoteWarrantMember_468cfa40-75f4-4d92-993b-2a3cd6b99e42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoteWarrantMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_f25b7c92-8e1d-4f61-87c3-8e2997f596cb" xlink:to="loc_us-gaap_NoteWarrantMember_468cfa40-75f4-4d92-993b-2a3cd6b99e42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_OverAllotmentOptionUnitMember_6a15f109-293d-4f32-b373-5454ae98014e" xlink:href="cmlf-20210804.xsd#cmlf_OverAllotmentOptionUnitMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_f25b7c92-8e1d-4f61-87c3-8e2997f596cb" xlink:to="loc_cmlf_OverAllotmentOptionUnitMember_6a15f109-293d-4f32-b373-5454ae98014e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_edb01bfb-0484-421e-92f9-366e396270b0" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_InitialPublicOfferingDetailsTable_bdc3bedf-9eb3-49b8-bcdb-8022dac48f25" xlink:to="loc_dei_LegalEntityAxis_edb01bfb-0484-421e-92f9-366e396270b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_c8125577-5de0-4f89-bd9a-7e8a5cfd018c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_edb01bfb-0484-421e-92f9-366e396270b0" xlink:to="loc_dei_EntityDomain_c8125577-5de0-4f89-bd9a-7e8a5cfd018c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLifeSciencesIncMember_37a6d356-ecf6-456c-9aec-3dbed6f6ba14" xlink:href="cmlf-20210804.xsd#cmlf_CMLifeSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_c8125577-5de0-4f89-bd9a-7e8a5cfd018c" xlink:to="loc_cmlf_CMLifeSciencesIncMember_37a6d356-ecf6-456c-9aec-3dbed6f6ba14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_InitialPublicOfferingDetailsLineItems_281f4ce3-52e4-471d-9a97-5a2a3235cf87" xlink:href="cmlf-20210804.xsd#cmlf_InitialPublicOfferingDetailsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_InitialPublicOfferingDetailsTable_bdc3bedf-9eb3-49b8-bcdb-8022dac48f25" xlink:to="loc_cmlf_InitialPublicOfferingDetailsLineItems_281f4ce3-52e4-471d-9a97-5a2a3235cf87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_PublicOfferingSaleOfUnits_587cef02-4fd4-4382-8abc-6fcf18c4e9b4" xlink:href="cmlf-20210804.xsd#cmlf_PublicOfferingSaleOfUnits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_InitialPublicOfferingDetailsLineItems_281f4ce3-52e4-471d-9a97-5a2a3235cf87" xlink:to="loc_cmlf_PublicOfferingSaleOfUnits_587cef02-4fd4-4382-8abc-6fcf18c4e9b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_186dfd8c-8268-4a37-80c8-a4c37fadf88b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_InitialPublicOfferingDetailsLineItems_281f4ce3-52e4-471d-9a97-5a2a3235cf87" xlink:to="loc_us-gaap_SharesIssued_186dfd8c-8268-4a37-80c8-a4c37fadf88b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_c3da492d-9641-41f6-ba1f-893b574c4079" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_InitialPublicOfferingDetailsLineItems_281f4ce3-52e4-471d-9a97-5a2a3235cf87" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_c3da492d-9641-41f6-ba1f-893b574c4079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2e3ae17f-fd22-4009-a540-8796fb852ced" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_InitialPublicOfferingDetailsLineItems_281f4ce3-52e4-471d-9a97-5a2a3235cf87" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2e3ae17f-fd22-4009-a540-8796fb852ced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_WarrantIssued_86fc486e-d321-48df-a32e-67c76c74c6ca" xlink:href="cmlf-20210804.xsd#cmlf_WarrantIssued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_InitialPublicOfferingDetailsLineItems_281f4ce3-52e4-471d-9a97-5a2a3235cf87" xlink:to="loc_cmlf_WarrantIssued_86fc486e-d321-48df-a32e-67c76c74c6ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/PrivatePlacement" xlink:type="simple" xlink:href="cmlf-20210804.xsd#PrivatePlacement"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/PrivatePlacement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_PrivatePlacementDisclosureAbstract_d2af667b-ab87-4ce1-aedb-d068520d5923" xlink:href="cmlf-20210804.xsd#cmlf_PrivatePlacementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_InitialPublicOfferingDetailsTable_93daab75-2b1d-4f9c-80bc-6927a387816d" xlink:href="cmlf-20210804.xsd#cmlf_InitialPublicOfferingDetailsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_PrivatePlacementDisclosureAbstract_d2af667b-ab87-4ce1-aedb-d068520d5923" xlink:to="loc_cmlf_InitialPublicOfferingDetailsTable_93daab75-2b1d-4f9c-80bc-6927a387816d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_e3d6229b-6c3c-4c78-9326-81b252bdd6d3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_InitialPublicOfferingDetailsTable_93daab75-2b1d-4f9c-80bc-6927a387816d" xlink:to="loc_dei_LegalEntityAxis_e3d6229b-6c3c-4c78-9326-81b252bdd6d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_5cb15e76-5567-487d-a43e-5de29511ba8c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_e3d6229b-6c3c-4c78-9326-81b252bdd6d3" xlink:to="loc_dei_EntityDomain_5cb15e76-5567-487d-a43e-5de29511ba8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLifeSciencesIncMember_e0f3d3c9-7d9e-472f-8b28-c6a6d1fc3c62" xlink:href="cmlf-20210804.xsd#cmlf_CMLifeSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_5cb15e76-5567-487d-a43e-5de29511ba8c" xlink:to="loc_cmlf_CMLifeSciencesIncMember_e0f3d3c9-7d9e-472f-8b28-c6a6d1fc3c62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_InitialPublicOfferingDetailsLineItems_5fefb4ff-3277-4598-9a1f-18008e2d6fae" xlink:href="cmlf-20210804.xsd#cmlf_InitialPublicOfferingDetailsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_InitialPublicOfferingDetailsTable_93daab75-2b1d-4f9c-80bc-6927a387816d" xlink:to="loc_cmlf_InitialPublicOfferingDetailsLineItems_5fefb4ff-3277-4598-9a1f-18008e2d6fae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_PrivatePlacementDisclosureTextBlockTextBlock_040c30eb-f66b-477a-8166-579a54402506" xlink:href="cmlf-20210804.xsd#cmlf_PrivatePlacementDisclosureTextBlockTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_InitialPublicOfferingDetailsLineItems_5fefb4ff-3277-4598-9a1f-18008e2d6fae" xlink:to="loc_cmlf_PrivatePlacementDisclosureTextBlockTextBlock_040c30eb-f66b-477a-8166-579a54402506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/PrivatePlacementDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#PrivatePlacementDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/PrivatePlacementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_PrivatePlacementDisclosureAbstract_834b48fd-d36b-4650-a64a-4d8e3a06d32f" xlink:href="cmlf-20210804.xsd#cmlf_PrivatePlacementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_PrivatePlacementDetailsTable_712ec6e9-cc66-4722-ae51-1a631fa43d6d" xlink:href="cmlf-20210804.xsd#cmlf_PrivatePlacementDetailsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_PrivatePlacementDisclosureAbstract_834b48fd-d36b-4650-a64a-4d8e3a06d32f" xlink:to="loc_cmlf_PrivatePlacementDetailsTable_712ec6e9-cc66-4722-ae51-1a631fa43d6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_7ce6d8c3-68b8-4028-84ce-18ee54669f72" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_PrivatePlacementDetailsTable_712ec6e9-cc66-4722-ae51-1a631fa43d6d" xlink:to="loc_srt_TitleOfIndividualAxis_7ce6d8c3-68b8-4028-84ce-18ee54669f72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_86355186-de97-4594-9cdc-0b4fc5ff5c9e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_7ce6d8c3-68b8-4028-84ce-18ee54669f72" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_86355186-de97-4594-9cdc-0b4fc5ff5c9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_SponsorMember_82491648-6a6e-4715-ae8a-ac65a43d238a" xlink:href="cmlf-20210804.xsd#cmlf_SponsorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_86355186-de97-4594-9cdc-0b4fc5ff5c9e" xlink:to="loc_cmlf_SponsorMember_82491648-6a6e-4715-ae8a-ac65a43d238a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_3f858a73-15a6-4eb9-8bee-c8ec7ca42b95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_PrivatePlacementDetailsTable_712ec6e9-cc66-4722-ae51-1a631fa43d6d" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_3f858a73-15a6-4eb9-8bee-c8ec7ca42b95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_59f6868e-7102-48ac-86a3-8a6fcc7bcf83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_3f858a73-15a6-4eb9-8bee-c8ec7ca42b95" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_59f6868e-7102-48ac-86a3-8a6fcc7bcf83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_86d170d2-dd52-476a-9344-e064a1874a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrivatePlacementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_59f6868e-7102-48ac-86a3-8a6fcc7bcf83" xlink:to="loc_us-gaap_PrivatePlacementMember_86d170d2-dd52-476a-9344-e064a1874a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_469788ac-3c33-4383-ad55-94325d821656" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_PrivatePlacementDetailsTable_712ec6e9-cc66-4722-ae51-1a631fa43d6d" xlink:to="loc_us-gaap_StatementClassOfStockAxis_469788ac-3c33-4383-ad55-94325d821656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_65734842-4488-4ad7-9154-bc76d5c3182c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_469788ac-3c33-4383-ad55-94325d821656" xlink:to="loc_us-gaap_ClassOfStockDomain_65734842-4488-4ad7-9154-bc76d5c3182c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_e5963081-5259-4283-93a4-52f34bc0e537" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_65734842-4488-4ad7-9154-bc76d5c3182c" xlink:to="loc_us-gaap_CommonClassAMember_e5963081-5259-4283-93a4-52f34bc0e537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_b748393b-7e94-4afa-b109-94ae2e8d9eee" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_PrivatePlacementDetailsTable_712ec6e9-cc66-4722-ae51-1a631fa43d6d" xlink:to="loc_dei_LegalEntityAxis_b748393b-7e94-4afa-b109-94ae2e8d9eee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_b5b7beb9-0453-4071-a470-83e77051d2ed" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_b748393b-7e94-4afa-b109-94ae2e8d9eee" xlink:to="loc_dei_EntityDomain_b5b7beb9-0453-4071-a470-83e77051d2ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLifeSciencesIncMember_62c0e8f6-1660-40a6-9a37-ab1dfe15e636" xlink:href="cmlf-20210804.xsd#cmlf_CMLifeSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_b5b7beb9-0453-4071-a470-83e77051d2ed" xlink:to="loc_cmlf_CMLifeSciencesIncMember_62c0e8f6-1660-40a6-9a37-ab1dfe15e636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_PrivatePlacementDetailsLineItems_6a19ecbc-8f7b-426e-afc6-ec33137213d0" xlink:href="cmlf-20210804.xsd#cmlf_PrivatePlacementDetailsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_PrivatePlacementDetailsTable_712ec6e9-cc66-4722-ae51-1a631fa43d6d" xlink:to="loc_cmlf_PrivatePlacementDetailsLineItems_6a19ecbc-8f7b-426e-afc6-ec33137213d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_d7e344e5-5b45-4c28-b506-f7c04cd44732" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_PrivatePlacementDetailsLineItems_6a19ecbc-8f7b-426e-afc6-ec33137213d0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_d7e344e5-5b45-4c28-b506-f7c04cd44732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_3fea9770-eb37-4a74-9e78-344e971a8e86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_PrivatePlacementDetailsLineItems_6a19ecbc-8f7b-426e-afc6-ec33137213d0" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_3fea9770-eb37-4a74-9e78-344e971a8e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssued1_d6b297bb-78f2-42b9-9873-78d7b03aae77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssued1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_PrivatePlacementDetailsLineItems_6a19ecbc-8f7b-426e-afc6-ec33137213d0" xlink:to="loc_us-gaap_StockIssued1_d6b297bb-78f2-42b9-9873-78d7b03aae77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_9d2790ea-e02a-45b9-8b50-87023a06a3d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_PrivatePlacementDetailsLineItems_6a19ecbc-8f7b-426e-afc6-ec33137213d0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_9d2790ea-e02a-45b9-8b50-87023a06a3d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_e7468d0d-e89c-4b53-b67d-ae6cd6da486f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_PrivatePlacementDetailsLineItems_6a19ecbc-8f7b-426e-afc6-ec33137213d0" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_e7468d0d-e89c-4b53-b67d-ae6cd6da486f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_8edbbbac-7b7a-4193-917f-f3a697556e25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_PrivatePlacementDetailsLineItems_6a19ecbc-8f7b-426e-afc6-ec33137213d0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_8edbbbac-7b7a-4193-917f-f3a697556e25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/RelatedPartyTransactions_1" xlink:type="simple" xlink:href="cmlf-20210804.xsd#RelatedPartyTransactions_1"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/RelatedPartyTransactions_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_223100f0-7264-4336-9ec6-5c80ae3baaf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_RelatedPartyTransactionsDetailsTable_41243c89-d8db-4439-8382-cf428acc26bc" xlink:href="cmlf-20210804.xsd#cmlf_RelatedPartyTransactionsDetailsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_223100f0-7264-4336-9ec6-5c80ae3baaf2" xlink:to="loc_cmlf_RelatedPartyTransactionsDetailsTable_41243c89-d8db-4439-8382-cf428acc26bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_581eb750-65d5-4900-b968-19152d79303d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_RelatedPartyTransactionsDetailsTable_41243c89-d8db-4439-8382-cf428acc26bc" xlink:to="loc_dei_LegalEntityAxis_581eb750-65d5-4900-b968-19152d79303d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_07033aad-e75f-4bd2-8751-e8968267ee35" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_581eb750-65d5-4900-b968-19152d79303d" xlink:to="loc_dei_EntityDomain_07033aad-e75f-4bd2-8751-e8968267ee35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLifeSciencesIncMember_b598065f-245d-4e5e-97cd-2b48e33208c5" xlink:href="cmlf-20210804.xsd#cmlf_CMLifeSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_07033aad-e75f-4bd2-8751-e8968267ee35" xlink:to="loc_cmlf_CMLifeSciencesIncMember_b598065f-245d-4e5e-97cd-2b48e33208c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_RelatedPartyTransactionsDetailsLineItems_fb3455da-126b-4292-bc64-016d93f42275" xlink:href="cmlf-20210804.xsd#cmlf_RelatedPartyTransactionsDetailsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_RelatedPartyTransactionsDetailsTable_41243c89-d8db-4439-8382-cf428acc26bc" xlink:to="loc_cmlf_RelatedPartyTransactionsDetailsLineItems_fb3455da-126b-4292-bc64-016d93f42275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_6f2b627c-ffef-4665-8708-ef3014c60495" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_RelatedPartyTransactionsDetailsLineItems_fb3455da-126b-4292-bc64-016d93f42275" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_6f2b627c-ffef-4665-8708-ef3014c60495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#RelatedPartyTransactionsDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/RelatedPartyTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_b27c9ce4-29a3-42fb-b0f8-21c39f7636a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_RelatedPartyTransactionsDetailsTable_6ba6698f-5a8d-47b6-8cf5-c26fdb1f6ae8" xlink:href="cmlf-20210804.xsd#cmlf_RelatedPartyTransactionsDetailsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_b27c9ce4-29a3-42fb-b0f8-21c39f7636a4" xlink:to="loc_cmlf_RelatedPartyTransactionsDetailsTable_6ba6698f-5a8d-47b6-8cf5-c26fdb1f6ae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_bac4987a-0376-4e3b-a8b9-50f52da05d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_RelatedPartyTransactionsDetailsTable_6ba6698f-5a8d-47b6-8cf5-c26fdb1f6ae8" xlink:to="loc_us-gaap_StatementClassOfStockAxis_bac4987a-0376-4e3b-a8b9-50f52da05d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f69a9886-5639-46fb-b178-db927c474441" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_bac4987a-0376-4e3b-a8b9-50f52da05d4e" xlink:to="loc_us-gaap_ClassOfStockDomain_f69a9886-5639-46fb-b178-db927c474441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_3857291f-26d0-44b0-b84f-61b611a6a113" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_f69a9886-5639-46fb-b178-db927c474441" xlink:to="loc_us-gaap_CommonClassBMember_3857291f-26d0-44b0-b84f-61b611a6a113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_FoundersSharesMember_9a4918dc-59af-447f-88ae-552569d37a6e" xlink:href="cmlf-20210804.xsd#cmlf_FoundersSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_f69a9886-5639-46fb-b178-db927c474441" xlink:to="loc_cmlf_FoundersSharesMember_9a4918dc-59af-447f-88ae-552569d37a6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_afff240d-75a8-4c36-b0fa-2dece74bf193" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_RelatedPartyTransactionsDetailsTable_6ba6698f-5a8d-47b6-8cf5-c26fdb1f6ae8" xlink:to="loc_srt_TitleOfIndividualAxis_afff240d-75a8-4c36-b0fa-2dece74bf193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_435cd77e-3587-43f3-9f06-f9cab819f34c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_afff240d-75a8-4c36-b0fa-2dece74bf193" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_435cd77e-3587-43f3-9f06-f9cab819f34c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_MunibIslamMember_78113654-cc4a-4a15-9489-a775e4c327bf" xlink:href="cmlf-20210804.xsd#cmlf_MunibIslamMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_435cd77e-3587-43f3-9f06-f9cab819f34c" xlink:to="loc_cmlf_MunibIslamMember_78113654-cc4a-4a15-9489-a775e4c327bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_EmilyLeproustMember_77dff27e-12e5-4e17-864b-23ae9d05723c" xlink:href="cmlf-20210804.xsd#cmlf_EmilyLeproustMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_435cd77e-3587-43f3-9f06-f9cab819f34c" xlink:to="loc_cmlf_EmilyLeproustMember_77dff27e-12e5-4e17-864b-23ae9d05723c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_NatTurnerMember_c50966ab-dd71-4089-8ee6-bc136cbd7baf" xlink:href="cmlf-20210804.xsd#cmlf_NatTurnerMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_435cd77e-3587-43f3-9f06-f9cab819f34c" xlink:to="loc_cmlf_NatTurnerMember_c50966ab-dd71-4089-8ee6-bc136cbd7baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_72d41949-9420-46b1-a5fb-bb76dc0dc418" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_RelatedPartyTransactionsDetailsTable_6ba6698f-5a8d-47b6-8cf5-c26fdb1f6ae8" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_72d41949-9420-46b1-a5fb-bb76dc0dc418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_9eee638a-6784-493b-81f4-76868fdd47f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_72d41949-9420-46b1-a5fb-bb76dc0dc418" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_9eee638a-6784-493b-81f4-76868fdd47f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_FounderSharesMember_bbd50939-700d-4986-b991-a7a52ad198d8" xlink:href="cmlf-20210804.xsd#cmlf_FounderSharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_9eee638a-6784-493b-81f4-76868fdd47f0" xlink:to="loc_cmlf_FounderSharesMember_bbd50939-700d-4986-b991-a7a52ad198d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_InitialShareholdersMember_81fe0230-c4c6-49cb-b2e2-317e3a00eba4" xlink:href="cmlf-20210804.xsd#cmlf_InitialShareholdersMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_9eee638a-6784-493b-81f4-76868fdd47f0" xlink:to="loc_cmlf_InitialShareholdersMember_81fe0230-c4c6-49cb-b2e2-317e3a00eba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_SponsorMember_e41db93c-db92-4994-b50a-ebefa8aecfde" xlink:href="cmlf-20210804.xsd#cmlf_SponsorMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_9eee638a-6784-493b-81f4-76868fdd47f0" xlink:to="loc_cmlf_SponsorMember_e41db93c-db92-4994-b50a-ebefa8aecfde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_WorkingCapitalLoansMember_f468708d-76a9-4d0f-ac7a-f6d58bf91c41" xlink:href="cmlf-20210804.xsd#cmlf_WorkingCapitalLoansMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_9eee638a-6784-493b-81f4-76868fdd47f0" xlink:to="loc_cmlf_WorkingCapitalLoansMember_f468708d-76a9-4d0f-ac7a-f6d58bf91c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2dbecf9f-8bbe-43e7-8b55-0f9b389d862b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_RelatedPartyTransactionsDetailsTable_6ba6698f-5a8d-47b6-8cf5-c26fdb1f6ae8" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2dbecf9f-8bbe-43e7-8b55-0f9b389d862b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_2ea2fafd-da26-423b-90f8-821397e6658e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2dbecf9f-8bbe-43e7-8b55-0f9b389d862b" xlink:to="loc_us-gaap_RelatedPartyDomain_2ea2fafd-da26-423b-90f8-821397e6658e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_SponsorMember_a7e3e047-ffc2-4eae-9b30-8326cbf1f42f" xlink:href="cmlf-20210804.xsd#cmlf_SponsorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_2ea2fafd-da26-423b-90f8-821397e6658e" xlink:to="loc_cmlf_SponsorMember_a7e3e047-ffc2-4eae-9b30-8326cbf1f42f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_33df3890-51ba-4f54-b1bf-2a2183544b66" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_RelatedPartyTransactionsDetailsTable_6ba6698f-5a8d-47b6-8cf5-c26fdb1f6ae8" xlink:to="loc_dei_LegalEntityAxis_33df3890-51ba-4f54-b1bf-2a2183544b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_16ac674c-67c0-4c38-a94b-da6af4e59241" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_33df3890-51ba-4f54-b1bf-2a2183544b66" xlink:to="loc_dei_EntityDomain_16ac674c-67c0-4c38-a94b-da6af4e59241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLifeSciencesIncMember_9078bb2a-eb6a-4e78-a150-5f74d8c53555" xlink:href="cmlf-20210804.xsd#cmlf_CMLifeSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_16ac674c-67c0-4c38-a94b-da6af4e59241" xlink:to="loc_cmlf_CMLifeSciencesIncMember_9078bb2a-eb6a-4e78-a150-5f74d8c53555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_RelatedPartyTransactionsDetailsLineItems_49c0ca5f-913d-4602-a730-2f699e92e981" xlink:href="cmlf-20210804.xsd#cmlf_RelatedPartyTransactionsDetailsLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_RelatedPartyTransactionsDetailsTable_6ba6698f-5a8d-47b6-8cf5-c26fdb1f6ae8" xlink:to="loc_cmlf_RelatedPartyTransactionsDetailsLineItems_49c0ca5f-913d-4602-a730-2f699e92e981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyCosts_56c14407-dd82-48fe-b8b8-e5aa5ff07cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_RelatedPartyTransactionsDetailsLineItems_49c0ca5f-913d-4602-a730-2f699e92e981" xlink:to="loc_us-gaap_RelatedPartyCosts_56c14407-dd82-48fe-b8b8-e5aa5ff07cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_63c43a5c-f6ac-4ad0-8f60-30b61bcc74da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_RelatedPartyTransactionsDetailsLineItems_49c0ca5f-913d-4602-a730-2f699e92e981" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_63c43a5c-f6ac-4ad0-8f60-30b61bcc74da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_AggregateTransferOfSponsorShares_f30dc921-e32f-47d5-9885-a9eacc327cf6" xlink:href="cmlf-20210804.xsd#cmlf_AggregateTransferOfSponsorShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_RelatedPartyTransactionsDetailsLineItems_49c0ca5f-913d-4602-a730-2f699e92e981" xlink:to="loc_cmlf_AggregateTransferOfSponsorShares_f30dc921-e32f-47d5-9885-a9eacc327cf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_2ddbed35-a272-4a2e-8132-f8d43b95eed4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_RelatedPartyTransactionsDetailsLineItems_49c0ca5f-913d-4602-a730-2f699e92e981" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_2ddbed35-a272-4a2e-8132-f8d43b95eed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_fab6a0ca-8a93-4ac9-9b39-adb70ac77470" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_RelatedPartyTransactionsDetailsLineItems_49c0ca5f-913d-4602-a730-2f699e92e981" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_fab6a0ca-8a93-4ac9-9b39-adb70ac77470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_ee2bb4b4-f7f2-4917-945d-83d7dc2a92ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_RelatedPartyTransactionsDetailsLineItems_49c0ca5f-913d-4602-a730-2f699e92e981" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_ee2bb4b4-f7f2-4917-945d-83d7dc2a92ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_IssuedAndOutstandingOrdinarySharesPercentage_b2551f1e-5250-4847-a14e-0fe4f82f3754" xlink:href="cmlf-20210804.xsd#cmlf_IssuedAndOutstandingOrdinarySharesPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_RelatedPartyTransactionsDetailsLineItems_49c0ca5f-913d-4602-a730-2f699e92e981" xlink:to="loc_cmlf_IssuedAndOutstandingOrdinarySharesPercentage_b2551f1e-5250-4847-a14e-0fe4f82f3754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_SharePriceLimitationOnAnyShareTransactions_9d951e06-5433-4e2c-824d-7b318b07cbbf" xlink:href="cmlf-20210804.xsd#cmlf_SharePriceLimitationOnAnyShareTransactions"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_RelatedPartyTransactionsDetailsLineItems_49c0ca5f-913d-4602-a730-2f699e92e981" xlink:to="loc_cmlf_SharePriceLimitationOnAnyShareTransactions_9d951e06-5433-4e2c-824d-7b318b07cbbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_0e9903b3-52d3-42d8-a1fd-48b6dc6ba9d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_RelatedPartyTransactionsDetailsLineItems_49c0ca5f-913d-4602-a730-2f699e92e981" xlink:to="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_0e9903b3-52d3-42d8-a1fd-48b6dc6ba9d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_OutstandingUnderPromissoryNote_2e813b9b-04b6-4eca-8b28-63c901987781" xlink:href="cmlf-20210804.xsd#cmlf_OutstandingUnderPromissoryNote"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_RelatedPartyTransactionsDetailsLineItems_49c0ca5f-913d-4602-a730-2f699e92e981" xlink:to="loc_cmlf_OutstandingUnderPromissoryNote_2e813b9b-04b6-4eca-8b28-63c901987781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayable_af4ae160-7c0f-4460-9fb4-495629ac0827" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayable"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_RelatedPartyTransactionsDetailsLineItems_49c0ca5f-913d-4602-a730-2f699e92e981" xlink:to="loc_us-gaap_ConvertibleNotesPayable_af4ae160-7c0f-4460-9fb4-495629ac0827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_fea2808d-859f-4a52-be9a-50638c0d6621" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_RelatedPartyTransactionsDetailsLineItems_49c0ca5f-913d-4602-a730-2f699e92e981" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_fea2808d-859f-4a52-be9a-50638c0d6621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences_473c5fd1-5844-49eb-a826-fcf8ddcf9ec5" xlink:href="cmlf-20210804.xsd#cmlf_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_RelatedPartyTransactionsDetailsLineItems_49c0ca5f-913d-4602-a730-2f699e92e981" xlink:to="loc_cmlf_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences_473c5fd1-5844-49eb-a826-fcf8ddcf9ec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_BusinessCombinationsTresholdTradingDaysToNotTransferAssignOrSellShares_fca8098f-dd6b-480e-8b81-c1f92be72cac" xlink:href="cmlf-20210804.xsd#cmlf_BusinessCombinationsTresholdTradingDaysToNotTransferAssignOrSellShares"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_RelatedPartyTransactionsDetailsLineItems_49c0ca5f-913d-4602-a730-2f699e92e981" xlink:to="loc_cmlf_BusinessCombinationsTresholdTradingDaysToNotTransferAssignOrSellShares_fca8098f-dd6b-480e-8b81-c1f92be72cac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_BusinessCombinationsConsecutiveThresholdTradingDaysToNotTransferAssignOrSellShares_46b064c3-9a16-42ed-89a1-6b5f0d7ca8cd" xlink:href="cmlf-20210804.xsd#cmlf_BusinessCombinationsConsecutiveThresholdTradingDaysToNotTransferAssignOrSellShares"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_RelatedPartyTransactionsDetailsLineItems_49c0ca5f-913d-4602-a730-2f699e92e981" xlink:to="loc_cmlf_BusinessCombinationsConsecutiveThresholdTradingDaysToNotTransferAssignOrSellShares_46b064c3-9a16-42ed-89a1-6b5f0d7ca8cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/CommitmentsandContingencies_1" xlink:type="simple" xlink:href="cmlf-20210804.xsd#CommitmentsandContingencies_1"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/CommitmentsandContingencies_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_543a9565-5f15-45d6-873b-502106b3f72a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CommitmentsandContingenciesDetailsTable_b48417ed-de3f-418e-b4a3-093648674582" xlink:href="cmlf-20210804.xsd#cmlf_CommitmentsandContingenciesDetailsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_543a9565-5f15-45d6-873b-502106b3f72a" xlink:to="loc_cmlf_CommitmentsandContingenciesDetailsTable_b48417ed-de3f-418e-b4a3-093648674582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_aae5a16a-9f27-468b-9f4b-8aba1a7efb9b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_CommitmentsandContingenciesDetailsTable_b48417ed-de3f-418e-b4a3-093648674582" xlink:to="loc_dei_LegalEntityAxis_aae5a16a-9f27-468b-9f4b-8aba1a7efb9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_8a43a1d2-0d20-47c9-88d7-2651c0dee65d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_aae5a16a-9f27-468b-9f4b-8aba1a7efb9b" xlink:to="loc_dei_EntityDomain_8a43a1d2-0d20-47c9-88d7-2651c0dee65d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLifeSciencesIncMember_d9c06e81-947b-4162-a883-d7b8047308df" xlink:href="cmlf-20210804.xsd#cmlf_CMLifeSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_8a43a1d2-0d20-47c9-88d7-2651c0dee65d" xlink:to="loc_cmlf_CMLifeSciencesIncMember_d9c06e81-947b-4162-a883-d7b8047308df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CommitmentsandContingenciesDetailsLineItems_840511b8-1a04-481c-a9ef-0e7b72f21350" xlink:href="cmlf-20210804.xsd#cmlf_CommitmentsandContingenciesDetailsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_CommitmentsandContingenciesDetailsTable_b48417ed-de3f-418e-b4a3-093648674582" xlink:to="loc_cmlf_CommitmentsandContingenciesDetailsLineItems_840511b8-1a04-481c-a9ef-0e7b72f21350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_e6b60a0e-e0ee-4fb1-bbc3-b2de72dc480d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_CommitmentsandContingenciesDetailsLineItems_840511b8-1a04-481c-a9ef-0e7b72f21350" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_e6b60a0e-e0ee-4fb1-bbc3-b2de72dc480d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/CommitmentsandContingenciesDetails_1" xlink:type="simple" xlink:href="cmlf-20210804.xsd#CommitmentsandContingenciesDetails_1"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/CommitmentsandContingenciesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c5c231e8-dc70-4c74-9c0e-91473af53944" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CommitmentsandContingenciesDetailsTable_87d6c26c-dd1c-4627-9c0d-ced96e24ad4b" xlink:href="cmlf-20210804.xsd#cmlf_CommitmentsandContingenciesDetailsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c5c231e8-dc70-4c74-9c0e-91473af53944" xlink:to="loc_cmlf_CommitmentsandContingenciesDetailsTable_87d6c26c-dd1c-4627-9c0d-ced96e24ad4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_TypeOfArrangementsAxis_989fae6b-846e-418c-af4c-521e48ef0cb5" xlink:href="cmlf-20210804.xsd#cmlf_TypeOfArrangementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_CommitmentsandContingenciesDetailsTable_87d6c26c-dd1c-4627-9c0d-ced96e24ad4b" xlink:to="loc_cmlf_TypeOfArrangementsAxis_989fae6b-846e-418c-af4c-521e48ef0cb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_TypeOfArrangementsDomain_d85f2864-6747-4426-b0ed-fc2d3a1cc07a" xlink:href="cmlf-20210804.xsd#cmlf_TypeOfArrangementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_TypeOfArrangementsAxis_989fae6b-846e-418c-af4c-521e48ef0cb5" xlink:to="loc_cmlf_TypeOfArrangementsDomain_d85f2864-6747-4426-b0ed-fc2d3a1cc07a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_UnderwritingAgreementMemberMember_03367f60-ecb2-4598-8fdd-e282697f701f" xlink:href="cmlf-20210804.xsd#cmlf_UnderwritingAgreementMemberMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_TypeOfArrangementsDomain_d85f2864-6747-4426-b0ed-fc2d3a1cc07a" xlink:to="loc_cmlf_UnderwritingAgreementMemberMember_03367f60-ecb2-4598-8fdd-e282697f701f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_3703e7ef-fb9f-486c-bde3-acf465eadf46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_CommitmentsandContingenciesDetailsTable_87d6c26c-dd1c-4627-9c0d-ced96e24ad4b" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_3703e7ef-fb9f-486c-bde3-acf465eadf46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2e97540e-0f8e-4fad-a566-1e2ab1c6dad8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_3703e7ef-fb9f-486c-bde3-acf465eadf46" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2e97540e-0f8e-4fad-a566-1e2ab1c6dad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_7b86a21a-9a97-4744-9f27-9cb684de072a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2e97540e-0f8e-4fad-a566-1e2ab1c6dad8" xlink:to="loc_us-gaap_OverAllotmentOptionMember_7b86a21a-9a97-4744-9f27-9cb684de072a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ForwardPurchaseAgreementMember_45d0255c-399a-438c-bc2c-f11d09ac4f34" xlink:href="cmlf-20210804.xsd#cmlf_ForwardPurchaseAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2e97540e-0f8e-4fad-a566-1e2ab1c6dad8" xlink:to="loc_cmlf_ForwardPurchaseAgreementMember_45d0255c-399a-438c-bc2c-f11d09ac4f34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_013ebe1d-79c7-4a88-b36c-ebb5bc01f39f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_CommitmentsandContingenciesDetailsTable_87d6c26c-dd1c-4627-9c0d-ced96e24ad4b" xlink:to="loc_dei_LegalEntityAxis_013ebe1d-79c7-4a88-b36c-ebb5bc01f39f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_bbf729c4-ecd9-4504-9e55-501469cc4607" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_013ebe1d-79c7-4a88-b36c-ebb5bc01f39f" xlink:to="loc_dei_EntityDomain_bbf729c4-ecd9-4504-9e55-501469cc4607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLifeSciencesIncMember_581ca63b-f59b-4adf-9a1a-3bc8009fa0dd" xlink:href="cmlf-20210804.xsd#cmlf_CMLifeSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_bbf729c4-ecd9-4504-9e55-501469cc4607" xlink:to="loc_cmlf_CMLifeSciencesIncMember_581ca63b-f59b-4adf-9a1a-3bc8009fa0dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_bb852b33-845e-4f11-a189-d5e188734250" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_CommitmentsandContingenciesDetailsTable_87d6c26c-dd1c-4627-9c0d-ced96e24ad4b" xlink:to="loc_us-gaap_StatementClassOfStockAxis_bb852b33-845e-4f11-a189-d5e188734250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b4c90371-aef2-41f9-a8b8-9614c6ac96d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_bb852b33-845e-4f11-a189-d5e188734250" xlink:to="loc_us-gaap_ClassOfStockDomain_b4c90371-aef2-41f9-a8b8-9614c6ac96d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_bcac6737-d67b-421a-93bd-cd5a12f7c498" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_b4c90371-aef2-41f9-a8b8-9614c6ac96d8" xlink:to="loc_us-gaap_CommonClassAMember_bcac6737-d67b-421a-93bd-cd5a12f7c498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_121cad8b-f9fb-4571-9e45-d9ef98b82392" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_b4c90371-aef2-41f9-a8b8-9614c6ac96d8" xlink:to="loc_us-gaap_CommonClassBMember_121cad8b-f9fb-4571-9e45-d9ef98b82392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6ed36b03-1334-409c-90bd-8efbcc59d59c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_CommitmentsandContingenciesDetailsTable_87d6c26c-dd1c-4627-9c0d-ced96e24ad4b" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6ed36b03-1334-409c-90bd-8efbcc59d59c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_e8845af7-2f6e-4c0c-aa24-d8ea1c47a055" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6ed36b03-1334-409c-90bd-8efbcc59d59c" xlink:to="loc_us-gaap_RelatedPartyDomain_e8845af7-2f6e-4c0c-aa24-d8ea1c47a055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CasdinAndCorvexMember_91caddda-d9b2-4292-abb0-82691ecb2ce1" xlink:href="cmlf-20210804.xsd#cmlf_CasdinAndCorvexMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_e8845af7-2f6e-4c0c-aa24-d8ea1c47a055" xlink:to="loc_cmlf_CasdinAndCorvexMember_91caddda-d9b2-4292-abb0-82691ecb2ce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_SponsorMember_79c967ad-cca3-4473-ad89-8fb8ac68f404" xlink:href="cmlf-20210804.xsd#cmlf_SponsorMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_e8845af7-2f6e-4c0c-aa24-d8ea1c47a055" xlink:to="loc_cmlf_SponsorMember_79c967ad-cca3-4473-ad89-8fb8ac68f404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CommitmentsandContingenciesDetailsLineItems_698dd4da-5dc7-48af-82ed-d8cc8319ea56" xlink:href="cmlf-20210804.xsd#cmlf_CommitmentsandContingenciesDetailsLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_CommitmentsandContingenciesDetailsTable_87d6c26c-dd1c-4627-9c0d-ced96e24ad4b" xlink:to="loc_cmlf_CommitmentsandContingenciesDetailsLineItems_698dd4da-5dc7-48af-82ed-d8cc8319ea56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_AggregateSaleOfStockPricePerShare_c2c200d4-171d-4529-999c-5a862a7fdbd6" xlink:href="cmlf-20210804.xsd#cmlf_AggregateSaleOfStockPricePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_CommitmentsandContingenciesDetailsLineItems_698dd4da-5dc7-48af-82ed-d8cc8319ea56" xlink:to="loc_cmlf_AggregateSaleOfStockPricePerShare_c2c200d4-171d-4529-999c-5a862a7fdbd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_AggregateUnderwritingCommissions_c3b7b526-6076-4171-adb2-3bb34ac42ab4" xlink:href="cmlf-20210804.xsd#cmlf_AggregateUnderwritingCommissions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_CommitmentsandContingenciesDetailsLineItems_698dd4da-5dc7-48af-82ed-d8cc8319ea56" xlink:to="loc_cmlf_AggregateUnderwritingCommissions_c3b7b526-6076-4171-adb2-3bb34ac42ab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_c9b21ec1-60f2-4d93-a127-7df160d242f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_CommitmentsandContingenciesDetailsLineItems_698dd4da-5dc7-48af-82ed-d8cc8319ea56" xlink:to="loc_us-gaap_SharesIssued_c9b21ec1-60f2-4d93-a127-7df160d242f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_86dcd26e-4e3f-49a6-8560-ac9495dca564" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_CommitmentsandContingenciesDetailsLineItems_698dd4da-5dc7-48af-82ed-d8cc8319ea56" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_86dcd26e-4e3f-49a6-8560-ac9495dca564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_1a538535-c0cb-402e-821a-c98aa4161cbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_CommitmentsandContingenciesDetailsLineItems_698dd4da-5dc7-48af-82ed-d8cc8319ea56" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_1a538535-c0cb-402e-821a-c98aa4161cbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockNoParValue_7a8ebe64-f36d-4ffc-bc64-2d2ac9de21b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockNoParValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_CommitmentsandContingenciesDetailsLineItems_698dd4da-5dc7-48af-82ed-d8cc8319ea56" xlink:to="loc_us-gaap_CommonStockNoParValue_7a8ebe64-f36d-4ffc-bc64-2d2ac9de21b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_AggregateAmountNotToExceed_e85cf732-8bec-4eb1-b573-387df43c3848" xlink:href="cmlf-20210804.xsd#cmlf_AggregateAmountNotToExceed"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_CommitmentsandContingenciesDetailsLineItems_698dd4da-5dc7-48af-82ed-d8cc8319ea56" xlink:to="loc_cmlf_AggregateAmountNotToExceed_e85cf732-8bec-4eb1-b573-387df43c3848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_DenominatorForConsiderationPayableToOtherParties_bc2ff7df-ab66-439e-b03f-50771739798c" xlink:href="cmlf-20210804.xsd#cmlf_DenominatorForConsiderationPayableToOtherParties"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_CommitmentsandContingenciesDetailsLineItems_698dd4da-5dc7-48af-82ed-d8cc8319ea56" xlink:to="loc_cmlf_DenominatorForConsiderationPayableToOtherParties_bc2ff7df-ab66-439e-b03f-50771739798c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_IssuableSharesOfCommonSharesOutstandingPercentage_f5242cde-f79b-4e3f-b800-1b2a8327e6d6" xlink:href="cmlf-20210804.xsd#cmlf_IssuableSharesOfCommonSharesOutstandingPercentage"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_CommitmentsandContingenciesDetailsLineItems_698dd4da-5dc7-48af-82ed-d8cc8319ea56" xlink:to="loc_cmlf_IssuableSharesOfCommonSharesOutstandingPercentage_f5242cde-f79b-4e3f-b800-1b2a8327e6d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_EarnOutSharePrice_0e960b2c-3d9e-45a6-8eb4-07a3dbbf1b82" xlink:href="cmlf-20210804.xsd#cmlf_EarnOutSharePrice"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_CommitmentsandContingenciesDetailsLineItems_698dd4da-5dc7-48af-82ed-d8cc8319ea56" xlink:to="loc_cmlf_EarnOutSharePrice_0e960b2c-3d9e-45a6-8eb4-07a3dbbf1b82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_AggregatePurchasePrice_9c330e6a-54cb-4b4d-8a57-f26f77b4149f" xlink:href="cmlf-20210804.xsd#cmlf_AggregatePurchasePrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_CommitmentsandContingenciesDetailsLineItems_698dd4da-5dc7-48af-82ed-d8cc8319ea56" xlink:to="loc_cmlf_AggregatePurchasePrice_9c330e6a-54cb-4b4d-8a57-f26f77b4149f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/StockholdersEquity" xlink:type="simple" xlink:href="cmlf-20210804.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_00234e2c-f157-45e4-b44a-04f8ee57291b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_StockholdersEquityDetailsTable_dcd6efe2-76e5-47c6-a8e0-938947645ba1" xlink:href="cmlf-20210804.xsd#cmlf_StockholdersEquityDetailsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_00234e2c-f157-45e4-b44a-04f8ee57291b" xlink:to="loc_cmlf_StockholdersEquityDetailsTable_dcd6efe2-76e5-47c6-a8e0-938947645ba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_98046834-02eb-4d03-873b-f2c69d784cfb" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_StockholdersEquityDetailsTable_dcd6efe2-76e5-47c6-a8e0-938947645ba1" xlink:to="loc_dei_LegalEntityAxis_98046834-02eb-4d03-873b-f2c69d784cfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_13b1be50-eb0d-43ef-843d-37b7968d88e6" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_98046834-02eb-4d03-873b-f2c69d784cfb" xlink:to="loc_dei_EntityDomain_13b1be50-eb0d-43ef-843d-37b7968d88e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLifeSciencesIncMember_675089bf-ffba-49c2-8580-4523b68cc8a9" xlink:href="cmlf-20210804.xsd#cmlf_CMLifeSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_13b1be50-eb0d-43ef-843d-37b7968d88e6" xlink:to="loc_cmlf_CMLifeSciencesIncMember_675089bf-ffba-49c2-8580-4523b68cc8a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_StockholdersEquityDetailsLineItems_f2e4c0de-839d-4f50-b785-759193cde9ef" xlink:href="cmlf-20210804.xsd#cmlf_StockholdersEquityDetailsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_StockholdersEquityDetailsTable_dcd6efe2-76e5-47c6-a8e0-938947645ba1" xlink:to="loc_cmlf_StockholdersEquityDetailsLineItems_f2e4c0de-839d-4f50-b785-759193cde9ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_a94cdcc8-b929-4846-a449-a035c7170f05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_StockholdersEquityDetailsLineItems_f2e4c0de-839d-4f50-b785-759193cde9ef" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_a94cdcc8-b929-4846-a449-a035c7170f05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/StockholdersEquityDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#StockholdersEquityDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/StockholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_3ef46a2f-bd4c-4992-b3ca-54cf44e3ecfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_StockholdersEquityDetailsTable_96926d9e-7a46-484b-b3aa-a198fcb577a8" xlink:href="cmlf-20210804.xsd#cmlf_StockholdersEquityDetailsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_3ef46a2f-bd4c-4992-b3ca-54cf44e3ecfc" xlink:to="loc_cmlf_StockholdersEquityDetailsTable_96926d9e-7a46-484b-b3aa-a198fcb577a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_097ba935-99dc-476a-b8a9-2435b7dab824" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_StockholdersEquityDetailsTable_96926d9e-7a46-484b-b3aa-a198fcb577a8" xlink:to="loc_us-gaap_StatementClassOfStockAxis_097ba935-99dc-476a-b8a9-2435b7dab824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_1c8af15d-83c2-4783-a413-eb8f48f6029e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_097ba935-99dc-476a-b8a9-2435b7dab824" xlink:to="loc_us-gaap_ClassOfStockDomain_1c8af15d-83c2-4783-a413-eb8f48f6029e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_50fc1656-ab5a-4aea-9257-48eff809a620" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1c8af15d-83c2-4783-a413-eb8f48f6029e" xlink:to="loc_us-gaap_CommonClassAMember_50fc1656-ab5a-4aea-9257-48eff809a620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_d5f92cfb-9807-43c8-8b67-5d022bd2660f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1c8af15d-83c2-4783-a413-eb8f48f6029e" xlink:to="loc_us-gaap_CommonClassBMember_d5f92cfb-9807-43c8-8b67-5d022bd2660f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_FoundersSharesMember_c700b356-540a-4c3c-859b-b367bb6184dd" xlink:href="cmlf-20210804.xsd#cmlf_FoundersSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1c8af15d-83c2-4783-a413-eb8f48f6029e" xlink:to="loc_cmlf_FoundersSharesMember_c700b356-540a-4c3c-859b-b367bb6184dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_5178a93e-b9b5-4f8e-a8a5-ba9fd0652475" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_StockholdersEquityDetailsTable_96926d9e-7a46-484b-b3aa-a198fcb577a8" xlink:to="loc_dei_LegalEntityAxis_5178a93e-b9b5-4f8e-a8a5-ba9fd0652475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_9710696a-bb79-40f7-b4b7-2175c15afa30" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_5178a93e-b9b5-4f8e-a8a5-ba9fd0652475" xlink:to="loc_dei_EntityDomain_9710696a-bb79-40f7-b4b7-2175c15afa30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLifeSciencesIncMember_9649f9bf-c807-4764-8202-69e132195db6" xlink:href="cmlf-20210804.xsd#cmlf_CMLifeSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_9710696a-bb79-40f7-b4b7-2175c15afa30" xlink:to="loc_cmlf_CMLifeSciencesIncMember_9649f9bf-c807-4764-8202-69e132195db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_bc440a7f-fbaf-40d0-84bf-9a5469f28c22" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_StockholdersEquityDetailsTable_96926d9e-7a46-484b-b3aa-a198fcb577a8" xlink:to="loc_srt_RangeAxis_bc440a7f-fbaf-40d0-84bf-9a5469f28c22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7d3ed5bb-e48a-471c-97df-a878053d8178" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_bc440a7f-fbaf-40d0-84bf-9a5469f28c22" xlink:to="loc_srt_RangeMember_7d3ed5bb-e48a-471c-97df-a878053d8178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_13f7b2e3-6eb1-4260-9970-cd8cdf12a2f0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7d3ed5bb-e48a-471c-97df-a878053d8178" xlink:to="loc_srt_MinimumMember_13f7b2e3-6eb1-4260-9970-cd8cdf12a2f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_StockholdersEquityDetailsLineItems_6ea102d9-add9-4fc7-bdac-911da6dc30f9" xlink:href="cmlf-20210804.xsd#cmlf_StockholdersEquityDetailsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_StockholdersEquityDetailsTable_96926d9e-7a46-484b-b3aa-a198fcb577a8" xlink:to="loc_cmlf_StockholdersEquityDetailsLineItems_6ea102d9-add9-4fc7-bdac-911da6dc30f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_508e9c3d-5a32-4922-ba49-1898e83eb7c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_StockholdersEquityDetailsLineItems_6ea102d9-add9-4fc7-bdac-911da6dc30f9" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_508e9c3d-5a32-4922-ba49-1898e83eb7c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_c5908232-e4bf-47a0-ae5b-9dc7ce19900a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_StockholdersEquityDetailsLineItems_6ea102d9-add9-4fc7-bdac-911da6dc30f9" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_c5908232-e4bf-47a0-ae5b-9dc7ce19900a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_4c2ed3dd-ee8f-4125-b298-5cfa4485948a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_StockholdersEquityDetailsLineItems_6ea102d9-add9-4fc7-bdac-911da6dc30f9" xlink:to="loc_us-gaap_PreferredStockSharesIssued_4c2ed3dd-ee8f-4125-b298-5cfa4485948a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_20d18088-9d34-4a5f-a131-d14eb5403875" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_StockholdersEquityDetailsLineItems_6ea102d9-add9-4fc7-bdac-911da6dc30f9" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_20d18088-9d34-4a5f-a131-d14eb5403875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_de7d44f5-99d7-4cee-b974-3af2ee878b25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_StockholdersEquityDetailsLineItems_6ea102d9-add9-4fc7-bdac-911da6dc30f9" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_de7d44f5-99d7-4cee-b974-3af2ee878b25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_ed223724-b2ce-4c8a-a328-2a4f4b6efa13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_StockholdersEquityDetailsLineItems_6ea102d9-add9-4fc7-bdac-911da6dc30f9" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_ed223724-b2ce-4c8a-a328-2a4f4b6efa13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_f58ce496-a553-4edb-b93d-1e7d751c6e45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_StockholdersEquityDetailsLineItems_6ea102d9-add9-4fc7-bdac-911da6dc30f9" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_f58ce496-a553-4edb-b93d-1e7d751c6e45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares_192ea490-1e23-46f0-9291-e56de853f891" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_StockholdersEquityDetailsLineItems_6ea102d9-add9-4fc7-bdac-911da6dc30f9" xlink:to="loc_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares_192ea490-1e23-46f0-9291-e56de853f891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_bb2aa8fa-06d0-4fac-b001-2ee0322f5113" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_StockholdersEquityDetailsLineItems_6ea102d9-add9-4fc7-bdac-911da6dc30f9" xlink:to="loc_us-gaap_CommonStockSharesIssued_bb2aa8fa-06d0-4fac-b001-2ee0322f5113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CommonStockToPossibleRedemption_f447bab2-63d2-4015-9dcc-baf4790716c8" xlink:href="cmlf-20210804.xsd#cmlf_CommonStockToPossibleRedemption"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_StockholdersEquityDetailsLineItems_6ea102d9-add9-4fc7-bdac-911da6dc30f9" xlink:to="loc_cmlf_CommonStockToPossibleRedemption_f447bab2-63d2-4015-9dcc-baf4790716c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_c361e114-1f4c-4782-82a6-f2dd135dd2ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_StockholdersEquityDetailsLineItems_6ea102d9-add9-4fc7-bdac-911da6dc30f9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_c361e114-1f4c-4782-82a6-f2dd135dd2ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_VotePerShare_a026ff66-4fe3-4ad0-820d-8a26aa0cbd34" xlink:href="cmlf-20210804.xsd#cmlf_VotePerShare"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_StockholdersEquityDetailsLineItems_6ea102d9-add9-4fc7-bdac-911da6dc30f9" xlink:to="loc_cmlf_VotePerShare_a026ff66-4fe3-4ad0-820d-8a26aa0cbd34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_94e93701-4ddc-4e72-aaf0-23d643490bb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_StockholdersEquityDetailsLineItems_6ea102d9-add9-4fc7-bdac-911da6dc30f9" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_94e93701-4ddc-4e72-aaf0-23d643490bb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/Warrants" xlink:type="simple" xlink:href="cmlf-20210804.xsd#Warrants"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/Warrants" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_1bbdb6d2-e32a-45bd-b03f-7a6cef78007e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_WarrantLiabilityDetailsTable_e1c094d4-46a1-4e86-b866-4594a4904424" xlink:href="cmlf-20210804.xsd#cmlf_WarrantLiabilityDetailsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_1bbdb6d2-e32a-45bd-b03f-7a6cef78007e" xlink:to="loc_cmlf_WarrantLiabilityDetailsTable_e1c094d4-46a1-4e86-b866-4594a4904424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_34ff6180-847e-4ba5-bf6e-673edbcc37fb" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_WarrantLiabilityDetailsTable_e1c094d4-46a1-4e86-b866-4594a4904424" xlink:to="loc_dei_LegalEntityAxis_34ff6180-847e-4ba5-bf6e-673edbcc37fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_1382db30-709d-4521-b3b3-1a28bde4359b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_34ff6180-847e-4ba5-bf6e-673edbcc37fb" xlink:to="loc_dei_EntityDomain_1382db30-709d-4521-b3b3-1a28bde4359b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLifeSciencesIncMember_17d7f4a7-0995-4635-8a1c-9551df1e9e9d" xlink:href="cmlf-20210804.xsd#cmlf_CMLifeSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_1382db30-709d-4521-b3b3-1a28bde4359b" xlink:to="loc_cmlf_CMLifeSciencesIncMember_17d7f4a7-0995-4635-8a1c-9551df1e9e9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_WarrantLiabilityDetailsLineItems_bf6cc148-1220-4ad6-87d4-f12206dc9c64" xlink:href="cmlf-20210804.xsd#cmlf_WarrantLiabilityDetailsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_WarrantLiabilityDetailsTable_e1c094d4-46a1-4e86-b866-4594a4904424" xlink:to="loc_cmlf_WarrantLiabilityDetailsLineItems_bf6cc148-1220-4ad6-87d4-f12206dc9c64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_WarrantsTextBlock_463e98e1-38f8-423c-8ed5-79c0941824fd" xlink:href="cmlf-20210804.xsd#cmlf_WarrantsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_WarrantLiabilityDetailsLineItems_bf6cc148-1220-4ad6-87d4-f12206dc9c64" xlink:to="loc_cmlf_WarrantsTextBlock_463e98e1-38f8-423c-8ed5-79c0941824fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/WarrantsDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#WarrantsDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/WarrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_4c474f6d-f358-462e-877d-f2bd0b5f94ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_WarrantLiabilityDetailsTable_3c2a8820-fceb-418c-afe2-35cc978fc930" xlink:href="cmlf-20210804.xsd#cmlf_WarrantLiabilityDetailsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_4c474f6d-f358-462e-877d-f2bd0b5f94ea" xlink:to="loc_cmlf_WarrantLiabilityDetailsTable_3c2a8820-fceb-418c-afe2-35cc978fc930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_31b0cfb2-a2cf-4417-896c-cd6189e7644d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_WarrantLiabilityDetailsTable_3c2a8820-fceb-418c-afe2-35cc978fc930" xlink:to="loc_dei_LegalEntityAxis_31b0cfb2-a2cf-4417-896c-cd6189e7644d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_d69783ab-1076-4e6d-b751-ffe023b99d20" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_31b0cfb2-a2cf-4417-896c-cd6189e7644d" xlink:to="loc_dei_EntityDomain_d69783ab-1076-4e6d-b751-ffe023b99d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLifeSciencesIncMember_7fd2d989-abef-4d05-bd68-e8cd365d3648" xlink:href="cmlf-20210804.xsd#cmlf_CMLifeSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_d69783ab-1076-4e6d-b751-ffe023b99d20" xlink:to="loc_cmlf_CMLifeSciencesIncMember_7fd2d989-abef-4d05-bd68-e8cd365d3648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5723f0d7-5f9f-4a22-9b79-1133cf5b7f35" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_WarrantLiabilityDetailsTable_3c2a8820-fceb-418c-afe2-35cc978fc930" xlink:to="loc_srt_RangeAxis_5723f0d7-5f9f-4a22-9b79-1133cf5b7f35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d70825e3-d68c-45a1-bac8-1ba5140c8641" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_5723f0d7-5f9f-4a22-9b79-1133cf5b7f35" xlink:to="loc_srt_RangeMember_d70825e3-d68c-45a1-bac8-1ba5140c8641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a47f16cc-cd06-4298-9030-cc3ded8af379" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d70825e3-d68c-45a1-bac8-1ba5140c8641" xlink:to="loc_srt_MinimumMember_a47f16cc-cd06-4298-9030-cc3ded8af379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a318070f-8ca2-4619-8fc6-a4bd6805cc28" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d70825e3-d68c-45a1-bac8-1ba5140c8641" xlink:to="loc_srt_MaximumMember_a318070f-8ca2-4619-8fc6-a4bd6805cc28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_WarrantExercisableTermConditionAxis_36023495-0d0f-4510-a52c-fe5abe7b3e52" xlink:href="cmlf-20210804.xsd#cmlf_WarrantExercisableTermConditionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_WarrantLiabilityDetailsTable_3c2a8820-fceb-418c-afe2-35cc978fc930" xlink:to="loc_cmlf_WarrantExercisableTermConditionAxis_36023495-0d0f-4510-a52c-fe5abe7b3e52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_WarrantExercisableTermConditionDomain_baef4f98-b176-4a2e-bec1-ed046ca4397c" xlink:href="cmlf-20210804.xsd#cmlf_WarrantExercisableTermConditionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_WarrantExercisableTermConditionAxis_36023495-0d0f-4510-a52c-fe5abe7b3e52" xlink:to="loc_cmlf_WarrantExercisableTermConditionDomain_baef4f98-b176-4a2e-bec1-ed046ca4397c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CompletionOfBusinessCombinationMember_c5367e9d-f5f9-4039-ad87-ef7a8a4f7af4" xlink:href="cmlf-20210804.xsd#cmlf_CompletionOfBusinessCombinationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_WarrantExercisableTermConditionDomain_baef4f98-b176-4a2e-bec1-ed046ca4397c" xlink:to="loc_cmlf_CompletionOfBusinessCombinationMember_c5367e9d-f5f9-4039-ad87-ef7a8a4f7af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_TimeFromTheClosingOfTheInitialPublicOfferingMember_015ba741-f49f-402e-bdd5-4204b07711cd" xlink:href="cmlf-20210804.xsd#cmlf_TimeFromTheClosingOfTheInitialPublicOfferingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_WarrantExercisableTermConditionDomain_baef4f98-b176-4a2e-bec1-ed046ca4397c" xlink:to="loc_cmlf_TimeFromTheClosingOfTheInitialPublicOfferingMember_015ba741-f49f-402e-bdd5-4204b07711cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_RedemptionPriceOf1800Member_5d3eee6c-e8e4-489b-a8d8-0a1aed8cb704" xlink:href="cmlf-20210804.xsd#cmlf_RedemptionPriceOf1800Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_WarrantExercisableTermConditionDomain_baef4f98-b176-4a2e-bec1-ed046ca4397c" xlink:to="loc_cmlf_RedemptionPriceOf1800Member_5d3eee6c-e8e4-489b-a8d8-0a1aed8cb704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_RedemptionPriceOf1000Member_56bdaaf5-795c-4451-86d5-44605cad4d5c" xlink:href="cmlf-20210804.xsd#cmlf_RedemptionPriceOf1000Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_WarrantExercisableTermConditionDomain_baef4f98-b176-4a2e-bec1-ed046ca4397c" xlink:to="loc_cmlf_RedemptionPriceOf1000Member_56bdaaf5-795c-4451-86d5-44605cad4d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_NewlyIssuedPriceMember_0f201bfc-93ad-4510-bafe-d38a16c71c12" xlink:href="cmlf-20210804.xsd#cmlf_NewlyIssuedPriceMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_WarrantExercisableTermConditionDomain_baef4f98-b176-4a2e-bec1-ed046ca4397c" xlink:to="loc_cmlf_NewlyIssuedPriceMember_0f201bfc-93ad-4510-bafe-d38a16c71c12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_MarketValueMember_4a0c5e65-90ae-4e1f-b87f-31e241d5b79e" xlink:href="cmlf-20210804.xsd#cmlf_MarketValueMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_WarrantExercisableTermConditionDomain_baef4f98-b176-4a2e-bec1-ed046ca4397c" xlink:to="loc_cmlf_MarketValueMember_4a0c5e65-90ae-4e1f-b87f-31e241d5b79e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_e94296cf-1d7c-4179-8202-906c82a371f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_WarrantLiabilityDetailsTable_3c2a8820-fceb-418c-afe2-35cc978fc930" xlink:to="loc_us-gaap_StatementClassOfStockAxis_e94296cf-1d7c-4179-8202-906c82a371f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_38ec2dd9-9617-4b14-bca5-ec9f4d93c971" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_e94296cf-1d7c-4179-8202-906c82a371f3" xlink:to="loc_us-gaap_ClassOfStockDomain_38ec2dd9-9617-4b14-bca5-ec9f4d93c971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_79ddb80f-2d75-4ab7-9df1-7f1172ae5114" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_38ec2dd9-9617-4b14-bca5-ec9f4d93c971" xlink:to="loc_us-gaap_CommonClassAMember_79ddb80f-2d75-4ab7-9df1-7f1172ae5114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_WarrantLiabilityDetailsLineItems_285aa336-c6fa-4447-9846-13465e8c18bb" xlink:href="cmlf-20210804.xsd#cmlf_WarrantLiabilityDetailsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_WarrantLiabilityDetailsTable_3c2a8820-fceb-418c-afe2-35cc978fc930" xlink:to="loc_cmlf_WarrantLiabilityDetailsLineItems_285aa336-c6fa-4447-9846-13465e8c18bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_67fc7d86-69e4-42b7-81c1-f857b469db16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_WarrantLiabilityDetailsLineItems_285aa336-c6fa-4447-9846-13465e8c18bb" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_67fc7d86-69e4-42b7-81c1-f857b469db16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_WarrantExercisableTerm_664b3505-a91b-4131-a733-83c9c2d9e6af" xlink:href="cmlf-20210804.xsd#cmlf_WarrantExercisableTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_WarrantLiabilityDetailsLineItems_285aa336-c6fa-4447-9846-13465e8c18bb" xlink:to="loc_cmlf_WarrantExercisableTerm_664b3505-a91b-4131-a733-83c9c2d9e6af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_WarrantRedemptionTriggerPrice_51054ea6-b386-4267-8989-2143f844db71" xlink:href="cmlf-20210804.xsd#cmlf_WarrantRedemptionTriggerPrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_WarrantLiabilityDetailsLineItems_285aa336-c6fa-4447-9846-13465e8c18bb" xlink:to="loc_cmlf_WarrantRedemptionTriggerPrice_51054ea6-b386-4267-8989-2143f844db71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_a4cd40e5-a9a0-48fd-a835-4db9df03cf71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_WarrantLiabilityDetailsLineItems_285aa336-c6fa-4447-9846-13465e8c18bb" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_a4cd40e5-a9a0-48fd-a835-4db9df03cf71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_afa9ef48-0d1d-4188-a8c9-020dbcedfc31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_WarrantLiabilityDetailsLineItems_285aa336-c6fa-4447-9846-13465e8c18bb" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_afa9ef48-0d1d-4188-a8c9-020dbcedfc31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_PercentageOfTotalEquityProceeds_da849d26-79f7-463c-b371-bc79c6a469f8" xlink:href="cmlf-20210804.xsd#cmlf_PercentageOfTotalEquityProceeds"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_WarrantLiabilityDetailsLineItems_285aa336-c6fa-4447-9846-13465e8c18bb" xlink:to="loc_cmlf_PercentageOfTotalEquityProceeds_da849d26-79f7-463c-b371-bc79c6a469f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_AdjustmentToRedemptionTriggerPrice_29e7b03f-3ee7-4a64-921c-3228a112e255" xlink:href="cmlf-20210804.xsd#cmlf_AdjustmentToRedemptionTriggerPrice"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_WarrantLiabilityDetailsLineItems_285aa336-c6fa-4447-9846-13465e8c18bb" xlink:to="loc_cmlf_AdjustmentToRedemptionTriggerPrice_29e7b03f-3ee7-4a64-921c-3228a112e255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays_c9a8e19d-b822-47be-af5f-515b840a1a58" xlink:href="cmlf-20210804.xsd#cmlf_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_WarrantLiabilityDetailsLineItems_285aa336-c6fa-4447-9846-13465e8c18bb" xlink:to="loc_cmlf_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays_c9a8e19d-b822-47be-af5f-515b840a1a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays_7e502ee9-f958-4d3d-ae39-8d3f5b242440" xlink:href="cmlf-20210804.xsd#cmlf_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_WarrantLiabilityDetailsLineItems_285aa336-c6fa-4447-9846-13465e8c18bb" xlink:to="loc_cmlf_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays_7e502ee9-f958-4d3d-ae39-8d3f5b242440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants_3745df0e-6bf1-4fff-967e-3567fa14fa1c" xlink:href="cmlf-20210804.xsd#cmlf_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_WarrantLiabilityDetailsLineItems_285aa336-c6fa-4447-9846-13465e8c18bb" xlink:to="loc_cmlf_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants_3745df0e-6bf1-4fff-967e-3567fa14fa1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/IncomeTax" xlink:type="simple" xlink:href="cmlf-20210804.xsd#IncomeTax"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/IncomeTax" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_4f030520-daf4-4d47-9606-ba8d5bdae256" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxNoteTable_42ddc7ca-78d9-4579-bc8f-46ea7fd25150" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalIncomeTaxNoteTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4f030520-daf4-4d47-9606-ba8d5bdae256" xlink:to="loc_us-gaap_FederalIncomeTaxNoteTable_42ddc7ca-78d9-4579-bc8f-46ea7fd25150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_a0ebe3db-89c4-4f10-a194-bb7437c3a1d6" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FederalIncomeTaxNoteTable_42ddc7ca-78d9-4579-bc8f-46ea7fd25150" xlink:to="loc_dei_LegalEntityAxis_a0ebe3db-89c4-4f10-a194-bb7437c3a1d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_c7553530-da59-4d21-9f09-0e176667dbb3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_a0ebe3db-89c4-4f10-a194-bb7437c3a1d6" xlink:to="loc_dei_EntityDomain_c7553530-da59-4d21-9f09-0e176667dbb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLifeSciencesIncMember_9ddf7d07-988b-4de6-b792-8ff172646452" xlink:href="cmlf-20210804.xsd#cmlf_CMLifeSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_c7553530-da59-4d21-9f09-0e176667dbb3" xlink:to="loc_cmlf_CMLifeSciencesIncMember_9ddf7d07-988b-4de6-b792-8ff172646452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_c9001c2b-e683-464b-bd9c-16c514ca4809" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FederalIncomeTaxNoteTable_42ddc7ca-78d9-4579-bc8f-46ea7fd25150" xlink:to="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_c9001c2b-e683-464b-bd9c-16c514ca4809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_c28afbf7-8eeb-4f6d-bbba-bd9b7f16b66e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_c9001c2b-e683-464b-bd9c-16c514ca4809" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_c28afbf7-8eeb-4f6d-bbba-bd9b7f16b66e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/IncomeTaxTables" xlink:type="simple" xlink:href="cmlf-20210804.xsd#IncomeTaxTables"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/IncomeTaxTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_5af6e2c5-ea73-431b-8458-f4f3dc1f80b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxNoteTable_d4c54e4f-6358-4a83-a76f-c16c58ac213c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalIncomeTaxNoteTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5af6e2c5-ea73-431b-8458-f4f3dc1f80b1" xlink:to="loc_us-gaap_FederalIncomeTaxNoteTable_d4c54e4f-6358-4a83-a76f-c16c58ac213c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_b4a859bf-d71b-4506-90fc-30937324bb45" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FederalIncomeTaxNoteTable_d4c54e4f-6358-4a83-a76f-c16c58ac213c" xlink:to="loc_dei_LegalEntityAxis_b4a859bf-d71b-4506-90fc-30937324bb45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_147539ee-b2f0-41a2-bfe8-c132a38a50fc" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_b4a859bf-d71b-4506-90fc-30937324bb45" xlink:to="loc_dei_EntityDomain_147539ee-b2f0-41a2-bfe8-c132a38a50fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLifeSciencesIncMember_8921f4f5-b7b2-4f20-86b9-adae5b990f3a" xlink:href="cmlf-20210804.xsd#cmlf_CMLifeSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_147539ee-b2f0-41a2-bfe8-c132a38a50fc" xlink:to="loc_cmlf_CMLifeSciencesIncMember_8921f4f5-b7b2-4f20-86b9-adae5b990f3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_25676e4f-0f43-456f-a134-fa18a8241962" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FederalIncomeTaxNoteTable_d4c54e4f-6358-4a83-a76f-c16c58ac213c" xlink:to="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_25676e4f-0f43-456f-a134-fa18a8241962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_faa0ae5c-013e-44da-8ed5-8cd1a0368327" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_25676e4f-0f43-456f-a134-fa18a8241962" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_faa0ae5c-013e-44da-8ed5-8cd1a0368327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_8a36e1c0-6e9a-4639-aaaf-7c8b61583e88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_25676e4f-0f43-456f-a134-fa18a8241962" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_8a36e1c0-6e9a-4639-aaaf-7c8b61583e88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_6eb40e6d-d227-4c90-b34a-6a7f149164eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_25676e4f-0f43-456f-a134-fa18a8241962" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_6eb40e6d-d227-4c90-b34a-6a7f149164eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/IncomeTaxDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#IncomeTaxDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/IncomeTaxDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_520c9dfc-3515-4f40-948d-3269e51e3023" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxNoteTable_86ad1171-d257-45ca-9ccb-5f94e1e28ede" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalIncomeTaxNoteTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_520c9dfc-3515-4f40-948d-3269e51e3023" xlink:to="loc_us-gaap_FederalIncomeTaxNoteTable_86ad1171-d257-45ca-9ccb-5f94e1e28ede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_c5442952-9e4b-439d-9d5b-809affe1362c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FederalIncomeTaxNoteTable_86ad1171-d257-45ca-9ccb-5f94e1e28ede" xlink:to="loc_dei_LegalEntityAxis_c5442952-9e4b-439d-9d5b-809affe1362c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_7e8f4112-0dcd-4e5b-862e-7f200ce3416b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_c5442952-9e4b-439d-9d5b-809affe1362c" xlink:to="loc_dei_EntityDomain_7e8f4112-0dcd-4e5b-862e-7f200ce3416b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLifeSciencesIncMember_dddde704-2fe2-497e-97a7-0614af6f51c2" xlink:href="cmlf-20210804.xsd#cmlf_CMLifeSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_7e8f4112-0dcd-4e5b-862e-7f200ce3416b" xlink:to="loc_cmlf_CMLifeSciencesIncMember_dddde704-2fe2-497e-97a7-0614af6f51c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_f966410c-c6e5-4b2f-8f9e-2f25a2847dca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FederalIncomeTaxNoteTable_86ad1171-d257-45ca-9ccb-5f94e1e28ede" xlink:to="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_f966410c-c6e5-4b2f-8f9e-2f25a2847dca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_6bca4f5f-1b71-4773-8d48-93fc0592caa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_f966410c-c6e5-4b2f-8f9e-2f25a2847dca" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_6bca4f5f-1b71-4773-8d48-93fc0592caa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_61691285-ba13-4bb7-9807-0a5918c716a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_f966410c-c6e5-4b2f-8f9e-2f25a2847dca" xlink:to="loc_us-gaap_OperatingLossCarryforwards_61691285-ba13-4bb7-9807-0a5918c716a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/IncomeTaxDetailsScheduleofcompanysnetdeferredtaxassets" xlink:type="simple" xlink:href="cmlf-20210804.xsd#IncomeTaxDetailsScheduleofcompanysnetdeferredtaxassets"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/IncomeTaxDetailsScheduleofcompanysnetdeferredtaxassets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ScheduleOfCompanySNetDeferredTaxAssetsAbstract_fe2f0939-3413-4488-9214-7d84bcd1df3a" xlink:href="cmlf-20210804.xsd#cmlf_ScheduleOfCompanySNetDeferredTaxAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxNoteTable_4de71547-fd86-4374-83c7-d35f149a98ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalIncomeTaxNoteTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_ScheduleOfCompanySNetDeferredTaxAssetsAbstract_fe2f0939-3413-4488-9214-7d84bcd1df3a" xlink:to="loc_us-gaap_FederalIncomeTaxNoteTable_4de71547-fd86-4374-83c7-d35f149a98ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_81be55d9-9639-44a7-b681-0acb3e820ab6" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FederalIncomeTaxNoteTable_4de71547-fd86-4374-83c7-d35f149a98ce" xlink:to="loc_dei_LegalEntityAxis_81be55d9-9639-44a7-b681-0acb3e820ab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_82e6f992-1fcc-4bb9-940e-20a612ceb127" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_81be55d9-9639-44a7-b681-0acb3e820ab6" xlink:to="loc_dei_EntityDomain_82e6f992-1fcc-4bb9-940e-20a612ceb127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLifeSciencesIncMember_0104b49a-0fde-4146-ad64-9347d43d5247" xlink:href="cmlf-20210804.xsd#cmlf_CMLifeSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_82e6f992-1fcc-4bb9-940e-20a612ceb127" xlink:to="loc_cmlf_CMLifeSciencesIncMember_0104b49a-0fde-4146-ad64-9347d43d5247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_aaa54fd2-84af-4d03-8ae9-8a4984c7f35e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FederalIncomeTaxNoteTable_4de71547-fd86-4374-83c7-d35f149a98ce" xlink:to="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_aaa54fd2-84af-4d03-8ae9-8a4984c7f35e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_0d37c22e-3a4c-4f74-9f9f-69a5c530270e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_aaa54fd2-84af-4d03-8ae9-8a4984c7f35e" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_0d37c22e-3a4c-4f74-9f9f-69a5c530270e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_OrganizationalCostsStartupExpenses_a7593659-750b-4f9b-8beb-85e46c9bde31" xlink:href="cmlf-20210804.xsd#cmlf_OrganizationalCostsStartupExpenses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_aaa54fd2-84af-4d03-8ae9-8a4984c7f35e" xlink:to="loc_cmlf_OrganizationalCostsStartupExpenses_a7593659-750b-4f9b-8beb-85e46c9bde31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_ca9e720a-602e-49df-a3f2-e5e1227f0ba7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_aaa54fd2-84af-4d03-8ae9-8a4984c7f35e" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_ca9e720a-602e-49df-a3f2-e5e1227f0ba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_fea829ae-5f9f-46b9-a1ec-20aab9e198a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_aaa54fd2-84af-4d03-8ae9-8a4984c7f35e" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_fea829ae-5f9f-46b9-a1ec-20aab9e198a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_231912e2-e881-41c2-a0c0-8f73d59fea4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_aaa54fd2-84af-4d03-8ae9-8a4984c7f35e" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_231912e2-e881-41c2-a0c0-8f73d59fea4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/IncomeTaxDetailsScheduleofincometaxprovision" xlink:type="simple" xlink:href="cmlf-20210804.xsd#IncomeTaxDetailsScheduleofincometaxprovision"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/IncomeTaxDetailsScheduleofincometaxprovision" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ScheduleOfIncomeTaxProvisionAbstract_402b6cc5-d409-4b1e-b991-c276d33c5c62" xlink:href="cmlf-20210804.xsd#cmlf_ScheduleOfIncomeTaxProvisionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxNoteTable_23370a13-0717-42c1-b3d1-a5f3d8d5d0b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalIncomeTaxNoteTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_ScheduleOfIncomeTaxProvisionAbstract_402b6cc5-d409-4b1e-b991-c276d33c5c62" xlink:to="loc_us-gaap_FederalIncomeTaxNoteTable_23370a13-0717-42c1-b3d1-a5f3d8d5d0b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_d5077dbb-9bb4-4d7d-be1b-df078c318866" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FederalIncomeTaxNoteTable_23370a13-0717-42c1-b3d1-a5f3d8d5d0b0" xlink:to="loc_dei_LegalEntityAxis_d5077dbb-9bb4-4d7d-be1b-df078c318866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_085ef820-77c1-4fec-8bdc-67c1c9c94856" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_d5077dbb-9bb4-4d7d-be1b-df078c318866" xlink:to="loc_dei_EntityDomain_085ef820-77c1-4fec-8bdc-67c1c9c94856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLifeSciencesIncMember_719946b0-7c6d-453f-b6d2-0b99b331c063" xlink:href="cmlf-20210804.xsd#cmlf_CMLifeSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_085ef820-77c1-4fec-8bdc-67c1c9c94856" xlink:to="loc_cmlf_CMLifeSciencesIncMember_719946b0-7c6d-453f-b6d2-0b99b331c063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_2ee449e2-2e10-49a4-971e-3af24c057988" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FederalIncomeTaxNoteTable_23370a13-0717-42c1-b3d1-a5f3d8d5d0b0" xlink:to="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_2ee449e2-2e10-49a4-971e-3af24c057988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_FederalAbstract_12e9babb-43d1-4472-9224-20dff5448599" xlink:href="cmlf-20210804.xsd#cmlf_FederalAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_2ee449e2-2e10-49a4-971e-3af24c057988" xlink:to="loc_cmlf_FederalAbstract_12e9babb-43d1-4472-9224-20dff5448599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_1e7392d1-bb2d-41d4-9093-c6eed3133e22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_FederalAbstract_12e9babb-43d1-4472-9224-20dff5448599" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_1e7392d1-bb2d-41d4-9093-c6eed3133e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_a22a45ac-d3e0-4b28-ad3f-8bcf4ea5432d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_FederalAbstract_12e9babb-43d1-4472-9224-20dff5448599" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_a22a45ac-d3e0-4b28-ad3f-8bcf4ea5432d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_StateAbstract_25bd1155-58da-42e1-b5c2-d79e505ecf99" xlink:href="cmlf-20210804.xsd#cmlf_StateAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_2ee449e2-2e10-49a4-971e-3af24c057988" xlink:to="loc_cmlf_StateAbstract_25bd1155-58da-42e1-b5c2-d79e505ecf99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_bb77e912-48ef-493a-82b4-c952f4934693" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_StateAbstract_25bd1155-58da-42e1-b5c2-d79e505ecf99" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_bb77e912-48ef-493a-82b4-c952f4934693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_c7d42a0a-d5dd-4fc9-98c1-ca8b29a864af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_StateAbstract_25bd1155-58da-42e1-b5c2-d79e505ecf99" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_c7d42a0a-d5dd-4fc9-98c1-ca8b29a864af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ChangeInValuationAllowance_2a77de25-26f8-47cc-b5ba-8f6d12af89cc" xlink:href="cmlf-20210804.xsd#cmlf_ChangeInValuationAllowance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_2ee449e2-2e10-49a4-971e-3af24c057988" xlink:to="loc_cmlf_ChangeInValuationAllowance_2a77de25-26f8-47cc-b5ba-8f6d12af89cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_cbbfb5b7-084f-496c-89df-ff626a7ca93c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_2ee449e2-2e10-49a4-971e-3af24c057988" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_cbbfb5b7-084f-496c-89df-ff626a7ca93c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/IncomeTaxDetailsScheduleofreconciliationoffederalincometaxratetothecompanyseffectivetaxrate" xlink:type="simple" xlink:href="cmlf-20210804.xsd#IncomeTaxDetailsScheduleofreconciliationoffederalincometaxratetothecompanyseffectivetaxrate"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/IncomeTaxDetailsScheduleofreconciliationoffederalincometaxratetothecompanyseffectivetaxrate" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ScheduleOfReconciliationOfFederalIncomeTaxRateToTheCompanySEffectiveTaxRateAbstract_8126b599-4fc0-48ad-a45e-2c9fd87ef633" xlink:href="cmlf-20210804.xsd#cmlf_ScheduleOfReconciliationOfFederalIncomeTaxRateToTheCompanySEffectiveTaxRateAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxNoteTable_8a85d3ed-31d6-498f-aebb-0f9b28706f0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalIncomeTaxNoteTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_ScheduleOfReconciliationOfFederalIncomeTaxRateToTheCompanySEffectiveTaxRateAbstract_8126b599-4fc0-48ad-a45e-2c9fd87ef633" xlink:to="loc_us-gaap_FederalIncomeTaxNoteTable_8a85d3ed-31d6-498f-aebb-0f9b28706f0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_5eb4bc96-a545-4d8c-8446-e23112506539" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FederalIncomeTaxNoteTable_8a85d3ed-31d6-498f-aebb-0f9b28706f0a" xlink:to="loc_dei_LegalEntityAxis_5eb4bc96-a545-4d8c-8446-e23112506539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_7156ad20-d460-474a-85c5-41c70681fe5c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_5eb4bc96-a545-4d8c-8446-e23112506539" xlink:to="loc_dei_EntityDomain_7156ad20-d460-474a-85c5-41c70681fe5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLifeSciencesIncMember_b62e17ec-ff40-4ea0-8153-d3df58b6e9be" xlink:href="cmlf-20210804.xsd#cmlf_CMLifeSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_7156ad20-d460-474a-85c5-41c70681fe5c" xlink:to="loc_cmlf_CMLifeSciencesIncMember_b62e17ec-ff40-4ea0-8153-d3df58b6e9be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_cdc292d4-0101-4e5c-aae2-4ea3017123e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FederalIncomeTaxNoteTable_8a85d3ed-31d6-498f-aebb-0f9b28706f0a" xlink:to="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_cdc292d4-0101-4e5c-aae2-4ea3017123e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_faba20ca-a6a5-4cc9-9504-89ed42d28625" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_cdc292d4-0101-4e5c-aae2-4ea3017123e6" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_faba20ca-a6a5-4cc9-9504-89ed42d28625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_d45c30e4-5d66-4a13-af29-c68f5c491208" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_cdc292d4-0101-4e5c-aae2-4ea3017123e6" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_d45c30e4-5d66-4a13-af29-c68f5c491208" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_EffectiveIncomeTaxRateReconciliationCompensationExpenses_a2c90095-a740-4972-8e5e-892ecc2f0ebc" xlink:href="cmlf-20210804.xsd#cmlf_EffectiveIncomeTaxRateReconciliationCompensationExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_cdc292d4-0101-4e5c-aae2-4ea3017123e6" xlink:to="loc_cmlf_EffectiveIncomeTaxRateReconciliationCompensationExpenses_a2c90095-a740-4972-8e5e-892ecc2f0ebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsOther_a1474cfb-47db-44d9-b6eb-48dd9c27330f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsOther"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_cdc292d4-0101-4e5c-aae2-4ea3017123e6" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsOther_a1474cfb-47db-44d9-b6eb-48dd9c27330f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_34a82f66-2faa-49fd-bc6e-944c09e705db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_cdc292d4-0101-4e5c-aae2-4ea3017123e6" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_34a82f66-2faa-49fd-bc6e-944c09e705db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e6ce5e84-c886-44d7-b73c-c5317df1cc7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems_cdc292d4-0101-4e5c-aae2-4ea3017123e6" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e6ce5e84-c886-44d7-b73c-c5317df1cc7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/FairValueMeasurements_1" xlink:type="simple" xlink:href="cmlf-20210804.xsd#FairValueMeasurements_1"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/FairValueMeasurements_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_a4026572-df2d-4a89-ab99-65016715a7ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_84d202b5-8f6b-44c7-b8fa-dbf9898f34b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a4026572-df2d-4a89-ab99-65016715a7ab" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_84d202b5-8f6b-44c7-b8fa-dbf9898f34b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_ff632997-f128-4eb6-9fcf-bc5e2184d9d9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_84d202b5-8f6b-44c7-b8fa-dbf9898f34b8" xlink:to="loc_dei_LegalEntityAxis_ff632997-f128-4eb6-9fcf-bc5e2184d9d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a36f4546-eb4b-420f-ae38-fd6dec7fcc7d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_ff632997-f128-4eb6-9fcf-bc5e2184d9d9" xlink:to="loc_dei_EntityDomain_a36f4546-eb4b-420f-ae38-fd6dec7fcc7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLifeSciencesIncMember_afceacf7-1674-40b4-85b7-5548b157f29f" xlink:href="cmlf-20210804.xsd#cmlf_CMLifeSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_a36f4546-eb4b-420f-ae38-fd6dec7fcc7d" xlink:to="loc_cmlf_CMLifeSciencesIncMember_afceacf7-1674-40b4-85b7-5548b157f29f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_465837ef-970c-41f8-bae1-bcc0ea24b4ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_84d202b5-8f6b-44c7-b8fa-dbf9898f34b8" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_465837ef-970c-41f8-bae1-bcc0ea24b4ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_e20dc36f-d901-49db-84d2-28773bfa9fe6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_465837ef-970c-41f8-bae1-bcc0ea24b4ed" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_e20dc36f-d901-49db-84d2-28773bfa9fe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/FairValueMeasurementsTables_1" xlink:type="simple" xlink:href="cmlf-20210804.xsd#FairValueMeasurementsTables_1"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/FairValueMeasurementsTables_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_925d01b9-f08a-4f42-989e-bb907460f748" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_848a6df5-c745-445c-8aaf-fd886d139eb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_925d01b9-f08a-4f42-989e-bb907460f748" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_848a6df5-c745-445c-8aaf-fd886d139eb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_273e8e44-4788-409d-ae17-19332b4b53e6" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_848a6df5-c745-445c-8aaf-fd886d139eb0" xlink:to="loc_dei_LegalEntityAxis_273e8e44-4788-409d-ae17-19332b4b53e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_11d63d7a-9716-4633-864f-accac2d88865" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_273e8e44-4788-409d-ae17-19332b4b53e6" xlink:to="loc_dei_EntityDomain_11d63d7a-9716-4633-864f-accac2d88865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLifeSciencesIncMember_4cf205d9-674f-4117-beed-6f72eac396a1" xlink:href="cmlf-20210804.xsd#cmlf_CMLifeSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_11d63d7a-9716-4633-864f-accac2d88865" xlink:to="loc_cmlf_CMLifeSciencesIncMember_4cf205d9-674f-4117-beed-6f72eac396a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c033a475-dedf-47ce-94a8-6bff62a541c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_848a6df5-c745-445c-8aaf-fd886d139eb0" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c033a475-dedf-47ce-94a8-6bff62a541c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_a8754ea8-248d-40d7-802d-b50a9f1dacee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c033a475-dedf-47ce-94a8-6bff62a541c6" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_a8754ea8-248d-40d7-802d-b50a9f1dacee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_363f5ecc-71c7-4fdc-ac16-38abebc68fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c033a475-dedf-47ce-94a8-6bff62a541c6" xlink:to="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_363f5ecc-71c7-4fdc-ac16-38abebc68fc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_3d33e974-7890-46bf-bf3a-0036ba5b94b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c033a475-dedf-47ce-94a8-6bff62a541c6" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_3d33e974-7890-46bf-bf3a-0036ba5b94b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_153509da-67da-45a8-81a3-e73018350520" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c033a475-dedf-47ce-94a8-6bff62a541c6" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_153509da-67da-45a8-81a3-e73018350520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/FairValueMeasurementsDetails_1" xlink:type="simple" xlink:href="cmlf-20210804.xsd#FairValueMeasurementsDetails_1"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/FairValueMeasurementsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b29f9e1d-f7e3-4012-9669-d15fb64c97b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_88a4eba8-b0d1-40c0-b866-367d501c5cbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b29f9e1d-f7e3-4012-9669-d15fb64c97b5" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_88a4eba8-b0d1-40c0-b866-367d501c5cbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_6a3ea53a-19d1-4cd1-9fe9-63258094a3fc" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_88a4eba8-b0d1-40c0-b866-367d501c5cbf" xlink:to="loc_dei_LegalEntityAxis_6a3ea53a-19d1-4cd1-9fe9-63258094a3fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_f0da211a-5b08-4ee2-9904-307a6f9ab986" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_6a3ea53a-19d1-4cd1-9fe9-63258094a3fc" xlink:to="loc_dei_EntityDomain_f0da211a-5b08-4ee2-9904-307a6f9ab986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLifeSciencesIncMember_831e3336-d42e-43cb-8941-1f3c4f4520a3" xlink:href="cmlf-20210804.xsd#cmlf_CMLifeSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_f0da211a-5b08-4ee2-9904-307a6f9ab986" xlink:to="loc_cmlf_CMLifeSciencesIncMember_831e3336-d42e-43cb-8941-1f3c4f4520a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a973aaf5-df9a-4444-9136-319b6203f3d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_88a4eba8-b0d1-40c0-b866-367d501c5cbf" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a973aaf5-df9a-4444-9136-319b6203f3d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldInTrust_69da61a4-51e5-48c9-b5e4-2fa09a9b12d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsHeldInTrust"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a973aaf5-df9a-4444-9136-319b6203f3d0" xlink:to="loc_us-gaap_AssetsHeldInTrust_69da61a4-51e5-48c9-b5e4-2fa09a9b12d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_FairValueAssumptionExercisePrice_2f98a055-9ed1-4502-9e1d-b71545bd7e3f" xlink:href="cmlf-20210804.xsd#cmlf_FairValueAssumptionExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a973aaf5-df9a-4444-9136-319b6203f3d0" xlink:to="loc_cmlf_FairValueAssumptionExercisePrice_2f98a055-9ed1-4502-9e1d-b71545bd7e3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/FairValueMeasurementsDetailsScheduleoffairvalueonarecurringbasis" xlink:type="simple" xlink:href="cmlf-20210804.xsd#FairValueMeasurementsDetailsScheduleoffairvalueonarecurringbasis"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/FairValueMeasurementsDetailsScheduleoffairvalueonarecurringbasis" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ScheduleOfFairValueOnARecurringBasisAbstract_8aa86765-e368-41d8-9aa3-1367b442f0c5" xlink:href="cmlf-20210804.xsd#cmlf_ScheduleOfFairValueOnARecurringBasisAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_FairValueMeasurementsDetailsScheduleoffairvalueonarecurringbasisTable_34646e72-d107-47b5-9ac7-e22bdc0e8abb" xlink:href="cmlf-20210804.xsd#cmlf_FairValueMeasurementsDetailsScheduleoffairvalueonarecurringbasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_ScheduleOfFairValueOnARecurringBasisAbstract_8aa86765-e368-41d8-9aa3-1367b442f0c5" xlink:to="loc_cmlf_FairValueMeasurementsDetailsScheduleoffairvalueonarecurringbasisTable_34646e72-d107-47b5-9ac7-e22bdc0e8abb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3ffbc09c-93ce-4e45-8e3e-2c5b90dcc209" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_FairValueMeasurementsDetailsScheduleoffairvalueonarecurringbasisTable_34646e72-d107-47b5-9ac7-e22bdc0e8abb" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3ffbc09c-93ce-4e45-8e3e-2c5b90dcc209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_692702d8-b7fd-4bf1-888f-b24e8f57001f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3ffbc09c-93ce-4e45-8e3e-2c5b90dcc209" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_692702d8-b7fd-4bf1-888f-b24e8f57001f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_d1f1da52-2c25-467a-bcfb-a3ba2aed6ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_692702d8-b7fd-4bf1-888f-b24e8f57001f" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_d1f1da52-2c25-467a-bcfb-a3ba2aed6ce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_a838c1a1-ff51-4f7b-93bf-3d3ef7e98d0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_692702d8-b7fd-4bf1-888f-b24e8f57001f" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_a838c1a1-ff51-4f7b-93bf-3d3ef7e98d0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_2a04c2ed-5c8d-4b18-9acc-dba49d5d54f3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_FairValueMeasurementsDetailsScheduleoffairvalueonarecurringbasisTable_34646e72-d107-47b5-9ac7-e22bdc0e8abb" xlink:to="loc_dei_LegalEntityAxis_2a04c2ed-5c8d-4b18-9acc-dba49d5d54f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_0e5e3036-b811-42f8-b58f-71eeb1bdf48c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_2a04c2ed-5c8d-4b18-9acc-dba49d5d54f3" xlink:to="loc_dei_EntityDomain_0e5e3036-b811-42f8-b58f-71eeb1bdf48c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLifeSciencesIncMember_0dc7ee7c-4335-4ce8-8b12-a2d8f8f1f32a" xlink:href="cmlf-20210804.xsd#cmlf_CMLifeSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_0e5e3036-b811-42f8-b58f-71eeb1bdf48c" xlink:to="loc_cmlf_CMLifeSciencesIncMember_0dc7ee7c-4335-4ce8-8b12-a2d8f8f1f32a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_FairValueMeasurementsDetailsScheduleoffairvalueonarecurringbasisLineItems_447c2b7a-a866-4a69-a137-8667c131e7dd" xlink:href="cmlf-20210804.xsd#cmlf_FairValueMeasurementsDetailsScheduleoffairvalueonarecurringbasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_FairValueMeasurementsDetailsScheduleoffairvalueonarecurringbasisTable_34646e72-d107-47b5-9ac7-e22bdc0e8abb" xlink:to="loc_cmlf_FairValueMeasurementsDetailsScheduleoffairvalueonarecurringbasisLineItems_447c2b7a-a866-4a69-a137-8667c131e7dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_6847aee2-664b-4c2d-b13a-65ea06077a57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_FairValueMeasurementsDetailsScheduleoffairvalueonarecurringbasisLineItems_447c2b7a-a866-4a69-a137-8667c131e7dd" xlink:to="loc_us-gaap_MarketableSecurities_6847aee2-664b-4c2d-b13a-65ea06077a57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_45758185-f73e-4bb3-9de5-2914551da6c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_FairValueMeasurementsDetailsScheduleoffairvalueonarecurringbasisLineItems_447c2b7a-a866-4a69-a137-8667c131e7dd" xlink:to="loc_us-gaap_LiabilitiesAbstract_45758185-f73e-4bb3-9de5-2914551da6c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ChangeInFairValueOfWarrantLiability_1e197d41-17eb-4a90-97da-4f323a4513fe" xlink:href="cmlf-20210804.xsd#cmlf_ChangeInFairValueOfWarrantLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_45758185-f73e-4bb3-9de5-2914551da6c0" xlink:to="loc_cmlf_ChangeInFairValueOfWarrantLiability_1e197d41-17eb-4a90-97da-4f323a4513fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_WarrantLiabilityPrivatePlacementWarrants_18bf87d9-0c97-4743-81d9-71dde98efb69" xlink:href="cmlf-20210804.xsd#cmlf_WarrantLiabilityPrivatePlacementWarrants"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_45758185-f73e-4bb3-9de5-2914551da6c0" xlink:to="loc_cmlf_WarrantLiabilityPrivatePlacementWarrants_18bf87d9-0c97-4743-81d9-71dde98efb69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/FairValueMeasurementsFairValueInputsDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#FairValueMeasurementsFairValueInputsDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/FairValueMeasurementsFairValueInputsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_12524510-4d10-4b93-b743-b97ffaacc773" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9699cb01-4891-4d10-8120-e18a74b276ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_12524510-4d10-4b93-b743-b97ffaacc773" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9699cb01-4891-4d10-8120-e18a74b276ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_1475290d-89be-4bfb-91c2-8d27a33210b9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9699cb01-4891-4d10-8120-e18a74b276ec" xlink:to="loc_dei_LegalEntityAxis_1475290d-89be-4bfb-91c2-8d27a33210b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_45d9a060-1459-46b5-aae5-bcb259393222" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1475290d-89be-4bfb-91c2-8d27a33210b9" xlink:to="loc_dei_EntityDomain_45d9a060-1459-46b5-aae5-bcb259393222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLifeSciencesIncMember_7564c326-c497-4dcb-8d79-9dbeaed4a070" xlink:href="cmlf-20210804.xsd#cmlf_CMLifeSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_45d9a060-1459-46b5-aae5-bcb259393222" xlink:to="loc_cmlf_CMLifeSciencesIncMember_7564c326-c497-4dcb-8d79-9dbeaed4a070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_5a24e12b-0070-49bf-a279-11d2df925548" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9699cb01-4891-4d10-8120-e18a74b276ec" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_5a24e12b-0070-49bf-a279-11d2df925548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e90d390d-f3c2-492a-9194-c399ae5c5c98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_5a24e12b-0070-49bf-a279-11d2df925548" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e90d390d-f3c2-492a-9194-c399ae5c5c98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c8304710-f672-4037-b6dd-f8fda1e8315f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_5a24e12b-0070-49bf-a279-11d2df925548" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c8304710-f672-4037-b6dd-f8fda1e8315f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_9a98c0cc-db34-4877-b458-2510e507a028" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_5a24e12b-0070-49bf-a279-11d2df925548" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_9a98c0cc-db34-4877-b458-2510e507a028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_073eec82-493e-4b99-9de4-2cdd7c5ff3bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_5a24e12b-0070-49bf-a279-11d2df925548" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_073eec82-493e-4b99-9de4-2cdd7c5ff3bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_cb15ba09-d6c7-4fc5-845b-948f08d7ab8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_5a24e12b-0070-49bf-a279-11d2df925548" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_cb15ba09-d6c7-4fc5-845b-948f08d7ab8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilities" xlink:type="simple" xlink:href="cmlf-20210804.xsd#FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilities"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_ScheduleOfChangesInTheFairValueOfWarrantLiabilitiesAbstract_f469a5fa-7eeb-4816-bb0a-bdbe4b839b40" xlink:href="cmlf-20210804.xsd#cmlf_ScheduleOfChangesInTheFairValueOfWarrantLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesTable_3f0f0f71-9e83-42ed-89e2-d37b7d16d281" xlink:href="cmlf-20210804.xsd#cmlf_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_ScheduleOfChangesInTheFairValueOfWarrantLiabilitiesAbstract_f469a5fa-7eeb-4816-bb0a-bdbe4b839b40" xlink:to="loc_cmlf_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesTable_3f0f0f71-9e83-42ed-89e2-d37b7d16d281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_11be1a24-3788-420b-95bd-4b8b85a5c623" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesTable_3f0f0f71-9e83-42ed-89e2-d37b7d16d281" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_11be1a24-3788-420b-95bd-4b8b85a5c623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3c4ad2fa-0afb-498a-b63b-3b0a9b763492" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_11be1a24-3788-420b-95bd-4b8b85a5c623" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3c4ad2fa-0afb-498a-b63b-3b0a9b763492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_d1f86a4d-924d-423b-80de-7ae0e5f6e7a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrivatePlacementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3c4ad2fa-0afb-498a-b63b-3b0a9b763492" xlink:to="loc_us-gaap_PrivatePlacementMember_d1f86a4d-924d-423b-80de-7ae0e5f6e7a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_PublicMember_aabb3941-45b1-4292-89ab-ca2b676d4b12" xlink:href="cmlf-20210804.xsd#cmlf_PublicMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3c4ad2fa-0afb-498a-b63b-3b0a9b763492" xlink:to="loc_cmlf_PublicMember_aabb3941-45b1-4292-89ab-ca2b676d4b12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_59b35cd2-3d9e-46fb-9f2d-85e8d633c863" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3c4ad2fa-0afb-498a-b63b-3b0a9b763492" xlink:to="loc_us-gaap_WarrantMember_59b35cd2-3d9e-46fb-9f2d-85e8d633c863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_8b195e4f-cf38-4d43-80bd-19780c1728b5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesTable_3f0f0f71-9e83-42ed-89e2-d37b7d16d281" xlink:to="loc_dei_LegalEntityAxis_8b195e4f-cf38-4d43-80bd-19780c1728b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_843d9f22-26e5-4e71-b3ed-fce729cfc709" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_8b195e4f-cf38-4d43-80bd-19780c1728b5" xlink:to="loc_dei_EntityDomain_843d9f22-26e5-4e71-b3ed-fce729cfc709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLifeSciencesIncMember_0bf4e5a0-e848-4961-ad4f-2e207f4bc73f" xlink:href="cmlf-20210804.xsd#cmlf_CMLifeSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_843d9f22-26e5-4e71-b3ed-fce729cfc709" xlink:to="loc_cmlf_CMLifeSciencesIncMember_0bf4e5a0-e848-4961-ad4f-2e207f4bc73f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesLineItems_616cc672-d84d-41bf-a69f-b0c4ad2a063e" xlink:href="cmlf-20210804.xsd#cmlf_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesTable_3f0f0f71-9e83-42ed-89e2-d37b7d16d281" xlink:to="loc_cmlf_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesLineItems_616cc672-d84d-41bf-a69f-b0c4ad2a063e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_FairValueNetAssetsLiabilityRollforwardRollForward_670ad865-06d6-487b-8b68-caed863c177a" xlink:href="cmlf-20210804.xsd#cmlf_FairValueNetAssetsLiabilityRollforwardRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesLineItems_616cc672-d84d-41bf-a69f-b0c4ad2a063e" xlink:to="loc_cmlf_FairValueNetAssetsLiabilityRollforwardRollForward_670ad865-06d6-487b-8b68-caed863c177a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetAssetLiability_e1f057aa-e209-44a7-b5d0-6ba3e9088805" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetAssetLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_FairValueNetAssetsLiabilityRollforwardRollForward_670ad865-06d6-487b-8b68-caed863c177a" xlink:to="loc_us-gaap_FairValueNetAssetLiability_e1f057aa-e209-44a7-b5d0-6ba3e9088805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_InitialMeasurement_0720356d-b7df-4efe-aaf1-508e007ea2c6" xlink:href="cmlf-20210804.xsd#cmlf_InitialMeasurement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_FairValueNetAssetsLiabilityRollforwardRollForward_670ad865-06d6-487b-8b68-caed863c177a" xlink:to="loc_cmlf_InitialMeasurement_0720356d-b7df-4efe-aaf1-508e007ea2c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_7c485efe-83e6-4d03-b366-0bd517d7dcae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_FairValueNetAssetsLiabilityRollforwardRollForward_670ad865-06d6-487b-8b68-caed863c177a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_7c485efe-83e6-4d03-b366-0bd517d7dcae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetAssetLiability_ed81e009-9f26-486b-9687-e9d3cc70a272" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetAssetLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_FairValueNetAssetsLiabilityRollforwardRollForward_670ad865-06d6-487b-8b68-caed863c177a" xlink:to="loc_us-gaap_FairValueNetAssetLiability_ed81e009-9f26-486b-9687-e9d3cc70a272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/SubsequentEvents_1" xlink:type="simple" xlink:href="cmlf-20210804.xsd#SubsequentEvents_1"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/SubsequentEvents_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_f9670adc-1129-42d5-bb52-529dff843059" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_8a798227-eed5-4806-abad-a8e82563a528" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_f9670adc-1129-42d5-bb52-529dff843059" xlink:to="loc_us-gaap_SubsequentEventTable_8a798227-eed5-4806-abad-a8e82563a528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_69323840-9156-44c2-97c1-d237a354eb1e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_8a798227-eed5-4806-abad-a8e82563a528" xlink:to="loc_dei_LegalEntityAxis_69323840-9156-44c2-97c1-d237a354eb1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_bb8d4cbe-bc23-4f76-b292-b9eaba97ab29" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_69323840-9156-44c2-97c1-d237a354eb1e" xlink:to="loc_dei_EntityDomain_bb8d4cbe-bc23-4f76-b292-b9eaba97ab29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLifeSciencesIncMember_7a878138-e4e0-4800-9113-8aa3401bc7d5" xlink:href="cmlf-20210804.xsd#cmlf_CMLifeSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_bb8d4cbe-bc23-4f76-b292-b9eaba97ab29" xlink:to="loc_cmlf_CMLifeSciencesIncMember_7a878138-e4e0-4800-9113-8aa3401bc7d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_577e8586-565a-4e1b-b3ed-e387f0796895" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_8a798227-eed5-4806-abad-a8e82563a528" xlink:to="loc_us-gaap_SubsequentEventLineItems_577e8586-565a-4e1b-b3ed-e387f0796895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_f39bdb51-61c6-4f12-a880-5cf00e66b2e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_577e8586-565a-4e1b-b3ed-e387f0796895" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_f39bdb51-61c6-4f12-a880-5cf00e66b2e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cmlifesciencesinc.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="cmlf-20210804.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://www.cmlifesciencesinc.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_2b054d98-a879-4756-a2c5-7eeb8abe0bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_SubsequentEventsDetailsTable_54c93314-0186-4f1b-b30e-a7db3755c10c" xlink:href="cmlf-20210804.xsd#cmlf_SubsequentEventsDetailsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_2b054d98-a879-4756-a2c5-7eeb8abe0bb0" xlink:to="loc_cmlf_SubsequentEventsDetailsTable_54c93314-0186-4f1b-b30e-a7db3755c10c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_4df24c59-16ca-41fc-905c-62b91b194044" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SubsequentEventsDetailsTable_54c93314-0186-4f1b-b30e-a7db3755c10c" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_4df24c59-16ca-41fc-905c-62b91b194044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_2ac889c9-c441-43bd-b070-7885dfb64b43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_4df24c59-16ca-41fc-905c-62b91b194044" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_2ac889c9-c441-43bd-b070-7885dfb64b43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_8a34a7bd-d3a0-4fb1-90de-d7878c4a5d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_2ac889c9-c441-43bd-b070-7885dfb64b43" xlink:to="loc_us-gaap_SubsequentEventMember_8a34a7bd-d3a0-4fb1-90de-d7878c4a5d8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_a36f5cf7-fcc7-491f-a8ed-548df5d4d287" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SubsequentEventsDetailsTable_54c93314-0186-4f1b-b30e-a7db3755c10c" xlink:to="loc_dei_LegalEntityAxis_a36f5cf7-fcc7-491f-a8ed-548df5d4d287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_47bfa6b5-a1d7-4822-b921-e4e498f504ff" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_a36f5cf7-fcc7-491f-a8ed-548df5d4d287" xlink:to="loc_dei_EntityDomain_47bfa6b5-a1d7-4822-b921-e4e498f504ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_CMLifeSciencesIncMember_031b1ddb-99a7-4956-9bcd-ddf644c18908" xlink:href="cmlf-20210804.xsd#cmlf_CMLifeSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_47bfa6b5-a1d7-4822-b921-e4e498f504ff" xlink:to="loc_cmlf_CMLifeSciencesIncMember_031b1ddb-99a7-4956-9bcd-ddf644c18908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_SubsequentEventsDetailsLineItems_36ff76cd-4381-46b5-a3ba-a4d62cca97b5" xlink:href="cmlf-20210804.xsd#cmlf_SubsequentEventsDetailsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SubsequentEventsDetailsTable_54c93314-0186-4f1b-b30e-a7db3755c10c" xlink:to="loc_cmlf_SubsequentEventsDetailsLineItems_36ff76cd-4381-46b5-a3ba-a4d62cca97b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_e7e65c89-85c4-4769-881c-94897052746d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SubsequentEventsDetailsLineItems_36ff76cd-4381-46b5-a3ba-a4d62cca97b5" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_e7e65c89-85c4-4769-881c-94897052746d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_AggregateAmountOfSharesPercentage_08aa6b28-1963-4b9e-a6d6-7910c883e2c8" xlink:href="cmlf-20210804.xsd#cmlf_AggregateAmountOfSharesPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SubsequentEventsDetailsLineItems_36ff76cd-4381-46b5-a3ba-a4d62cca97b5" xlink:to="loc_cmlf_AggregateAmountOfSharesPercentage_08aa6b28-1963-4b9e-a6d6-7910c883e2c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_6d41e57d-93c9-45ea-af31-8c5904eb9878" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Cash"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SubsequentEventsDetailsLineItems_36ff76cd-4381-46b5-a3ba-a4d62cca97b5" xlink:to="loc_us-gaap_Cash_6d41e57d-93c9-45ea-af31-8c5904eb9878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_30ef959f-a0e7-4974-b1f4-f4719b1413b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SubsequentEventsDetailsLineItems_36ff76cd-4381-46b5-a3ba-a4d62cca97b5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_30ef959f-a0e7-4974-b1f4-f4719b1413b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cmlf_AggregatePurchasePrice_51c02e1f-7ac2-403e-9a51-eb91e876c3dd" xlink:href="cmlf-20210804.xsd#cmlf_AggregatePurchasePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmlf_SubsequentEventsDetailsLineItems_36ff76cd-4381-46b5-a3ba-a4d62cca97b5" xlink:to="loc_cmlf_AggregatePurchasePrice_51c02e1f-7ac2-403e-9a51-eb91e876c3dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
